<SEC-DOCUMENT>0001213900-25-002689.txt : 20250110
<SEC-HEADER>0001213900-25-002689.hdr.sgml : 20250110
<ACCEPTANCE-DATETIME>20250110164146
ACCESSION NUMBER:		0001213900-25-002689
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20250110
FILED AS OF DATE:		20250110
DATE AS OF CHANGE:		20250110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEUROONE MEDICAL TECHNOLOGIES Corp
		CENTRAL INDEX KEY:			0001500198
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				270863354
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40439
		FILM NUMBER:		25523567

	BUSINESS ADDRESS:	
		STREET 1:		7599 ANAGRAM DR
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344
		BUSINESS PHONE:		(952) 426-1383

	MAIL ADDRESS:	
		STREET 1:		7599 ANAGRAM DR
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Original Source Entertainment, Inc.
		DATE OF NAME CHANGE:	20100830
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>ea0226835-pre14a_neuroone.htm
<DESCRIPTION>PRELIMINARY PROXY STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proxy Statement Pursuant to Section&nbsp;14(a)<BR>
of the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934<BR>
(Amendment No.______)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify; width: 90%"><FONT STYLE="font-size: 10pt">Filed by the Registrant</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Filed&nbsp;by&nbsp;a&nbsp;Party&nbsp;other&nbsp;than&nbsp;the&nbsp;Registrant</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Confidential, for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting Material Under &sect;240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>NeuroOne Medical
Technologies Corporation<BR>
</B></FONT><B><FONT STYLE="font-size: 10pt">(Name of Registrant as Specified In Its Charter)</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A<BR>
(Name of Person(s)&nbsp;Filing Proxy Statement, if other than the Registrant)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment of Filing Fee (Check all boxes that apply):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">No fee required</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee paid previously with preliminary materials</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee computed on table in exhibit required by Item&nbsp;25(b)&nbsp;per Exchange&nbsp;Act Rules 14a-6(i)(1)&nbsp;and&nbsp;0-11</FONT></TD></TR>
  </TABLE>


<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"></DIV><!-- Field: /Rule-Page -->


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF 2025 ANNUAL<BR>
MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt; width: 24%"><FONT STYLE="font-size: 10pt"><B>WHEN</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify; width: 75%"><FONT STYLE="font-size: 10pt">February 14, 2025 at 9:00&nbsp;a.m. local time</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-size: 10pt"><B>WHERE</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">7599 Anagram Dr., Eden Prairie, MN&nbsp;55344*</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-size: 10pt"><B>PURPOSE OF MEETING AND AGENDA</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the 2025 Annual Meeting, stockholders will
    vote:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -12pt">1.&nbsp;&nbsp;to elect
    the Class&nbsp;II director named in the Proxy Statement to a three-year term;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -12pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -12pt">2.&nbsp;&nbsp;to ratify
    the appointment of our independent registered public accounting firm for 2025;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -12pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -12pt">3.&nbsp;&nbsp;to approve
    an amendment to our Certificate of Incorporation to effect a reverse split of our outstanding common stock at a ratio in the range of
    1-for-2 to 1-for-15 to be determined at the discretion of our Board of Directors, whereby each outstanding 2 to 15 shares would be combined,
    converted and changed into 1 share of our common stock, to enable the Company to comply with the Nasdaq Stock Market&rsquo;s continued
    listing requirements (the &ldquo;Reverse Stock Split Proposal&rdquo;);</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -12pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -12pt">4.&nbsp;&nbsp;to approve
    the NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan; and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -12pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -12pt">5.&nbsp;&nbsp;to authorize
    one or more adjournments of the Annual Meeting to solicit additional proxies in the event there are insufficient votes to approve the
    Reverse Stock Split Proposal described above.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-size: 10pt"><B>WHO CAN VOTE</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">Stockholders of record at the close of business on January&nbsp;3, 2025.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-size: 10pt"><B>VOTING</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Your vote is very important. Please submit your proxy or voting instructions as soon as possible, whether or not you plan to attend the Annual Meeting.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><FONT STYLE="font-size: 10pt"><B>ADMISSION TO THE ANNUAL MEETING</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">All of our stockholders are invited to attend the Annual Meeting. If you attend, you will need to bring valid, government-issued photo identification. The doors to the meeting room will be closed promptly at the start of the meeting.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">We currently intend to hold the Annual Meeting in person.
However, in the event we determine it is not possible or advisable to hold the Annual Meeting in person, we will publicly announce alternative
arrangements for the Annual Meeting as promptly as practicable before the Annual Meeting. Please monitor our website at <I>www.nmtc1.com
</I>for updated information.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">David Rosa</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">President and Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Eden Prairie, Minnesota</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">January &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NEUROONE MEDICAL TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY STATEMENT FOR&nbsp;2025 ANNUAL MEETING
OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 90%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 9%"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_001">GENERAL INFORMATION ABOUT THE ANNUAL MEETING</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">1</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_002">PROPOSAL NO. 1 ELECTION OF CLASS&nbsp;II DIRECTOR</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">4</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_003">BOARD AND COMMITTEE INFORMATION</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_004">AUDIT COMMITTEE REPORT</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">13</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_005">PROPOSAL NO. 2 RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">14</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_006">PROPOSAL NO. 3 VOTE TO APPROVE REVERSE STOCK SPLIT PROPOSAL</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">15</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_007">PROPOSAL NO. 4 VOTE TO APPROVE 2025 EQUITY INCENTIVE PLAN</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">23</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_008">PROPOSAL NO. 5 VOTE TO APPROVE ADJOURNMENT OF REVERSE STOCK SPLIT PROPOSAL</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">30</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_009">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">31</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_010">EXECUTIVE OFFICERS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">33</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_011">EXECUTIVE COMPENSATION</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">35</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_012">PAY VERSUS PERFORMANCE</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">43</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_013">CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">46</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_014">ADDITIONAL INFORMATION</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">47</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#a_015">OTHER MATTERS</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">50</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#z_001">APPENDIX A</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">A-1</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="#z_002">APPENDIX B</A></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center">B-1</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>NEUROONE MEDICAL TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY STATEMENT FOR THE 2025 ANNUAL MEETING
OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>GENERAL INFORMATION ABOUT THE ANNUAL MEETING</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board of Directors (the &ldquo;Board&rdquo;) solicits your proxy
on our behalf for the 2025 Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) and at any postponement or adjournment of
the Annual Meeting for the purposes set forth in this proxy statement (the &ldquo;Proxy Statement&rdquo;) and the accompanying Notice
of 2025 Annual Meeting of Stockholders (the &ldquo;Notice&rdquo;). The Annual Meeting will be held at our principal executive offices
at 7599 Anagram Dr., Eden Prairie, MN&nbsp;55344, on Thursday, February 14, 2025 at 9:00&nbsp;a.m. local time. This Proxy Statement is
first being sent to stockholders on or about January&nbsp;21, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently intend to hold the Annual Meeting
in person. However, in the event we determine it is not possible or advisable to hold the Annual Meeting in person, we will publicly announce
alternative arrangements for the Annual Meeting as promptly as practicable before the Annual Meeting. Please monitor our website at <I>www.nmtc1.com</I>
for updated information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless we state otherwise or the context otherwise
requires, references in this Proxy Statement to &ldquo;we,&rdquo; &ldquo;our,&rdquo; &ldquo;us,&rdquo; or the &ldquo;Company&rdquo; are
to NeuroOne Medical Technologies Corporation, a Delaware corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Purpose of the Annual Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Annual Meeting, stockholders will act upon
the proposals described in this Proxy Statement. In addition, we will consider any other matters that are properly presented for a vote
at the Annual Meeting. We are not aware of any other matters to be submitted for consideration at the Annual Meeting. If any other matters
are properly presented for a vote at the Annual Meeting, the persons named in the proxy, who are officers of the Company, have the authority
in their discretion to vote the shares represented by the proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Record Date; Quorum</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Only holders of record of the Company&rsquo;s common stock, par value
of $0.001 per share (the &ldquo;Common Stock&rdquo;), at the close of business on January&nbsp;3, 2025, the record date, will be entitled
to vote at the Annual Meeting. At the close of business on January&nbsp;3, 2025, 30,857,923&nbsp;shares of Common Stock were outstanding
and entitled to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The holders of a majority of the outstanding shares
of stock entitled to vote at the Annual Meeting as of the record date must be present, in person or by proxy duly authorized at the Annual
Meeting in order to hold the Annual Meeting and conduct business. This presence is called a quorum. Your shares are counted as present
at the Annual Meeting if you are present and vote in person at the Annual Meeting or if you have properly submitted a proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting Rights; Required Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each holder of shares of Common Stock is entitled
to one vote for each share of Common Stock held as of the close of business on January&nbsp;3, 2025, the record date. You may vote all
shares owned by you at such date, including (1)&nbsp;shares held directly in your name as the stockholder of record and (2)&nbsp;shares
held for you as the beneficial owner in street name through a broker, bank, trustee or other nominee. Dissenters&rsquo; rights are not
applicable to any of the matters being voted on.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Stockholder of Record: Shares Registered in
Your Name.&nbsp;&nbsp;&nbsp;&nbsp;</I>If on January&nbsp;3, 2025, your shares were registered directly in your name with our transfer
agent, Equiniti Trust Company, then you are considered the stockholder of record with respect to those shares. As a stockholder of record,
you may vote at the Annual Meeting, or vote in advance through the Internet, by telephone or by mail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Beneficial Owner: Shares Registered in the
Name of a Broker or Nominee</I>.&nbsp;&nbsp;&nbsp;&nbsp;If on January&nbsp;3, 2025, your shares were held in an account with a brokerage
firm, bank or other nominee, then you are the beneficial owner of the shares held in street name. As a beneficial owner, you have the
right to direct your broker on how to vote the shares held in your account, and your broker has enclosed or provided voting instructions
for you to use in directing it on how to vote your shares. Because the brokerage firm, bank or other nominee that holds your shares is
the stockholder of record, if you wish to attend the Annual Meeting and vote your shares you must obtain a valid proxy from the firm that
holds your shares giving you the right to vote the shares at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Votes Required to Adopt Proposals.&nbsp;&nbsp;&nbsp;&nbsp;</I>Each
director will be elected by a plurality of the votes of shares present in person or represented by proxy at the Annual Meeting and entitled
to vote on the election of directors. This means that the individual nominated for election to the Board at the Annual Meeting receiving
the highest number of &ldquo;FOR&rdquo; votes will be elected. You may either vote &ldquo;FOR&rdquo; the nominee or &ldquo;WITHHOLD&rdquo;
your vote with respect to the nominees. You may not cumulate votes in the election of directors. Approval of Proposals 2, 4 and 5 will
be obtained if the holders of a majority of the shares present in person or represented by proxy at the Annual Meeting and entitled to
vote at the Annual Meeting vote &ldquo;FOR,&rdquo; in the case of Proposals 2, 4 and 5. Approval of Proposal 3, or the Reverse Stock Split
Proposal, will be obtained if holders of a majority of the votes cast at the Annual Meeting vote &ldquo;FOR&rdquo; the Reverse Stock Split
Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A proxy submitted by a stockholder may indicate
that the shares represented by the proxy are not being voted with respect to a particular matter. In addition, a broker may not be permitted
to vote on shares held in street name on a particular matter in the absence of instructions from the beneficial owner of the stock (broker
non-vote). The shares subject to a proxy which are not being voted on a particular matter because of either stockholder withholding or
broker non-votes will count for purposes of determining the presence of a quorum. Abstentions and broker non-votes will have no effect
on Proposals&nbsp;1 and 3. For Proposals&nbsp;2, 4 and 5, abstentions and broker non-votes will have no effect on the outcome unless you
return your proxy or attend the Annual Meeting and select &ldquo;ABSTAIN&rdquo;, which will have the same effect as an &ldquo;AGAINST&rdquo;
vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board recommends a vote &ldquo;FOR&rdquo;
the director nominee listed in this Proxy Statement, &ldquo;FOR&rdquo; the ratification of Baker Tilly US, LLP&rsquo;s appointment as
our independent registered accounting firm, &ldquo;FOR&rdquo; the approval of the Reverse Stock Split Proposal, &ldquo;FOR&rdquo; the
approval of the NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan, and &ldquo;FOR&rdquo; the authorization for one
or more adjournments of the annual meeting to solicit additional proxies in the event there are insufficient votes to approve the Reverse
Stock Split Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting Instructions; Voting of Proxies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are a stockholder of record, you may:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Vote in person&nbsp;&mdash;&nbsp;we will provide a ballot
to stockholders who attend the Annual Meeting and wish to vote in person. Submitting a proxy will not prevent a stockholder from attending
the Annual Meeting, revoking their earlier-submitted proxy, and voting in person.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Vote through the Internet&nbsp;&mdash;&nbsp;you may vote
through the Internet. To vote by Internet, you will need to use a control number provided to you in the materials with this Proxy Statement
and follow the additional steps when prompted. The steps have been designed to authenticate your identity, allow you to give voting instructions,
and confirm that those instructions have been recorded properly.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Vote by telephone&nbsp;&mdash;&nbsp;if you received your
annual meeting materials by paper delivery, you may vote by telephone as indicated on your enclosed proxy card or voting instruction
card. To vote by telephone, you will need to use a control number provided to you in the materials with this Proxy Statement and follow
the voting instructions.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Vote by mail&nbsp;&mdash;&nbsp;complete, sign and date the
accompanying proxy card and return it as soon as possible before the Annual Meeting in the envelope provided.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Votes submitted through the Internet or by telephone
must be received by 11:59&nbsp;p.m., Eastern Time, on February 13, 2025. Submitting your proxy, whether through the Internet, by telephone
or by mail, will not prevent a stockholder from attending the Annual Meeting, revoking their earlier-submitted proxy, and voting in person.
If you are not the stockholder of record, please refer to the voting instructions provided by your nominee to direct it on how to vote
your shares. You may either vote &ldquo;FOR&rdquo; the nominee to the Board, or you may withhold your vote from the nominee. For Proposals&nbsp;2,&nbsp;3,
4 and 5, you may vote &ldquo;FOR&rdquo; or &ldquo;AGAINST&rdquo; or &ldquo;ABSTAIN&rdquo; from voting. Your vote is important. Whether
or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure that your vote is counted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All proxies will be voted in accordance with the
instructions specified on the proxy card. If you sign a physical proxy card and return it without instructions as to how your shares should
be voted on a particular proposal at the Annual Meeting, your shares will be voted in accordance with the recommendations of our Board
stated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you do not vote and you hold your shares in
street name, and your broker does not have discretionary power to vote your shares, your shares may constitute &ldquo;broker non-votes&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you receive more than one proxy card, your
shares are registered in more than one name or are registered in different accounts. To make certain all of your shares are voted, please
complete, sign and return each proxy card to ensure that all of your shares are voted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Expenses of Soliciting Proxies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will pay the expenses associated with soliciting
proxies. Following the original distribution and mailing of the solicitation materials, we or our agents may solicit proxies by mail,
electronic mail, telephone, facsimile, by other similar means, or in person. Our directors, officers and other employees, without additional
compensation, may solicit proxies personally or in writing, by telephone, e-mail or otherwise. Following the original distribution and
mailing of the solicitation materials, we will request brokers, custodians, nominees and other record holders to forward copies of those
materials to persons for whom they hold shares and to request authority for the exercise of proxies. In such cases, we, upon the request
of the record holders, will reimburse such holders for their reasonable expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Revocability of Proxies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A stockholder of record who has given a proxy
may revoke it at any time before the closing of the polls by the inspector of elections at the Annual Meeting by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">delivering to our Secretary (by any means, including facsimile)
a written notice stating that the proxy is revoked;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">signing and delivering a proxy bearing a later date;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">voting again through the Internet or by telephone; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">attending and voting at the Annual Meeting (although attendance
at the Annual Meeting will not, by itself, revoke a proxy).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please note, however, that if your shares are
held of record by a brokerage firm, bank or other nominee and you wish to revoke a proxy, you must contact that firm to revoke or change
any prior voting instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Voting results will be tabulated and certified
by the inspector of elections appointed for the Annual Meeting. The preliminary voting results will be announced at the Annual Meeting.
The final results will be tallied by the inspector of elections and filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
in a current report on Form&nbsp;8-K or Form 10-Q within four&nbsp;business&nbsp;days of the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_002"></A>PROPOSAL NO. 1<BR>
ELECTION OF CLASS&nbsp;II DIRECTOR</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board is divided into three classes. Members
of each class serve staggered three-year terms. Our Class&nbsp;II director will stand for election at this meeting. The terms of office
of directors in Class&nbsp;III and Class&nbsp;I do not expire until the annual meetings of stockholders to be held in 2026 and 2027, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Director Nominee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has nominated David Rosa, age&nbsp;60,
for election as a Class&nbsp;II director to serve for a three-year term ending at the 2028 annual meeting or until his successor is elected
and qualified. Mr.&nbsp;Rosa is a current member of our Board, and has consented to serve if elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Rosa will be elected by a plurality of
the votes present in person or represented by proxy at the Annual Meeting and entitled to vote. This means that the individual nominated
for election to the Board at the Annual Meeting receiving the highest number of &ldquo;FOR&rdquo; votes will be elected. You may either
vote &ldquo;FOR&rdquo; a nominee or &ldquo;WITHHOLD&rdquo; your vote with respect to a nominee. Shares represented by proxies will be
voted &ldquo;FOR&rdquo; the election of the Class&nbsp;II nominee, unless the proxy is marked to withhold authority to so vote. If any
nominee is unable or unwilling to serve at the time of the Annual Meeting, the persons named as proxies may vote for a substitute nominee
chosen by the present Board, or the Board will have a vacancy, which it may fill at a later date or reduce the size of the Board. We have
no reason to believe that the nominee will be unwilling or unable to serve if elected as a director. Additional information regarding
the directors of the Company is set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>David Rosa</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Rosa has served as the Chief Executive
Officer, President and a director of the Company since July&nbsp;2017 and served as chief executive officer and a director of NeuroOne,
Inc., formerly our wholly-owned subsidiary, from October&nbsp;2016 until December&nbsp;2019, when NeuroOne, Inc. merged with and into
the Company. From November&nbsp;2009 to November&nbsp;2015, Mr.&nbsp;Rosa served as the chief executive officer and president of Sunshine
Heart, Inc., n/k/a Nuwellis, Inc. (Nasdaq: NUWE), a publicly-held early-stage medical device company. From 2008 to November&nbsp;2009,
Mr.&nbsp;Rosa served as chief executive officer of Milksmart, Inc., a company that specializes in medical devices for animals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From 2004 to 2008, Mr.&nbsp;Rosa served as the
vice president of global marketing for cardiac surgery and cardiology at St. Jude Medical, Inc. Currently, he serves as a director on
the board of directors of Biotricity Inc. (Nasdaq: BTCY), BioRestorative Therapies, Inc. (Nasdaq: BRTX) and Healthcare Triangle, Inc.
(Nasdaq: HCTI). Mr.&nbsp;Rosa holds an MBA from Duquesne University and a B.S. in Commerce and Engineering from Drexel University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Rosa&rsquo;s qualifications to serve
on the Board include his senior leadership experience in the medical device industry. In addition, his&nbsp;day-to-day leadership of the
Company gives him critical insights into the Company&rsquo;s operations, strategy and competition, and he facilitates the Board&rsquo;s
ability to perform its oversight function. Throughout his career at the Company and his former positions, he has demonstrated strong technical,
strategic, and operational expertise, and he possesses in-depth knowledge of the medical device industry on a global basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Continuing Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides information regarding the directors who
are serving for terms that end following the Annual Meeting as of January&nbsp;21, 2025:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%"><FONT STYLE="font-size: 10pt"><B>NAME</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; white-space: nowrap; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 10%"><FONT STYLE="font-size: 10pt"><B>AGE</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; white-space: nowrap; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 35%"><FONT STYLE="font-size: 10pt"><B>TITLE</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; white-space: nowrap; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 17%"><FONT STYLE="font-size: 10pt"><B>CLASS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Jeffrey Mathiesen</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">63</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Class&nbsp;III</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Edward Andrle</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">66</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Class&nbsp;III</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Paul Buckman</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">69</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Director and Chairman</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Class&nbsp;I</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Jeffrey Mathiesen</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Mathiesen has served as a member of the
Board since August&nbsp;2017, and served as a director of NeuroOne, Inc., from April&nbsp;2017 until December&nbsp;2019. Since June&nbsp;2021,
Mr.&nbsp;Mathiesen has served as Chief Financial Officer, Treasurer and Secretary of Helius Medical Technologies, Inc. (Nasdaq: HSDT),
a publicly traded medical device company, developing noninvasive platform technologies focused on neurological wellness, and he has served
as director since May&nbsp;2022 and previously served as director and Audit Committee Chair from June&nbsp;2020 through June&nbsp;2021.
Additionally, Mr.&nbsp;Mathiesen has served as Vice Chair and Lead Independent Director since March&nbsp;2020 and as director and Audit
Committee Chair, since 2015, of Panbela Therapeutics, Inc. (Nasdaq: PBLA), a publicly traded biopharmaceutical company developing therapies
for pancreatic diseases, and served as a director and Audit Committee Chair of Healthcare Triangle, Inc. (Nasdaq: HCTI), a publicly traded
provider of cloud and data transformation platform and solutions for healthcare and life sciences, from March&nbsp;2021 to December&nbsp;2022,
and as a director of eNeura, Inc., a privately held medical technology company providing therapy for both acute treatment and prevention
of migraine, from 2018 to 2020. Mr.&nbsp;Mathiesen served as advisor to the chief executive officer of Teewinot Life Sciences Corporation,
a privately held global leader in the biosynthetic development and production of cannabinoids and their derivatives for consumer and pharmaceutical
products, from October&nbsp;2019 to December&nbsp;2019, and served as chief financial officer from March&nbsp;2019 to October&nbsp;2019.
In August&nbsp;2020, Teewinot Life Insurance Sciences filed a voluntary petition under Chapter&nbsp;11 of the United&nbsp;States Bankruptcy
Code. Mr.&nbsp;Mathiesen previously served as chief financial officer of Gemphire Therapeutics Inc., which was acquired by NeuroBo Pharmaceuticals,
Inc. (Nasdaq: NRBO) in January&nbsp;2020, a publicly-held clinical-stage biopharmaceutical company developing therapies for patients with
cardiometabolic disorders, from 2015 to 2018, and as chief financial officer of Sunshine Heart, Inc., n/k/a Nuwellis, Inc. (Nasdaq: NUWE),
a publicly-held early-stage medical device company, from 2011 to 2015. Mr.&nbsp;Mathiesen received a B.S. in Accounting from the University
of South Dakota and is a Certified Public Accountant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that Mr.&nbsp;Mathiesen brings financial
insight and leadership and a wealth of experience in capital markets to the Board, as well as knowledge of public company accounting and
financial reporting requirements and familiarity with the life sciences industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Edward Andrle</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Andrle has served as a member of the
Board since February&nbsp;2020. Since February 2023, Mr.&nbsp;Andrle has served as the Chairman of the Board and Co-Founder of Arcos Interventional,
Inc. a structural heart company. Prior to that, he most recently served as the general manager of Neuromodulation of LivaNova PLC (Nasdaq:
LIVN), a publicly-traded medical device company, from January&nbsp;2018 to January&nbsp;2020, and as senior vice president of strategy
and business development of LivaNova PLC from September&nbsp;2015 to January&nbsp;2018. Prior to these roles, Mr.&nbsp;Andrle served as
vice president of business development and strategy of Sorin S.p.A from 2010 to September&nbsp;2015, when Sorin S.p.A. was merged with
Cyberonics, Inc. to become LivaNova PLC.&nbsp;Prior to joining Sorin, he co-founded three medical device companies: Myocor Inc., TERAMED
Inc. and StarFire Medical Inc. All three companies were eventually acquired. He also held executive positions with Boston Scientific,
Inc. (NYSE:&nbsp;BSX) and Baxter International, Inc. (NYSE:&nbsp;BAX), leading large product portfolios in cardiovascular and dialysis.
Mr.&nbsp;Andrle received his MBA from Stanford Graduate School of Business and his B.S. in Chemical Engineering from the University of
Notre Dame.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that Mr.&nbsp;Andrle&rsquo;s substantial
experience in medical device companies and business development experience provides the Company with valuable insight on product development
and strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Paul Buckman</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Buckman has served as Chairman of the
Board since August&nbsp;2017, and served as chairman of the board of NeuroOne, Inc., from October&nbsp;2016 until December&nbsp;2019.
Since April 2024, Mr. Buckman has served as Chief Executive Officer of Rhythmlink International LLC. Mr.&nbsp;Buckman previously served
as President of Advanced Circulatory Support for LivaNova PLC (Nasdaq: LIVN) and as President, North America and the general manager of
structural heart for LivaNova PLC beginning in April&nbsp;2017. Prior to joining LivaNova PLC, Mr.&nbsp;Buckman served as chief executive
officer of Conventus Orthopaedics, a Minnesota-based company specializing in peri-articular bone fracture fixation, from September&nbsp;2013
until March of 2017. Mr.&nbsp;Buckman was chief executive officer of Sentreheart, Inc., a medical technology company focused on closure
of various anatomic structures, from February&nbsp;2012 to September&nbsp;2013. Previously, Mr.&nbsp;Buckman served as chief executive
officer and chairman of Pathway Medical Technologies, Inc., a medical device company focused on treatment of peripheral arterial disease,
from September&nbsp;2008 to February&nbsp;2012; as chief executive officer of Devax, Inc., a developer and manufacturer of drug eluting
stents, from December&nbsp;2006 to September&nbsp;2008; as president of the cardiology division of St. Jude Medical, Inc., a publicly
traded diversified medical products company, from August&nbsp;2004 to December&nbsp;2006; and as chairman of the board of directors and
chief executive officer of ev3, LLC, a Minnesota-based medical device company focused on endovascular therapies that Mr.&nbsp;Buckman
founded and developed into an $80&nbsp;million business, from January&nbsp;2001 to January&nbsp;2004. Mr.&nbsp;Buckman has worked in the
medical device industry for over 30&nbsp;years, including 10&nbsp;years at Scimed Life Systems, Inc. and Boston Scientific Corporation
(NYSE:&nbsp;BSX), a publicly traded medical device manufacturer, where he held several executive positions before becoming president of
the cardiology division of Boston Scientific in January&nbsp;2000. Mr.&nbsp;Buckman also currently serves as a director for Helius Medical
Technologies Corporation (Nasdaq: HSDT), Ablative Solutions, Inc., ActivOrtho Inc., a privately held company, Shoulder Innovations, Inc.,
a privately held company, Rhythmlink International LLC, a privately held company, and as chairman of Miromatrix, Inc. He previously served
as a director of Aortica, Inc., DyaMX, Inc., Conventus Orthopaedics, Caisson Interventional LLC, Velocimed, Inc., where he was a co-founder,
EndiCor, Inc., Microvena, Inc., Sunshine Heart, Inc., n/k/a Nuwellis, Inc. (Nasdaq: NUWE), a publicly-held early-stage medical device
company, NexGen Medical, and Micro Therapeutics, Inc. Mr.&nbsp;Buckman received a Master&rsquo;s degree in Business Administration and
Finance and a B.A. degree in Business Administration from Western Michigan University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that Mr.&nbsp;Buckman&rsquo;s strong
executive experience in medical device companies provides the Company with valuable guidance on product development and operational matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Non-Employee Director Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee establishes and oversees
our director compensation program. Director compensation is established with a view to attract highly qualified non-management directors
and fairly compensate non-management directors for their time and effort on behalf of stockholders. In consultation with Grant Thornton,
LLP, our compensation consultant, the Compensation Committee periodically benchmarks our director compensation to that of our peers to
ensure that it remains competitive to attract and retain non-employee directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our non-employee directors receive a mix of cash
and share-based compensation intended to encourage non-employee directors to continue to serve on our Board, further align the interests
of the directors and stockholders, and attract new non-employee directors with outstanding qualifications. Directors who are employees
or officers of the Company do not receive any additional compensation for Board service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>2025 Compensation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of its review of director compensation
in consultation with Grant Thornton, in October 2024, the Board adopted an updated policy with respect to non-employee director compensation.
Pursuant to this policy, each of our non-employee directors receive an annual retainer of $50,000, except that our non-executive chairman
receives an annual retainer of $100,000. Additionally, the chairman and members of our Audit Committee receive an additional annual payment
of $17,000 and $9,000, respectively, the chairman and members of our Compensation Committee receive an additional annual payment of $10,000
and $6,000, respectively, and the chairman and members of our Nominating and Corporate Governance Committees receive an additional annual
payment of $10,000 and $5,000, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The non-employee director policy provides that
on the date of each annual stockholder meeting of the Company, each director automatically receives an equity award with an aggregate
value on the date of grant equal to $50,000. Two-thirds of the equity award is issued in the form of restricted stock units, and one-third
is issued in the form of stock options, each of which vest in twelve monthly installments, subject to such director&rsquo;s continued
service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>2024 Compensation</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For service during 2024, each of our non-employee
directors receive an annual retainer of $50,000, except that our non-executive chairman receives an annual retainer of $100,000. Additionally,
the chairman and members of our Audit Committee receive an additional annual payment of $12,500 and $5,000, respectively, and the chairmen
and members of each of our Compensation and Nominating and Corporate Governance Committees receive an additional annual payment of $10,000
and $4,000, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides compensation information
for the fiscal year ended September&nbsp;30, 2024 for each non-employee member of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Fees Earned or<BR> Paid in Cash<BR> ($)<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total<BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Paul Buckman</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">169,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">169,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Edward Andrle</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">119,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">119,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Jeffrey Mathiesen</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">These represent amounts earned in fiscal year 2024.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a named executive officer of the Company, compensation
paid to Mr.&nbsp;Rosa for fiscal year 2024 is fully reflected under &ldquo;Executive Compensation&nbsp;&mdash;&nbsp;Summary Compensation
Table.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD OF DIRECTORS RECOMMENDS A VOTE <I>&ldquo;FOR&rdquo;</I>
THE ELECTION OF<BR>
THE NOMINATED CLASS&nbsp;II DIRECTOR.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_003"></A>BOARD AND COMMITTEE INFORMATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are committed to good corporate governance
practices. These practices provide an important framework within which our Board and management pursue our strategic objectives for the
benefit of our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board Leadership Structure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board is currently chaired by Paul Buckman,
who has authority, among other things, to call and preside over meetings of our Board, to set meeting agendas and to determine materials
to be distributed to the Board and, accordingly, has substantial ability to shape the work of the Board. The positions of our chairman
of the Board and Chief Executive Officer are presently separated. Separating these positions allows our Chief Executive Officer, Mr.&nbsp;Rosa,
to focus on our&nbsp;day-to-day business, while allowing Mr.&nbsp;Buckman to lead the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Role of the Board in Risk Oversight</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board does not have a standing risk management
committee, but rather administers its risk oversight function directly through the Board as a whole. The Board&rsquo;s risk oversight
is administered primarily through the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">review and approval of an annual business plan;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">review of a summary of risks and opportunities at meetings
of the Board;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">review of business developments, business plan implementation
and financial results;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">oversight of internal controls over financial reporting;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">review of employee compensation and its relationship to our
business plans.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Director Independence</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nasdaq listing standards require that the Company&rsquo;s
Board consist of a majority of independent directors, as determined under the applicable rules and regulations of Nasdaq. Based upon information
requested from and provided by each proposed director concerning his or her background, employment and affiliations, including family
relationships, the Company believes that each current member of the Board qualifies as an &ldquo;independent director&rdquo; as defined
under the applicable rules and regulations of the SEC and the listing requirements and rules of Nasdaq, except Mr.&nbsp;Rosa, the Company&rsquo;s
President and Chief Executive Officer. These directors include Paul Buckman, Jeffrey Mathiesen and Ed Andrle. In making such independence
determinations, the Board considers the current and prior relationships that each non-employee director has with the Company and all other
facts and circumstances that the Board deems relevant in determining each non-employee director&rsquo;s independence, including the participation
by the Company&rsquo;s non-employee directors, or their affiliates, in certain financing transactions and the beneficial ownership of
the Company&rsquo;s Common Stock by each non-employee director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Structure and Operation of the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because our Common Stock is listed on Nasdaq,
the Company is subject to the Nasdaq listing requirements regarding committee matters. The Company currently has the following committees:
an audit committee, a compensation committee and a nominating and corporate governance committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Nominating and Corporate Governance Committee</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The nominating and corporate governance committee
reviews, evaluates and seeks out candidates qualified to become Board members. The Board includes individuals with a diversity of experience,
including scientific, business, financial and academic backgrounds. Nominations may be submitted by directors, officers, employees, stockholders
and others for recommendation to the Board. In fulfilling this responsibility, the Company&rsquo;s nominating and corporate governance
committee also consults with the Board and the Chief Executive Officer concerning director candidates. The nominating and corporate governance
committee&rsquo;s charter is available on our website, <I>www.nmtc1.com</I>, under <I>Investors&nbsp;&mdash;&nbsp;Governance</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The responsibilities of the Company&rsquo;s nominating
and corporate governance committee include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">reviewing, evaluating and seeking out candidates qualified
to become members of the Board;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">reviewing committee structure and recommending directors
for appointment to committees;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">developing, reevaluating (not less frequently than every
three&nbsp;years) and recommending the selection criteria for board and committee membership;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">establishing procedures to oversee evaluation of the board,
its committees, individual directors and management; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">developing and recommending guidelines on corporate governance.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current members of our nominating and corporate
governance committee are Mr.&nbsp;Buckman, Mr.&nbsp;Andrle, and Mr.&nbsp;Mathiesen, each of whom has been determined by the Board to be
independent under the rules and regulations of the Nasdaq Stock Market LLC.&nbsp;Mr.&nbsp;Andrle is the chair of the nominating and corporate
governance committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The nominating and corporate governance committee
reviews and makes recommendations to the Board, from time to time, regarding the appropriate skills and characteristics required of members
of our Board in the context of the current make-up of the Board, the operations of the Company and the long-term interests of stockholders.
The committee does not have a specific diversity policy underlying its nomination process, although it seeks to ensure the Board includes
directors with diverse backgrounds, qualifications, skills and experience relevant to our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the case of an incumbent director whose term
of office is set to expire, the nominating and corporate governance committee will generally re-nominate incumbent directors who continue
to satisfy the committee&rsquo;s criteria for membership on the Board, continue to make important contributions to the Board and consent
to continue their service on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a vacancy on the Board occurs or the Board
increases in size, the nominating and corporate governance committee will actively seek individuals that satisfy the committee&rsquo;s
criteria for membership on the Board and the committee may rely on multiple sources for identifying and evaluating potential nominees,
including referrals from our current directors and management. In 2024, the nominating and corporate governance committee did not employ
a search firm or pay fees to other third parties in connection with identifying or evaluating Board nominee candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The nominating and corporate governance committee
will consider recommendations of director nominees by stockholders so long as such recommendations are sent on a timely basis and are
otherwise in accordance with our Amended and Restated Bylaws and applicable law. See &ldquo;<I>Additional Information&nbsp;&mdash;&nbsp;Stockholder
Proposals to be Presented at Next Annual Meeting</I>&rdquo; for additional information. The nominating and corporate governance committee
will evaluate nominees recommended by stockholders against the same criteria that it uses to evaluate other nominees. We did not receive
any nominations of directors by stockholders for the 2025 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Compensation Committee</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation committee&rsquo;s charter is
available on our website, <I>www.nmtc1.com</I>, under <I>Investors&nbsp;&mdash;&nbsp;Governance</I>. The responsibilities of the compensation
committee include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">fixing salaries of executive officers and reviewing salary
plans for other executives in senior management positions;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">reviewing and making recommendations with respect to the
compensation and benefits for the Company&rsquo;s non-employee directors, including through equity-based plans;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">evaluating the performance of the Company&rsquo;s chief executive
officer and other senior executives and assisting the Board in developing and evaluating potential candidates for executive positions;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">administering the Company&rsquo;s incentive compensation,
deferred compensation and equity-based plans pursuant to the terms of the respective plans; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">evaluating risks associate with and potential consequences
of our compensation policies and practices, as applicable to all of our employees.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Historically, the non-employee directors and the
compensation committee, have typically made any significant adjustments to annual compensation, determined bonus and equity awards and
established new performance objectives at one or more meetings held during the first quarter of the fiscal year. Generally, the process
consists of two related elements: the determination of compensation levels and the establishment of performance objectives for the current
year. For executives other than the Chief Executive Officer, the compensation committee solicits and considers evaluations and recommendations
submitted to the Committee by the Chief Executive Officer. In the case of the Chief Executive Officer, the evaluation of his performance
is conducted by the Compensation Committee, which determines any adjustments to his compensation as well as awards to be granted. The
Chief Executive Officer may not be present during these discussions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current members of the compensation committee
include Mr.&nbsp;Buckman, Mr.&nbsp;Andrle, and Mr.&nbsp;Mathiesen. Mr.&nbsp;Buckman is the chair of the compensation committee. The compensation
committee may form and delegate authorities to subcommittees as appropriate, including, but not limited to, a subcommittee composed of
one or more members of the Board or officers of the Company to grant stock awards under the Company&rsquo;s equity incentive plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To qualify as independent to serve on the Company&rsquo;s
compensation committee, the listing standards of Nasdaq require a director not to accept any consulting, advisory, or other compensatory
fee from the Company, other than for service on the Board, and that the Board consider whether a director is affiliated with the Company
and, if so, whether such affiliation would impair the director&rsquo;s judgment as a member of the Company&rsquo;s compensation committee.
The Board has concluded that the members of the compensation committee meet the requirements for independence under the rules and regulations
of Nasdaq and the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To fulfill its responsibilities, the Compensation
Committee has the authority to retain and obtain advice from advisors. For fiscal year 2024, the Compensation Committee hired Grant Thornton
LLP (&ldquo;Grant Thornton&rdquo;) to serve as an independent compensation advisor. The Compensation Committee worked with Grant Thornton
and the Chief Executive Officer to make final decisions regarding the design of the programs used to compensate the Company&rsquo;s executive
officers in a manner which is consistent with the Company&rsquo;s compensation objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Audit Committee</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The audit committee reviews with management and
the Company&rsquo;s independent public accountants the Company&rsquo;s financial statements, the accounting principles applied in their
preparation, the scope of the audit, any comments made by the independent accountants upon the financial condition of the Company and
its accounting controls and procedures and such other matters as the audit committee deems appropriate. The audit committee&rsquo;s charter
is available on our website, <I>www.nmtc1.com</I>, under <I>Investors&nbsp;&mdash;&nbsp;Governance</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The audit committee currently consists of three
directors: Mr.&nbsp;Buckman, Mr.&nbsp;Mathiesen and Mr.&nbsp;Andrle. The Board has determined that each of Mr.&nbsp;Buckman, Mr.&nbsp;Mathiesen
and Mr.&nbsp;Andrle is &ldquo;independent&rdquo; under Nasdaq independence standards. Additionally, the Board has determined that each
of Mr.&nbsp;Mathiesen and Mr.&nbsp;Buckman qualifies as an &ldquo;audit committee financial expert&rdquo; as that term is defined in rules
promulgated by the SEC.&nbsp;The designation of an &ldquo;audit committee financial expert&rdquo; does not impose upon such persons any
duties, obligations or liabilities that are greater than those generally imposed on each of them as a member of the audit committee and
the Board, and such designation does not affect the duties, obligations or liabilities of any other member of the audit committee or the
Board. Mr.&nbsp;Mathiesen is the chair of the audit committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The functions of the audit committee include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">selecting our independent auditors;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">reviewing the results and scope of the audit and other services
provided by our independent auditors;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">reviewing and evaluating our audit and control functions;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">reviewing and overseeing compliance with legal and regulatory
requirements.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Code of Business Conduct and Ethics</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has adopted a code of business conduct
and ethics that applies to all of our employees, officers and directors, including our Chief Executive Officer, Chief Financial Officer
and other executive officers. We intend to disclose future amendments to certain provisions of our code of business conduct and ethics,
or waivers of these provisions, in public filings. A copy of the code of business conduct and ethics is available on our website, <I>www.nmtc1.com</I>,
under <I>Investors&nbsp;&mdash;&nbsp;Governance</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Insider Trading and Hedging Policy</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s Insider Trading Policy is
designed to create reasonable processes to prevent the Company and its directors, officers, employees and specified other persons from
insider trading and any appearance of improper conduct. The Company, pursuant to the terms of its Insider Trading Policy, prohibits all
directors, officers, employees, and certain contractors from engaging in hedging transactions including prepaid variable forwards, equity
swaps, collars and exchange funds with respect to the Company&rsquo;s securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Policy for the Recovery of Erroneously Awarded
Compensation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As required by the listing standards adopted by
Nasdaq as a result of SEC rulemaking, our Board adopted a new Policy for the Recovery of Erroneously Awarded Compensation. The policy
provides that the Company must promptly recover specified incentive-based compensation that is received by our Section 16 officers on
or after October 2, 2023, regardless of fault or misconduct, upon specified accounting restatements of the Company&rsquo;s financial statements
that result in such persons receiving an amount that exceeded the amount that would have been received if based on the restated financial
statements. There are limited exceptions to the recovery required as set forth in the listing standards. Incentive-based compensation
is defined as any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a financial reporting
measure. The subject compensation will be determined without regard to any net settlement of, or taxes paid or payable or withheld on,
such compensation, but there will not be any duplicative recovery by the Company. As specified in the listing standards, the Company cannot
indemnify, or pay or reimburse for insurance for, a Section 16 officer for recoveries under this policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The recovery period under this policy is three
full years preceding the date our Board or a committee thereof as directed by the Board concludes, or reasonably should have concluded,
that an accounting restatement is required. If applicable, the Company will provide the current or former Section 16 officer with a written
demand for repayment or return and the method thereof. If such repayment or return is not made when due, the policy provides that the
Company will take all reasonable and appropriate actions to recover such erroneously awarded compensation from such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Corporate Governance Guidelines</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has adopted Corporate Governance Guidelines
that set forth expectations for directors, director independence standards, Board structure and functions and other policies for the governance
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company currently does not meet the diversity
objectives of Nasdaq Rule&nbsp;5605(f)(2)(D). Our Nominating and Corporate Governance Committee is committed to ensuring that our Board&rsquo;s
composition appropriately reflects the current and anticipated needs of our Board of Directors and the Company and believes that our current
directors are well-suited to serve as directors based on the expertise and experience. Our Nominating and Corporate Governance Committee,
however, has and will continue to consider diverse candidates for membership on our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board Meetings and Attendance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Board Meetings in 2024</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board meets regularly throughout the year
and holds special meetings and acts by written consent from time to time. During fiscal year 2024, the Board held six meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each director attended at least 75% of the aggregate
number of meetings of the Board of Directors and committees on which each served during the period of his or her service in 2024. The
independent members of the Board also meet separately to discuss such matters as the independent directors consider appropriate. All of
our directors attended the 2024 Annual Meeting of Stockholders. We do not have a policy regarding attendance by directors at the Company&rsquo;s
annual meetings of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Committee Meetings in 2024</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During fiscal year 2024, the audit committee held
four meetings, the compensation committee held six meetings, and the nominating and corporate governance committee held one meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Communications with Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders and interested parties who wish to
communicate with our Board, non-management members of our Board as a group, or a specific member of our Board (including our Chairman)
may do so by letters addressed to the attention of our Secretary, NeuroOne Medical Technologies Corporation, 7599 Anagram Dr., Eden Prairie,
MN&nbsp;55344.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All communications by letter addressed to the
attention of our Secretary will be reviewed by the Secretary and provided to the members of the Board unless such communications are unsolicited
items, sales materials and other routine items and items unrelated to the duties and responsibilities of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_004"></A>AUDIT COMMITTEE REPORT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained in the following report
is not considered to be &ldquo;soliciting material,&rdquo; &ldquo;filed&rdquo; or incorporated by reference in any past or future filing
by us under the Exchange&nbsp;Act or the Securities Act unless and only to the extent that we specifically incorporate it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The audit committee has reviewed and discussed
with our management and Baker Tilly US, LLP our audited financial statements as of and for the fiscal year ended September&nbsp;30, 2024.
The audit committee has discussed with the independent auditors the matters required to be discussed by the applicable requirements of
the Public Company Accounting Oversight Board (&ldquo;PCAOB&rdquo;) and the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The audit committee has received and reviewed
the written disclosures and the letter from Baker Tilly US, LLP required by applicable requirements of the PCAOB regarding the independent
accountant&rsquo;s communications with the audit committee concerning independence, and has discussed with Baker Tilly US, LLP its independence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the review and discussions referred to
above, the audit committee recommended to the Board that the audited financial statements be included in our Company&rsquo;s Annual Report
on Form&nbsp;10-K for the fiscal year ended September&nbsp;30, 2024 for filing with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Audit Committee:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Paul Buckman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jeffrey Mathiesen</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Edward Andrle</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_005"></A>PROPOSAL NO. 2<BR>
RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Baker Tilly US, LLP (&ldquo;Baker Tilly&rdquo;)
audited our financial statements as of and for the fiscal year ended September&nbsp;30, 2024. We expect that representatives of Baker
Tilly will be present at the Annual Meeting, will be able to make a statement if they so desire and will be available to respond to appropriate
questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Annual Meeting, the stockholders are being
asked to ratify the appointment of Baker Tilly as our independent registered public accounting firm for the fiscal year ending September&nbsp;30,
2025. Our Board is submitting the selection of Baker Tilly to our stockholders because we value our stockholders&rsquo; views on our independent
registered public accounting firm and as a matter of good corporate governance. If this proposal does not receive the affirmative approval
of a majority of the votes present in person or by proxy and entitled to vote on the proposal, the Board would reconsider the appointment.
Even if our stockholders ratify the selection, our Board, in its discretion, may appoint another independent registered public accounting
firm at any time during the year if the Board believes that such a change would be in our best interests and the interests of our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Service Fees Paid to the Independent Registered
Public Accounting Firms</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee retained Baker Tilly to audit
the Company&rsquo;s consolidated financial statements as of and for the&nbsp;years ended September&nbsp;30, 2024 and September&nbsp;30,
2023, respectively. The following table sets forth the fees that Baker Tilly billed for their audit and other services. The Audit Committee
approved all of the services described below in conformity with its pre-approval policies and procedures described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">FEE CATEGORY</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">FY 2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">FY 2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Audit fees</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">259,414</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">235,764</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Audit-related fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">155,667<SUP></SUP></TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">119,175</FONT></TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(1)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Tax fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">All other fees</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total fees</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">415,081</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">354,939</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Audit-related fees represent fees for services relating to comfort
letters, consents and registration statement filings by the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Pre-Approval Policies and Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Audit Committee has adopted policies and procedures
for the pre-approval of audit services and permitted non-audit and tax services rendered by our independent registered public accounting
firm. The policy generally provides for pre-approval of specified services in the defined categories of audit services, audit-related
services and tax services. Pre-approval may also be given as part of the Audit Committee&rsquo;s approval of the scope of the engagement
of the independent auditor or on an individual, explicit, case-by-case basis before the independent auditor is engaged to provide each
service. The Audit Committee must pre-approve all services provided by the independent registered public accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee has determined that the rendering
of services other than audit services by Baker Tilly US, LLP is compatible with maintaining the principal accountant&rsquo;s independence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD OF DIRECTORS RECOMMENDS A VOTE <I>&ldquo;FOR&rdquo;</I>
APPROVAL OF PROPOSAL NO. 2.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_006"></A>PROPOSAL NO. 3<BR>
VOTE TO APPROVE REVERSE STOCK SPLIT PROPOSAL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has unanimously approved an amendment to the Company&rsquo;s
Certificate of Incorporation to effect a reverse split of the Company&rsquo;s Common Stock any time prior to the first anniversary of
its approval by the stockholders at a ratio in the range of 1-for-2 to 1-for-15, to be determined at the discretion of the Board, whereby
each outstanding 2 to 15 shares would be combined, converted and changed into 1 share of the Company&rsquo;s Common Stock. A form of the
certificate of amendment to the Certificate of Incorporation for the reverse stock split (the &ldquo;<B><I>Reverse Stock Split Certificate
of Amendment</I></B>&rdquo;) is attached hereto as <U>Appendix A</U>. The following discussion is qualified in its entirety by the full
text of the Reverse Stock Split Certificate of Amendment, which is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has recommended that the proposed Reverse
Stock Split Certificate of Amendment to effect the reverse stock split be presented to the Company&rsquo;s stockholders for approval.
If the Reverse Stock Split Certificate of Amendment is approved by a majority of the Company&rsquo;s stockholders, the Board will have
discretion to determine, as it deems to be in the best interest of the Company&rsquo;s stockholders, the specific ratio to be used within
the range described above and the timing of the reverse stock split, which must occur any time prior to the first anniversary of its approval
by the stockholders. The Board believes that stockholder approval of the range of reverse stock split ratios (as opposed to approval of
a single reverse stock split ratio) provides the Board with maximum flexibility to achieve the purpose of a reverse stock split, as discussed
below, and therefore is in the best interests of the Company and its stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board may, in its discretion, determine not
to effect the reverse stock split if it determines, subsequent to obtaining stockholder approval, that such action is not in the best
interests of the Company. By voting in favor of the reverse stock split, you are expressly authorizing the Board to determine not to proceed
with, and abandon, the reverse stock split if it should so decide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Reasons for the Reverse Stock Split </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s Common Stock is quoted on
the Nasdaq Capital Market under the symbol &ldquo;NMTC&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the Common Stock to continue trading on the
Nasdaq Capital Market, the Company must comply with various listing standards, including that our Common Stock maintain a minimum bid
price of $1.00&nbsp;per share, as set forth in Nasdaq Listing Rule&nbsp;5550(a)(2) (the &ldquo;<B><I>Minimum Bid Price Requirement</I></B>&rdquo;).
The closing price of the Company&rsquo;s Common Stock on the Nasdaq Capital Market on January 3, 2025 was $0.92 per share and, over the
prior 52&nbsp;weeks, the closing price of the Company&rsquo;s Common Stock has ranged from $0.59 to $1.45 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously disclosed, on July 11, 2024, the
Company received a letter (the &ldquo;<B><I>Notice</I></B>&rdquo;) from the Listing Qualifications Department of The Nasdaq Stock Market
(&ldquo;<B><I>Nasdaq</I></B>&rdquo;) indicating that, based on the closing bid price of the Company&rsquo;s Common Stock for the 30 consecutive
business days preceding the Notice, the Company no longer meets the Minimum Bid Price Requirement. The Notice has no effect on the listing
of the Common Stock at this time, and the Common Stock continues to trade on the Nasdaq Capital Market under the symbol &ldquo;NMTC.&rdquo;
In accordance with Nasdaq Listing Rule&nbsp;5810(c)(3)(A), the Company was provided a period of 180 calendar days in which to regain compliance.
As a result, the Company had until January 7, 2025 to regain compliance with the Minimum Bid Price Requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has not regained compliance with the
Minimum Bid Price Requirement by the end of the applicable compliance period, and intends to request a hearing before a Nasdaq Hearings
Panel to address its plan to remedy the deficiency, which request would stay any delisting action by the Listing Qualifications staff
pending the ultimate outcome of the hearing process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board is asking the stockholders to grant
it the authority, at its discretion, to effect a reverse stock split, which the Board believes is an effective way to increase the minimum
bid price of our Common Stock proportionately by reducing the number of outstanding shares of Common Stock and put us in a position to
regain compliance with Nasdaq Listing Rule&nbsp;5550(a)(2). The Board further believes that the increased market price of our Common Stock
expected as a result of implementing the reverse stock split may improve marketability and liquidity of our Common Stock and may encourage
trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In evaluating whether or not to recommend that
stockholders authorize the reverse stock split, in addition to the considerations described above, the Board took into account various
negative factors associated with a reverse stock split. These factors include: the negative perception of reverse stock splits held by
some investors, analysts, and other stock market participants; the fact that the stock price of some companies that have effected reverse
stock splits has subsequently declined, with a corresponding decline in market capitalization; the adverse effect on liquidity that might
be caused by a reduced number of shares outstanding; and the costs associated with implementing a reverse stock split. Conversely, we
believe the current low market price of our Common Stock impairs its acceptability to important segments of the institutional investor
community and the investing public. Many investors look upon low-priced stock as unduly speculative in nature and, as a matter of policy,
avoid investment in such stocks. We believe that the low market price of our Common Stock has reduced the effective marketability of our
shares because of the reluctance of many brokerage firms to recommend low-priced stock to their clients. Further, a variety of brokerage
house policies and practices tend to discourage individual brokers within those firms from dealing in low-priced stocks. Some of those
policies and practices pertain to the payment of brokers&rsquo; commissions and to time-consuming procedures that function to make the
handling of low-priced stocks unattractive to brokers from an economic standpoint. In addition, the structure of trading commissions also
tends to have an adverse impact upon holders of low-priced stock because the brokerage commission on a sale of low-priced stock generally
represents a higher percentage of the sales price than the commission on a relatively higher-priced issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board believes that maintaining the listing
of the Company&rsquo;s Common Stock on Nasdaq is in the best interests of the Company and its stockholders. The Board believes that the
delisting of the Company&rsquo;s Common Stock from Nasdaq would impair our ability to raise additional funds and result in lower prices
and larger spreads in the bid and ask prices for the Company&rsquo;s Common Stock, among other things. See &ldquo;<I>Certain Risk Factors
Associated with the Reverse Stock Split or Nasdaq Delisting</I>&rdquo; below for more information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Determination of the Reverse Stock Split Ratio
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board only intends to implement the reverse
stock split to the extent it believes necessary to maintain the Company&rsquo;s listing on Nasdaq. In determining the ratio to be used,
the Board will consider various factors, including but not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the potential impact and anticipated
benefits to the Company and its stockholders;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">market conditions and existing
and expected market price of the Company&rsquo;s Common Stock at such time;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">existing and expected marketability
of the Common Stock;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the number of shares that will be outstanding after the reverse stock split; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the stockholders&rsquo; equity at such time; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the trading volume of the Company&rsquo;s
Common Stock at such time.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Impact of the Reverse Stock Split, if Implemented
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s Certificate of Incorporation,
as previously corrected (the &ldquo;<B><I>Certificate of Incorporation</I></B>&rdquo;), currently authorizes the issuance of 100,000,000
shares of Common Stock. On September 30, 2024, the Company had: 30,816,499 shares of Common Stock issued and outstanding, 2,814,096 shares
of Common Stock issuable upon the exercise of outstanding options, 7,045,875 shares of Common Stock issuable upon the exercise of outstanding
warrants, 1,129,766 shares of Common stock issuable upon settlement of restricted stock units and 297,461 shares of Common Stock reserved
for future issuance under the Company&rsquo;s 2017 Equity Incentive Plan and 2021 Inducement Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a matter of Delaware law, the implementation
of a reverse stock split does not require a reduction in the total number of authorized shares. If the Company&rsquo;s stockholders adopt
and approve the Reverse Stock Split Certificate of Amendment and the reverse stock split is implemented by the Company, the authorized
number of shares of the Company&rsquo;s Common Stock would not be reduced by the reverse stock split ratio determined by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If approved and effected, the reverse stock split
will automatically apply to all shares of the Company&rsquo;s Common Stock, and each stockholder will own a reduced number of shares of
the Company&rsquo;s Common Stock. However, except for adjustments that may result from the treatment of fractional shares, as described
below, or as a result of adjustments to the conversion prices of certain convertible securities, as described below, the reverse stock
split will not affect any stockholder&rsquo;s percentage ownership or proportionate voting power.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the Company&rsquo;s capitalization as
of September 30, 2024, the principal effect of the reverse stock split (at a ratio between 1-for-2 and 1-for-15), not taking into account
the treatment of fractional shares described under <I>&ldquo;&mdash;Procedure for Effecting the Reverse Stock Split&mdash;Treatment of
Fractional Shares</I>&rdquo; below, would be that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of the Company&rsquo;s Common Stock issued and outstanding would be reduced from 30,816,499 shares to between approximately 2,054,433 shares and 15,408,249 shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of the Company&rsquo;s Common Stock issuable upon the exercise of outstanding stock options would be reduced from 2,814,096 to between approximately 187,606 shares and 1,407,048 shares (and the respective exercise prices of the options would increase by a factor equal to the inverse of the split ratio);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of the Company&rsquo;s Common Stock issuable upon the exercise of outstanding warrants would be reduced from 7,045,875 to between approximately 469,725 shares and 3,522,937 shares (and the respective exercise prices of the warrants would increase by a factor equal to the inverse of the split ratio);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of the Company&rsquo;s Common Stock issuable upon the settlement of outstanding restricted stock units would be reduced from 1,129,766 to between approximately 75,317 shares and 564,883 shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the aggregate number of shares of the Company&rsquo;s Common Stock reserved for issuance, in connection with future awards under the Company&rsquo;s 2017 Equity Incentive Plan and 2021 Inducement Plan would be reduced from 297,461 to between approximately 19,830 shares and 148,730 shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of the Company&rsquo;s authorized Common Stock would remain unchanged at 100,000,000 shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the 10,000,000 shares of the Company&rsquo;s authorized preferred stock would remain unchanged; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of the Company&rsquo;s Common Stock that are authorized, but unissued and unreserved, would increase from 50,850,428 to between approximately 75,425,216 shares and 96,723,364 shares; and the par value of the Company&rsquo;s Common Stock and preferred stock would remain unchanged at $0.001 per share, and, as a result, the stated capital attributable to Common Stock on the Company&rsquo;s balance sheet would be reduced proportionately based on the reverse stock split ratio, the additional paid-in capital account would be credited with the amount by which the stated capital is reduced, and the per-share net income or loss and net book value of the Company&rsquo;s Common Stock would be restated because there would be fewer shares of Common Stock outstanding.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table contains approximate information
relating to our Common Stock immediately following the reverse stock split under certain possible exchange ratios, based on share information
as of September 30, 2024. All share numbers are rounded down to the nearest whole share but otherwise do not reflect the potential effect
of rounding down for fractional shares that may result from the reverse stock split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 0.125in">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Pre-Reverse<BR> Split</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">1-for-2</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">1-for-5</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">1-for-10</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">1-for-15</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 40%">Number of authorized shares of Common Stock</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">Number of outstanding shares of Common Stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,816,499</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,408,249</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,163,299</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,081,649</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,054,433</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Number of shares of Common Stock issuable upon exercise of outstanding stock options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,814,096</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,407,048</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562,819</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">281,409</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">187,606</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Number of shares of Common Stock issuable upon exercise of outstanding warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,045,875</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,522,937</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,409,175</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">704,587</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">469,725</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Number of shares of Common Stock issuable upon settlement of outstanding restricted stock units</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,129,766</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">564,883</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">225,953</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,976</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,317</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Number of shares of Common Stock reserved for issuance in connection with future awards under the Company&rsquo;s 2017 Equity Incentive Plan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">297,461</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">148,730</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">59,492</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,746</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,830</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Number of shares of Common Stock authorized, but unissued and unreserved</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,850,428</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,425,216</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,170,087</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">95,085,046</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96,723,364</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See also &ldquo;<I>Certain Risk Factors Associated
with the Reverse Stock Split or Nasdaq Delisting</I>&rdquo; and <I>&ldquo;&mdash;Procedure for Effecting the Reverse Stock Split&mdash;Treatment
of Fractional Shares</I>&rdquo; below for additional information regarding the potential impact of the reverse stock split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Anti-Takeover and Dilutive Effects</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number of authorized shares of our Common
Stock and preferred stock will not be reduced as a result of the reverse stock split. The Common Stock and preferred stock that is authorized
but unissued provide the Board with flexibility to effect, among other transactions, public or private financings, acquisitions, stock
dividends, stock splits and the granting of equity incentive awards. However, these authorized but unissued shares may also be used by
the Board, consistent with and subject to its fiduciary duties, to deter future attempts to gain control of us or make such actions more
expensive and less desirable. Following stock split, our Board would continue to have the authority to issue additional shares from time
to time without further action by the stockholders except as may be required by applicable law or regulations. The Reverse Stock Split
Certificate of Amendment is not being recommended in response to any specific effort of which we are aware to obtain control of us, nor
does our Board have any present intent to use the authorized but unissued Common Stock or preferred stock to impede a takeover attempt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects to require additional financing
to fund its ongoing activities. Other than the foregoing, and except for the Company&rsquo;s obligation to issue Common Stock upon the
exercise of outstanding options and warrants, we have no specific plan, commitment, arrangement, understanding or agreement, either oral
or written, regarding the issuance of Common Stock subsequent to the reverse stock split at this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Certain Risk Factors Associated with the Reverse
Stock Split or Nasdaq Delisting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>A reverse stock split may negatively impact
the market for our Common Stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Factors such as our financial results, market
conditions and the market perception of our business may adversely affect the market price of our Common Stock. As a result, there can
be no assurance that the total market capitalization of our Common Stock after the proposed reverse stock split will be equal to or greater
than the total market capitalization before the proposed reverse stock split or that the per share market price of our Common Stock following
the reverse stock split will increase in proportion to the reduction in the number of shares of Common Stock outstanding before the reverse
stock split. A decline in the market price of our Common Stock after the reverse stock split may result in a greater percentage decline
than would occur in the absence of a reverse stock split, and the liquidity of our Common Stock could be adversely affected following
such a reverse stock split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the reverse stock split may increase
the number of stockholders who own odd lots (less than 100&nbsp;shares). Any stockholder who owns fewer than 200 to 1,500 shares of Common
Stock, depending on the final ratio, prior to the reverse stock split will own fewer than 100&nbsp;shares of Common Stock following the
reverse stock split. Stockholders who hold odd lots typically experience an increase in the cost of selling their shares and may have
greater difficulty in effecting sales. Furthermore, some stockholders may cease being stockholders of the Company following the reverse
stock split. Any stockholder who owns fewer than 2 to 15 shares of Common Stock, depending on the final ratio, prior to the reverse stock
split will own less than one share of Common Stock following the reverse stock split and therefore such stockholder will receive cash
equal to the market value of such fractional share and cease being a stockholder of the Company, as further described below under &ldquo;&mdash;Procedure
for Effecting the Reverse Stock Split&mdash;Treatment of Fractional Shares&rdquo;.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market price of our Common Stock will also
be based on our performance and other factors, including those factors listed under the heading &ldquo;Risk Factors&rdquo; and elsewhere
in our Annual Report on Form&nbsp;10-K for the year ended September 30, 2024, and other reports that we file with the SEC and the Canadian
securities regulators. There can also be no assurance that the minimum bid price per share of our Common Stock will remain in excess of
$1.00 following the reverse stock split for a sustained period of time, if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Nasdaq may delist the Company&rsquo;s Common
Stock, which could seriously harm the liquidity of the Common Stock and the Company&rsquo;s ability to raise capital.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 11, 2024, the Company received the Notice
from Nasdaq staff indicating that, based upon the closing bid price of the Common Stock for the last 30 consecutive business days, the
Company no longer meets the Minimum Bid Price Requirement. In accordance with Nasdaq Listing Rule&nbsp;5810(c)(3)(A), the Company was
provided a period of 180 calendar days, or until January 7, 2025, in which to regain compliance. The Company has not regained compliance
with the Minimum Bid Price Requirement by the end of the applicable compliance period, and intends to request a hearing before a Nasdaq
Hearings Panel to address its plan to remedy the deficiency, which request would stay any delisting action by the Listing Qualifications
staff pending the ultimate outcome of the hearing process. If the Company is unable to regain compliance with the Minimum Bid Price Requirement
or other listing requirements, the Company could lose eligibility for continued listing on the Nasdaq Capital Market or any comparable
trading market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we cease to be eligible to trade on Nasdaq:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 20pt; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">We may have to pursue trading in
the United States on a less recognized or accepted market, such as the OTC Bulletin Board or the &ldquo;pink sheets&rdquo;;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 20pt; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Shares of our Common Stock could
be less liquid and marketable, thereby reducing the ability of stockholders to purchase or sell our shares as quickly and as inexpensively
as they have done historically;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 20pt; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Our Common Stock may be deemed
a &ldquo;penny stock,&rdquo; and transactions in our Common Stock would be more difficult and cumbersome;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 20pt; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">We may be unable to access capital
on favorable terms or at all, as companies trading on alternative markets may be viewed as less attractive investments with higher associated
risks, such that existing or prospective institutional investors may be less interested in, or prohibited from, investing in our Common
Stock; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 20pt; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The market price of the Common
Stock may further decline.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>A reverse stock split would increase the
Company&rsquo;s authorized but unissued shares of Common Stock, which could negatively impact a potential investor if they purchased shares
of Common Stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the number of authorized shares of the
Company&rsquo;s Common Stock will not be reduced proportionately, the reverse stock split will increase the Board&rsquo;s ability to issue
authorized and unissued shares without further stockholder action. The issuance of additional shares of Common Stock or securities convertible
into Common Stock may have a dilutive effect on earnings per share and relative voting power and may cause a decline in the trading price
of the Common Stock. The Company could use the shares that are available for future issuance in dilutive equity financing transactions,
or to oppose a hostile takeover attempt or delay or prevent changes in control or changes in or removal of management, including transactions
that are favored by a majority of the stockholders or in which the stockholders might otherwise receive a premium for their shares over
then-current market prices or benefit in some other manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects to require additional financing
to fund its ongoing activities. Other than the foregoing, and except for the Company&rsquo;s obligation to issue Common Stock upon the
exercise of outstanding options and warrants, the Company has no specific plan, commitment, arrangement, understanding or agreement, either
oral or written, regarding the issuance of Common Stock subsequent to the reverse stock split at this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Procedure for Effecting the Reverse Stock Split
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When and if the Board decides to implement the
reverse stock split at any time before the first anniversary of its approval by the stockholders, the Company will promptly file the Reverse
Stock Split Certificate of Amendment with the Secretary of State of the State of Delaware to amend its existing Certificate of Incorporation.
The reverse stock split will become effective upon filing the Reverse Stock Split Certificate of Amendment with the Secretary of State
of the State of Delaware or at a later date and time set forth therein, if any, which effective time is referred to as the &ldquo;reverse
stock split effective date&rdquo;. Beginning on the reverse stock split effective date, each certificate representing pre-reverse stock
split shares will be deemed for all corporate purposes to evidence ownership of post-reverse stock split shares. The text of the Reverse
Stock Split Certificate of Amendment is set forth in <U>Appendix A</U> to this proxy statement. The text of the Reverse Stock Split Certificate
of Amendment is subject to modification to include such changes as may be required by the office of the Secretary of State of the State
of Delaware and as the Board deems necessary and advisable to effect the reverse stock split, including the applicable ratio for the reverse
stock split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the reverse stock split effective date,
our Common Stock will have a new CUSIP number, which is a number used to identify securities, and stock certificates with the old CUSIP
number will need to be exchanged for stock certificates with the new CUSIP number using the procedures described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exchange of Stock Certificates</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As soon as practicable after the effective date
of the reverse stock split, stockholders holding certificated shares will be notified that the reverse stock split has been effected.
Computershare Investor Services Inc., the Company&rsquo;s transfer agent, will act as exchange agent for purposes of implementing the
exchange of stock certificates. Holders of pre-split shares in certificated form will be asked to surrender to the exchange agent certificates
representing pre-split shares in exchange for certificates representing post-split shares in accordance with the procedures to be set
forth in a letter of transmittal that will be delivered to the stockholders. No new certificates will be issued to a stockholder until
the stockholder has surrendered to the exchange agent his, her or its outstanding certificate(s) together with the properly completed
and executed letter of transmittal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">STOCKHOLDERS SHOULD NOT DESTROY ANY STOCK CERTIFICATES
AND SHOULD NOT SUBMIT THEIR STOCK CERTIFICATES UNTIL THEY RECEIVE A TRANSMITTAL FORM FROM THE EXCHANGE AGENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">STOCKHOLDERS ARE ENCOURAGED TO PROMPTLY SURRENDER
CERTIFICATES TO THE EXCHANGE AGENT FOLLOWING RECEIPT OF TRANSMITTAL FORMS IN ORDER TO AVOID HAVING SHARES POSSIBLY BECOMING SUBJECT TO
ESCHEAT LAWS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders whose shares are held by their stockbroker
do not need to submit old share certificates for exchange. Their accounts will automatically reflect the new quantity of shares based
on the selected reverse stock split ratio. Beginning on the reverse stock split effective date, each certificate representing pre-split
shares will be deemed for all corporate purposes to evidence ownership of post-split shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Treatment of Fractional Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To avoid the existence of fractional shares of
Common Stock after the reverse stock split, fractional shares that would be created as a result of the reverse stock split will be rounded
down to the next whole share and the stockholder will receive cash equal to the market value of the fractional share, determined by multiplying
such fraction by the closing sales price of the Company&rsquo;s Common Stock as reported on Nasdaq on the last trading day before the
reverse stock split effective date (as adjusted to give effect to the reverse stock split). The ownership of a fractional share will not
give the holder any voting, dividend or other right except to receive the cash payment therefor. If a stockholder is entitled to a cash
payment in lieu of any fractional share, a check will be mailed to the stockholder&rsquo;s registered address as soon as practicable after
the reverse stock split effective date. By signing and cashing the check, stockholders will warrant that they owned the shares of Common
Stock for which they received such cash payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>No Appraisal Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Delaware General Corporation Law, our
stockholders do not have a right to dissent and are not entitled to appraisal rights with respect to the proposed Reverse Stock Split
Certificate of Amendment to effect the reverse stock split, and we will not independently provide our stockholders with any such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Material Federal Income Tax Consequences </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following discussion of certain U.S. federal
income tax consequences to the Company&rsquo;s stockholders of the reverse stock split, if effected, does not purport to be a complete
discussion of all of the possible U.S. federal income tax consequences and is included for general information only. It not intended as
tax advice to any person and is not a comprehensive description of the tax consequences that may be relevant to each stockholder&rsquo;s
own particular circumstances. The discussion is based on the Internal Revenue Code of 1986, as amended (the &ldquo;<B><I>Code</I></B>&rdquo;),
applicable Treasury Regulations promulgated thereunder, judicial authority and current administrative rulings and practices as in effect
on the date of this proxy statement. Changes to the laws could alter the tax consequences described below, possibly with retroactive effect.
The Company has not sought and will not seek an opinion of counsel or a ruling from the Internal Revenue Service regarding the U.S. federal
income tax consequences of the reverse stock split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This discussion addresses the U.S. federal income
tax consequences only to a stockholder that is (i)&nbsp;a citizen or individual resident of the United States, (ii)&nbsp;a corporation
organized in or under the laws of the United States or any state thereof or the District of Columbia or otherwise subject to U.S. federal
income taxation on a net income basis in respect of our Common Stock, (iii)&nbsp;a trust if (1)&nbsp;a U.S. court is able to exercise
primary supervision over administration of such trust and one or more U.S. persons have the authority to control all substantial decisions
of the trust or (2)&nbsp;it has a valid election in place to be treated as a U.S. person, or (iv)&nbsp;an estate whose income is subject
to U.S. federal income taxation regardless of its source. This discussion addresses only those stockholders who hold their pre-reverse
stock split shares as &ldquo;capital assets&rdquo; as defined in the Code (generally, property held for investment), and will hold the
shares received in the reverse stock split as capital assets. Further, it does not address any state, local, foreign or other income tax
consequences, nor does it address the tax consequences to stockholders that are subject to special tax rules, such as, without limitation,
stockholders who are subject to the alternative minimum tax, banks, insurance companies, regulated investment companies, personal holding
companies, stockholders who are not &ldquo;United States persons&rdquo; as defined in Section 7701(a)(30) of the Code, U.S. persons whose
functional currency is not the U.S. dollar, broker-dealers, tax-exempt entities, or S&nbsp;corporations, partnerships or other entities
or arrangements treated as partnerships for U.S. federal income tax purposes (or investors therein). If an entity or arrangement treated
as a partnership for U.S. federal income tax purposes holds pre-reverse stock split shares of the Company&rsquo;s stock, the U.S. federal
income tax treatment of a partner of the partnership will depend on the status of the partner and the activities of the partnership and
upon certain determinations made at the partnership level. Partners in partnerships holding our Common Stock are urged to consult their
own tax advisors about the U.S. federal income tax consequences of the reverse stock split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Stockholders are advised to consult their own
tax advisers regarding the U.S. federal income tax consequences of the reverse stock split in light of their personal circumstances and
the consequences under state, local and foreign tax laws, and also as to any estate or gift tax considerations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exchange Pursuant to Reverse Stock Split</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No gain or loss will be recognized by a stockholder
upon such stockholder&rsquo;s exchange of pre-reverse stock split shares for post-reverse stock split shares pursuant to the reverse stock
split, except to the extent of cash, if any, received in lieu of fractional shares, further described in &ldquo;&mdash;<I>Cash in Lieu
of Fractional Shares</I>&rdquo; below. The aggregate tax basis of the post-reverse stock split shares received in the reverse stock split,
including any fractional share deemed to have been received, will be equal to the aggregate tax basis of the pre-reverse stock split shares
exchanged therefor, and the holding period of the post-reverse stock split shares will include the holding period of the pre-reverse stock
split shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Cash in Lieu of Fractional Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A stockholder who receives cash in lieu of a fractional
post-reverse stock split share should generally be treated as having received such fractional share pursuant to the reverse stock split
and then as having exchanged such fractional share for cash in a redemption of such fractional share. The amount of any gain or loss should
be equal to the difference between the ratable portion of the tax basis of the pre-reverse stock split shares exchanged in the reverse
stock split that is allocated to such fractional share and the cash received in lieu thereof. In general, any such gain or loss will constitute
a long-term capital gain or loss if the stockholder&rsquo;s holding period for such pre-reverse stock split shares exceeds one year at
the time of the reverse stock split. Deductibility of capital losses by holders is subject to limitations. Depending on a stockholder&rsquo;s
individual facts and circumstances, it is possible that cash received in lieu of a fractional share could be treated as a distribution
under Section&nbsp;301 of the Code, so stockholders should consult their own tax advisors as to that possibility and the resulting tax
consequences to them in that event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will not recognize any gain or loss
as a result of the reverse stock split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Vote Required </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The affirmative vote of holders of a majority
of the votes cast at the Annual Meeting is required for the approval of the reverse stock split. Abstentions are not considered votes
cast and will have no effect on the vote for this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD OF DIRECTORS RECOMMENDS A VOTE &ldquo;<I>FOR</I>&rdquo;
APPROVAL OF PROPOSAL NO. 3.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_007"></A>PROPOSAL NO. 4<BR>
VOTE TO APPROVE 2025 EQUITY INCENTIVE PLAN</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our stockholders are being asked to approve the
NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan (the&nbsp;<B><I>&ldquo;2025 Plan&rdquo;</I></B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board believes that it is in the best interest
of us and our stockholders for the Company to be in a position to offer equity awards to executive officers, key employees, outside directors,
consultants and advisors in accordance with the terms of the 2025 Plan. We have relied upon and anticipate continuing to rely upon the
equity incentive program to a disproportionate degree in lieu of cash compensation to our executive officers. We intend to recruit additional
employees and consultants and retain our existing employees and consultants, and the equity available under the Company&rsquo;s existing
incentive plans is not sufficient to support the equity compensation of such consultants and employees. This provides our Board with the
discretion to pay a portion of annual bonus payments in the form of equity versus cash. Our Board believes that the structure of these
agreements benefits stockholders by providing additional incentive to the executives regarding value creation. The life sciences market
is highly competitive, and our results are largely attributable to the talents, expertise, efforts and dedication of our employees and
consultants. Our compensation program, including the granting of equity compensation, is a crucial way to attract and recruit new employees
and consultants and retain existing employees and consultants, with equity compensation serving as our primary recruitment, retention
and motivational tool as opposed to cash compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are often competing for highly-skilled talent
with many companies that offer aggressive equity compensation to their executive and key professional positions, with many of our competitors
having evergreen plans that allow automatic replenishment of the equity share pool on an annual basis. We do not currently have enough
shares in the 2017 Equity Incentive Plan (the&nbsp;<B><I>&ldquo;2017 Plan&rdquo;</I></B>) and the 2021 Inducement Plan (the&nbsp;<B><I>&ldquo;Inducement
Plan&rdquo;</I></B>) to assist with recruitment and retention of the necessary talent and the evergreen provision in our 2017 Plan does
not provide for a sufficient annual increase of new shares to grant. We are therefore requesting stockholder approval for a larger share
pool together with an evergreen provision to provide for annual increases in the share pool that will accommodate future equity awards
needed to achieve our recruiting and retention goals. Our approval of the new 2025 Plan, with a greater total share pool and evergreen
provision, is intended to enable us to position our pay at a competitive opportunity level, while reducing emphasis on cash compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The full text of the proposed 2025 Plan is set forth on&nbsp;<I>Appendix
B</I>&nbsp;to this proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Requested Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to adjustment for certain changes in our
capitalization, if this Proposal 4 is approved by our stockholders, the aggregate number of shares of our common stock that may be issued
under the 2025 Plan will not exceed the sum of (1) 3,000,000, (2) the number of shares of our common stock available for grant of new
awards under the 2017 Plan and (3) any shares subject to outstanding stock awards under the 2017 Plan that are forfeited or otherwise
returned to the share reserve. In addition, the number of shares of common stock reserved for issuance under the 2025 Plan would automatically
increase on January 1 of each calendar year, starting on January 1, 2026 through January 1, 2035, in an amount equal to (i) 5% of the
total number of shares of Common Stock outstanding on December 31 of the preceding year, or (ii) a lesser number of shares determined
by our Board prior to the date of the increase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At December 31, 2024, equity awards covering an
aggregate of 3,906,056 shares were outstanding under the 2017 Plan and the Inducement Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides certain additional
information regarding our equity incentive program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<BR>
 December&nbsp;31, <BR>
2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify">Total number of shares of common stock subject to outstanding stock options</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,814,096</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Weighted-average exercise price of outstanding stock options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.13</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Weighted-average remaining term of outstanding stock options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.4</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total number of shares of common stock available for grant under the 2017 Plan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">129,671</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total number of shares of common stock available for grant under the Inducement Plan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167,790</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total number of shares of common stock subject to unvested restricted stock units</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,091,960</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total number of shares of common stock outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,841,830</TD><TD STYLE="text-align: left"></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are committed to using the shares available
under the 2025 Plan prudently to advance the Company&rsquo;s interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We continue to believe that equity awards such
as stock options and other types of stock awards are a vital part of our overall compensation program. Our compensation philosophy reflects
broad-based eligibility for equity incentive awards, and we grant awards to substantially all of our employees. However, we recognize
that equity awards dilute existing stockholders, and, therefore, we must responsibly manage our use of equity compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are committed to effectively monitoring our
equity compensation share reserve, including our burn rate, to ensure that we maximize stockholders&rsquo; value by granting the appropriate
number of equity incentive awards necessary to attract, reward, and retain employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Summary of the 2025 Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The material features of the 2025 Plan are described
below. The following description of the 2025 Plan is a summary only and is qualified in its entirety by reference to the complete text
of the 2025 Plan. Stockholders are urged to read the actual text of the 2025 Plan in its entirety, which is attached to this proxy statement
as&nbsp;<I>Appendix B.</I>&nbsp;If our stockholders approve the 2025 Plan, a registration statement on Form S-8 covering the shares in
the share reserve of the 2025 Plan will be filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Awards</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2025 Plan provides for the grant of incentive
stock options (<B><I>&ldquo;ISOs&rdquo;</I></B>), nonstatutory stock options (<B><I>&ldquo;NSOs&rdquo;</I></B>), stock appreciation rights,
restricted stock awards, restricted stock unit awards, performance awards and other forms of awards to employees, directors and consultants,
including employees and consultants of the Company&rsquo;s affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Authorized Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Initially, the maximum number of shares of common
stock that may be issued under the 2025 Plan after it becomes effective will not exceed (1) 3,000,000 and (2) any shares subject to outstanding
stock awards under the 2017 Plan that are forfeited or otherwise returned to the share reserve. In addition, the number of shares of common
stock reserved for issuance under the 2025 Plan would automatically increase on January 1 of each calendar year, starting on January 1,
2026 through January 1, 2035, in an amount equal to (i) 5% of the number of shares of common stock outstanding on December 31 before the
date of each automatic increase, or (ii) a lesser number of shares determined by our Board prior to the date of the increase. The maximum
number of shares of common stock that may be issued on the exercise of ISOs under the 2025 Plan is 9,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares subject to stock awards granted under the
2025 Plan that expire or terminate without being exercised in full or that are paid out in cash rather than in shares do not reduce the
number of shares available for issuance under the 2025 Plan. If any shares of common stock issued pursuant to a stock award are forfeited
back to or repurchased or reacquired by the Company (1) because of a failure to meet a contingency or condition required for the vesting
of such shares; (2) to satisfy the exercise, strike or purchase price of an award; or (3) to satisfy a tax withholding obligation in connection
with an award, the shares that are forfeited or repurchased or reacquired will revert to and again become available for issuance under
the 2025 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Plan Administration</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board, or a duly authorized committee of our
Board, will administer the 2025 Plan and is referred to as the &ldquo;plan administrator&rdquo;. Our Board has determined that the Compensation
Committee will be the plan administrator. The plan administrator may also delegate to one or more of the Company&rsquo;s officers the
authority to: (1) designate employees (other than officers) to receive specified stock awards; and (2) determine the number of shares
subject to such stock awards. Under the 2025 Plan, the plan administrator has the authority to determine award recipients, grant dates,
the numbers and types of stock awards to be granted, the applicable fair market value, and the provisions of each stock award, including
the period of exercisability and the vesting schedule applicable to a stock award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the 2025 Plan, the plan administrator also
generally has the authority to effect, with the consent of any materially adversely affected participant, (A) the reduction of the exercise,
purchase, or strike price of any outstanding option or stock appreciation right; (B) the cancellation of any outstanding option or stock
appreciation right and the grant in substitution therefore of other awards, cash, or other consideration; or (C) any other action that
is treated as a repricing under U.S. GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Eligibility and Participation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All current and prospective eligible employees and consultants and
all current non-employee directors are eligible to be granted non-qualified stock options, restricted stock awards and other stock-based
awards under the 2025 Plan. As of January 21, 2025, we have three non-employee directors, five executive officers, 12 non-executive employees
and eight other consultants eligible to receive awards under the 2025 Plan. Only employees of ours are eligible to be granted incentive
stock options (sometimes referred to as&nbsp;<B><I>&ldquo;ISO&rdquo;</I></B>&nbsp;or&nbsp;<B><I>&ldquo;ISOs&rdquo;</I></B>), under the
2025 Plan. Eligibility for awards under the 2025 Plan is determined by the plan administrator in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Types of Awards</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Stock Options</I>. ISOs and NSOs are granted
under stock option agreements adopted by the plan administrator.<I>&nbsp;</I>The plan administrator determines the exercise price for
stock options, within the terms and conditions of the 2025<I>&nbsp;</I>Plan; provided that the exercise price of a stock option generally
cannot be less than 100% of the fair market value<I>&nbsp;</I>of common stock on the date of grant. Options granted under the 2025 Plan
vest at the rate specified in the stock<I>&nbsp;</I>option agreement as determined by the plan administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The plan administrator determines the term of
stock options granted under the 2025 Plan, up to a maximum of 10 years. Unless the terms of an optionholder&rsquo;s stock option agreement
provide otherwise, if an optionholder&rsquo;s service relationship with the Company or any of its affiliates ceases for any reason other
than disability, death, or cause, the optionholder may generally exercise any vested options for a period of three months following the
cessation of service. This period may be extended in the event that exercise of the option is prohibited by applicable securities laws.
If an optionholder&rsquo;s service relationship with us or any of our affiliates ceases due to death, or an optionholder dies within a
certain period following cessation of service, the optionholder or a beneficiary may generally exercise any vested options for a period
of 18 months following the date of death. If an optionholder&rsquo;s service relationship with us or any of our affiliates ceases due
to disability, the optionholder may generally exercise any vested options for a period of 12 months following the cessation of service.
In the event of a termination for cause, options generally terminate upon the termination date. In no event may an option be exercised
beyond the expiration of its term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acceptable consideration for the purchase of common
stock issued upon the exercise of a stock option will be determined by the plan administrator and may include: (1) cash, check, bank draft
or money order; (2) a broker-assisted cashless exercise; (3) the tender of shares of common stock previously owned by the optionholder;
(4) a net exercise of the option if it is an NSO; or (5) other legal consideration approved by the plan administrator. Unless the plan
administrator provides otherwise, options or stock appreciation rights generally are not transferable except by will or the laws of descent
and distribution. Subject to approval of the plan administrator or a duly authorized officer, an option may be transferred pursuant to
a domestic relations order, official marital settlement agreement, or other divorce or separation instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Tax Limitations on ISOs</I>. The aggregate
fair market value, determined at the time of grant, of common stock with<I>&nbsp;</I>respect to ISOs that are exercisable for the first
time by an award holder during any calendar year under all of our<I>&nbsp;</I>stock plans may not exceed $100,000. Options or portions
thereof that exceed such limit will generally be treated as<I>&nbsp;</I>NSOs. No ISO may be granted to any person who, at the time of
the grant, owns or is deemed to own stock possessing<I>&nbsp;</I>more than 10% of the Company&rsquo;s total combined voting power or that
of any of its parent or subsidiary corporations<I>&nbsp;</I>unless: (1) the option exercise price is at least 110% of the fair market
value of the stock subject to the option on the<I>&nbsp;</I>date of grant; and (2) the term of the ISO does not exceed five years from
the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Restricted Stock Unit Awards</I>. Restricted
stock unit awards are granted under restricted stock unit award<I>&nbsp;</I>agreements adopted by the plan administrator. Restricted stock
unit awards may be granted in consideration for any<I>&nbsp;</I>form of legal consideration that may be acceptable to our Board and permissible
under applicable law. A restricted<I>&nbsp;</I>stock unit award may be settled by cash, delivery of stock, a combination of cash and stock
as deemed appropriate<I>&nbsp;</I>by the plan administrator, or in any other form of consideration set forth in the restricted stock unit
award agreement.<I>&nbsp;</I>Additionally, dividend equivalents may be credited in respect of shares covered by a restricted stock unit
award.<I>&nbsp;</I>Except as otherwise provided in the applicable award agreement, restricted stock unit awards that have not vested will<I>&nbsp;</I>be
forfeited once the participant&rsquo;s continuous service ends for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Restricted Stock Awards</I>. Restricted stock
awards are granted under restricted stock award agreements adopted<I>&nbsp;</I>by the plan administrator. A restricted stock award may
be awarded in consideration for cash, check, bank draft or<I>&nbsp;</I>money order, past or future services to us, or any other form of
legal consideration that may be acceptable to our<I>&nbsp;</I>Board and permissible under applicable law. The plan administrator determines
the terms and conditions of restricted<I>&nbsp;</I>stock awards, including vesting and forfeiture terms. If a participant&rsquo;s service
relationship with the Company ends for any reason, it may receive any or all of the shares of common stock held by the participant that
have not vested as of the date the participant terminates service with us through a forfeiture condition or a repurchase right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Stock Appreciation Rights</I>. Stock appreciation
rights are granted under stock appreciation right agreements<I>&nbsp;</I>adopted by the plan administrator. The plan administrator determines
the purchase price or strike price for a stock<I>&nbsp;</I>appreciation right, which generally cannot be less than 100% of the fair market
value of common stock on the date<I>&nbsp;</I>of grant. A stock appreciation right granted under the 2025 Plan vests at the rate specified
in the stock appreciation<I>&nbsp;</I>right agreement as determined by the plan administrator. Stock appreciation rights may be settled
in cash or shares<I>&nbsp;</I>of common stock or in any other form of payment as determined by our Board and specified in the stock appreciation<I>&nbsp;</I>right
agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The plan administrator determines the term of
stock appreciation rights granted under the 2025 Plan, up to a maximum of 10 years. If a participant&rsquo;s service relationship with
us or any of our affiliates ceases for any reason other than cause, disability, or death, the participant may generally exercise any vested
stock appreciation right for a period of three months following the cessation of service. This period may be further extended in the event
that exercise of the stock appreciation right following such a termination of service is prohibited by applicable securities laws. If
a participant&rsquo;s service relationship with us, or any of our affiliates, ceases due to disability or death, or a participant dies
within a certain period following cessation of service, the participant or a beneficiary may generally exercise any vested stock appreciation
right for a period of 12 months in the event of disability and 18 months in the event of death. In the event of a termination for cause,
stock appreciation rights generally terminate immediately upon the occurrence of the event giving rise to the termination of the individual
for cause. In no event may a stock appreciation right be exercised beyond the expiration of its term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Performance Awards</I>. The 2025 Plan permits
the grant of performance awards that may be settled in stock, cash<I>&nbsp;</I>or other property. Performance awards may be structured
so that the stock or cash will be issued or paid only<I>&nbsp;</I>following the achievement of certain pre-established performance goals
during a designated performance period.<I>&nbsp;</I>Performance awards that are settled in cash or other property are not required to
be valued in whole or in part by<I>&nbsp;</I>reference to, or otherwise based on, the common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The performance goals may be based on any measure
of performance selected by our Board. The performance goals may be based on company-wide performance or performance of one or more business
units, divisions, affiliates, or business segments, and may be either absolute or relative to the performance of one or more comparable
companies or the performance of one or more relevant indices. Unless specified otherwise by our Board at the time the performance award
is granted, the Board will appropriately make adjustments in the method of calculating the attainment of performance goals as follows:
(i) to exclude restructuring charges; (ii) to exclude exchange rate effects; (iii) to exclude the effects of changes to generally accepted
accounting principles; (iv) to exclude the effects of any statutory adjustments to corporate tax rates; (v) to exclude the effects of
items that are &ldquo;unusual&rdquo; in nature or occur &ldquo;infrequently&rdquo; as determined under U.S. GAAP; (vi) to exclude the
dilutive effects of acquisitions or joint ventures; (vii) to assume that any portion of the Company&rsquo;s business which is divested
achieved performance objectives at targeted levels during the balance of a performance period following such divestiture; (viii) to exclude
the effect of any change in the outstanding shares of common stock by reason of any stock dividend or split, stock repurchase, reorganization,
recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions
to common stockholders other than regular cash dividends; (ix) to exclude the effects of stock based compensation and the award of bonuses
under the Company&rsquo;s bonus plans; (x) to exclude costs incurred in connection with potential acquisitions or divestitures that are
required to be expensed under U.S. GAAP; and (xi) to exclude the goodwill and intangible asset impairment charges that are required to
be recorded under U.S. GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Other Stock Awards</I>. The plan administrator
may grant other awards based in whole or in part by reference to<I>&nbsp;</I>common stock. The plan administrator will set the number
of shares under the stock award (or cash equivalent) and<I>&nbsp;</I>all other terms and conditions of such awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Non-Employee Director Compensation Limit</I>.
The aggregate value of all compensation granted or paid to any<I>&nbsp;</I>non-employee director with respect to any calendar year, including
awards granted and cash fees paid by the<I>&nbsp;</I>Company to such non-employee director, will not exceed $750,000 in total value or,
in the event such non-employee<I>&nbsp;</I>director is first appointed or elected to the Board during such calendar year, $1,000,000 in
total value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Changes to Capital Structure</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event there is a specified type of change
in our capital structure, such as a stock split, reverse stock split, or recapitalization, appropriate adjustments will be made to: (1)
the class and maximum number of shares reserved for issuance under the 2025 Plan; (2) the class and maximum number of shares by which
the share reserve may increase automatically each year; (3) the class and maximum number of shares that may be issued on the exercise
of ISOs; and (4) the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all outstanding
stock awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Corporate Transactions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following applies to stock awards under the
2025 Plan in the event of a corporate transaction (as defined in the 2025 Plan), unless otherwise provided in a participant&rsquo;s stock
award agreement or other written agreement with us or one of our affiliates or unless otherwise expressly provided by the plan administrator
at the time of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a corporate transaction, any stock
awards outstanding under the 2025 Plan may be assumed, continued or substituted for by any surviving or acquiring corporation (or its
parent company), and any reacquisition or repurchase rights held by us with respect to the stock award may be assigned to the successor
(or its parent company). If the surviving or acquiring corporation (or its parent company) does not assume, continue or substitute for
such stock awards, then (i) with respect to any such stock awards that are held by participants whose continuous service has not terminated
prior to the effective time of the corporate transaction, or current participants, the vesting (and exercisability, if applicable) of
such stock awards will be accelerated in full to a date prior to the effective time of the corporate transaction (contingent upon the
effectiveness of the corporate transaction), and such stock awards will terminate if not exercised (if applicable) at or prior to the
effective time of the corporate transaction, and any reacquisition or repurchase rights held by us with respect to such stock awards will
lapse (contingent upon the effectiveness of the corporate transaction), and (ii) any such stock awards that are held by persons other
than current participants will terminate if not exercised (if applicable) prior to the effective time of the corporate transaction, except
that any reacquisition or repurchase rights held by us with respect to such stock awards will not terminate and may continue to be exercised
notwithstanding the corporate transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event a stock award will terminate if not
exercised prior to the effective time of a corporate transaction, the plan administrator may provide, in its sole discretion, that the
holder of such stock award may not exercise such stock award but instead will receive a payment equal in value to the excess (if any)
of (i) value of the property that Participant would have received upon the exercise of the award, over (ii) any per share exercise price
payable by such holder, if applicable. In addition, any escrow, holdback, earn out or similar provisions in the definitive agreement for
the corporate transaction may apply to such payment to the same extent and in the same manner as such provisions apply to the holders
of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Change in Control</I>. Awards granted under
the 2025 Plan may be subject to acceleration of vesting and<I>&nbsp;</I>exercisability upon or after a change in control (as defined in
the 2025 Plan) as may be provided in the applicable<I>&nbsp;</I>stock award agreement or in any other written agreement between us or
any affiliate and the participant, but in the<I>&nbsp;</I>absence of such provision, no such acceleration will automatically occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Term</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awards under the 2025 Plan may not be made after January 10, 2035,
but awards granted prior to such date may extend beyond that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms of each stock option shall be decided
by the plan administrator provided that no stock options shall be exercisable more than ten years after the date such stock option is
granted (or in the case of an incentive stock option granted to a 10% stockholder, no more than five years after the date such stock option
is granted.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Amendment and Termination</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the rules referred to in the balance
of this paragraph, our Board may, without stockholder approval, at any time amend, in whole or in part, any or all of the provisions of
the 2025 Plan, or suspend or terminate it entirely, retroactively or otherwise. Except as required to comply with applicable law, no such
amendment may materially reduce the rights of a participant with respect to awards previously granted without the consent of such participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>United States Federal Income Tax Consequences</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following discussion of the principal U.S.
federal income tax consequences with respect to stock options granted under the 2025 Plan is based on statutory authority and judicial
and administrative interpretations as of the date of this proxy statement, which are subject to change at any time (possibly with retroactive
effect) and may vary in individual circumstances. The discussion is limited to the U.S. federal income tax consequences (state, local
and other tax consequences are not addressed below) to individuals who are citizens or residents of the U.S., other than those individuals
who are taxed on a residence basis in a foreign country. In addition, the following discussion does not set forth any gift, estate, social
security or state or local tax consequences that may be applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.S. federal income tax law is technical and
complex and the discussion below represents only a general summary. The following summary is included for general information only and
does not purport to address all the tax considerations that may be relevant. Each recipient of a grant is urged to consult his or her
own tax advisor as to the specific tax consequences to such grantee and the disposition of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Incentive Stock Options.&nbsp;</I>The grant
or exercise of an ISO generally has no income tax consequences for the<I>&nbsp;</I>optionee or us. No taxable income results to the optionee
upon the grant or exercise of an ISO. However, the amount<I>&nbsp;</I>by which the fair market value of the stock acquired pursuant to
the exercise of an ISO exceeds the exercise price<I>&nbsp;</I>is an adjustment item and will be considered income for purposes of alternative
minimum tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate fair market value of common stock
(determined at the time of grant) with respect to which ISOs can be exercisable for the first time by an optionee during any calendar
year cannot exceed $100,000. In such case, the ISOs will be treated as a non-qualified stock option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The sale of common stock received pursuant to
the exercise of an option that satisfied all of the ISO requirements, as well as the holding period requirement described below, will
result in a long-term capital gain or loss equal to the difference between the amount realized on the sale and the exercise price. To
receive ISO treatment, an optionee must be an employee of the Company (or certain affiliates) at all times during the period beginning
on the date of the grant of the ISO and ending on the day three months before the date of exercise, and the optionee must not dispose
of the common stock purchased pursuant to the exercise of an option either (i) within two years from the date the ISO was granted, or
(ii) within one year from the date of exercise of the ISO. Any gain or loss realized upon a subsequent disposition of the shares of common
stock will be treated as a long-term capital gain or loss to the optionee (depending on the applicable holding period). The Company will
not be entitled to a tax deduction upon such exercise of an ISO, or upon a subsequent disposition of the shares of common stock, unless
such disposition occurs prior to the expiration of the holding period described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, if the optionee does not satisfy the
foregoing holding periods, any gain (in an amount equal to the lesser of the fair market value of the common stock on the date of exercise
(or, with respect to officers subject to Section 16(b) of the Exchange Act, the date that sale of such common stock would not create liability,
referred to as Section 16(b) liability, under Section 16(b) of the Exchange Act) minus the exercise price, or the amount realized on the
disposition minus the exercise price) will constitute ordinary income. In the event of such a disposition before the expiration of the
holding periods described above, subject to the limitations under Code Sections 162(m) and 280G, the Company is generally entitled to
a deduction at that time equal to the amount of ordinary income recognized by the optionee and any gain in excess of the amount recognized
by the optionee as ordinary income would be taxed to the optionee as short-term or long-term capital gain (depending on the applicable
holding period).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Non-Qualified Stock Options.&nbsp;</I>In general,
an optionee will realize no taxable income upon the grant of an NSO<I>&nbsp;</I>and the Company will not receive a deduction at the time
of such grant unless the option has a readily ascertainable<I>&nbsp;</I>fair market value (as determined under applicable tax law) at
the time of grant. Upon exercise of an NSO, an optionee<I>&nbsp;</I>generally will recognize ordinary income in an amount equal to the
excess of the fair market value of the stock on<I>&nbsp;</I>the date of exercise over the exercise price. Upon a subsequent sale of the
stock by the optionee, the optionee will<I>&nbsp;</I>recognize short-term or long-term capital gain or loss depending upon his or her
holding period for the stock. Subject<I>&nbsp;</I>to the limitations under Code Sections 162(m) and 280G, the Company will generally be
allowed a deduction equal<I>&nbsp;</I>to the amount recognized by the optionee as ordinary income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Code Section 162(m).&nbsp;</I>Compensation
of persons who are &ldquo;covered employees&rdquo; of the Company is subject to the<I>&nbsp;</I>tax deduction limits of Section 162(m)
of the Code. The exemption from Section 162(m)&rsquo;s deduction limit for<I>&nbsp;</I>performance-based compensation has been repealed,
effective for taxable years beginning after December 31, 2017,<I>&nbsp;</I>such that compensation paid to our covered employees in excess
of $1 million will not be deductible unless it<I>&nbsp;</I>qualifies for transition relief applicable to certain arrangements in place
as of November 2, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Parachute Payments.&nbsp;</I>In the event that
the payment or vesting of any award under the 2025 Plan is accelerated<I>&nbsp;</I>because of a change in ownership (as defined in Code
Section 280G(b)(2)) and such payment of an award, either alone or together with any other payments made to certain participants, constitute
parachute payments under Code Section<I>&nbsp;</I>280G, then subject to certain exceptions, a portion of such payments would be nondeductible
to the Company and the participant would be subject to a 20% excise tax on such portion of the payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Code Section 409A.&nbsp;</I>Code Section 409A
provides that all amounts deferred under a nonqualified deferred<I>&nbsp;</I>compensation plan are includible in a participant&rsquo;s
gross income to the extent such amounts are not subject to a<I>&nbsp;</I>substantial risk of forfeiture, unless certain requirements are
satisfied. If the requirements are not satisfied, in addition<I>&nbsp;</I>to current income inclusion, interest at the underpayment rate
plus 1% will be imposed on the participant&rsquo;s<I>&nbsp;</I>underpayments that would have occurred had the deferred compensation been
includible in gross income for the<I>&nbsp;</I>taxable year in which first deferred or, if later, the first taxable year in which such
deferred compensation is not<I>&nbsp;</I>subject to a substantial risk of forfeiture. The amount required to be included in income is
also subject to an additional<I>&nbsp;</I>20% tax. While most awards under the 2025 Plan are anticipated to be exempt from the requirements
of Code<I>&nbsp;</I>Section 409A, awards that are not exempt are intended to comply with Code Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>New Plan Benefits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the 2025 Plan, the terms and number of options
or other awards to be granted in the future are to be determined in the discretion of the plan administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The affirmative vote of holders of a majority
of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote as of the record date at the Annual
Meeting is required for the approval of this proposal. Abstentions will have the same effect as votes against the matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD OF DIRECTORS RECOMMENDS A VOTE&nbsp;<I>&ldquo;FOR&rdquo;</I></B>&nbsp;<B>APPROVAL
OF PROPOSAL NO. 4.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_008"></A>PROPOSAL NO. 5<BR>
VOTE TO APPROVE ADJOURNMENT OF REVERSE STOCK SPLIT PROPOSAL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has approved the submission to the stockholders
of a proposal to approve one or more adjournments of the Annual Meeting in the event that there is not a sufficient number of votes at
the Annual Meeting to approve Proposal&nbsp;3. In order to permit proxies that have been timely received to be voted for such adjournments,
we are submitting this proposal as a separate matter for your consideration. If it is necessary to adjourn the Annual Meeting, the adjournment
is for a period of less than 30&nbsp;days and the record date remains unchanged, no notice of the time and place of the reconvened meeting
will be given to stockholders, other than an announcement made at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The affirmative vote of holders of a majority
of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote as of the record date at the Annual
Meeting is required for the approval of this proposal. Abstentions will have the same effect as votes against the matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD OF DIRECTORS RECOMMENDS A VOTE &ldquo;<I>FOR</I>&rdquo;
APPROVAL OF PROPOSAL NO. 5.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_009"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the beneficial
ownership of our Common Stock as of January&nbsp;3, 2025 for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 20pt; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">each person, or group of affiliated persons, who is known by
us to beneficially own more than 5% of our Common Stock;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 20pt; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">each of our named executive officers;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 20pt; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">each of our directors; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 20pt; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">all of our current executive officers and directors as a group.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table lists applicable percentage ownership based on 30,857,923&nbsp;shares
of Common Stock outstanding as of January&nbsp;3, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have determined beneficial ownership in accordance
with the rules of the SEC.&nbsp;These rules generally attribute beneficial ownership of securities to persons who possess sole or shared
voting power or investment power with respect to those securities. Unless otherwise indicated, the persons or entities identified in this
table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community
property laws. In addition, the rules include shares of our Common Stock issuable pursuant to the exercise of stock options and warrants
that are either immediately exercisable or exercisable within 60&nbsp;days of January&nbsp;3, 2025. These shares are deemed to be outstanding
and beneficially owned by the person holding those options for the purpose of computing the percentage ownership of that person, but they
are not treated as outstanding for the purpose of computing the percentage ownership of any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise noted below, the address for
persons listed in the table is c/o NeuroOne Medical Technologies Corporation, 7599 Anagram Dr., Eden Prairie, MN&nbsp;55344.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name and address of beneficial owner</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <BR> shares of <BR> Common&nbsp;Stock <BR> beneficially <BR> owned</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage of <BR> Common&nbsp;Stock <BR> beneficially <BR> owned<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; text-indent: -10pt; padding-left: 10pt">Greater than 5% Stockholders:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Morgan C. Frank<SUP>(2)</SUP></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c/o Manchester Management Company, LLC</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2 Calle Candina, #1701</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt">San Juan, Puerto Rico 00907</P></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,438,126</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7.9</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt">AWM Investment Company, Inc. <SUP>(3)</SUP></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt">c/o Special Situations Funds</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt">527 Madison Avenue, Suite 2600</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt">New York, NY 10022</P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,387,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.7</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Laurence W. Lytton<SUP>(4)</SUP></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">467 Central Park West</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt">New York, NY 10025</P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,059,922</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.6</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; text-indent: -10pt; padding-left: 10pt">Directors and Named Executive Officers:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Rosa<SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,395,484</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward Andrle<SUP>(6)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">124,973</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Buckman<SUP>(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">234,649</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey Mathiesen<SUP>(8)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,919</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronald McClurg<SUP>(9)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">295,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher Volker<SUP>(10)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">183,186</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All Current Directors and Officers as a Group (8 persons)<SUP>(11)</SUP></B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,906,272</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.9</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 20%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Based on 30,857,923&nbsp;shares of Common Stock outstanding as of January&nbsp;3,
2025.</P></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Based on a Schedule&nbsp;13G/A filed by James E.&nbsp;Besser,
Morgan C.&nbsp;Frank, Manchester Management Co LLC, Manchester Management PR, LLC, and Manchester Explorer, L.P. on August&nbsp;2, 2023.&nbsp;Manchester
Explorer, L.P. reports shared voting and investment powers over 2,364,052&nbsp;shares; Manchester Management Company, LLC and Manchester
Management PR, LLC report shared voting and shared investment powers over 2,364,052&nbsp;shares; Mr.&nbsp;Besser reports sole voting
and investment powers over 80,983&nbsp;shares, and shared voting and investment powers over 2,355,055&nbsp;shares; and Mr.&nbsp;Frank
reports sole voting and investment powers over 83,333 shares, and shared voting and investment powers over 2,354,793 shares. The reporting
persons, except Messrs. Besser and Frank, disclaim beneficial ownership of the reported securities except to the extent of their pecuniary
interest therein.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Based on a Schedule 13G/A filed by AWM Investment Company, Inc.
Includes shares of common stock and warrants held by Special Situations Private Equity Fund, L.P. (&ldquo;SSPE&rdquo;) and Special Situations
Life Sciences Fund, L.P. (&ldquo;SSLS&rdquo;). AWM Investment Company, Inc. (&ldquo;AWM&rdquo;) is the investment adviser to Cayman,
SSFQP, SSPE and SSLS (collectively, the &ldquo;Funds&rdquo;). According to the Schedule 13G filed on November 14, 2024, AWM is the investment
adviser to the Funds and, as of November 14, 2024, holds sole voting and investment power over 2,387,500 shares of common stock and warrants
to purchase 1,250,000 shares of common stock held by SSPE and SSLS. The warrants may only be exercised to the extent that the total number
of shares of common stock beneficially owned does not exceed 9.99% of the outstanding shares.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: justify">Based on a Schedule&nbsp;13G/A filed by Laurence W.&nbsp;Lytton
on November 25, 2024.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">Includes 171,082 restricted stock units and 798,799&nbsp;shares of
Common Stock issuable upon exercise of outstanding options that have vested or vest within 60&nbsp;days of January&nbsp;3, 2025.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(6)</TD><TD STYLE="text-align: justify">Includes 60,748&nbsp;shares of Common Stock issuable upon exercise
of outstanding options that have vested or vest within 60&nbsp;days of January&nbsp;3, 2025.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(7)</TD><TD STYLE="text-align: justify">Includes 125,623&nbsp;shares of Common Stock issuable upon exercise
of outstanding options that have vested or vest within 60&nbsp;days of January&nbsp;3, 2025.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(8)</TD><TD STYLE="text-align: justify">Includes 114,283&nbsp;shares of Common Stock issuable upon exercise
of outstanding options that have vested or vest within 60&nbsp;days of January&nbsp;3, 2025.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(9)</TD><TD STYLE="text-align: justify">Includes 28,742 restricted stock units and 141,896&nbsp;shares of Common
Stock issuable upon exercise of outstanding options that have vested or vest within 60&nbsp;days of January&nbsp;3, 2025.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(10)</TD><TD STYLE="text-align: justify">Includes 108,186&nbsp;shares of Common Stock issuable upon exercise
of outstanding options that have vested or vest within 60&nbsp;days of January&nbsp;3, 2025.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(11)</TD><TD STYLE="text-align: justify">Includes 232,693 restricted stock units and 1,476,963&nbsp;shares of
Common Stock issuable upon exercise of outstanding options, in each case that have vested or vest within 60&nbsp;days of January&nbsp;3,
2025.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Less than 1%</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><B></B></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_010"></A>EXECUTIVE OFFICERS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides information regarding
our executive officers as of January&nbsp;10, 2025:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 20%"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 5%"><FONT STYLE="font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 73%"><FONT STYLE="font-size: 10pt"><B>Position(S)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">David Rosa</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-size: 10pt">60</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer, President and Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">Ronald McClurg</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-size: 10pt">66</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">Christopher Volker</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-size: 10pt">53</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">Chief Operating Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">Steve Mertens</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-size: 10pt">62</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">Chief Technology Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">Mark Christianson</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-size: 10pt">57</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">Business Development Director, Medical Sales Liaison</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See &ldquo;Proposal&nbsp;No.&nbsp;1&nbsp;&mdash;&nbsp;Election
of Class&nbsp;II Director&rdquo; for biographical and other information regarding Mr.&nbsp;Rosa.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Ronald McClurg</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;McClurg has served as Chief Financial
Officer of the Company since January&nbsp;2021. Prior to joining the Company, from October&nbsp;2003 to June&nbsp;2019, Mr.&nbsp;McClurg
served as vice president&nbsp;&mdash;&nbsp;finance and administration and chief financial officer of Incisive Surgical, Inc., a privately-held
medical device manufacturer, where he was responsible for all aspects of the financial function, including raising capital, financial
reporting, budgeting, banking and risk management. From 1997 to 2002, Mr.&nbsp;McClurg served as chief financial officer and treasurer
of Wavecrest Corporation, a privately-held manufacturer of electronic test instruments for the semiconductor industry. Prior to 1997,
Mr.&nbsp;McClurg served as chief financial officer for several publicly-held companies, including Video Sentry Corporation, Insignia Systems,
Inc. (Nasdaq: ISIG), and Orthomet, Inc. Currently, he serves on the board of governors of Biomagnetic Sciences, LLC and serves as a director
and audit committee chair for Biotricity, Inc. (Nasdaq: BTCY), and serves as a director and audit committee chair for Healthcare Triangle,
Inc. (Nasdaq: HCTI). Mr.&nbsp;McClurg holds a Bachelor of Business Administration degree in accounting from the University of Wisconsin&nbsp;&mdash;&nbsp;Eau
Claire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Christopher Volker</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Volker has served as Chief Operating
Officer of the Company since November&nbsp;2023. Prior to joining the Company, Mr.&nbsp;Volker served as Head of Commercial Integration
for Abbott Laboratories which acquired Cardiovascular Systems, Inc. in April&nbsp;2023. From May&nbsp;2017 until August&nbsp;2023, Mr.&nbsp;Volker
held the role of Vice President and General Manager, International for Cardiovascular Systems, Inc. and was responsible for all of the
company&rsquo;s international business, including sales, marketing, training and education, and program management. From August&nbsp;2014
until May&nbsp;2017, Mr.&nbsp;Volker served as Vice President of Corporate Development and Health Economics&nbsp;&amp; Reimbursement at
Cardiovascular Systems, Inc. In such capacity, he led cross-functional teams in developing corporate strategic plans, negotiations with
distribution partners, and developed and implemented reimbursement strategies for new technology. Mr.&nbsp;Volker received a Bachelor
of Arts in Economics and Management from St. John&rsquo;s University and a Master of Business Administration in Finance from The Wharton
School at the University of Pennsylvania.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Steve Mertens</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Mertens has served as Chief Technology
Officer of the Company since April&nbsp;2019. From September&nbsp;2018 through April&nbsp;2019, Mr.&nbsp;Mertens was the principal and
owner of Steve Mertens Consulting, L.L.C., where he provided new product development engineering support and assessment services to various
clients. From November&nbsp;2012 through September&nbsp;2018, Mr.&nbsp;Mertens served as the senior vice president of research and development
and operations at Nuvaira Inc., a privately held lung denervation company developing minimally invasive product for obstructive lung diseases.
Prior to Nuvaira<B>,</B> Mr.&nbsp;Mertens served as a senior vice president of research and development for Boston Scientific Corporation
(NYSE:&nbsp;BSX), guiding a wide range of technologies through product development for the cardiology, electrophysiology and peripheral
vascular markets. He holds a bachelor&rsquo;s degree in chemical engineering from the University of Minnesota and a Master&rsquo;s degree
in business administration from the University of St. Thomas. Currently, he serves on the board of directors of the University Enterprise
Laboratories.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Mark Christianson</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Christianson is a co-founder of the Company
and has served as Business Development Director and Medical Sales Liaison of the Company since February&nbsp;2019. Previously, he served
as Vice President of Business Development and Marketing of the Company from July&nbsp;2017 until February&nbsp;2019 and served as vice
president of sales and marketing of our wholly-owned subsidiary, NeuroOne, Inc., since December&nbsp;2016. From May&nbsp;2013 to December&nbsp;2016
Mr.&nbsp;Christianson served as North American sales manager for Cortec Corporation. From February&nbsp;2012 to May&nbsp;2013 Mr.&nbsp;Christianson
held the position of business development executive for Robert Half International (NYSE:&nbsp;RHI). From May&nbsp;2009 to February&nbsp;2012,
Mr.&nbsp;Christianson held the position of regional sales manager for PMT Corporation. Mr.&nbsp;Christianson studied accounting at Augsburg
College in Minneapolis. Mr.&nbsp;Christianson brings 15&nbsp;years of high performing sales, sales management, and project management
experience to the NeuroOne team. In addition, he has contributed to the development and corporate strategy of the Company given his experience
in the neurological field and his close relationships with key epilepsy opinion leaders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>





<!-- Field: Split-Segment; Name: 2 -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_011"></A>EXECUTIVE COMPENSATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Summary Compensation Table for Fiscal&nbsp;Years
2024 and 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows the compensation earned
or received during the fiscal&nbsp;years ended September&nbsp;30, 2024 and 2023 by each of our named executive officers (as determined
pursuant to the SEC&rsquo;s disclosure requirements for executive compensation in Item&nbsp;402 of Regulation&nbsp;S-K).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name and Principal Position</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Salary <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Stock <BR> Awards <BR> ($)<SUP>(1)</SUP></B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 6pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Option <BR> Awards <BR> ($)<SUP>(2)</SUP></B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Non-Equity <BR>
Incentive Plan <BR>
Compensation<BR>
 ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: justify">Dave Rosa,</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 9%; text-align: center">2024</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">521,856</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">683,402</TD><TD STYLE="padding-bottom: 6pt; width: 1%; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">562,175</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">228,312</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,995,745</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: 0in; padding-left: 0.125in; font-style: italic; text-align: justify">Chief Executive Officer and President</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">506,655</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">145,485</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">84,090</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">253,328</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">989,558</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 6pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Christoper Volker,</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2024</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">256,364</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 6pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">366,056</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">89,727</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">712,147</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in; font-style: italic; text-align: justify">Chief Operating Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2023</FONT><SUP>(3)</SUP></TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 6pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 6pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Ron McClurg,</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2024</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">316,764</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">117,129</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">95,368</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,292</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">598,553</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in; font-style: italic; text-align: justify">Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">307,538</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,875</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,488</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">51,256</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">390,157</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Amounts reported reflect the aggregate grant date fair value
of restricted stock units.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Amounts reported reflect the aggregate grant date fair value
of option awards, calculated in accordance with FASB Topic&nbsp;718, excluding the impact of potential forfeitures. For a discussion
of the weighted-average assumptions used in the valuation of option awards under the Black-Scholes option-pricing model, you should refer
to the &ldquo;Stock Options&rdquo; section in Note&nbsp;8 to the Company&rsquo;s financial statements in our Annual Report on Form&nbsp;10-K
for the year ended September&nbsp;30, 2024.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Mr. Volker was appointed as the Chief Operating Officer of the
Company effective on November 10, 2023.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify; text-indent: -23.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Narrative Disclosure to Summary Compensation
Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation program for the Company&rsquo;s
named executive officers for fiscal year 2024 had three components: base salary, annual cash bonus and stock option and RSU grants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Base Salary.&nbsp;&nbsp;&nbsp;&nbsp;</I>We
have entered into employment agreements or offer letters with each of our named executive officers that establish annual base salaries,
which are reviewed periodically by our Compensation Committee in order to compensate our named executive officers for the satisfactory
performance of duties to the Company. Annual base salaries are intended to provide a fixed component of compensation to our named executive
officers, reflecting their skill sets, experience, roles and responsibilities. Base salaries for our named executive officers have generally
been set at levels deemed necessary to attract and retain individuals with superior talent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was a 3% increase for cost of living adjustments
for the Company&rsquo;s named executive officers for fiscal year 2024, as compared to fiscal year 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Non-Equity Incentive Plan.&nbsp;&nbsp;&nbsp;&nbsp;</I>In
fiscal year 2024, each of the Company&rsquo;s named executive officers had a target bonus, set forth as a percentage of annual base salary.
In fiscal year 2024, target bonuses for Mr. Volker and Mr. McClurg were 40% and 25% of base salary, respectively. Mr.&nbsp;Rosa&rsquo;s
target bonus was set at 50% of base salary pursuant to his employment agreement, as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November&nbsp;2023, the Compensation Committee
established weighted performance targets for fiscal year 2024 that it would consider in approving bonus payments for fiscal year 2024.
These targets included various corporate objectives related to certain research and development, financing goals, commercialization milestones
and other corporate goals. In October 2024, the Compensation Committee determined that 85% of the performance targets had been met, and
approved the bonus payments to Messrs. Rosa, Volker and McClurg at 85% each of their respective targets, which targets were 50%, 40% and
25% of each of their base salaries, respectively, as discussed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Equity Grants.&nbsp;&nbsp;&nbsp;&nbsp;</I>Our
equity-based incentive awards which are mainly comprised of stock options are designed to align our interests with those of our employees
and consultants, including our named executive officers. Our compensation committee has responsibility for granting equity-based incentive
awards to our named executive officers. Our compensation committee has not established policies and practices regarding timing of equity
awards in relation to the release of material nonpublic information and does not time the public release of such information based on
equity award grant dates nor for the purpose of affecting the value of executive compensation. Our compensation committee does not consider
material nonpublic information in setting terms of equity awards, such as grant size or vesting conditions. Vesting of equity awards is
generally tied to continuous service with us and serves as an additional retention measure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our executives generally are awarded an initial
new hire grant upon commencement of employment. Additional grants may occur periodically in order to specifically incentivize executives
with respect to achieving certain corporate goals or to reward executives for exceptional performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with Mr.&nbsp;Volker&rsquo;s appointment
as Chief Operating Officer on November 10, 2023, the Board granted Mr.&nbsp;Volker an incentive stock option award to purchase 324,560
shares of Common Stock. Twenty-five percent of the shares vested on November 10, 2024, with the remaining shares vesting in equal monthly
installments on the last day of each month over the 36 months, subject to continued service on such vesting date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, the Compensation Committee granted
David Rosa and Ronald McClurg stock options in the amounts of 526,303 and 89,283, respectively. Twenty-five percent of the shares vested
on November 9, 2024, with the remaining shares vesting in equal monthly installments on the last&nbsp;day of each month over the next
36 months, subject to continued service on such vesting date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2024, the Compensation Committee granted
David Rosa and Ronald McClurg restricted stock units in the amounts of 663,497 and 113,717, respectively. Twenty-five percent of the shares
shall vest on the first, second, third and fourth anniversary of the grant date, subject to continued service on such vesting date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Employment Agreement and Arrangements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have an employment agreement with our Chief
Executive Officer, Mr.&nbsp;Rosa, and an offer letter for each of Mr. Volker and Mr.&nbsp;McClurg. Each of our named executive officers
has also executed our standard form of proprietary information, inventions assignment and non-competition agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mr.&nbsp;Rosa</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Rosa&rsquo;s employment agreement (&ldquo;Amended
Employment Agreement&rdquo;) was effective on August&nbsp;4, 2017 and amended on September 9, 2024, continues through the third anniversary
and automatically renews for an additional one-year period at the end of the initial term and each anniversary thereafter, provided that
Mr.&nbsp;Rosa notifies the Board of such renewal at least 30&nbsp;days prior to the expiration of the initial term or any renewal terms
and the Board does not notify Mr.&nbsp;Rosa of its intention not to renew the Amended Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Amended Employment Agreement also entitles
Mr.&nbsp;Rosa to, among other benefits, the following compensation: (i)&nbsp;an opportunity to participate in any stock option, performance
share, performance unit or other equity based long-term incentive compensation plan commensurate with the terms and conditions applicable
to other senior executive officers; and (ii)&nbsp;participation in welfare benefit plans, practices, policies and programs provided by
the Company and its affiliated companies (including, without limitation, medical, prescription, dental, disability, employee life, group
life, accidental death and travel accident insurance plans and programs) to the extent available generally or to our other senior executive
officers. Mr.&nbsp;Rosa is entitled to receive a target award value, determined in accordance with the policies and practices generally
available to other senior executive officers, for an annual cash bonus and if determined by the Board or a committee of the Board, a long-term
incentive bonus. Mr.&nbsp;Rosa is entitled to retain all shares of Common Stock he held as of the commencement date. Mr.&nbsp;Rosa is
also entitled to certain severance benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Amended Employment Agreement,
regardless of the manner in which Mr.&nbsp;Rosa&rsquo;s service terminates, Mr.&nbsp;Rosa is entitled to receive amounts earned during
his term of service, including salary and other benefits. The Company is permitted to terminate Mr.&nbsp;Rosa&rsquo;s employment for the
following reasons: (i)&nbsp;death or disability, (ii)&nbsp;Termination for Cause (as defined below), or (iii)&nbsp;for any other reason
or no reason. Mr.&nbsp;Rosa is permitted Termination for Good Reason (as defined below) of his employment. In addition, he may terminate
his employment upon written notice to the Company 30&nbsp;days prior to the effective date of such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of Mr.&nbsp;Rosa&rsquo;s death during
the employment period or a termination due to his disability, his beneficiaries or legal representatives shall be provided the sum of
(i)&nbsp;any annual base salary earned, but unpaid, for services rendered to the Company on or prior to the date on which the employment
period ends and (ii)&nbsp;certain other benefits provided for in the employment agreement (the &ldquo;Unconditional Entitlements&rdquo;).
In the event of Mr.&nbsp;Rosa&rsquo;s Termination for Cause by the Company or the termination of Mr.&nbsp;Rosa&rsquo;s employment as a
result of his resignation other than a Termination for Good Reason, Mr.&nbsp;Rosa shall be provided the Unconditional Entitlements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a Termination for Good Reason
by Mr.&nbsp;Rosa or the exercise by the Company of its termination rights to terminate Mr.&nbsp;Rosa other than by Termination for Cause,
death or disability, Mr.&nbsp;Rosa shall be provided the Unconditional Entitlements and, subject to his signing and delivering to the
Company and not revoking a general release of claims in favor of the Company and certain related parties, the Company shall provide Mr.&nbsp;Rosa:
(a)&nbsp;a severance amount equal to the aggregate annual base salary he would have earned from the&nbsp;day after his termination date
through the end of the employment period and a prorated portion of his cash bonus for the year in which the termination date occurs, provided,
however, in no event would the severance amount be less than 12&nbsp;months or more than 18&nbsp;months of his annual base salary; (b)&nbsp;continued
health insurance coverage for 12&nbsp;months following his termination date, provided that such coverage shall cease if Mr.&nbsp;Rosa
becomes eligible to receive health insurance coverage from another employer group health plan; (c)&nbsp;vesting of all stock options in
accordance with the stock option award documents, subject to the same conditions that would be applicable to Mr.&nbsp;Rosa if he remained
employed through the end of the employment period; and (d)&nbsp;continued vesting of equity awards in accordance with the terms of the
award agreements, provided, however, Mr.&nbsp;Rosa would have 90&nbsp;days from the termination date to exercise any vested options (the
&ldquo;Conditional Benefits&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If within 12 months following or three months
prior to the effective date of a change in control, the Company terminates Mr.&nbsp;Rosa other than due to Mr.&nbsp;Rosa&rsquo;s death
or disability or a Termination for Cause, or Mr.&nbsp;Rosa effects a Termination for Good Reason, the Company will pay to Mr.&nbsp;Rosa,
subject to his signing and delivering to the Company and not revoking a general release of claims in favor of the Company and certain
related parties, in a lump sum in cash within 30&nbsp;days after the termination date, an amount equal to the sum of: (i)&nbsp;the product
of 2.0 times Mr. Rosa&rsquo;s annual base salary as is then in effect as of the termination date and (ii) the product of 2.0 times Mr.
Rosa&rsquo;s target bonus for the year in which the termination date occurs. Additionally, Mr. Rosa will be entitled to continued health
insurance coverage for himself and covered dependents for up to 24 months following the termination date, with 100% of the cost of such
insurance premiums payable by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Amended Employment Agreement, &ldquo;Termination
for Cause&rdquo; means a termination of Mr.&nbsp;Rosa&rsquo;s employment by the Company due to (A)&nbsp;an act or acts of dishonesty undertaken
by Mr.&nbsp;Rosa and intended to result in substantial gain or personal enrichment to Mr.&nbsp;Rosa at the expense of the Company, (B)&nbsp;unlawful
conduct or gross misconduct that is willful and deliberate on Mr.&nbsp;Rosa&rsquo;s part and that, in either event, is materially injurious
to the Company, (C)&nbsp;the conviction of Mr.&nbsp;Rosa of, or Mr.&nbsp;Rosa&rsquo;s entry of a no contest or nolo contendere plea to,
a felony, (D)&nbsp;breach by Mr.&nbsp;Rosa of his fiduciary obligations as an officer or director of the Company, (E)&nbsp;a persistent
failure by Mr.&nbsp;Rosa to perform his duties and responsibilities of his employment under the Amended Employment Agreement, which failure
is not remedied by Mr.&nbsp;Rosa within 30&nbsp;days after his receipt of written notice from the Company of such failure, provided, however,
the Company is not obligated to provide written notice and opportunity to cure if the action or conduct is not reasonably susceptible
to cure, or (F)&nbsp;material breach of any terms and conditions of the Amended Employment Agreement, any contract or agreement between
Mr.&nbsp;Rosa and the Company, or of any Company policy, or of any statutory duty he owes to the Company, which breach has not been cured
by Mr.&nbsp;Rosa within ten&nbsp;days after written notice thereof to Mr.&nbsp;Rosa from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Amended Employment Agreement, &ldquo;Termination
for Good Reason&rdquo; means a termination of Mr.&nbsp;Rosa&rsquo;s employment by Mr.&nbsp;Rosa within 30&nbsp;days of the Company&rsquo;s
failure to cure, in accordance with the procedures set forth below, any of the following events: (A)&nbsp;a reduction in his annual base
salary as in effect immediately prior to such reduction by more than 10% without his written consent, unless such reduction is made pursuant
to an across the board reduction applicable to all senior executives of the Company; (B)&nbsp;a material reduction in his duties, position
and responsibilities as in effect immediately prior to such reduction without his written consent; provided, however, that a mere change
in title or reporting relationship following a Change in Control by itself will not constitute &ldquo;Good Reason&rdquo; for Mr.&nbsp;Rosa&rsquo;s
resignation, and further provided that the acquisition of the Company and subsequent conversion of the Company to a division or unit of
the acquiring entity will not by itself result in a &ldquo;reduction&rdquo; of duties, position or responsibility; or (C)&nbsp;a material
breach of any material provision of the Amended Employment Agreement by the Company. A termination by Mr.&nbsp;Rosa shall not be treated
as a Termination for Good Reason if Mr.&nbsp;Rosa consented in writing to the occurrence of the event giving rise to the claim of Termination
for Good Reason or unless Mr.&nbsp;Rosa shall have delivered a written notice to the Board within 45&nbsp;days of Mr.&nbsp;Rosa&rsquo;s
having actual knowledge of the occurrence of one of such events stating that Mr.&nbsp;Rosa intends to terminate his employment by Termination
for Good Reason and specifying the factual basis for such termination, and such event, if capable of being cured, shall not have been
cured within 21&nbsp;days of the receipt of such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mr.&nbsp;Volker</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 10, 2023, the Company and Mr.&nbsp;Volker
executed an employment offer letter, as amended on September 9, 2024 (as amended, the &ldquo;Volker Offer Letter&rdquo;) under which,
effective November 10, 2023, Mr.&nbsp;Volker was appointed Chief Operating Officer of the Company. The Volker Offer letter provides that
Mr.&nbsp;Volker is an at-will employee of the Company meaning that either Mr.&nbsp;Volker or the Company may end the employment relationship
at any time, for any reason, and with or without notice or cause. Under the Volker Offer Letter, the Company agreed to provide Mr.&nbsp;Volker:
(a)&nbsp;an annual base salary in the amount of $288,000, subject to applicable deductions and adjustment; (b)&nbsp;an annual discretionary
bonus of up to 40% percent of Mr.&nbsp;Volker&rsquo;s base salary based on his performance and the Company&rsquo;s performance, all as
determined in the sole discretion of the Board or committee thereof; (c)&nbsp;subject to the terms of Company&rsquo;s 2021 Inducement
Plan, a stock option award to purchase 324,560&nbsp;shares of the Company&rsquo;s Common Stock with an exercise price of $1.32 per share,
25% of which vested on November 10, 2024, and 75% of which vest in 36 equal monthly installments beginning on November 30, 2024; and (d)&nbsp;the
right to participate in the benefit programs and arrangements that the Company makes available to its employees, including paid vacation
and sick leave, contributory and non-contributory welfare and benefit plans, disability plans, and medical, death benefit and life insurance
plans for which Mr.&nbsp;Volker is eligible under the terms of those plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mr.&nbsp;McClurg</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January&nbsp;1, 2021, the Company and Mr.&nbsp;McClurg
executed an employment offer letter, as amended on September 9, 2024, (as amended, the &ldquo;McClurg Offer Letter&rdquo;) under which,
effective January&nbsp;1, 2021, Mr.&nbsp;McClurg was appointed Chief Financial Officer of the Company. The McClurg Offer Letter provides
that Mr.&nbsp;McClurg is an at-will employee of the Company meaning that either Mr.&nbsp;McClurg or the Company may end the employment
relationship at any time, for any reason, and with or without notice or cause. Under the McClurg Offer Letter, the Company agreed to provide
Mr.&nbsp;McClurg: (a)&nbsp;an annual base salary in the amount of $250,000, subject to review and adjustment based upon the Company&rsquo;s
normal performance review practices; (b)&nbsp;an annual performance bonus of up to 25% of Mr.&nbsp;McClurg&rsquo;s then effective base
salary for the applicable bonus year based upon his performance and the Company&rsquo;s performance, all as determined in the sole discretion
of the Board or committee thereof; (c)&nbsp;the right to participate in the benefit programs and arrangements that the Company makes available
to its employees, including paid vacation and sick leave, contributory and non-contributory welfare and benefit plans, disability plans,
and medical, death benefit and life insurance plans for which Mr.&nbsp;McClurg is eligible under the terms of those plans; and (d)&nbsp;subject
to the terms of Company&rsquo;s 2017 Equity Incentive Plan, a stock option award to purchase 60,000&nbsp;shares of the Company&rsquo;s
Common Stock with an exercise price of $4.71 per share, 25% of which vested on January&nbsp;1, 2022, with the balance vesting in equal
monthly installments on the last&nbsp;day of each month over the next thirty-six (36)&nbsp;months following January&nbsp;1, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Potential Payments Upon Termination or Change
in Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>David Rosa</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a discussion of payments to Mr.&nbsp;Rosa
upon termination or change in control under his Amended Employment Agreement, see &ldquo;<I>Employment Agreement and Arrangements&nbsp;&mdash;&nbsp;Mr.&nbsp;Rosa</I>&rdquo;
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I></I></B></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Christopher Volker and Ronald McClurg</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of Mr. Volker&rsquo;s and Mr. McClurg&rsquo;s&rsquo;
offer letter provides that if within 12 months following or three months prior to the effective date of a change in control, the Company
terminates the executive officer other than due to the executive officer&rsquo;s death or disability or a Termination for Cause, or the
executive officer effects a Termination for Good Reason, the Company will pay to the executive officer, subject to his signing and delivering
to the Company and not revoking a general release of claims in favor of the Company and certain related parties, in a lump sum in cash
within 30&nbsp;days after the termination date, an amount equal to the sum of: (i)&nbsp;the product of 1.25 times his annual base salary
as is then in effect as of the termination date and (ii) the product of 1.25 times his target bonus for the year in which the termination
date occurs. Additionally, the executive officer will be entitled to continued health insurance coverage for himself and covered dependents
for up to 15 months following the termination date, with 100% of the cost of such insurance premiums payable by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under both the Volker Offer Letter and McClurg
Offer Letter, &ldquo;Termination for Cause&rdquo; means a termination of the executive officer&rsquo;s employment by the Company due to
(i) an act or acts of dishonesty undertaken by him and intended to result in substantial gain or personal enrichment to him at the expense
of the Company; (ii) unlawful conduct or gross misconduct that is willful and deliberate on his part in the performance of his employment
duties and that, in either event, is injurious to the Company; (iii) the conviction of the executive officer of, or his entry of a no
contest or nolo contendere plea to, a felony; (iv) breach by the executive officer of his fiduciary obligations as an officer of the Company;
(v) a persistent failure by the executive officer to perform the duties and responsibilities of his employment with the Company, which
failure is willful and deliberate on the executive officer&rsquo;s part and is not remedied by him within thirty (30) days after his receipt
of written notice from the Company of such failure; or (vi) material breach of any terms and conditions of this letter agreement or the
PIIA by the executive officer, which breach has not been cured by him within ten (10) days after written notice thereof to him from the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under both the Volker Offer Letter and McClurg
Offer Letter , &ldquo;Termination for Good Reason&rdquo; means a termination of the executive officer&rsquo;s employment with the Company
by him within thirty (30) days of the Company&rsquo;s failure to cure, in accordance with the procedures set forth below, any of the following
events: (i) a reduction in his annual base salary as in effect immediately prior to such reduction by more than ten percent (10%) without
his written consent, unless such reduction is made pursuant to an across the board reduction applicable to all employees of the Company;
(ii) a material reduction in the executive officer&rsquo;s duties, position and responsibilities as in effect immediately prior to such
reduction without his written consent, and further provided that the acquisition of the Company and subsequent conversion of the Company
to a division or unit of the acquiring entity will not by itself result in a &ldquo;reduction&rdquo; of duties, position or responsibility;
(iii) a requirement by the Company that the executive officer relocate his principal employment responsibilities to a location that is
more than 25 miles from the location at which his principal employment responsibilities are then being performed; or (iv) a material breach
of any material provision of this letter agreement by the Company. Notwithstanding the foregoing, a termination shall not be treated as
a Termination for Good Reason (y) if the executive officer shall have consented in writing to the occurrence of the event giving rise
to the claim of Termination for Good Reason, or (z) unless the executive officer shall have delivered a written notice to the Board within
forty-five (45) days of him having actual knowledge of the occurrence of one of such events stating that he intends to terminate his employment
with the Company for Good Reason and specifying the factual basis for such termination, and such event, if capable of being cured, shall
not have been cured within twenty-one (21) days of the receipt of such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>2017 Equity Incentive Plan</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In April&nbsp;2017, the Board adopted and the
stockholders approved the 2017 Equity Incentive Plan. The 2017 Equity Incentive Plan is designed to provide a vehicle under which a variety
of stock-based and other awards can be granted to the Company&rsquo;s employees, consultants and directors, which align the interests
of award recipients with those of our stockholders, reinforce key goals and objectives that help drive stockholder value, and attract,
motivate and retain experienced and highly qualified individuals who contribute to the Company&rsquo;s financial success. The Board believes
that the 2017 Equity Incentive Plan serves a critical role in attracting and retaining high caliber employees, consultants and directors
essential to our success and in motivating these individuals to strive to meet our goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Corporate Transactions.&nbsp;&nbsp;&nbsp;&nbsp;</I>The
2017 Equity Incentive Plan provides that in the event of certain specified significant corporate transactions, including: (1)&nbsp;a sale
of all or substantially all of our assets, (2)&nbsp;the sale or disposition of more than 90% of our outstanding securities, (3)&nbsp;the
consummation of a merger or consolidation where we do not survive the transaction, and (4)&nbsp;the consummation of a merger or consolidation
where we do survive the transaction but the shares of our Common Stock outstanding before such transaction are converted or exchanged
into other property by virtue of the transaction, unless otherwise provided in an award agreement or other written agreement between us
and the award holder, the plan administrator may take one or more of the following actions with respect to such stock awards:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">arrange for the assumption, continuation, or substitution of
a stock award by a successor corporation;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">arrange for the assignment of any reacquisition or repurchase
rights held by us to a successor corporation;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">accelerate the vesting, in whole or in part, of the stock award
and provide for its termination before the transaction;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">arrange for the lapse, in whole or in part, of any reacquisition
or repurchase rights held by us;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">cancel or arrange for the cancellation of the stock award before
the transaction in exchange for a cash payment, or no payment, as determined by the Board; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">make a payment, in the form determined by our Board, equal to
the excess, if any, of the value of the property the participant would have received on exercise of the awards before the transaction
over any exercise price payable by the participant in connection with the exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The plan administrator is not obligated to treat
all stock awards or portions of stock awards, even those that are of the same type, in the same manner and is not obligated to treat all
participants in the same manner. In the event of a change in control, awards granted under the 2017 Equity Incentive Plan will not receive
automatic acceleration of vesting and exercisability, although this treatment may be provided for in an award agreement. Under the 2017
Equity Incentive Plan, a change in control is defined to include (1)&nbsp;the acquisition by any person or company of more than 50% of
the combined voting power of our then outstanding stock, (2)&nbsp;a merger, consolidation, or similar transaction in which our stockholders
immediately before the transaction do not own, directly or indirectly, more than 50% of the combined voting power of the surviving entity
(or the parent of the surviving entity), (3)&nbsp;a sale, lease, exclusive license, or other disposition of all or substantially all of
our assets other than to an entity more than 50% of the combined voting power of which is owned by our stockholders, and (4)&nbsp;an unapproved
change in the majority of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Outstanding Equity Awards at Fiscal Year&nbsp;&mdash;&nbsp;End
2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information regarding
outstanding option awards held by our named executive officers as of September&nbsp;30, 2024:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">NAME</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">GRANT <BR> DATE</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">NUMBER OF <BR> SECURITIES <BR> UNDERLYING <BR> UNEXERCISED <BR> OPTIONS <BR> EXERCISABLE <BR> (#)</TD><TD STYLE="text-align: center; padding-bottom: 6pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">NUMBER OF <BR> SECURITIES <BR> UNDERLYING <BR> UNEXERCISED <BR> OPTIONS <BR> UNEXERCISABLE <BR> (#)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">OPTION <BR> EXERCISE <BR> PRICE <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">OPTION <BR> EXPIRATION <BR> DATE</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; text-align: justify">David Rosa</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 16%; text-align: center">November&nbsp;5,&nbsp;2019</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">166,667</TD><TD STYLE="padding-bottom: 6pt; width: 1%; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">6.42</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: center">November&nbsp;5,&nbsp;2029</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">David Rosa</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">January&nbsp;27,&nbsp;2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">397,750</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,097</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.97</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">January&nbsp;27,&nbsp;2031</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">David Rosa</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">April&nbsp;21,&nbsp;2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,312</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,188</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.59</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">April&nbsp;20,&nbsp;2033</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">David Rosa</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">November 9, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(4)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">526,303</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.25</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">November 8, 2033</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Ronald McClurg</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">January&nbsp;1,&nbsp;2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,250</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.71</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">January&nbsp;1,&nbsp;2031</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Ronald McClurg</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">January&nbsp;27,&nbsp;2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,667</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(6)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,889</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.97</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">January&nbsp;27,&nbsp;2031</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Ronald McClurg</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">April&nbsp;21,&nbsp;2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,687</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(7)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,813</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.59</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">April&nbsp;20,&nbsp;2033</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Ronald McClurg</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">November 9, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(8)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">89,283</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.25</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">November 8, 2033</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Christopher Volker</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">November 10, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(9)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">324,560</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.32</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">November 10, 2024</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">25% of the shares underlying the option vested on November&nbsp;5,
2020 and the remaining 75% vest in 36 equal monthly installments beginning on December&nbsp;1, 2020, subject to acceleration upon achieving
certain performance milestones. As of September&nbsp;30, 2021, 50% of the shares underlying the options had vested upon the achievement
of performance milestones.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">25% of the shares underlying the option vested on January&nbsp;27,
2022, the remaining vest monthly in equal increments over a 36 month period thereafter, subject to acceleration upon achieving certain
performance milestones. As of September&nbsp;30, 2021, 20% of the shares underlying the options had vested upon the achievement of performance
milestones.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">25% of the shares underlying the option vested on April&nbsp;21,
2024, the remaining vest in 12 equal quarterly installments on the last&nbsp;day of each quarter beginning on June&nbsp;30, 2024.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: justify">25% of the shares underlying the options vest on November 9,
2024, the remaining vest monthly in equal increments over a 36 month period thereafter.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">25% of the shares underlying the option vested on January&nbsp;1,
2022, the remaining vest monthly in equal increments over a 36 month period thereafter.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(6)</TD><TD STYLE="text-align: justify">25% of the shares underlying the option vested on January&nbsp;27,
2022, the remaining vest monthly in equal increments over a 36 month period thereafter.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(7)</TD><TD STYLE="text-align: justify">25% of the shares underlying the options vested on April&nbsp;21,
2024, the remaining vest in 12 equal quarterly installments on the last&nbsp;day of each quarter beginning on June&nbsp;30, 2024.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(8)</TD><TD STYLE="text-align: justify">25% of the shares underlying the options vest on November 9,
2024, the remaining vest monthly in equal increments over a 36 month period thereafter.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(9)</TD><TD STYLE="text-align: justify">25% of the shares underlying the options vest on November 10,
2024, the remaining vest monthly in equal increments over a 36 month period thereafter.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information regarding
outstanding restricted stock units held by our named executive officers as of September&nbsp;30, 2024:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">NAME</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">GRANT <BR> DATE</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">NUMBER OF <BR> SHARES OF <BR> STOCK THAT <BR> HAVE NOT <BR> VESTED <BR> (#)</TD><TD STYLE="text-align: center; padding-bottom: 6pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">MARKET <BR> VALUE OF <BR> SHARES OF <BR> STOCK THAT <BR> HAVE NOT <BR> VESTED <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 45%; text-align: justify">David Rosa</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: center">February&nbsp;3,&nbsp;2022</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">20,834</TD><TD STYLE="padding-bottom: 6pt; width: 1%; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">20,626</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">David Rosa</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">April&nbsp;21,&nbsp;2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,313</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,970</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">David Rosa</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">February 18, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">663,497</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">656,862</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Ronald McClurg</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">February&nbsp;3,&nbsp;2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,250</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,238</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Ronald McClurg</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">April&nbsp;21,&nbsp;2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,688</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,641</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Ronald McClurg</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">February 18, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">113,717</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,580</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">50% of the shares underlying the restricted stock units vest
on the first anniversary of the grant date; the remaining vest monthly in equal increments over a 24&nbsp;month period thereafter.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">50% of the shares underlying the restricted stock units vest
on the first anniversary of the grant date; the remaining vest quarterly in equal installments on the last&nbsp;day of each quarter over
the next 8 quarters, beginning on June&nbsp;30, 2024.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">25% of the shares underlying the restricted stock units vest
on the first, second, third and fourth anniversaries of the grant date, beginning on February 18, 2025.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Grant of Certain Equity Awards Close in Time
to the Release of Material Nonpublic Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Item 402(x) of Regulation S-K under
the Exchange Act, we are providing the following information regarding option awards granted to Mr. Rosa and Mr. McClurg on November 9,
2023, three business days before we filed a Current Report on Form 8-K disclosing Mr. Volker&rsquo;s appointment as Chief Operating Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Grant Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <BR>
Securities <BR>
Underlying the <BR>
Award</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise <BR>
Price of the <BR>
Award <BR>
($/Sh)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Grant Date <BR>
Fair Value <BR>
of the <BR>
Award <SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage Change in the Closing <BR>
Market Price of the Securities <BR>
Underlying the Award Between the <BR>
Trading Day Ending Immediately <BR>
Prior to the Disclosure of MNPI and <BR>
the Trading Day Beginning <BR>
Immediately Following the Disclosure <BR>
of Material Nonpublic Information</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; text-align: justify">David Rosa</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: center">November 9, 2023</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">526,303</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">1.25</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">562,175</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 34%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.4</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Ronald McClurg</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">November 9, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">89,283</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.25</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">95,368</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13.4</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify; text-indent: -23.75pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify; text-indent: -23.75pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Amounts reported reflect the aggregate grant date fair value
of option awards, calculated in accordance with FASB Topic&nbsp;718, excluding the impact of potential forfeitures. For a discussion
of the weighted-average assumptions used in the valuation of option awards under the Black-Scholes option-pricing model, you should refer
to the &ldquo;Stock Options&rdquo; section in Note&nbsp;8 to the Company&rsquo;s financial statements in our Annual Report on Form&nbsp;10-K
for the year ended September&nbsp;30, 2024.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify; text-indent: -23.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Chief Executive Officer Pay Ratio</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a &ldquo;smaller reporting company&rdquo;,
we are not required to provide information relating to the ratio of total compensation of our Chief Executive Officer to the median of
the annual total compensation of all of our employees, as required by the Investor Protection and Securities Reform Act&nbsp;of&nbsp;2010,
which is part of the Dodd-Frank Wall Street Reform and Consumer Protection Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Securities Authorized for Issuance Under Equity
Compensation Plans</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain information
as of September&nbsp;30, 2024 concerning our equity compensation plans:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Plan Category</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <BR> securities to <BR> be issued upon <BR> exercise of <BR> outstanding <BR> options, <BR> warrants and <BR> rights</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted- <BR> average <BR> exercise price <BR> of outstanding <BR> options, <BR> warrants and <BR> rights</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of <BR> securities <BR> remaining <BR> available for <BR> future issuance <BR> under equity <BR> compensation <BR> plans <BR> (excluding <BR> securities <BR> reflected in <BR> column (a))</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 6pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(a)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(b)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(c)</TD><TD STYLE="padding-bottom: 6pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-weight: bold; text-align: justify">Equity compensation plans approved by security holders</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,411,536</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3.41</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">129,671</TD><TD STYLE="padding-bottom: 6pt; width: 1%; text-align: left"><SUP>(1)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Equity compensation plans not approved by security holders</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">420,560</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1.43</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">167,790</TD><TD STYLE="padding-bottom: 6pt; text-align: left"><SUP>(2)</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,814,096</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3.13</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">297,461</TD><TD STYLE="padding-bottom: 6pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Consists of shares available under the NeuroOne Medical Technologies
Corporation 2017 Equity Incentive Plan (the &ldquo;2017 Plan&rdquo;). The number of shares of our Common Stock reserved under the 2017
Plan will automatically increase on January&nbsp;1 of each calendar year through January&nbsp;1, 2027 by 13.0% of the fully-diluted shares
of our Common Stock outstanding on December&nbsp;31 of the preceding calendar year.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Consists of shares available under the NeuroOne Medical Technologies
Corporation 2021 Inducement Plan (the &ldquo;Inducement Plan&rdquo;). The Inducement Plan was adopted in October&nbsp;2021, pursuant
to which the Company initially reserved 420,350 shares of its Common Stock to be used exclusively for grants of awards to individuals
who were not previously employees or directors of the Company, as an inducement material to the individual&rsquo;s entry into employment
with the Company within the meaning of Rule&nbsp;5635(c)(4)&nbsp;of the Nasdaq Listing Rules. On November&nbsp;9, 2023, the Company&rsquo;s
board of directors adopted the First Amendment to the Company&rsquo;s Inducement Plan, increasing the aggregate number of shares of common
stock that may be issued pursuant to equity incentive awards under the Inducement Plan by 150,000 shares for a total of 570,350 shares
of common stock that may be issued pursuant to equity incentive awards under the Inducement Plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_012"></A>PAY VERSUS PERFORMANCE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Pay Versus Performance Table</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Year</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Summary <BR> Compensation <BR> Table Total for <BR> PEO <BR> ($)<SUP>(1)</SUP></B></FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Compensation <BR> Actually Paid <BR> to PEO <BR> ($)<SUP>(2)</SUP></B></FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Average <BR> Summary <BR> Compensation <BR> Table Total <BR> for Non-PEO <BR> NEOs <BR> ($)<SUP>(3)</SUP></B></FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Average <BR> Compensation <BR> Actually Paid <BR> to Non-PEO <BR> NEOs <BR> ($)<SUP>(4)</SUP></B></FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total <BR> Shareholder <BR> Return <BR> ($)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Loss <BR> ($)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left">2024</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,995,745</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,923,606</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">655,350</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">593,882</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">24.75</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">12,318,110</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">989,558</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">716,284</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">423,936</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">362,534</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">22.25</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,859,491</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,186,410</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">539,030</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">384,604</P></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">269,850</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">42.25</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,999,613</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Reflects the amount reported in the &ldquo;Total&rdquo; column
of the Summary Compensation Table for Mr.&nbsp;Rosa for each corresponding year.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Amounts reported reflect CAP for Mr.&nbsp;Rosa, as computed
in accordance with Item&nbsp;402(v)&nbsp;of Regulation&nbsp;S-K, for each corresponding year, which amounts do not reflect the actual
amount of compensation earned by or paid to Mr.&nbsp;Rosa during the applicable year. The adjustments below were made to Mr.&nbsp;Rosa&rsquo;s
total compensation for each year to determine the CAP for such fiscal year in accordance with the requirements of Item&nbsp;402(v)&nbsp;of
Regulation&nbsp;S-K.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Reported <BR> Summary <BR> Compensation <BR> Table Total for <BR> PEO <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Less</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Reported <BR> Value of <BR> Equity <BR> Awards <BR> ($)<SUP>(a)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Plus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Equity <BR> Award <BR> Adjustments <BR> ($)<SUP>(b)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Equals</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">CAP for <BR> PEO <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; text-align: left">2024</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,995,745</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,245,577</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,173,438</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,923,606</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">989,558</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">229,575</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,699</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">716,284</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,186,410</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">525,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(122,381</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">539,030</P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Amounts reflect the grant date fair value of equity awards as
reported in the &ldquo;Option Awards&rdquo; and &ldquo;Stock Awards&rdquo; columns in the Summary Compensation Table for the applicable
year.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">The equity award adjustments were calculated in accordance with
Item&nbsp;402(v)&nbsp;of Regulation&nbsp;S-K and include: (i)&nbsp;the year-end fair value of any equity awards granted in the applicable
year that are outstanding and unvested as of the end of the year; (ii)&nbsp;the amount of change as of the end of the applicable year
(from the end of the prior fiscal year) in fair value of any awards granted in prior&nbsp;years that are outstanding and unvested as
of the end of the applicable year; and (iii)&nbsp;for awards granted in prior&nbsp;years that vest in the applicable year, the amount
equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value. The amounts deducted or added in calculating
the equity award adjustments for Mr.&nbsp;Rosa are as follows:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: left">Year</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Year End Fair <BR> Value of Equity Awards <BR> Granted in the Year and <BR> Outstanding and Unvested <BR> at Year End <BR> ($)</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Year over Year <BR> Change in Fair Value of <BR> Outstanding and Unvested <BR> Equity Awards <BR> ($)</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Change in Fair Value to <BR> the Vesting Date of <BR> Equity&nbsp;Awards&nbsp;Granted&nbsp;in <BR> Prior&nbsp;Years that <BR> Vested in the Year <BR> ($)</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total <BR> Equity <BR> Award <BR> Adjustments <BR> ($)</TD><TD STYLE="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">2024</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,067,786</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">33,277</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">72,375</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,173,438</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">116,489</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(94,850</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(65,337</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,699</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">422,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(284,353</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(260,527</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(122,380</TD><TD STYLE="text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Reflects the average amount reported in the &ldquo;Total&rdquo;
column of the Summary Compensation Table for our other NEOs as a group (excluding Mr.&nbsp;Rosa) for each corresponding year. For the
Fiscal Year 2024, the names of each of the other NEOs (excluding Mr.&nbsp;Rosa) included for purposes of calculating the average amounts
are Mr.&nbsp;McClurg and Mr.&nbsp;Volker. For the Fiscal Years 2023 and 2022, the names of each of the other NEOs (excluding Mr. Rosa)
included for purposes of calculating the average amounts are Mr. McClurg and Mr. Steve Mertens, our Chief Technology Officer.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: justify">Amounts reported reflect CAP for the other NEOs as a group (excluding
Mr.&nbsp;Rosa), as computed in accordance with Item&nbsp;402(v)&nbsp;of Regulation&nbsp;S-K, for each corresponding year, which amounts
do not reflect an average of the actual amount of compensation earned by or paid to the other NEOs as a group (excluding Mr.&nbsp;Rosa)
during the applicable year. The adjustments below were made to the average total compensation for the NEOs as a group (excluding Mr.&nbsp;Rosa)
for each year to determine the CAP for such year in accordance with the requirements of Item&nbsp;402(v)&nbsp;of Regulation&nbsp;S-K.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Year</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average <BR> Reported <BR> Summary <BR> Compensation <BR> Table Total <BR> for Non-PEO <BR> NEOs <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Less</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average <BR> Reported <BR> Value of <BR> Equity <BR> Awards <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Plus</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Average <BR> Equity <BR> Award <BR> Adjustments <BR> ($)<SUP>(a)</SUP></B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equals</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average <BR> CAP for <BR> Non-PEO <BR> NEOs <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; text-align: justify">2024</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">655,350</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">289,277</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">227,808</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">593,882</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">423,936</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">78,407</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,006</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">362,534</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">384,604</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">59,588</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(55,166</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">269,850</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-size: 6pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">See note (b)&nbsp;to footnote (2)&nbsp;above for an explanation
of the equity award adjustments made in accordance with Item&nbsp;402(v)&nbsp;of Regulation&nbsp;S-K.&nbsp;The amounts deducted or added
in calculating the total average equity award adjustments for the other NEOs as a group (excluding Mr.&nbsp;Rosa) are as follows:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Year</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average Year End Fair <BR> Value of Equity Awards <BR> Granted in the Year and <BR> Outstanding and Unvested <BR> at Year End <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year over Year Average <BR> Change in Fair Value of <BR> Outstanding and Unvested <BR> Equity Awards <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average Change in Fair <BR> Value to the Vesting Date <BR> of&nbsp;Equity&nbsp;Awards&nbsp;Granted <BR> in Prior&nbsp;Years that <BR> Vested in the Year <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total <BR> Average <BR> Equity Award <BR> Adjustments <BR> ($)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">2024</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">216,947</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,907</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7,954</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">227,808</P></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,784</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,742</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,037</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,006</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47,954</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(55,859</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,261</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(55,166</TD><TD STYLE="text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B><I></I></B></FONT></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Analysis of Information Presented in the
Pay Versus Performance Table</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B>The Company is providing the following descriptions of the relationships between information presented
in the Pay versus Performance table, including CAP, as required by Item&nbsp;402(v)&nbsp;of Regulation&nbsp;S-K.&nbsp;The compensation
committee utilizes several performance measures to align executive compensation with Company performance, and only some of those Company
measures are presented in the Pay versus Performance table above and the graphs below. The compensation committee has not previously
used or considered CAP as computed in accordance with Item&nbsp;402(v)&nbsp;of Regulation&nbsp;S-K to set target compensation amounts
or align our NEO compensation to Company performance. See &ldquo;Executive Compensation&rdquo; for a discussion of how the compensation
committee designs our compensation program and sets target compensation amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 289px; width: 481px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 6pt"><IMG SRC="image_005.jpg" ALT="" STYLE="height: 288px; width: 481px">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 6pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_013"></A>CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following includes a summary of transactions
since October&nbsp;1, 2022 to which the Company has been a participant in which the amount involved exceeded or will exceed the lesser
of $120,000 or 1% of the average of the Company&rsquo;s total assets at year end for the last two completed fiscal&nbsp;years, and in
which any of our directors, director nominees, executive officers or holders of more than five percent of our capital stock, or any members
of their immediate family, had or will have a direct or indirect material interest. Other than described below, there have not been, nor
are there currently any proposed, transactions or series of similar transactions to which we have been or will be a party other than compensation
arrangements, which include equity and other compensation, termination, change in control and other arrangements, which are described
under &ldquo;<I>Executive Compensation</I>&rdquo; and as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>2024 Private Placement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 1, 2024, we entered into a Securities
Purchase Agreement with certain purchasers pursuant to which we agreed to issue and sell an aggregate of (i) 2,944,446 shares of the our
Common Stock, and (ii) warrants to purchase an aggregate of 2,208,338 shares of Common Stock at a purchase price of $0.90 per unit, consisting
of one share and a PIPE warrant to purchase 0.75 shares of Common Stock (the &ldquo;2024 Private Placement&rdquo;). The 2024 Private Placement
closed on August 2, 2024 and resulted in total gross proceeds of approximately $2.65 million before deducting estimated expenses. In connection
with the 2024 Private Placement, we filed a registration statement with the SEC covering the resale of the securities issued in the 2024
Private Placement. One of the purchasers in the 2024 Private Placement was Paul Buckman, a director on our Board, who purchased $25,000
of our Common Stock and warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Indemnification Agreements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Certificate of Incorporation contains provisions
limiting the liability of directors, and our bylaws provides that we indemnify each of our directors to the fullest extent permitted under
Delaware law. Our Certificate of Incorporation and bylaws also provide our Board with discretion to indemnify our officers and employees
when determined appropriate by the Board. In addition, we have entered into an indemnification agreement with our directors and our executive
officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Policies and Procedures for Transactions with
Related Parties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To assist the Company in complying with its disclosure
obligations and to enhance the Company&rsquo;s disclosure controls, the Board approved a formal policy in January&nbsp;2018 regarding
related person transactions. A &ldquo;related person&rdquo; is a director, officer, nominee for director or a more than 5% stockholder
(of any class of the Company&rsquo;s voting stock) since the beginning of the Company&rsquo;s last two completed fiscal&nbsp;years, and
their immediate family members. A related person transaction as defined in the policy is any transaction or any series of transactions
in which the Company was or is to be a participant, the amount involved exceeds $120,000, and in which any related person had or will
have a direct or indirect material interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Specifically, the policy establishes a process
for identifying related persons and procedures for reviewing and approving such related person transactions. In addition, directors and
executive officers are required to complete an annual questionnaire in connection with the Company&rsquo;s proxy statement for its annual
meeting of stockholders, which includes questions regarding related person transactions, and such persons also are required to provide
written notice to the Company or outside legal counsel of any updates to such information prior to the annual meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee and/or the independent directors
of the Board review such proposed business transactions to ensure that the Company&rsquo;s involvement in such transactions is on terms
comparable to those that could be obtained in arm&rsquo;s length dealings with an unrelated third party and is in the best interests of
the Company and its stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_014"></A>ADDITIONAL INFORMATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Proxy Statement contains forward-looking
statements that involve substantial risks and uncertainties. In some cases, you can identify forward-looking statements by the words &ldquo;may,&rdquo;
&ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;should,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo;
&ldquo;plan,&rdquo; &ldquo;objective,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;predict,&rdquo;
&ldquo;project,&rdquo; &ldquo;potential,&rdquo; &ldquo;target,&rdquo; &ldquo;seek,&rdquo; &ldquo;contemplate,&rdquo; &ldquo;continue&rdquo;
and &ldquo;ongoing,&rdquo; or the negative of these terms, or other comparable terminology intended to identify statements about the future.
These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity,
performance or achievements to be materially different from the information expressed or implied by these forward-looking statements.
Although we believe that we have a reasonable basis for each forward-looking statement contained in this Proxy Statement, we caution you
that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about
which we cannot be certain. Forward-looking statements include statements about:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the timing of and our ability to maintain regulatory clearance
of our cortical strip and grid electrode technology;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to obtain and maintain regulatory clearance for
our RF ablation system;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to successfully commercialize our technology in
the United&nbsp;States;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to achieve or sustain profitability;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to raise additional capital and to fund our operations;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to access available, additional capital on acceptable
terms or at all or when needed;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the clinical utility of our cortical strip, grid and depth electrode
including technology under development;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to develop additional applications of our cortical
strip, grid and depth electrode technology with the benefits we hope to offer as compared to existing technology, or at all;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the results of our development and distribution relationship
with Zimmer, Inc. (&ldquo;Zimmer&rdquo;);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the performance, productivity, reliability and regulatory compliance
of our third party manufacturers of our cortical strip, grid electrode and depth electrode technology;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to develop future generations of our cortical strip,
grid and depth electrode technology;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our future development priorities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to obtain reimbursement coverage for our cortical
strip, grid and depth electrode technology;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our expectations about the willingness of healthcare providers
to recommend our cortical strip, grid and depth electrode technology to people with epilepsy, Parkinson&rsquo;s disease, dystonia, essential
tremors, chronic pain due to failed back surgeries and other related neurological disorders;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our future commercialization, marketing and manufacturing capabilities
and strategy;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to comply with applicable regulatory requirements;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to maintain our intellectual property position;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our expectations regarding international opportunities for commercializing
our cortical strip, grid and depth electrode technology under including technology under development;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our estimates regarding the size of, and future growth in, the
market for our technology, including technology under development; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our estimates regarding our future expenses and needs for additional
financing.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are based on management&rsquo;s
current expectations, estimates, forecasts and projections about our business and the industry in which we operate, and management&rsquo;s
beliefs and assumptions are not guarantees of future performance or development and involve known and unknown risks, uncertainties and
other factors that are in some cases beyond our control. You should refer to the &ldquo;Risk Factors&rdquo; section of our annual report
on Form&nbsp;10-K for a discussion of important factors that may cause our actual results to differ materially from those expressed or
implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this
Proxy Statement will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be
material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation
or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These forward-looking statements speak only as
of the date of this Proxy Statement. Except as required by law, we assume no obligation to update or revise these forward-looking statements
for any reason, even if new information becomes available in the future. You should, however, review the factors and risks and other information
we describe in the reports we will file from time to time with the SEC after the date of this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Stockholder Proposals to be Presented at Next
Annual Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Requirements for Stockholder Proposals to be
Brought Before an Annual Meeting.&nbsp;&nbsp;&nbsp;&nbsp;</I>Our Amended and Restated Bylaws provide that for stockholder nominations
to our Board or other proposals to be considered at an annual meeting, the stockholder must give timely notice thereof in writing to the
Secretary at 7599 Anagram Dr., Eden Prairie, MN&nbsp;55344.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To be timely for the Company&rsquo;s 2026 annual
meeting of stockholders, a stockholder&rsquo;s notice must be delivered to or mailed and received by our Secretary at our principal executive
offices not earlier than the close of business on October 17, 2025 and not later than the close of business on November 16, 2025. A stockholder&rsquo;s
notice to the Secretary must set forth as to each matter the stockholder proposes to bring before the annual meeting the information required
by applicable law and our bylaws. In no event will the public announcement of an adjournment or a postponement of our annual meeting commence
a new time period for the giving of a stockholder&rsquo;s notice as provided above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Requirements for Stockholder Proposals to be
Considered for Inclusion in our Proxy Materials.&nbsp;&nbsp;&nbsp;&nbsp;</I>Stockholder proposals submitted pursuant to Rule&nbsp;14a-8
under the Exchange&nbsp;Act and intended to be presented at our 2026 annual meeting of stockholders must be received by us not later than
September 23, 2025 in order to be considered for inclusion in our proxy materials for that meeting. A stockholder&rsquo;s notice
to the Secretary must set forth as to each matter the stockholder proposes to bring before the annual meeting the information required
by applicable law and our bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To comply with the universal proxy rules, stockholders
who intend to solicit proxies in support of director nominees other than the company&rsquo;s nominees must provide notice that sets forth
the information required by Rule&nbsp;14a-19 under the Exchange&nbsp;Act not earlier than the close of business on October 17, 2025 and
not later than the close of business on November 16, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, stockholders who intend to solicit
proxies in support of director nominees other than the Company&rsquo;s nominees must also comply with the additional requirements of Rule&nbsp;14a-19(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Delinquent Section&nbsp;16(a)&nbsp;Reports</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section&nbsp;16(a)&nbsp;of the Exchange&nbsp;Act
requires our directors, executive officers and persons who beneficially own more than 10 percent of our Common Stock to file initial reports
of ownership and changes in ownership with the SEC.&nbsp;Based solely on our review of the copies of such forms furnished to us or written
representations from our directors and executive officers, we believe that during fiscal year 2024 each of our directors, executive officers,
and persons who beneficially own more than 10 percent of our Common Stock timely complied with applicable reporting requirements for transactions
in our equity securities, except that one Form&nbsp;4 on behalf of Mr.&nbsp;Christianson was filed late on June 11, 2024 to report the
sale of 2,189&nbsp;shares of our Common Stock that occurred on June 6, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&ldquo;Householding&rdquo;&nbsp;&mdash;&nbsp;Stockholders
Sharing the Same Address</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC has adopted rules that permit companies
and intermediaries (such as brokers) to implement a delivery procedure called &ldquo;householding.&rdquo; Under this procedure, multiple
stockholders who reside at the same address may receive a single copy of our annual report on Form&nbsp;10-K and proxy materials unless
the affected stockholder has provided other instructions. This procedure reduces printing costs and postage fees, and helps protect the
environment as well.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect that a number of brokers with account
holders who are our stockholders will be &ldquo;householding&rdquo; our annual report on Form&nbsp;10-K and proxy materials. A single
set of an annual report on Form&nbsp;10-K and other proxy materials will be delivered to multiple stockholders sharing an address unless
contrary instructions have been received from one or more of the affected stockholders. Once you have received notice from your broker
that it will be &ldquo;householding&rdquo; communications to your address, &ldquo;householding&rdquo; will continue until you are notified
otherwise or until you revoke your consent. Stockholders may revoke their consent at any time by contacting your broker.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon written or oral request, we will undertake
to promptly deliver a separate copy of the annual report on Form&nbsp;10-K and other proxy materials to any stockholder at a shared address
to which a single copy of any of those documents was delivered. To receive a separate copy of the annual report on Form&nbsp;10-K and
other proxy materials, now or in the future, you may write our Chief Financial Officer at 7599 Anagram Dr., Eden Prairie, MN&nbsp;55344,
or call&nbsp;952-426-1383.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any stockholders who share the same address and
currently receive multiple copies of our annual report on Form&nbsp;10-K and other proxy materials who wish to receive only one copy in
the future can contact their bank, broker or other holder of record to request information about &ldquo;householding&rdquo; or our Chief
Financial Officer at the address or telephone number listed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Available Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will mail without charge, upon written request,
a copy of our annual report on Form&nbsp;10-K for the fiscal year ended September&nbsp;30, 2024, including the financial statements and
list of exhibits, and any exhibit specifically requested. Requests should be sent to Ronald McClurg, our Chief Financial Officer, 7599
Anagram Dr., Eden Prairie, MN&nbsp;55344.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="a_015"></A>OTHER MATTERS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board does not presently intend to bring any
other business before the Annual Meeting and, so far as is known to the Board, no matters are to be brought before the Annual Meeting
except as specified in the Notice of the Annual Meeting. As to any business that may arise and properly come before the Annual Meeting,
however, it is intended that proxies, in the form enclosed, will be voted in respect thereof in accordance with the judgment of the persons
voting such proxies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B><A NAME="z_001"></A>Appendix A</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CERTIFICATE OF<BR>
AMENDMENT TO THE<BR>
CERTIFICATE OF INCORPORATION OF<BR>
NEUROONE MEDICAL TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NEUROONE MEDICAL TECHNOLOGIES CORPORATION</B>
(the <B><I>&ldquo;Corporation&rdquo;</I></B>), a corporation organized and existing under and by virtue of the General Corporation Law
of the State of Delaware (the <B><I>&ldquo;DGCL&rdquo;</I></B>), does hereby certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>FIRST:</B> The name of the Corporation is NeuroOne
Medical Technologies Corporation and the date on which the Certificate of Incorporation of the Corporation was originally filed with the
Secretary of State of the State of Delaware was June 26, 2017 (the <B><I>&ldquo;Certificate of Incorporation&rdquo;</I></B>);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SECOND: </B>The Board of Directors of the Corporation
has duly adopted resolutions proposing and declaring advisable that the Certificate of Incorporation be amended as set forth herein and
calling for the consideration and approval thereof at a meeting of the stockholders of the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIRD: </B>The Certificate of Incorporation
is hereby amended by deleting the Paragraph A of ARTICLE IV in its entirety and inserting the following in lieu thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;The Corporation is authorized to issue
two classes of stock to be designated, respectively, <B><I>&ldquo;Common Stock&rdquo; </I></B>and <B><I>&ldquo;Preferred Stock&rdquo;</I></B>.
The total number of shares that the Corporation is authorized to issue is One Hundred Ten Million (110,000,000) shares, each with a par
value of $0.001 per share. One Hundred Million (100,000,000) shares shall be Common Stock and Ten Million (10,000,000) shares shall be
Preferred Stock. Upon the filing and effectiveness (the <B><I>&ldquo;Effective Time&rdquo;</I></B>) pursuant to the General Corporation
Law of the State of Delaware (the <B><I>&ldquo;DGCL&rdquo;</I></B>) of this Certificate of Amendment to the Certificate of Incorporation
of the Corporation, as previously amended (the <B><I>&ldquo;Restated Certificate&rdquo;</I></B>), each [&nbsp;&nbsp;&nbsp;] shares of the Corporation&rsquo;s
Common Stock issued and outstanding immediately prior to the Effective Time shall, automatically and without any action on the part of
the Corporation or respective holders thereof, be combined and converted into one (1) validly issued, fully paid and non-assessable share
of Common Stock (the <B><I>&ldquo;Reverse Split&rdquo;</I></B>); provided, however, that the Corporation shall issue no fractional shares
as a result of the actions set forth herein but shall instead pay to the holder of such fractional share a sum in cash equal to such fraction
multiplied by the closing sales price of the Common Stock as reported on The Nasdaq Capital Market on the last trading day before the
Effective Time (as adjusted to give effect to the Reverse Split).&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>FOURTH: </B>Pursuant to a resolution of Board
of Directors of the Corporation, this Certificate of Amendment was submitted to the stockholders of the Company for their approval, and
was duly adopted in accordance with the provisions of Section 242 of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>FIFTH: </B>This Certificate of Amendment to
the Certificate of Incorporation shall have an Effective Time of [&nbsp;&nbsp;&nbsp;], 2025 at 5:00 p.m. Eastern Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IN WITNESS WHEREOF</B>, NeuroOne Medical Technologies
Corporation has caused this Certificate of Amendment to be executed by its duly authorized officer on this [ &nbsp;&nbsp;]<SUP>th</SUP> day of [ &nbsp;&nbsp;],
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>NEUROONE MEDICAL TECHNOLOGIES CORPORATION</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 54; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><A NAME="z_002"></A>Appendix B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>NEUROONE MEDICAL TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>2025 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>ADOPTED BY THE BOARD OF DIRECTORS: [&nbsp;&nbsp;&nbsp;], 2025<BR>
APPROVED BY THE STOCKHOLDERS: [&nbsp;&nbsp;&nbsp;], 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1. GENERAL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;Successor
to and Continuation of Prior Plans.</B> The Plan is the successor to and continuation of the Prior Plans. As of the Effective Date, (i)&nbsp;no
additional awards may be granted under the Prior Plans; (ii) any Returning Shares will become available for issuance pursuant to Awards
granted under this Plan; and (iii)&nbsp;all outstanding awards granted under the Prior Plans will remain subject to the terms of the
Prior Plans (except to the extent such outstanding awards result in Returning Shares that become available for issuance pursuant to Awards
granted under this Plan). All Awards granted under this Plan will be subject to the terms of this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;Plan
Purpose.</B> The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide
incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which
such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;Available
Awards.</B> The Plan provides for the grant of the following Awards: (i)&nbsp;Incentive Stock Options; (ii)&nbsp;Nonstatutory Stock
Options; (iii)&nbsp;SARs; (iv)&nbsp;Restricted Stock Awards; (v)&nbsp;RSU Awards; (vi)&nbsp;Performance Awards; and (vii)&nbsp;Other
Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)&nbsp;Adoption
Date; Effective Date. </B>The Plan will come into existence on the Adoption Date, but no Award may be granted prior to the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>2. SHARES
SUBJECT TO THE PLAN.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;Share
Reserve. </B>Subject to adjustment in accordance with <U>Section&nbsp;2(c)</U>&nbsp;and any adjustments as necessary to implement any
Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Awards will not exceed the sum
of (i)&nbsp;3,000,000 shares, plus (ii) the number of Returning Shares, if any, as such shares become available from time to time. In
addition, subject to any adjustments as necessary to implement any Capitalization Adjustments, such aggregate number of shares of Common
Stock will automatically increase on January&nbsp;1st of each year for a period of ten years commencing on January&nbsp;1, 2026 and
ending on (and including) January&nbsp;1, 2035, in an amount equal to five percent (5%) of the total number of shares of Common Stock
outstanding on December 31 of the preceding year; provided, however that the Board may act prior to the effective date of any such annual
increase to provide that the increase for such year will be a lesser number of shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;Aggregate
Incentive Stock Option Limit.</B> Notwithstanding anything to the contrary in <U>Section&nbsp;2(a)</U>&nbsp;and subject to any adjustments
as necessary to implement any Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant
to the exercise of Incentive Stock Options is 9,000,000 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;Share
Reserve Operation</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;Limit
Applies to Common Stock Issued Pursuant to Awards. </B>For clarity, the Share Reserve is a limit on the number of shares of Common Stock
that may be issued pursuant to Awards and does not limit the granting of Awards, except that the Company will keep available at all times
the number of shares of Common Stock reasonably required to satisfy its obligations to issue shares pursuant to such Awards. Shares may
be issued in connection with a merger or acquisition as permitted by, as applicable, Nasdaq Listing Rule&nbsp;5635(c), NYSE Listed Company
Manual Section&nbsp;303A.08, NYSE American Company Guide Section&nbsp;711 or other applicable rule, and such issuance will not reduce
the number of shares available for issuance under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 55; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;Actions
that Do Not Constitute Issuance of Common Stock and Do Not Reduce Share Reserve.</B> The following actions do not result in an issuance
of shares under the Plan and accordingly do not reduce the number of shares subject to the Share Reserve and available for issuance under
the Plan: (1)&nbsp;the expiration or termination of any portion of an Award without the shares covered by such portion of the Award having
been issued; (2)&nbsp;the settlement of any portion of an Award in cash (<I>i.e.</I>, the Participant receives cash rather than Common
Stock); (3)&nbsp;the withholding of shares that would otherwise be issued by the Company to satisfy the exercise, strike or purchase
price of an Award; or (4)&nbsp;the withholding of shares that would otherwise be issued by the Company to satisfy a tax withholding obligation
in connection with an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;Reversion
of Previously Issued Shares of Common Stock to Share Reserve.</B> The following shares of Common Stock previously issued pursuant to an
Award and accordingly initially deducted from the Share Reserve will be added back to the Share Reserve and again become available for
issuance under the Plan: (1)&nbsp;any shares that are forfeited back to or repurchased by the Company because of a failure to meet a
contingency or condition required for the vesting of such shares; (2)&nbsp;any shares that are reacquired by the Company to satisfy the
exercise, strike or purchase price of an Award; and (3)&nbsp;any shares that are reacquired by the Company to satisfy a tax withholding
obligation in connection with an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3. ELIGIBILITY
AND LIMITATIONS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;Eligible
Award Recipients.</B> Subject to the terms of the Plan, Employees, Directors and Consultants are eligible to receive Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;Specific
Award Limitations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;Limitations
on Incentive Stock Option Recipients.</B> Incentive Stock Options may be granted only to Employees of the Company or a &#8220;parent corporation&#8221;
or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections 424(e)&nbsp;and (f)&nbsp;of the Code).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;Incentive
Stock Option $100,000 Limitation.</B> To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock
with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all
plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does not comply with
the rules&nbsp;governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which
they were granted) or otherwise do not comply with such rules&nbsp;will be treated as Nonstatutory Stock Options, notwithstanding any
contrary provision of the applicable Option Agreement(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;Limitations
on Incentive Stock Options Granted to Ten Percent Stockholders.</B> A Ten Percent Stockholder may not be granted an Incentive Stock Option
unless (i)&nbsp;the exercise price of such Option is at least 110% of the Fair Market Value on the date of grant of such Option and (ii)&nbsp;the
Option is not exercisable after the expiration of five years from the date of grant of such Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)&nbsp;Limitations
on Nonstatutory Stock Options and SARs.</B> Nonstatutory Stock Options and SARs may not be granted to Employees, Directors and Consultants
who are providing Continuous Service only to any &#8220;parent&#8221; of the Company (as such term is defined in Rule&nbsp;405) unless
the stock underlying such Awards is treated as &#8220;service recipient stock&#8221; under Section&nbsp;409A because the Awards are granted
pursuant to a corporate transaction (such as a spin off transaction) or unless such Awards otherwise comply with the distribution requirements
of Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;Aggregate
Incentive Stock Option Limit.</B> The aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of
Incentive Stock Options is the number of shares specified in <U>Section&nbsp;2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)&nbsp;Non-Employee
Director Compensation Limit. </B>The aggregate value of all compensation granted or paid, as applicable, to any individual for
service as a Non-Employee Director with respect to any fiscal year, including Awards granted and cash fees paid by the Company to
such Non-Employee Director, will not exceed (i)&nbsp;$750,000 in total value or (ii)&nbsp;in the event such Non-Employee Director is
first appointed or elected to the Board during such fiscal year, $1,000,000 in total value, in each case calculating the value of
any equity awards based on the grant date fair value of such equity awards for financial reporting purposes. For avoidance of doubt,
compensation will count towards this limit for the fiscal year in which it was granted or earned, and not later when distributed, in
the event it is deferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.&nbsp;OPTIONS
AND STOCK APPRECIATION RIGHTS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Option and SAR will have
such terms and conditions as determined by the Board. Each Option will be designated in writing as an Incentive Stock Option or Nonstatutory
Stock Option at the time of grant; provided, however, that if an Option is not so designated, then such Option will be a Nonstatutory
Stock Option. The shares purchased upon exercise of each type of Option will be accounted for separately. Each SAR will be denominated
in shares of Common Stock equivalents. The terms and conditions of separate Options and SARs need not be identical; provided, however,
that each Option Agreement and SAR Agreement will conform (through incorporation of provisions hereof by reference in the Award Agreement
or otherwise) to the substance of each of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;Term.</B>
Subject to <U>Section&nbsp;3(b)</U>&nbsp;regarding Incentive Stock Options granted to Ten Percent Stockholders, no Option or SAR will
be exercisable after the expiration of ten years from the date of grant of such Award or such shorter period specified in the Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;Exercise
or Strike Price.</B> Subject to <U>Section&nbsp;3(b)</U>&nbsp;regarding Ten Percent Stockholders, the exercise or strike price of each
Option or SAR will not be less than 100% of the Fair Market Value on the date of grant of such Award. Notwithstanding the foregoing, an
Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value on the date of grant of such Award
if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Corporate
Transaction and in a manner consistent with the provisions of Sections 409A and, if applicable, 424(a)&nbsp;of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;Exercise
Procedure and Payment of Exercise Price for Options.</B> In order to exercise an Option, the Participant must provide notice of exercise
to the Plan Administrator in accordance with the procedures specified in the Option Agreement or otherwise provided by the Company. The
Board has the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability
to use certain methods) and to grant Options that require the consent of the Company to utilize a particular method of payment. The exercise
price of an Option may be paid, to the extent permitted by Applicable Law and as determined by the Board, by one or more of the following
methods of payment to the extent set forth in the Option Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;</B>by
cash or check, wire, bank draft or money order (or an electronic equivalent thereof) payable to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;</B>pursuant
to a &#8220;cashless exercise&#8221; program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the
issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of
irrevocable instructions to pay the exercise price to the Company from the sales proceeds;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;</B>by
delivery to the Company (either by actual delivery or attestation) of shares of Common Stock that are already owned by the Participant
free and clear of any liens, claims, encumbrances or security interests, with a Fair Market Value on the date of exercise that does not
exceed the exercise price, provided that (1)&nbsp;at the time of exercise the Common Stock is publicly traded, (2)&nbsp;any remaining
balance of the exercise price not satisfied by such delivery is paid by the Participant in cash or other permitted form of payment, (3)&nbsp;such
delivery would not violate any Applicable Law or agreement restricting the redemption of the Common Stock, (4)&nbsp;any certificated
shares are endorsed or accompanied by an executed assignment separate from certificate, and (5)&nbsp;such shares have been held by the
Participant for any minimum period necessary to avoid adverse accounting treatment as a result of such delivery;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)&nbsp;</B>by a
&#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon
exercise by the largest whole number of shares with a Fair Market Value on the date of exercise that does not exceed the exercise
price, provided that (1)&nbsp;such shares used to pay the exercise price will not be exercisable thereafter and (2)&nbsp;any
remaining balance of the exercise price not satisfied by such net exercise is paid by the Participant in cash or other permitted
form of payment; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(v)&nbsp;</B>in
any other form of consideration that may be acceptable to the Board and permissible under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)&nbsp;Exercise
Procedure and Payment of Appreciation Distribution for SARs.</B> In order to exercise any SAR, the Participant must provide notice of
exercise to the Plan Administrator in accordance with the SAR Agreement. The appreciation distribution payable to a Participant upon the
exercise of a SAR will not be greater than an amount equal to the excess of (i)&nbsp;the aggregate Fair Market Value on the date of exercise
of a number of shares of Common Stock equal to the number of Common Stock equivalents that are vested and being exercised under such SAR,
over (ii)&nbsp;the strike price of such SAR. Such appreciation distribution may be paid to the Participant in the form of Common Stock
or cash (or any combination of Common Stock and cash) or in any other form of payment, as determined by the Board and specified in the
SAR Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)&nbsp;Transferability.</B>
Options and SARs may not be transferred to third party financial institutions for value. The Board may impose such additional limitations
on the transferability of an Option or SAR as it determines. In the absence of any such determination by the Board, the following restrictions
on the transferability of Options and SARs will apply, provided that except as explicitly provided herein, neither an Option nor a SAR
may be transferred for consideration and <I>provided, further</I>, that if an Option is an Incentive Stock Option, such Option may be
deemed to be a Nonstatutory Stock Option as a result of such transfer:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;Restrictions
on Transfer.</B> An Option or SAR will not be transferable, except by will or by the laws of descent and distribution, and will be exercisable
during the lifetime of the Participant only by the Participant; provided, however, that the Board may permit transfer of an Option or
SAR in a manner that is not prohibited by applicable tax and securities laws upon the Participant&#8217;s request, including to a trust
if the Participant is considered to be the sole beneficial owner of such trust (as determined under Section&nbsp;671 of the Code and
applicable state law) while such Option or SAR is held in such trust, provided that the Participant and the trustee enter into a transfer
and other agreements required by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;Domestic
Relations Orders.</B> Notwithstanding the foregoing, subject to the execution of transfer documentation in a format acceptable to the
Company and subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to a domestic
relations order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(f)&nbsp;Vesting.</B>
The Board may impose such restrictions on or conditions to the vesting and/or exercisability of an Option or SAR as determined by the
Board. Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate,
vesting of Options and SARs will cease upon termination of the Participant&#8217;s Continuous Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(g)&nbsp;Termination
of Continuous Service for Cause.</B> Except as explicitly otherwise provided in the Award Agreement or other written agreement between
a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service is terminated for Cause, the Participant&#8217;s
Options and SARs will terminate and be forfeited immediately upon such termination of Continuous Service, and the Participant will be
prohibited from exercising any portion (including any vested portion) of such Awards on and after the date of such termination of Continuous
Service and the Participant will have no further right, title or interest in such forfeited Award, the shares of Common Stock subject
to the forfeited Award, or any consideration in respect of the forfeited Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(h)&nbsp;Post-Termination
Exercise Period Following Termination of Continuous Service for Reasons Other than Cause.</B> Subject to <U>Section&nbsp;4(i)</U>, if
a Participant&#8217;s Continuous Service terminates for any reason other than for Cause, the Participant may exercise his or her Option
or SAR to the extent vested, but only within the following period of time or, if applicable, such other period of time provided in the
Award Agreement or other written agreement between a Participant and the Company or an Affiliate; provided, however, that in no event
may such Award be exercised after the expiration of its maximum term (as set forth in <U>Section&nbsp;4(a)</U>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;</B>three
months following the date of such termination if such termination is a termination without Cause (other than any termination due to the
Participant&#8217;s Disability or death);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;</B>12
months following the date of such termination if such termination is due to the Participant&#8217;s Disability;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;</B>18
months following the date of such termination if such termination is due to the Participant&#8217;s death; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)&nbsp;</B>18
months following the date of the Participant&#8217;s death if such death occurs following the date of such termination but during the
period such Award is otherwise exercisable (as provided in (i)&nbsp;or (ii)&nbsp;above).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the date of such
termination, to the extent the Participant does not exercise such Award within the applicable Post-Termination Exercise Period (or, if
earlier, prior to the expiration of the maximum term of such Award), such unexercised portion of the Award will terminate, and the Participant
will have no further right, title or interest in the terminated Award, the shares of Common Stock subject to the terminated Award, or
any consideration in respect of the terminated Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;Restrictions
on Exercise; Extension of Exercisability. </B>A Participant may not exercise an Option or SAR at any time that the issuance of shares
of Common Stock upon such exercise would violate Applicable Law. Except as otherwise provided in the Award Agreement or other written
agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates for any reason
other than for Cause and, at any time during the last thirty days of the applicable Post-Termination Exercise Period: (i)&nbsp;the exercise
of the Participant&#8217;s Option or SAR would be prohibited solely because the issuance of shares of Common Stock upon such exercise
would violate Applicable Law, or (ii)&nbsp;the immediate sale of any shares of Common Stock issued upon such exercise would violate the
Company&#8217;s Trading Policy, then the applicable Post-Termination Exercise Period will be extended to the last day of the calendar
month that commences following the date the Award would otherwise expire, with an additional extension of the exercise period to the last
day of the next calendar month to apply if any of the foregoing restrictions apply at any time during such extended exercise period, generally
without limitation as to the maximum permitted number of extensions; provided, however, that in no event may such Award be exercised after
the expiration of its maximum term (as set forth in <U>Section&nbsp;4(a)</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(j)&nbsp;Non-Exempt
Employees.</B> No Option or SAR, whether or not vested, granted to an Employee who is a non-exempt employee for purposes of the Fair Labor
Standards Act of 1938, as amended, will be first exercisable for any shares of Common Stock until at least six months following the date
of grant of such Award. Notwithstanding the foregoing, in accordance with the provisions of the Worker Economic Opportunity Act, any vested
portion of such Award may be exercised earlier than six months following the date of grant of such Award in the event of (i)&nbsp;such
Participant&#8217;s death or Disability, (ii)&nbsp;a Corporate Transaction in which such Award is not assumed, continued or substituted,
(iii)&nbsp;a Change in Control, or (iv)&nbsp;such Participant&#8217;s retirement (as such term may be defined in the Award Agreement
or another applicable agreement or, in the absence of any such definition, in accordance with the Company&#8217;s then current employment
policies and guidelines). This <U>Section&nbsp;4(j)</U>&nbsp;is intended to operate so that any income derived by a non-exempt employee
in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(k)&nbsp;Whole
Shares.</B> Options and SARs may be exercised only with respect to whole shares of Common Stock or their equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5. AWARDS
OTHER THAN OPTIONS AND STOCK APPRECIATION RIGHTS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;Restricted
Stock Awards and RSU Awards.</B> Each Restricted Stock Award and RSU Award will have such terms and conditions as determined by the Board;
provided, however, that each Restricted Stock Award Agreement and RSU Award Agreement will conform (through incorporation of the provisions
hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i) Form&nbsp;of
Award</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(1)&nbsp;RSAs</B>.
To the extent consistent with the Company&#8217;s Bylaws, at the Board&#8217;s election, shares of Common Stock subject to a Restricted
Stock Award may be (A)&nbsp;held in book entry form subject to the Company&#8217;s instructions until such shares become vested or any
other restrictions lapse, or (B)&nbsp;evidenced by a certificate, which certificate will be held in such form and manner as determined
by the Board. Unless otherwise determined by the Board, a Participant will have voting and other rights as a stockholder of the Company
with respect to any shares subject to a Restricted Stock Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(2)&nbsp;RSUs</B>.
An RSU Award represents a Participant&#8217;s right to be issued on a future date the number of shares of Common Stock that is equal to
the number of restricted stock units subject to the RSU Award. As a holder of an RSU Award, a Participant is an unsecured creditor of
the Company with respect to the Company&#8217;s unfunded obligation, if any, to issue shares of Common Stock in settlement of such Award
and nothing contained in the Plan or any RSU Agreement, and no action taken pursuant to its provisions, will create or be construed to
create a trust of any kind or a fiduciary relationship between a Participant and the Company or an Affiliate or any other person. A Participant
will not have voting or any other rights as a stockholder of the Company with respect to any RSU Award (unless and until shares are actually
issued in settlement of a vested RSU Award).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;Consideration</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(1)&nbsp;RSA</B>.
A Restricted Stock Award may be granted in consideration for (A)&nbsp;cash or check, wire, bank draft or money order payable to the Company,
(B)&nbsp;past services to the Company or an Affiliate, or (C)&nbsp;any other form of consideration (including future services)as the
Board may determine and permissible under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(2)&nbsp;RSU</B>.
Unless otherwise determined by the Board at the time of grant, an RSU Award will be granted in consideration for the Participant&#8217;s
services to the Company or an Affiliate, such that the Participant will not be required to make any payment to the Company (other than
such services) with respect to the grant or vesting of the RSU Award, or the issuance of any shares of Common Stock pursuant to the RSU
Award. If, at the time of grant, the Board determines that any consideration must be paid by the Participant (in a form other than the
Participant&#8217;s services to the Company or an Affiliate) upon the issuance of any shares of Common Stock in settlement of the RSU
Award, such consideration may be paid in any form of consideration as the Board may determine and permissible under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;Vesting.
</B>The Board may impose such restrictions on or conditions to the vesting of a Restricted Stock Award or RSU Award as determined by the
Board. Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate,
vesting of Restricted Stock Awards and RSU Awards will cease upon termination of the Participant&#8217;s Continuous Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)&nbsp;Termination
of Continuous Service.</B> Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the
Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates for any reason, (1)&nbsp;the Company may receive through
a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant under their Restricted Stock
Award that have not vested as of the date of such termination as set forth in the Restricted Stock Award Agreement and (2)&nbsp;any portion
of his or her RSU Award that has not vested will be forfeited upon such termination and the Participant will have no further right, title
or interest in the RSU Award, the shares of Common Stock issuable pursuant to the RSU Award, or any consideration in respect of the RSU
Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(v)&nbsp;Dividends
and Dividend Equivalents. </B>Dividends or dividend equivalents may be paid or credited, as applicable, with respect to any shares of
Common Stock subject to a Restricted Stock Award or RSU Award, as determined by the Board and specified in the Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(vi)&nbsp;Settlement
of RSU Awards</B>. An RSU Award may be settled by the issuance of shares of Common Stock or cash (or any combination thereof) or in any
other form of payment, as determined by the Board and specified in the RSU Award Agreement. At the time of grant, the Board may determine
to impose such restrictions or conditions that delay such delivery to a date following the vesting of the RSU Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;Performance
Awards</B>. With respect to any Performance Award, the length of any Performance Period, the Performance Goals to be achieved during the
Performance Period, the other terms and conditions of such Award, and the measure of whether and to what degree such Performance Goals
have been attained will be determined by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;Other
Awards</B>. Other forms of Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation
in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the Fair Market Value at the
time of grant) may be granted either alone or in addition to Awards provided for under <U>Section&nbsp;4</U> and the preceding provisions
of this <U>Section&nbsp;5</U>. Subject to the provisions of the Plan, the Board will have sole and complete discretion to determine the
persons to whom and the time or times at which such Other Awards will be granted, the number of shares of Common Stock (or the cash equivalent
thereof) to be granted pursuant to such Other Awards and all other terms and conditions of such Other Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6. ADJUSTMENTS
UPON CHANGES IN COMMON STOCK; OTHER CORPORATE EVENTS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;Capitalization
Adjustments</B>. In the event of a Capitalization Adjustment, the Board shall appropriately and proportionately adjust: (i)&nbsp;the
class(es) and maximum number of shares of Common Stock subject to the Plan and the maximum number of shares by which the Share Reserve
may annually increase pursuant to <U>Section&nbsp;2(a)</U>; (ii)&nbsp;the class(es) and maximum number of shares that may be issued
pursuant to the exercise of Incentive Stock Options pursuant to <U>Section&nbsp;2(b)</U>; and (iii)&nbsp;the class(es) and number of
securities and exercise price, strike price or purchase price of the Common Stock subject to outstanding Awards. The Board shall make
such adjustments, and its determination shall be final, binding and conclusive. Notwithstanding the foregoing, no fractional shares or
rights for fractional shares of Common Stock shall be created in order to implement any Capitalization Adjustment. The Board shall determine
an appropriate equivalent benefit, if any, for any fractional shares or rights to fractional shares that might be created by the adjustments
referred to in the preceding provisions of this <U>Section&nbsp;6</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;Dissolution
or Liquidation</B>. Except as otherwise provided in the Award Agreement, in the event of a dissolution or liquidation of the Company,
all outstanding Awards (other than Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition
or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and
the shares of Common Stock subject to the Company&#8217;s repurchase rights or subject to a forfeiture condition may be repurchased or
reacquired by the Company notwithstanding the fact that the holder of such Award is providing Continuous Service; provided, however, that
the Board may determine to cause some or all Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture
(to the extent such Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent
on its completion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;Corporate
Transaction. </B>The following provisions will apply to Awards in the event of a Corporate Transaction, except as set forth in <U>Section&nbsp;11</U>,
unless otherwise provided in the instrument evidencing the Award or any other written agreement between the Company or any Affiliate and
the Participant or unless otherwise expressly provided by the Board at the time of grant of an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;Awards
May&nbsp;Be Assumed.</B> In the event of a Corporate Transaction, any surviving or acquiring corporation (or the surviving or acquiring
corporation&#8217;s parent company) may assume or continue any or all Awards outstanding under the Plan or may substitute similar awards
for Awards outstanding under the Plan (including but not limited to awards to acquire the same consideration paid to the stockholders
of the Company pursuant to the Corporate Transaction), and any reacquisition or repurchase rights held by the Company in respect of the
Common Stock issued pursuant to Awards may be assigned by the Company to the successor of the Company (or the successor&#8217;s parent
company, if any), in connection with such Corporate Transaction. A surviving or acquiring corporation (or its applicable parent) may choose
to assume or continue only a portion of an Award or substitute a similar award for only a portion of an Award, or may choose to assume
or continue the Awards held by some, but not all Participants. The terms of any assumption, continuation or substitution will be set by
the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;Awards Held
by Current Participants.</B> In the event of a Corporate Transaction in which the surviving or acquiring corporation (or its parent
company) does not assume or continue outstanding Awards or substitute similar awards for such outstanding Awards, then with respect
to Awards that have not been assumed, continued or substituted and that are held by Participants whose Continuous Service has not
terminated prior to the effective time of the Corporate Transaction (referred to as the <B><I>&#8220;Current
Participants&#8221;</I></B>), the vesting of such Awards (and, with respect to Options and Stock Appreciation Rights, the time when
such Awards may be exercised) will be accelerated in full to a date prior to the effective time of such Corporate Transaction
(contingent upon the effectiveness of the Corporate Transaction) that the Board determines (or, if the Board does not determine such
a date, to the date that is five (5)&nbsp;days prior to the effective time of the Corporate Transaction). Awards so accelerated will
terminate if not exercised (if applicable) at or prior to the effective time of the Corporate Transaction, and any reacquisition or
repurchase rights held by the Company with respect to such Awards will lapse (contingent upon the effectiveness of the Corporate
Transaction). With respect to the vesting of Performance Awards that (a)&nbsp;will accelerate upon the occurrence of a Corporate
Transaction pursuant to this subsection (ii)&nbsp;and (b)&nbsp;have multiple vesting levels depending on the level of performance,
unless otherwise provided in the Award Agreement or unless otherwise provided by the Board, the vesting of such Performance Awards
will accelerate at 100% of the target level upon the occurrence of a Corporate Transaction in which the Awards are not assumed,
continued or substituted for in accordance with <U>Section&nbsp;6(c)(i)</U>. With respect to the vesting of cash-settled Awards that
will accelerate upon the occurrence of a Corporate Transaction pursuant to this subsection (ii), such cash payment will be made no
later than 30 days following the occurrence of the Corporate Transaction or such later date as required by Section&nbsp;409A of the
Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;Awards
Held by Persons other than Current Participants.</B> In the event of a Corporate Transaction in which the surviving or acquiring corporation
(or its parent company) does not assume or continue such outstanding Awards or substitute similar awards for such outstanding Awards,
then with respect to Awards that have not been assumed, continued or substituted and that are held by persons other than Current Participants,
such Awards will terminate if not exercised (if applicable) prior to the occurrence of the Corporate Transaction; provided, however, that
any reacquisition or repurchase rights held by the Company with respect to such Awards will not terminate and may continue to be exercised
notwithstanding the Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)&nbsp;Payment
for Awards in Lieu of Exercise.</B> Notwithstanding the foregoing, in the event an Award will terminate if not exercised prior to the
effective time of a Corporate Transaction, the Board may provide, in its sole discretion, that the holder of such Award may not exercise
such Award but will receive a payment, in such form as may be determined by the Board, equal in value, at the effective time, to the excess,
if any, of (1)&nbsp;the value of the property the Participant would have received upon the exercise of the Award (including, at the discretion
of the Board, any unvested portion of such Award), over (2)&nbsp;any exercise price payable by such holder in connection with such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)&nbsp;Appointment
of Stockholder Representative.</B> As a condition to the receipt of an Award under this Plan, a Participant will be deemed to have agreed
that the Award will be subject to the terms of any agreement governing a Corporate Transaction involving the Company, including, without
limitation, a provision for the appointment of a stockholder representative that is authorized to act on the Participant&#8217;s behalf
with respect to any escrow, indemnities and any contingent consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)&nbsp;No
Restriction on Right to Undertake Transactions</B>. The grant of any Award under the Plan and the issuance of shares pursuant to any Award
does not affect or restrict in any way the right or power of the Company or the stockholders of the Company to make or authorize any adjustment,
recapitalization, reorganization or other change in the Company&#8217;s capital structure or its business, any merger or consolidation
of the Company, any issue of stock or of options, rights or options to purchase stock or of bonds, debentures, preferred or prior preference
stocks whose rights are superior to or affect the Common Stock or the rights thereof or which are convertible into or exchangeable for
the Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business,
or any other corporate act or proceeding, whether of a similar character or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7. ADMINISTRATION.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;Administration
by Board.</B> The Board will administer the Plan unless and until the Board delegates administration of the Plan to a Committee or Committees,
as provided in subsection (c)&nbsp;below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;Powers
of Board.</B> The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;</B>To
determine from time to time (1)&nbsp;which of the persons eligible under the Plan will be granted Awards; (2)&nbsp;when and how each
Award will be granted; (3)&nbsp;what type or combination of types of Award will be granted; (4)&nbsp;the provisions of each Award granted
(which need not be identical), including the time or times when a person will be permitted to receive an issuance of the Common Stock
or other payment pursuant to an Award; (5)&nbsp;the number of shares of Common Stock or cash equivalent with respect to which an Award
will be granted to each such person; (6)&nbsp;the Fair Market Value applicable to an Award; and (7)&nbsp;the terms of any Performance
Award that is not valued in whole or in part by reference to, or otherwise based on, the Common Stock, including the amount of cash payment
or other property that may be earned and the timing of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;</B>To
construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules&nbsp;and regulations for its administration.
The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement, in
a manner and to the extent it deems necessary or expedient to make the Plan or Award fully effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;</B>To
settle all controversies regarding the Plan and Awards granted under it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)&nbsp;</B>To
accelerate the time at which an Award may first be exercised or the time during which an Award or any part thereof will vest, notwithstanding
the provisions in the Award Agreement stating the time at which it may first be exercised or the time during which it will vest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(v) &nbsp;</B>To
prohibit the exercise of any Option, SAR or other exercisable Award during a period of up to 30 days prior to the consummation of any
pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal
cash dividends) of Company assets to stockholders, or any other change affecting the shares of Common Stock or the share price of the
Common Stock including any Corporate Transaction, for reasons of administrative convenience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(vi)&nbsp;</B>To
suspend or terminate the Plan at any time. Suspension or termination of the Plan will not Materially Impair rights and obligations under
any Award granted while the Plan is in effect except with the written consent of the affected Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(vii)&nbsp;</B>To
amend the Plan in any respect the Board deems necessary or advisable; provided, however<I>,</I> that stockholder approval will be required
for any amendment to the extent required by Applicable Law. Except as provided above, rights under any Award granted before amendment
of the Plan will not be Materially Impaired by any amendment of the Plan unless (1)&nbsp;the Company requests the consent of the affected
Participant, and (2)&nbsp;such Participant consents in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(viii)&nbsp;</B>To
submit any amendment to the Plan for stockholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ix)&nbsp;</B>To
approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited
to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified
limits in the Plan that are not subject to Board discretion; <I>provided however</I>, that, a Participant&#8217;s rights under any Award
will not be Materially Impaired by any such amendment unless (1)&nbsp;the Company requests the consent of the affected Participant, and
(2)&nbsp;such Participant consents in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(x) &nbsp;</B>Generally,
to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company
and that are not in conflict with the provisions of the Plan or Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(xi)&nbsp;</B>To
adopt such procedures and sub-plans as are necessary or appropriate to permit and facilitate participation in the Plan by, or take
advantage of specific tax treatment for Awards granted to, Employees, Directors or Consultants who are foreign nationals or employed
outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award
Agreement to ensure or facilitate compliance with the laws of the relevant foreign jurisdiction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(xii)&nbsp;</B>To
effect, at any time and from time to time, subject to the consent of any Participant whose Award is Materially Impaired by such action,
(1)&nbsp;the reduction of the exercise price (or strike price) of any outstanding Option or SAR; (2)&nbsp;the cancellation of any outstanding
Option or SAR and the grant in substitution therefor of (A)&nbsp;a new Option, SAR, Restricted Stock Award, RSU Award or Other Award,
under the Plan or another equity plan of the Company, covering the same or a different number of shares of Common Stock, (B)&nbsp;cash
and/or (C)&nbsp;other valuable consideration (as determined by the Board); or (3)&nbsp;any other action that is treated as a repricing
under generally accepted accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;Delegation
to Committee</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;General.</B>
The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of the Plan is delegated
to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board
that have been delegated to the Committee, including the power to delegate to another Committee or a subcommittee of the Committee any
of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the
Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted
from time to time by the Board. Each Committee may retain the authority to concurrently administer the Plan with Committee or subcommittee
to which it has delegated its authority hereunder and may, at any time, revest in such Committee some or all of the powers previously
delegated. The Board may retain the authority to concurrently administer the Plan with any Committee and may, at any time, revest in the
Board some or all of the powers previously delegated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;Rule&nbsp;16b-3
Compliance.</B> To the extent an Award is intended to qualify for the exemption from Section&nbsp;16(b)&nbsp;of the Exchange Act that
is available under Rule&nbsp;16b-3 under the Exchange Act, the Award will be granted by the Board or a Committee that consists solely
of two or more Non-Employee Directors, as determined under Rule&nbsp;16b-3(b)(3)&nbsp;under the Exchange Act and thereafter any action
establishing or modifying the terms of the Award will be approved by the Board or a Committee meeting such requirements to the extent
necessary for such exemption to remain available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)&nbsp;Effect
of Board&#8217;s Decision.</B> All determinations, interpretations and constructions made by the Board or any Committee in good faith
will not be subject to review by any person and will be final, binding and conclusive on all persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)&nbsp;Delegation
to an Officer.</B> The Board or any Committee may delegate to one or more Officers the authority to do one or both of the following (i)&nbsp;designate
Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by Applicable Law, other types of Awards)
and, to the extent permitted by Applicable Law, the terms thereof, and (ii)&nbsp;determine the number of shares of Common Stock to be
subject to such Awards granted to such Employees; provided, however, that the resolutions or charter adopted by the Board or any Committee
evidencing such delegation will specify the total number of shares of Common Stock that may be subject to the Awards granted by such Officer
and that such Officer may not grant an Award to himself or herself. Any such Awards will be granted on the applicable form of Award Agreement
most recently approved for use by the Board or the Committee, unless otherwise provided in the resolutions approving the delegation authority.
Notwithstanding anything to the contrary herein, neither the Board nor any Committee may delegate to an Officer who is acting solely in
the capacity of an Officer (and not also as a Director) the authority to determine the Fair Market Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8. TAX
WITHHOLDING.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;Withholding
Authorization. </B>As a condition to acceptance of any Award under the Plan, a Participant authorizes withholding from payroll and
any other amounts payable to such Participant, and otherwise agrees to make adequate provision for (including), any sums required to
satisfy any U.S. federal, state, local and/or foreign tax or social insurance contribution withholding obligations of the Company or
an Affiliate, if any, which arise in connection with the exercise, vesting or settlement of such Award, as applicable. Accordingly,
a Participant may not be able to exercise an Award even though the Award is vested, and the Company shall have no obligation to
issue shares of Common Stock subject to an Award, unless and until such obligations are satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;Satisfaction
of Withholding Obligation.</B> To the extent permitted by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy
any U.S. federal, state, local and/or foreign tax or social insurance withholding obligation relating to an Award by any of the following
means or by a combination of such means: (i)&nbsp;causing the Participant to tender a cash payment; (ii)&nbsp;withholding shares of
Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award; (iii)&nbsp;withholding
cash from an Award settled in cash; (iv)&nbsp;withholding payment from any amounts otherwise payable to the Participant; (v)&nbsp;by
allowing a Participant to effectuate a &#8220;cashless exercise&#8221; pursuant to a program developed under Regulation T as promulgated
by the Federal Reserve Board; or (vi)&nbsp;by such other method as may be set forth in the Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;No
Obligation to Notify or Minimize Taxes; No Liability to Claims. </B>Except as required by Applicable Law the Company has no duty or obligation
to any Participant to advise such holder as to the time or manner of exercising such Award. Furthermore, the Company has no duty or obligation
to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may
not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award and will
not be liable to any holder of an Award for any adverse tax consequences to such holder in connection with an Award. As a condition to
accepting an Award under the Plan, each Participant (i)&nbsp;agrees to not make any claim against the Company, or any of its Officers,
Directors, Employees or Affiliates related to tax liabilities arising from such Award or other Company compensation and (ii)&nbsp;acknowledges
that such Participant was advised to consult with their own personal tax, financial and other legal advisors regarding the tax consequences
of the Award and has either done so or knowingly and voluntarily declined to do so. Additionally, each Participant acknowledges any Option
or SAR granted under the Plan is exempt from Section&nbsp;409A only if the exercise or strike price is at least equal to the &#8220;fair
market value&#8221; of the Common Stock on the date of grant as determined by the Internal Revenue Service and there is no other impermissible
deferral of compensation associated with the Award. Additionally, as a condition to accepting an Option or SAR granted under the Plan,
each Participant agrees not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates in the event
that the Internal Revenue Service asserts that such exercise price or strike price is less than the &#8220;fair market value&#8221; of
the Common Stock on the date of grant as subsequently determined by the Internal Revenue Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)&nbsp;Withholding
Indemnification. </B>As a condition to accepting an Award under the Plan, in the event that the amount of the Company&#8217;s and/or its
Affiliate&#8217;s withholding obligation in connection with such Award was greater than the amount actually withheld by the Company and/or
its Affiliates, each Participant agrees to indemnify and hold the Company and/or its Affiliates harmless from any failure by the Company
and/or its Affiliates to withhold the proper amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9. MISCELLANEOUS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;Source
of Shares.</B> The stock issuable under the Plan will be shares of authorized but unissued or reacquired shares of Common Stock, including
shares repurchased by the Company on the open market or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;Use
of Proceeds from Sales of the Common Stock. </B>Proceeds from the sale of shares of Common Stock pursuant to Awards will constitute general
funds of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;Corporate
Action Constituting Grant of Awards.</B> Corporate action constituting a grant by the Company of an Award to any Participant will be deemed
completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate,
or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate
records (e.g., Board consents, resolutions or minutes) documenting the corporate action approving the grant contain terms (e.g., exercise
price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result
of a clerical error in the Award Agreement or related grant documents, the corporate records will control and the Participant will have
no legally binding right to the incorrect term in the Award Agreement or related grant documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)&nbsp;Stockholder
Rights.</B> No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of
Common Stock subject to such Award unless and until (i)&nbsp;such Participant has satisfied all requirements for exercise of the Award
pursuant to its terms, if applicable, and (ii)&nbsp;the issuance of the Common Stock subject to such Award is reflected in the records
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)&nbsp;No
Employment or Other Service Rights.</B> Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection
with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in
the capacity in effect at the time the Award was granted or affect the right of the Company or an Affiliate to terminate at will and without
regard to any future vesting opportunity that a Participant may have with respect to any Award (i)&nbsp;the employment of an Employee
with or without notice and with or without cause, (ii)&nbsp;the service of a Consultant pursuant to the terms of such Consultant&#8217;s
agreement with the Company or an Affiliate, or (iii)&nbsp;the service of a Director pursuant to the Bylaws of the Company or an Affiliate,
and any applicable provisions of the corporate law of the state or foreign jurisdiction in which the Company or the Affiliate is incorporated,
as the case may be. Further, nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with
any Award will constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future
work assignments, future compensation or any other term or condition of employment or service or confer any right or benefit under the
Award or the Plan unless such right or benefit has specifically accrued under the terms of the Award Agreement and/or Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(f)&nbsp;Change
in Time Commitment.</B> In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services
for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and
the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the
date of grant of any Award to the Participant, the Board may determine, to the extent permitted by Applicable Law, to (i)&nbsp;make a
corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become
payable after the date of such change in time commitment, and (ii)&nbsp;in lieu of or in combination with such a reduction, extend the
vesting or payment schedule applicable to such Award. In the event of any such reduction, the Participant will have no right with respect
to any portion of the Award that is so reduced or extended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(g)&nbsp;Execution
of Additional Documents.</B> As a condition to accepting an Award under the Plan, the Participant agrees to execute any additional documents
or instruments necessary or desirable, as determined in the Plan Administrator&#8217;s sole discretion, to carry out the purposes or intent
of the Award, or facilitate compliance with securities and/or other regulatory requirements, in each case at the Plan Administrator&#8217;s
request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(h)&nbsp;Electronic
Delivery and Participation.</B> Any reference herein or in an Award Agreement to a &#8220;written&#8221; agreement or document will include
any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the
Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access). By accepting
any Award the Participant consents to receive documents by electronic delivery and to participate in the Plan through any on-line electronic
system established and maintained by the Plan Administrator or another third party selected by the Plan Administrator. The form of delivery
of any Common Stock (e.g., a stock certificate or electronic entry evidencing such shares) shall be determined by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;Clawback/Recovery.</B>
All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to
adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are
listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Law and any clawback
policy that the Company otherwise adopts, to the extent applicable and permissible under Applicable Law. In addition, the Board may impose
such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including
but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence
of Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a Participant&#8217;s right to voluntarily
terminate employment upon a &#8220;resignation for good reason,&#8221; or for a &#8220;constructive termination&#8221; or any similar
term under any plan of or agreement with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(j)&nbsp;Securities
Law Compliance. </B>A Participant will not be issued any shares in respect of an Award unless either (i)&nbsp;the shares are registered
under the Securities Act; or (ii)&nbsp;the Company has determined that such issuance would be exempt from the registration requirements
of the Securities Act. Each Award also must comply with other Applicable Law governing the Award, and a Participant will not receive such
shares if the Company determines that such receipt would not be in material compliance with Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(k)&nbsp;Transfer
or Assignment of Awards; Issued Shares.</B> Except as expressly provided in the Plan or the form of Award Agreement, Awards granted under
the Plan may not be transferred or assigned by the Participant. After the vested shares subject to an Award have been issued, or in the
case of Restricted Stock and similar awards, after the issued shares have vested, the holder of such shares is free to assign, hypothecate,
donate, encumber or otherwise dispose of any interest in such shares provided that any such actions are in compliance with the provisions
herein, the terms of the Trading Policy and Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(l)&nbsp;Effect
on Other Employee Benefit Plans. </B>The value of any Award granted under the Plan, as determined upon grant, vesting or settlement, shall
not be included as compensation, earnings, salaries, or other similar terms used when calculating any Participant&#8217;s benefits under
any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides. The Company expressly
reserves its rights to amend, modify, or terminate any of the Company&#8217;s or any Affiliate&#8217;s employee benefit plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(m)&nbsp;Deferrals.</B>
To the extent permitted by Applicable Law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment
of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may also establish programs and
procedures for deferral elections to be made by Participants. Deferrals will be made in accordance with the requirements of Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(n)&nbsp;Section&nbsp;409A.
</B>Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent
possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section&nbsp;409A, and, to the extent not so exempt,
in compliance with the requirements of Section&nbsp;409A. If the Board determines that any Award granted hereunder is not exempt from
and is therefore subject to Section&nbsp;409A, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary
to avoid the consequences specified in Section&nbsp;409A(a)(1)&nbsp;of the Code, and to the extent an Award Agreement is silent on terms
necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding anything to the contrary
in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and
if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221; under Section&nbsp;409A is a &#8220;specified
employee&#8221; for purposes of Section&nbsp;409A, no distribution or payment of any amount that is due because of a &#8220;separation
from service&#8221; (as defined in Section&nbsp;409A without regard to alternative definitions thereunder) will be issued or paid before
the date that is six months and one day following the date of such Participant&#8217;s &#8220;separation from service&#8221; or, if earlier,
the date of the Participant&#8217;s death, unless such distribution or payment can be made in a manner that complies with Section&nbsp;409A,
and any amounts so deferred will be paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter
on the original schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(o)&nbsp;Choice
of Law. </B>This Plan and any controversy arising out of or relating to this Plan shall be governed by, and construed in accordance with,
the internal laws of the State of Delaware, without regard to conflict of law principles that would result in any application of any law
other than the law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>10.&nbsp;COVENANTS
OF THE COMPANY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will seek to
obtain from each regulatory commission or agency, as may be deemed to be necessary, having jurisdiction over the Plan such authority
as may be required to grant Awards and to issue and sell shares of Common Stock upon exercise or vesting of the Awards; provided,
however, that this undertaking will not require the Company to register under the Securities Act the Plan, any Award or any Common
Stock issued or issuable pursuant to any such Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to
obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary or advisable for the
lawful issuance and sale of the Common Stock under the Plan, the Company will be relieved from any liability for failure to issue
and sell the Common Stock upon exercise or vesting of such Awards unless and until such authority is obtained. A Participant is not
eligible for the grant of an Award or the subsequent issuance of the Common Stock pursuant to the Award if such grant or issuance
would be in violation of any Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>11.&nbsp;ADDITIONAL
RULES FOR AWARDS SUBJECT TO SECTION&nbsp;409A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;Application.
</B>Unless the provisions of this <U>Section&nbsp;11</U> of the Plan are expressly superseded by the provisions in the form of Award
Agreement, the provisions of this <U>Section&nbsp;11</U> shall apply and shall supersede anything to the contrary set forth in the Award
Agreement for a Non-Exempt Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;Non-Exempt
Awards Subject to Non-Exempt Severance Arrangements.</B> To the extent a Non-Exempt Award is subject to Section&nbsp;409A due to application
of a Non-Exempt Severance Arrangement, the following provisions of this subsection (b)&nbsp;apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i) &nbsp;</B>If
the Non-Exempt Award vests in the ordinary course during the Participant&#8217;s Continuous Service in accordance with the vesting schedule
set forth in the Award Agreement, and does not accelerate vesting under the terms of a Non-Exempt Severance Arrangement, in no event will
the shares be issued in respect of such Non-Exempt Award any later than the later of: (i)&nbsp;December&nbsp;31st of the calendar year
that includes the applicable vesting date, or (ii)&nbsp;the 60th day that follows the applicable vesting date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii) &nbsp;</B>If
vesting of the Non-Exempt Award accelerates under the terms of a Non-Exempt Severance Arrangement in connection with the Participant&#8217;s
Separation from Service, and such vesting acceleration provisions were in effect as of the date of grant of the Non-Exempt Award and,
therefore, are part of the terms of such Non-Exempt Award as of the date of grant, then the shares will be earlier issued in settlement
of such Non-Exempt Award upon the Participant&#8217;s Separation from Service in accordance with the terms of the Non-Exempt Severance
Arrangement, but in no event later than the 60th day that follows the date of the Participant&#8217;s Separation from Service. However,
if at the time the shares would otherwise be issued the Participant is subject to the distribution limitations contained in Section&nbsp;409A
applicable to &#8220;specified employees,&#8221; as defined in Section&nbsp;409A(a)(2)(B)(i)&nbsp;of the Code, such shares shall not
be issued before the date that is six months following the date of such Participant&#8217;s Separation from Service, or, if earlier, the
date of the Participant&#8217;s death that occurs within such six month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;</B>If
vesting of a Non-Exempt Award accelerates under the terms of a Non-Exempt Severance Arrangement in connection with a Participant&#8217;s
Separation from Service, and such vesting acceleration provisions were not in effect as of the date of grant of the Non-Exempt Award and,
therefore, are not a part of the terms of such Non-Exempt Award on the date of grant, then such acceleration of vesting of the Non-Exempt
Award shall not accelerate the issuance date of the shares, but the shares shall instead be issued on the same schedule as set forth in
the Grant Notice as if they had vested in the ordinary course during the Participant&#8217;s Continuous Service, notwithstanding the vesting
acceleration of the Non-Exempt Award. Such issuance schedule is intended to satisfy the requirements of payment on a specified date or
pursuant to a fixed schedule, as provided under Treasury Regulations Section&nbsp;1.409A-3(a)(4).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;Treatment
of Non-Exempt Awards Upon a Corporate Transaction for Employees and Consultants.</B> The provisions of this subsection (c)&nbsp;shall
apply and shall supersede anything to the contrary set forth in the Plan with respect to the permitted treatment of any Non-Exempt Award
in connection with a Corporate Transaction if the Participant was either an Employee or Consultant upon the applicable date of grant of
the Non-Exempt Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;Vested
Non-Exempt Awards</B>. The following provisions shall apply to any Vested Non-Exempt Award in connection with a Corporate Transaction:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(1)&nbsp;</B>If
the Corporate Transaction is also a Section&nbsp;409A Change in Control then the Acquiring Entity may not assume, continue or substitute
the Vested Non-Exempt Award. Upon the Section&nbsp;409A Change in Control the settlement of the Vested Non-Exempt Award will automatically
be accelerated and the shares will be immediately issued in respect of the Vested Non-Exempt Award. Alternatively, the Company may instead
provide that the Participant will receive a cash settlement equal to the Fair Market Value of the shares that would otherwise be issued
to the Participant upon the Section&nbsp;409A Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(2)&nbsp;</B>If
the Corporate Transaction is not also a Section&nbsp;409A Change in Control, then the Acquiring Entity must either assume, continue or
substitute each Vested Non-Exempt Award. The shares to be issued in respect of the Vested Non-Exempt Award shall be issued to the Participant
by the Acquiring Entity on the same schedule that the shares would have been issued to the Participant if the Corporate Transaction had
not occurred. In the Acquiring Entity&#8217;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute
a cash payment on each applicable issuance date, equal to the Fair Market Value of the shares that would otherwise be issued to the Participant
on such issuance dates, with the determination of the Fair Market Value of the shares made on the date of the Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;Unvested
Non-Exempt Awards.</B> The following provisions shall apply to any Unvested Non-Exempt Award unless otherwise determined by the Board
pursuant to <U>Section&nbsp;11(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(1)&nbsp;</B>In
the event of a Corporate Transaction, the Acquiring Entity shall assume, continue or substitute any Unvested Non-Exempt Award. Unless
otherwise determined by the Board, any Unvested Non-Exempt Award will remain subject to the same vesting and forfeiture restrictions that
were applicable to the Award prior to the Corporate Transaction. The shares to be issued in respect of any Unvested Non-Exempt Award shall
be issued to the Participant by the Acquiring Entity on the same schedule that the shares would have been issued to the Participant if
the Corporate Transaction had not occurred. In the Acquiring Entity&#8217;s discretion, in lieu of an issuance of shares, the Acquiring
Entity may instead substitute a cash payment on each applicable issuance date, equal to the Fair Market Value of the shares that would
otherwise be issued to the Participant on such issuance dates, with the determination of Fair Market Value of the shares made on the date
of the Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(2)&nbsp;</B>If
the Acquiring Entity will not assume, substitute or continue any Unvested Non-Exempt Award in connection with a Corporate Transaction,
then such Award shall automatically terminate and be forfeited upon the Corporate Transaction with no consideration payable to any Participant
in respect of such forfeited Unvested Non-Exempt Award. Notwithstanding the foregoing, to the extent permitted and in compliance with
the requirements of Section&nbsp;409A, the Board may in its discretion determine to elect to accelerate the vesting and settlement of
the Unvested Non-Exempt Award upon the Corporate Transaction, or instead substitute a cash payment equal to the Fair Market Value of such
shares that would otherwise be issued to the Participant, as further provided in subsection (e)(ii)&nbsp;below. In the absence of such
discretionary election by the Board, any Unvested Non-Exempt Award shall be forfeited without payment of any consideration to the affected
Participants if the Acquiring Entity will not assume, substitute or continue the Unvested Non-Exempt Awards in connection with the Corporate
Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><B>(3)&nbsp;</B>The
foregoing treatment shall apply with respect to all Unvested Non-Exempt Awards upon any Corporate Transaction, and regardless of whether
or not such Corporate Transaction is also a Section&nbsp;409A Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)&nbsp;Treatment
of Non-Exempt Awards Upon a Corporate Transaction for Non-Employee Directors.</B> The following provisions of this subsection (d)&nbsp;shall
apply and shall supersede anything to the contrary that may be set forth in the Plan with respect to the permitted treatment of a Non-Exempt
Director Award in connection with a Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;</B>If
the Corporate Transaction is also a Section&nbsp;409A Change in Control then the Acquiring Entity may not assume, continue or substitute
the Non-Exempt Director Award. Upon the Section&nbsp;409A Change in Control the vesting and settlement of any Non-Exempt Director Award
will automatically be accelerated and the shares will be immediately issued to the Participant in respect of the Non-Exempt Director Award.
Alternatively, the Company may provide that the Participant will instead receive a cash settlement equal to the Fair Market Value of the
shares that would otherwise be issued to the Participant upon the Section&nbsp;409A Change in Control pursuant to the preceding provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;</B>If the
Corporate Transaction is not also a Section&nbsp;409A Change in Control, then the Acquiring Entity must either assume, continue or
substitute the Non-Exempt Director Award. Unless otherwise determined by the Board, the Non-Exempt Director Award will remain
subject to the same vesting and forfeiture restrictions that were applicable to the Award prior to the Corporate Transaction. The
shares to be issued in respect of the Non-Exempt Director Award shall be issued to the Participant by the Acquiring Entity on the
same schedule that the shares would have been issued to the Participant if the Corporate Transaction had not occurred. In the
Acquiring Entity&#8217;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash payment on
each applicable issuance date, equal to the Fair Market Value of the shares that would otherwise be issued to the Participant on
such issuance dates, with the determination of Fair Market Value made on the date of the Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)&nbsp;</B>If
the RSU Award is a Non-Exempt Award, then the provisions in this Section&nbsp;11(e)&nbsp;shall apply and supersede anything to the contrary
that may be set forth in the Plan or the Award Agreement with respect to the permitted treatment of such Non-Exempt Award:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;</B>Any
exercise by the Board of discretion to accelerate the vesting of a Non-Exempt Award shall not result in any acceleration of the scheduled
issuance dates for the shares in respect of the Non-Exempt Award unless earlier issuance of the shares upon the applicable vesting dates
would be in compliance with the requirements of Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;</B>The
Company explicitly reserves the right to earlier settle any Non-Exempt Award to the extent permitted and in compliance with the requirements
of Section&nbsp;409A, including pursuant to any of the exemptions available in Treasury Regulations Section&nbsp;1.409A-3(j)(4)(ix).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;</B>To
the extent the terms of any Non-Exempt Award provide that it will be settled upon a Change in Control or Corporate Transaction, to the
extent it is required for compliance with the requirements of Section&nbsp;409A, the Change in Control or Corporate Transaction event
triggering settlement must also constitute a Section&nbsp;409A Change in Control. To the extent the terms of a Non-Exempt Award provides
that it will be settled upon a termination of employment or termination of Continuous Service, to the extent it is required for compliance
with the requirements of Section&nbsp;409A, the termination event triggering settlement must also constitute a Separation From Service.
However, if at the time the shares would otherwise be issued to a Participant in connection with a &#8220;separation from service&#8221;
such Participant is subject to the distribution limitations contained in Section&nbsp;409A applicable to &#8220;specified employees,&#8221;
as defined in Section&nbsp;409A(a)(2)(B)(i)&nbsp;of the Code, such shares shall not be issued before the date that is six months following
the date of the Participant&#8217;s Separation From Service, or, if earlier, the date of the Participant&#8217;s death that occurs within
such six month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)&nbsp;</B>The
provisions in this subsection (e)&nbsp;for delivery of the shares in respect of the settlement of an RSU Award that is a Non-Exempt Award
are intended to comply with the requirements of Section&nbsp;409A so that the delivery of the shares to the Participant in respect of
such Non-Exempt Award will not trigger the additional tax imposed under Section&nbsp;409A, and any ambiguities herein will be so interpreted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>12.&nbsp;SEVERABILITY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If all or any part of the
Plan or any Award Agreement is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity
shall not invalidate any portion of the Plan or such Award Agreement not declared to be unlawful or invalid. Any Section&nbsp;of the
Plan or any Award Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner
which will give effect to the terms of such Section&nbsp;or part of a Section&nbsp;to the fullest extent possible while remaining lawful
and valid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>13.&nbsp;TERMINATION
OF THE PLAN.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may suspend or terminate
the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the earlier of: (i)&nbsp;the Adoption
Date, or (ii)&nbsp;the date the Plan is approved by the Company&#8217;s stockholders. No Awards may be granted under the Plan while the
Plan is suspended or after it is terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>14.&nbsp;DEFINITIONS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in the Plan, the following
definitions apply to the capitalized terms indicated below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)&nbsp;<I>&#8220;Acquiring
Entity&#8221;</I></B> means the surviving or acquiring corporation (or its parent company) in connection with a Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)&nbsp;<I>&#8220;Adoption
Date&#8221;</I></B> means the date the Plan is first approved by the Board or Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)&nbsp;<I>&#8220;Affiliate&#8221;</I></B>
means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in
Rule&nbsp;405 promulgated under the Securities Act. The Board may determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221;
status is determined within the foregoing definition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)&nbsp;<I>&#8220;Applicable
Law&#8221;</I></B> means any applicable securities, federal, state, foreign, material local or municipal or other law, statute, constitution,
principle of common law, resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement
issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (including
under the authority of any applicable self-regulating organization such as the Nasdaq Stock Market, New York Stock Exchange, or the Financial
Industry Regulatory Authority).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)&nbsp;<I>&#8220;Award&#8221;</I></B>
means any right to receive Common Stock, cash or other property granted under the Plan (including an Incentive Stock Option, a Nonstatutory
Stock Option, a Restricted Stock Award, an RSU Award, a SAR, a Performance Award or any Other Award).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(f)&nbsp;<I>&#8220;Award
Agreement&#8221;</I></B> means a written or electronic agreement between the Company and a Participant evidencing the terms and conditions
of an Award. The Award Agreement generally consists of the Grant Notice and the agreement containing the written summary of the general
terms and conditions applicable to the Award and which is provided, including through electronic means, to a Participant along with the
Grant Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(g)&nbsp;<I>&#8220;Board&#8221;</I></B>
means the Board of Directors of the Company (or its designee). Any decision or determination made by the Board shall be a decision or
determination that is made in the sole discretion of the Board (or its designee), and such decision or determination shall be final and
binding on all Participants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(h)&nbsp;<I>&#8220;Capitalization
Adjustment&#8221;</I></B> means any change that is made in, or other events that occur with respect to, the Common Stock subject to the
Plan or subject to any Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation,
reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend,
stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any
similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards
Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the
Company will not be treated as a Capitalization Adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;<I>&#8220;Cause&#8221;</I></B>
has the meaning ascribed to such term in any written agreement between a Participant and the Company defining such term and, in the absence
of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events: (i)&nbsp;the Participant&#8217;s
dishonest statements or acts with respect to the Company or any Affiliate of the Company, or any current or prospective customers, suppliers,
vendors or other third parties with which such entity does business; (ii)&nbsp;the Participant&#8217;s commission of (A)&nbsp;a felony
or (B)&nbsp;any misdemeanor involving moral turpitude, deceit, dishonesty or fraud; (iii)&nbsp;the Participant&#8217;s failure to perform
the Participant&#8217;s assigned duties and responsibilities to the reasonable satisfaction of the Company which failure continues, in
the reasonable judgment of the Company, after written notice given to the Participant by the Company; (iv)&nbsp;the Participant&#8217;s
gross negligence, willful misconduct or insubordination with respect to the Company or any Affiliate of the Company; or (v)&nbsp;the
Participant&#8217;s material violation of any provision of any agreement(s)&nbsp;between the Participant and the Company relating to
noncompetition, nonsolicitation, nondisclosure and/or assignment of inventions. The determination that a termination of the Participant&#8217;s
Continuous Service is either for Cause or without Cause will be made by the Board with respect to Participants who are executive officers
of the Company and by the Company&#8217;s Chief Executive Officer with respect to Participants who are not executive officers of the Company.
Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of
outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or
such Participant for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(j)&nbsp;<I>&#8220;Change
in Control&#8221;</I></B> or <B><I>&#8220;Change of Control&#8221;</I></B> means the occurrence, in a single transaction or in a series
of related transactions, of any one or more of the following events; provided, however, to the extent necessary to avoid adverse personal
income tax consequences to the Participant in connection with an Award, also constitutes a Section&nbsp;409A Change in Control:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;</B>any
Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined
voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction.
Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (A)&nbsp;on account of the acquisition of securities
of the Company directly from the Company, (B)&nbsp;on account of the acquisition of securities of the Company by an investor, any affiliate
thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions
the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C)&nbsp;solely because
the level of Ownership held by any Exchange Act Person (the <B><I>&#8220;Subject Person&#8221;</I></B>) exceeds the designated percentage
threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing
the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result
of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any
additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then
outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control shall be
deemed to occur;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;</B>there
is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the
consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own,
directly or indirectly, either (A)&nbsp;outstanding voting securities representing more than 50% of the combined outstanding voting power
of the surviving Entity in such merger, consolidation or similar transaction or (B)&nbsp;more than 50% of the combined outstanding voting
power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same
proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;</B>there
is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company
and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of
the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities of which are Owned
by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company
immediately prior to such sale, lease, license or other disposition; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv) </B>individuals
who, on the date the Plan is adopted by the Board, are members of the Board (the <B><I>&#8220;Incumbent Board&#8221;</I></B>) cease for
any reason to constitute at least a majority of the members of the Board; provided, however, that if the appointment or election (or nomination
for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still
in office, such new member shall, for purposes of this Plan, be considered as a member of the Incumbent Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing
or any other provision of this Plan, (A)&nbsp;the term Change in Control shall not include a sale of assets, merger or other transaction
effected exclusively for the purpose of changing the domicile of the Company, and (B)&nbsp;the definition of Change in Control (or any
analogous term) in an individual written agreement between the Company or any Affiliate and the Participant shall supersede the foregoing
definition with respect to Awards subject to such agreement; provided, however, that if no definition of Change in Control or any analogous
term is set forth in such an individual written agreement, the foregoing definition shall apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(k)&nbsp;<I>&#8220;Code&#8221;</I></B>
means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(l) <I>&#8220;Committee&#8221;</I></B>
means the Compensation Committee and any other committee of one or more Directors to whom authority has been delegated by the Board or
Compensation Committee in accordance with the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(m)&nbsp;<I>&#8220;Common
Stock&#8221;</I></B> means the Common Stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(n)&nbsp;<I>&#8220;Company&#8221;</I></B>
means NeuroOne Medical Technologies Corporation, a Delaware corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(o)&nbsp;<I>&#8220;Compensation
Committee&#8221;</I></B> means the Compensation Committee of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(p)&nbsp;<I>&#8220;Consultant&#8221;</I></B>
means any person, including an advisor, who is (i)&nbsp;engaged by the Company or an Affiliate to render consulting or advisory services
and is compensated for such services, or (ii)&nbsp;serving as a member of the board of directors of an Affiliate and is compensated for
such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered
a &#8220;Consultant&#8221; for purposes of the Plan. Notwithstanding the foregoing, a person is treated as a Consultant under this Plan
only if a Form&nbsp;S-8 Registration Statement under the Securities Act is available to register either the offer or the sale of the
Company&#8217;s securities to such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(q)&nbsp;<I>&#8220;Continuous
Service&#8221;</I></B> means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Director or
Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate
as an Employee, Director or Consultant or a change in the Entity for which the Participant renders such service, provided that there is
no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s
Continuous Service; provided, however<I>,</I> that if the Entity for which a Participant is rendering services ceases to qualify as an
Affiliate, as determined by the Board, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such
Entity ceases to qualify as an Affiliate. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate
or to a Director will not constitute an interruption of Continuous Service. To the extent permitted by law, the Board or the Chief Executive
Officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted
in the case of (i)&nbsp;any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or
any other personal leave, or (ii)&nbsp;transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing,
a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in
the Company&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant,
or as otherwise required by law. In addition, to the extent required for exemption from or compliance with Section&nbsp;409A, the determination
of whether there has been a termination of Continuous Service will be made, and such term will be construed, in a manner that is consistent
with the definition of &#8220;separation from service&#8221; as defined under Treasury Regulation Section&nbsp;1.409A-1(h)&nbsp;(without
regard to any alternative definition thereunder).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(r)&nbsp;<I>&#8220;Corporate
Transaction&#8221;</I></B> means the consummation, in a single transaction or in a series of related transactions, of any one or more
of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)&nbsp;</B>a
sale or other disposition of all or substantially all, as determined by the Board, of the consolidated assets of the Company and its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)&nbsp;</B>a
sale or other disposition of at least 50% of the outstanding securities of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;</B>a
merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)&nbsp;</B>a
merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding
immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation
or similar transaction into other property, whether in the form of securities, cash or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the
foregoing or any other provision of this Plan, (A)&nbsp;the term Corporate Transaction shall not include a sale of assets, merger or
other transaction effected exclusively for the purpose of changing the domicile of the Company, (B)&nbsp;the definition of Corporate
Transaction (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant
shall supersede the foregoing definition with respect to Awards subject to such agreement; provided, however, that if no definition
of Corporate Transaction or any analogous term is set forth in such an individual written agreement, the foregoing definition shall
apply, and (C)&nbsp;with respect to any nonqualified deferred compensation that becomes payable on account of the Corporate
Transaction, the transaction or event described in clause (i), (ii), (iii), or (iv)&nbsp;also constitutes a Section&nbsp;409A Change
in Control if required in order for the payment not to violate Section&nbsp;409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(s)&nbsp;<I>&#8220;Director&#8221;</I></B>
means a member of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(t)&nbsp;<I>&#8220;determine&#8221;
</I></B>or <B><I>&#8220;determined&#8221; </I></B>means as determined by the Board or the Committee (or its designee) in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(u)&nbsp;<I>&#8220;Disability&#8221;</I></B>
means, with respect to a Participant, such Participant is unable to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for
a continuous period of not less than 12 months, as provided in Section&nbsp;22(e)(3)&nbsp;of the Code, and will be determined by the
Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(v)&nbsp;<I>&#8220;Effective
Date&#8221;</I></B> means the effective date of this Plan, which is the date this Plan (as amended from time to time) is approved by the
Company&#8217;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(w)&nbsp;<I>&#8220;Employee&#8221;</I></B>
means any person employed by the Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services,
will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(x)&nbsp;<I>&#8220;Employer&#8221;</I></B>
means the Company or the Affiliate of the Company that employs the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(y)&nbsp;<I>&#8220;Entity&#8221;
</I></B>means a corporation, partnership, limited liability company or other entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(z)&nbsp;<I>&#8220;Exchange
Act&#8221;</I></B> means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(aa) &nbsp;<I>&#8220;Exchange
Act Person&#8221;</I></B> means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section&nbsp;13(d)&nbsp;or
14(d)&nbsp;of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i)&nbsp;the Company or any Subsidiary
of the Company, (ii)&nbsp;any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary
holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)&nbsp;an underwriter temporarily
holding securities pursuant to a registered public offering of such securities, (iv)&nbsp;an Entity Owned, directly or indirectly, by
the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v)&nbsp;any natural
person, Entity or &#8220;group&#8221; (within the meaning of Section&nbsp;13(d)&nbsp;or 14(d)&nbsp;of the Exchange Act) that, as of
the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting
power of the Company&#8217;s then outstanding securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(bb) &nbsp;<I>&#8220;Fair
Market Value&#8221;</I></B> means, as of any date, unless otherwise determined by the Board, the value of the Common Stock (as determined
on a per share or aggregate basis, as applicable) determined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i) &nbsp;</B>If
the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value will be the closing
sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the
Common Stock) on the date of determination, as reported in a source the Board deems reliable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii) &nbsp;</B>If
there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling
price on the last preceding date for which such quotation exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)&nbsp;</B>In
the absence of such markets for the Common Stock, or if otherwise determined by the Board, the Fair Market Value will be determined by
the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(cc) &nbsp;<I>Reserved</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(dd) &nbsp;<I>&#8220;Governmental
Body&#8221; </I></B>means any: (i)&nbsp;nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction
of any nature; (ii)&nbsp;federal, state, local, municipal, foreign or other government; (iii)&nbsp;governmental or regulatory body,
or quasi-governmental body of any nature (including any governmental division, department, administrative agency or bureau, commission,
authority, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal,
and for the avoidance of doubt, any Tax authority) or other body exercising similar powers or authority; or&nbsp;(iv)&nbsp;self-regulatory
organization (including the Nasdaq Stock Market, New York Stock Exchange, and the Financial Industry Regulatory Authority).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ee) &nbsp;<I>&#8220;Grant
Notice&#8221;</I></B> means the notice provided to a Participant that he or she has been granted an Award under the Plan and which includes
the name of the Participant, the type of Award, the date of grant of the Award, number of shares of Common Stock subject to the Award
or potential cash payment right, (if any), the vesting schedule for the Award (if any) and other key terms applicable to the Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ff) &nbsp;<I>&#8220;Incentive
Stock Option&#8221;</I></B> means an option granted pursuant to <U>Section&nbsp;4</U> of the Plan that is intended to be, and qualifies
as, an &#8220;incentive stock option&#8221; within the meaning of Section&nbsp;422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(gg) &nbsp;<I>&#8220;Materially
Impair&#8221;</I></B> means any amendment to the terms of the Award that materially adversely affects the Participant&#8217;s rights under
the Award. A Participant&#8217;s rights under an Award will not be deemed to have been Materially Impaired by any such amendment if the
Board, in its sole discretion, determines that the amendment, taken as a whole, does not Materially Impair the Participant&#8217;s rights.
For example, the following types of amendments to the terms of an Award do not Materially Impair the Participant&#8217;s rights under
the Award: (i)&nbsp;imposition of reasonable restrictions on the minimum number of shares subject to an Option or SAR that may be exercised;
(ii)&nbsp;to maintain the qualified status of the Award as an Incentive Stock Option under Section&nbsp;422 of the Code; (iii)&nbsp;to
change the terms of an Incentive Stock Option in a manner that disqualifies, impairs or otherwise affects the qualified status of the
Award as an Incentive Stock Option under Section&nbsp;422 of the Code; (iv)&nbsp;to clarify the manner of exemption from, or to bring
the Award into compliance with or qualify it for an exemption from, Section&nbsp;409A; or (v)&nbsp;to comply with other Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(hh) &nbsp;<I>&#8220;Non-Employee
Director&#8221;</I></B> means a Director who either (i)&nbsp;is not a current employee or officer of the Company or an Affiliate, does
not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in
any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a)&nbsp;of Regulation
S-K promulgated pursuant to the Securities Act (<B><I>&#8220;Regulation S-K&#8221;</I></B>)), does not possess an interest in any other
transaction for which disclosure would be required under Item 404(a)&nbsp;of Regulation S-K, and is not engaged in a business relationship
for which disclosure would be required pursuant to Item&nbsp;404(b)&nbsp;of Regulation S-K; or (ii)&nbsp;is otherwise considered a
&#8220;non-employee director&#8221; for purposes of Rule&nbsp;16b-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)&nbsp;<I>&#8220;Non-Exempt
Award&#8221;</I></B> means any Award that is subject to, and not exempt from, Section&nbsp;409A, including as the result of (i)&nbsp;a
deferral of the issuance of the shares subject to the Award which is elected by the Participant or imposed by the Company, or (ii)&nbsp;the
terms of any Non-Exempt Severance Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(jj) &nbsp;<I>&#8220;Non-Exempt
Director Award&#8221;</I></B> means a Non-Exempt Award granted to a Participant who was a Director but not an Employee on the applicable
grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(kk)
&nbsp;<I>&#8220;Non-Exempt Severance Arrangement&#8221; </I></B>means a severance arrangement or other agreement between the
Participant and the Company that provides for acceleration of vesting of an Award and issuance of the shares in respect of such
Award upon the Participant&#8217;s termination of employment or separation from service (as such term is defined in
Section&nbsp;409A(a)(2)(A)(i)&nbsp;of the Code (and without regard to any alternative definition thereunder)
(<B><I>&#8220;Separation from Service&#8221;</I></B>) and such severance benefit does not satisfy the requirements for an exemption
from application of Section&nbsp;409A provided under Treasury Regulations Section&nbsp;1.409A-1(b)(4), 1.409A-1(b)(9)&nbsp;or
otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ll) &nbsp;<I>&#8220;Nonstatutory
Stock Option&#8221; </I></B>means any option granted pursuant to <U>Section&nbsp;4</U> of the Plan that does not qualify as an Incentive
Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(mm) &nbsp;<I>&#8220;Officer&#8221;</I></B>
means a person who is an officer of the Company within the meaning of Section&nbsp;16 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(nn) &nbsp;<I>&#8220;Option&#8221;</I></B>
means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(oo)&nbsp;<I>&#8220;Option
Agreement&#8221;</I></B> means a written or electronic agreement between the Company and the Optionholder evidencing the terms and conditions
of the Option grant. The Option Agreement includes the Grant Notice for the Option and the agreement containing the written summary of
the general terms and conditions applicable to the Option and which is provided, including through electronic means, to a Participant
along with the Grant Notice. Each Option Agreement will be subject to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(pp) &nbsp;<I>&#8220;Optionholder&#8221;</I></B>
means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(qq) &nbsp;<I>&#8220;Other
Award&#8221;</I></B> means an award valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation
in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the Fair Market Value at the
time of grant) that is not an Incentive Stock Option, Nonstatutory Stock Option, SAR, Restricted Stock Award, RSU Award or Performance
Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(rr) &nbsp;<I>&#8220;Other
Award Agreement&#8221;</I></B> means a written agreement between the Company and a holder of an Other Award evidencing the terms and conditions
of an Other Award grant. Each Other Award Agreement will be subject to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ss) &nbsp;<I>&#8220;Own&#8221;</I></B>,
<B><I>&#8220;Owned&#8221;</I></B>, <B><I>&#8220;Owner&#8221; </I></B>or <B><I>&#8220;Ownership&#8221;</I></B> means that a person or Entity
will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221;
of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise,
has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(tt) &nbsp;<I>&#8220;Participant&#8221;</I></B>
means an Employee, Director or Consultant to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds
an outstanding Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(uu) &nbsp;<I>&#8220;Performance
Award&#8221;</I></B> means an Award that may vest or may be exercised or a cash award that may vest or become earned and paid contingent
upon the attainment during a Performance Period of certain Performance Goals and which is granted under the terms and conditions of <U>Section&nbsp;5(b)</U>&nbsp;pursuant
to such terms as are approved by the Board. In addition, to the extent permitted by Applicable Law and set forth in the applicable Award
Agreement, the Board may determine that cash or other property may be used in payment of Performance Awards. Performance Awards that are
settled in cash or other property are not required to be valued in whole or in part by reference to, or otherwise based on, the Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(vv)
&nbsp;<I>&#8220;Performance Criteria&#8221;</I></B> means one or more criteria that the Board will select for purposes of
establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such
Performance Goals may be based on any one of, or combination of, the following as determined by the Board: earnings (including
earnings per share and net earnings); earnings before interest, taxes and depreciation; earnings before interest, taxes,
depreciation and amortization; total stockholder return; return on equity or average stockholder&#8217;s equity; return on assets,
investment, or capital employed; stock price; margin (including gross margin); income (before or after taxes); operating income;
operating income after taxes; pre-tax profit; operating cash flow; sales or revenue targets; increases in revenue or product
revenue; expenses and cost reduction goals; improvement in or attainment of working capital levels; economic value added (or an
equivalent metric); market share; cash flow; cash flow per share; share price performance; debt reduction; customer satisfaction;
stockholders&#8217; equity; capital expenditures; debt levels; operating profit or net operating profit; workforce diversity; growth
of net income or operating income; billings; product development goals; financing; regulatory milestones, including approval of a
product; stockholder liquidity; corporate governance and compliance; product commercialization; intellectual property; personnel
matters; progress of internal research; progress of partnered programs; partner satisfaction; budget management; data from clinical
studies, partner or collaborator achievements; internal controls, including those related to the Sarbanes-Oxley Act of 2002;
investor relations, analysts and communication; manufacturing achievements (including obtaining particular yields from manufacturing
runs and other measurable objectives related to process development activities); employee retention; strategic partnerships or
transactions (including in-licensing and out-licensing of intellectual property); establishing relationships with commercial
entities with respect to the marketing, distribution and sale of the Company&#8217;s products; supply chain achievements;
co-development, co-marketing, profit sharing, joint venture or other similar arrangements; individual performance goals; corporate
development and planning goals; and other measures of performance selected by the Board or Committee whether or not listed
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ww) &nbsp;<I>&#8220;Performance
Goals&#8221;</I></B> means, for a Performance Period, one or more goals established by the Board for the Performance Period based upon
the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions,
Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the
performance of one or more relevant indices. Unless specified otherwise by the Board (i)&nbsp;in the Award Agreement at the time the
Award is granted or (ii)&nbsp;in such other document setting forth the Performance Goals at the time the Performance Goals are established,
the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period
as follows: (1)&nbsp;to exclude restructuring and/or other nonrecurring charges; (2)&nbsp;to exclude exchange rate effects; (3)&nbsp;to
exclude the effects of changes to generally accepted accounting principles; (4)&nbsp;to exclude the effects of any statutory adjustments
to corporate tax rates; (5)&nbsp;to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221;
as determined under generally accepted accounting principles; (6)&nbsp;to exclude the dilutive effects of acquisitions or joint ventures;
(7)&nbsp;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of
a Performance Period following such divestiture; (8)&nbsp;to exclude the effect of any change in the outstanding shares of common stock
of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off,
combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash
dividends; (9)&nbsp;to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans;
(10)&nbsp;to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under
generally accepted accounting principles; and (11)&nbsp;to exclude the goodwill and intangible asset impairment charges that are required
to be recorded under generally accepted accounting principles. In addition, the Board may establish or provide for other adjustment items
in the Award Agreement at the time the Award is granted or in such other document setting for the Performance Goals at the time the Performance
Goals are established. In addition, the Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon
attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance
Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement
as specified in the Award Agreement or the written terms of a Performance Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(xx)&nbsp;<I>&#8220;Performance
Period&#8221; </I></B>means the period of time selected by the Board over which the attainment of one or more Performance Goals will be
measured for the purpose of determining a Participant&#8217;s right to vesting or exercise of an Award. Performance Periods may be of
varying and overlapping duration, at the sole discretion of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(yy) &nbsp;<I>&ldquo;Plan&#8221;</I></B>
means this NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(zz) <I>&ldquo;Plan
Administrator&#8221; </I></B>means the person, persons, and/or third-party administrator designated by the Company to administer the day
to day operations of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(aaa) &nbsp;<I>&ldquo;Post-Termination
Exercise Period&#8221; </I></B>means the period following termination of a Participant&#8217;s Continuous Service within which an Option
or SAR is exercisable, as specified in <U>Section&nbsp;4(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(bbb)</B> Reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ccc) &nbsp;&ldquo;<I>Prior
Plans&#8221;</I></B> means the NeuroOne Medical Technologies Corporation 2017 Equity Incentive Plan and the NeuroOne Medical Technologies
2016 Equity Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ddd) &nbsp;&ldquo;<I>Prospectus&#8221;</I></B>
means the document containing the Plan information specified in Section&nbsp;10(a)&nbsp;of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(eee) &nbsp;<I>&ldquo;Restricted
Stock Award&#8221;</I></B> or <B><I>&#8220;RSA&#8221;</I></B> means an Award of shares of Common Stock which is granted pursuant to the
terms and conditions of <U>Section&nbsp;5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(fff) &nbsp;<I>&#8220;Restricted
Stock Award Agreement&#8221; </I></B>means a written or electronic agreement between the Company and a holder of a Restricted Stock Award
evidencing the terms and conditions of a Restricted Stock Award grant. The Restricted Stock Award Agreement includes the Grant Notice
for the Restricted Stock Award and the agreement containing the written summary of the general terms and conditions applicable to the
Restricted Stock Award and which is provided, including by electronic means, to a Participant along with the Grant Notice. Each Restricted
Stock Award Agreement will be subject to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ggg) &nbsp;<I>&ldquo;Returning
Shares&#8221;</I></B> means shares subject to outstanding stock awards granted under the Prior Plans and that following the Effective
Date:&nbsp;(A)&nbsp;are not issued because such stock award or any portion thereof expires or otherwise terminates without all of the
shares covered by such stock award having been issued;&nbsp;(B)&nbsp;are not issued because such stock award or any portion thereof
is settled in cash;&nbsp;(C)&nbsp;are forfeited back to or repurchased by the Company because of the failure to meet a contingency or
condition required for the vesting of such shares;&nbsp;(D)&nbsp;are withheld or reacquired to satisfy the exercise, strike or purchase
price; or&nbsp;(E)&nbsp;are withheld or reacquired to satisfy a tax withholding obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(hhh) &nbsp;&ldquo;<I>RSU
Award&#8221;</I></B> or <B><I>&#8220;RSU&#8221;</I></B> means an Award of restricted stock units representing the right to receive an
issuance of shares of Common Stock which is granted pursuant to the terms and conditions of <U>Section&nbsp;5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)&nbsp;<I>&#8220;RSU
Award Agreement&#8221;</I></B> means a written or electronic agreement between the Company and a holder of an RSU Award evidencing the
terms and conditions of an RSU Award grant. The RSU Award Agreement includes the Grant Notice for the RSU Award and the agreement containing
the written summary of the general terms and conditions applicable to the RSU Award and which is provided, including by electronic means,
to a Participant along with the Grant Notice. Each RSU Award Agreement will be subject to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(jjj) &nbsp;<I>&ldquo;Rule&nbsp;16b-3&#8221;</I></B>
means Rule&nbsp;16b-3 promulgated under the Exchange Act or any successor to Rule&nbsp;16b-3, as in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(kkk) &nbsp;<I>&#8220;Rule&nbsp;405&#8221;</I></B>
means Rule&nbsp;405 promulgated under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(lll) &nbsp;<I>&#8220;SAR
Agreement&#8221;</I></B> means a written or electronic agreement between the Company and a holder of a SAR evidencing the terms and conditions
of a SAR grant. The SAR Agreement includes the Grant Notice for the SAR and the agreement containing the written summary of the general
terms and conditions applicable to the SAR and which is provided, including by electronic means, to a Participant along with the Grant
Notice. Each SAR Agreement will be subject to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(mmm) &nbsp;&ldquo;<I>Section&nbsp;409A&#8221;</I></B>
means Section&nbsp;409A of the Code and the regulations and other guidance thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(nnn) &nbsp;<I>&#8220;Section&nbsp;409A
Change in Control&#8221; </I></B>means a change in the ownership or effective control of the Company, or in the ownership of a substantial
portion of the Company&#8217;s assets, as provided in Section&nbsp;409A(a)(2)(A)(v)&nbsp;of the Code and Treasury Regulations Section&nbsp;1.409A-3(i)(5)&nbsp;(without
regard to any alternative definition thereunder).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ooo) &nbsp;<I>&ldquo;Securities
Act&#8221;</I></B> means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ppp)&nbsp;<I>&#8220;Share
Reserve&#8221;</I></B> means the number of shares available for issuance under the Plan as set forth in <U>Section&nbsp;2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(qqq) &nbsp;<I>&#8220;Stock
Appreciation Right&#8221; </I></B>or <B><I>&#8220;SAR&#8221;</I></B> means a right to receive the appreciation on the Common Stock that
is granted pursuant to the terms and conditions of <U>Section&nbsp;4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(rrr) &nbsp;<I>&ldquo;Subsidiary&#8221;</I></B>
means, with respect to the Company, (i)&nbsp;any corporation of which more than 50% of the outstanding capital stock having ordinary
voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other
class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time,
directly or indirectly, Owned by the Company, and (ii)&nbsp;any partnership, limited liability company or other entity in which the Company
has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(sss) &nbsp;<I>&ldquo;Ten
Percent Stockholder&#8221;</I></B> means a person who Owns (or is deemed to Own pursuant to Section&nbsp;424(d)&nbsp;of the Code) stock
possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ttt) &nbsp;<I>&ldquo;Trading
Policy&#8221;</I></B> means the Company&#8217;s policy permitting certain individuals to sell Company shares only during certain &#8220;window&#8221;
periods and/or otherwise restricts the ability of certain individuals to transfer or encumber Company shares, as in effect from time to
time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(uuu) &nbsp;<I>&#8220;Unvested
Non-Exempt Award&#8221;</I></B> means the portion of any Non-Exempt Award that had not vested in accordance with its terms upon or prior
to the date of any Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(vvv) &nbsp;<I>&#8220;Vested
Non-Exempt Award&#8221;</I></B> means the portion of any Non-Exempt Award that had vested in accordance with its terms upon or prior to
the date of a Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">* * * *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="width: 812px; height: 950px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_003.jpg" ALT="" STYLE="width: 812px; height: 950px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  E .@# 2(  A$! Q$!_\0
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MSXQ_PPOJ^#U'_"*_%K'/)_Y@7<U\@:YJFN?\$Z/^"B^M^+M:T34+OP%K.O\
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M\'B,3A<5F^-J4X8;"4,="M0PE&56T)1Q$X_QV_M^<?MS?M@YSQ^T?\6S[_\
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MCOQ/+\0(O%JZQ\-9-"%@GA%_#YMB?$^A7_VO[6WBG71,,6AA^S_98CF3S//
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+4K5JDM9U962C_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0: RP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVXYSCKQ6O+XWO])\5Z/HVOZ7#:0ZK"/*NHIRZK/@9B.0.YQGW% &OHW@K0=
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M(OY(C- 2?,CD SQN P#P?RK O_BCXNTS4+6QNO IBGO)#':HUX,S$>G'N.M
M':>)/ 'AGQ9,D^L:9'/.HVB56*/CT)!&?QJ[H/A;1?#-@]EH]A':PR<R;<EG
M.,<L>37+7GQ)N=$\.VESKOA^XMM:O9VAM=*A<2/)C'S9[#D?F*@LOB??6FK6
M=CXL\+W6B)>N([>Y:0/'N/0,>W]* .QT+PUI7AO2&TO3;<I9N[NT<CE\EOO9
MSV]JQU^&7A=-"FT5;2<:=+<BZ,'VF3"R#H5YR!["H_%GCX:#JUOH>EZ5<:QK
M<Z>8MK =H1/[S'MTJ/PI\0)-<U:[T35=%N=(UBVB\XP2G<KKZAOR_I0!VX
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MGB.[CTS4;:^DD8W'RB53C!![]/Q!&*M> ]1M]3\>^,O&<68-!\I(Q<R#:KE
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MRD)N!]K@>'?$.LB[@,J..?>J%IXTAU/Q-I>G6"2?9[JVN)V:>!XV8)Y>QDW
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M-BO7FG5)+G[)Y9MW\Q9L9\LIC(;VQW'K1_PFNC?V?]J\RXW_ &C[+]E^SO\
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M<Y!.>^#0!V'B?Q9%X8NM(BFM7EBO[CR7E5L"!>,N1W R*?K7BF'1_$&C:/\
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MY!!^E!8# ) STYZUYQ\/Y+6'7KBTM5TZ8-9)(UUI,K^0V&P/,C;(24YSG))
M.>E&N?V$_BC7AXMD5$2VB.F^:Y7$>T[S#C_EIO\ 3YONT =G<:]:6^O6^BB.
MXEO)H_.(BB++$F2 SGHH)!%:A8 9) [<UYMX3L9'\;6%WJUJG]K_ /".6\L\
MCH/,$I=U+'_:P #5OQ)_8S^,ID\5O&NF+IJM9"X<K&9-[^:5[>9CR\=\=.]
M'?%E7&2!GUH+*."0.W6O+=WAZ?49O^$I::*Q&DVK:6NI.RR"/8?,(YYFSMSC
MYNE9,&FMJ&@>)+[6TE?5+30[61'E8AX9!$[!_:3A<GKQ]: /:-R\\CCKSTI-
MZXSN'7'7O7D7B*PMM,MM1AL@T"W?AT33E7.9)!*@$A.>6^8\]:T;SPOHH\2Z
MU8BS7[*FBI<"#>VSS<R#S<9^_@#YNM 'I*QPQ2O($1))2-S8 +$# R>]2%E'
M4@?4UY%:SZ/>I)-XPN 6.C6<FGO.Y!*F+,C18ZR>9G./F^[VQ5O3M(36[XCQ
M% UQ=Q^'+9I$F)^60F3+$?W^!SU'- 'J=5KZ_MM-T^YOKF0);VT;2RL!G:JC
M)X%87AN>2Z^&NESSW$_F2:5&SSQ@M+GRAEAW+=_<UYI'#IYT/5;&!=.U(2:%
M</\ :M/9QNV ,K7,+9Q+GD-G.<C% 'ML4T<D*2JPV. 5)[YIY8#&2!GIFO,,
M>&'U6%-;>S&A+I$+:8&?%N3EO-*$<>9]SI\V.G>LO2I+"6!SX[DDV)I<3:9]
MK9ED,>9,E/6;'EY_CSMH ]6@U6VN-3O=/0MY]D(S-N&% <$K@]^AJ]Q7CVI-
M*/$=[>72S/X<@33WU.VFR)RIC;:TF#RJ-M9U[X.>!7;>.Y#_ ,(S"RNXT]KN
MW^VO"3Q:EQO.5YVXQDCMF@#>U35;/2-*N-2O)=EK;H7=E&XX] !U.>*ADUNV
MM] ?6;M+BTMHXC+(L\161 /5>N:\M\26^D2Z5XJCT-8)="CL;>0B([H$N_,(
MS'V!V8W;?;-=QX\TZU7X;:Q:1VL?D0VC&.)4^5-O(P/;&: -Z'5[2?5)=/1F
M\^*".=LC"[7)"X/K\IJ\64$9(&>F:\U71=#UGQ'>@V\%Q8Q:#;_951OW:J3)
MAEQQGC@]NU<K',^H6\<VNWVG(#HMH]G-J9E+;3%\[PE",R;\YQELA?:@#W0D
M $D@ <DGM7,_\)YHN5D(O18,_EC4C:N+4G.W_68QMSQN^[[U,UI?WW@!K,7+
M37\^FF,3LAC+N8\!BK<J2?7I6+8^,="M?!UE:E5GO8[>.U.C*H,YE "F+RSZ
M$=3Q@9SB@#MC'";A961/."E58@;@IZ@>W _*I-RYQD9],UY'JK6!M/$,MW(P
M\8I?N-.7<?/!W#[.(A_<(VYQP?FSWHUO3+6>Q\8ZG*K"_M]5@6&=)"&@X@!V
M$'Y<[CG'7- 'K@92,@CKCK0&!&001ZBO)?$MEIVD3>(+&)7M-,#Z7-*D#,-N
MZ9@[#'()"C)')QFGWMSI%BOB'^QD,WAUH+2.5;6X,< N&E(;]XN=J;"ID*]O
M>@#U8,I&0P(]<TNY?[PZXZ]Z\1N'@6U\6VMG)I\=J]A:OLTIW\@/YQ!*L>"V
M-N2N!T[YK?UCP\EOKFIZ?H,(@E&D0ZA#$C'#7,4Q*,?]HXVD]\\T >GY'3/-
M8]YXFTRQEO(I97,EH\"3*B$E3,P5/KU_"LWP9.FM-J/BA=QCU*14M=PP1;QC
M"\=LL9#^-<9XHLM-_M[Q;$T<45U<2:8?E.V1HVE0.0>N,@9([XH ]=!!Z$'M
M5/4M4M-*L'OKN7; C*A91NY9@H''N17G>K)8>'+SQ5:6]K(FG-9V3O;6\S1*
M'>1T+EARBD ;B.PKF=2CT]QX@@5-)-BEM87#1Z>6:V5A=;7?)X)V'#, !C&:
M /;KZ]@TW3[B^NI-EO;QM+(V,X4#)Z57L]:L[Z]GM(6;S8(HI6++@;9 2N#_
M ,!-9?B^VM;KX=ZO#!%'-;'3I#"B ,I 3*[<?0$5Q=GHNA:L^N2+!!/;6^AV
MIM?*;Y(SLE.Y<<!LCKU&/K0!Z8VG6AU=-492+M83;JQ8@;"P8C'3J!5PD#D\
M5XQ>3/?W=E)KEWI@MVT*UDMI-5,FUF*MYK1E2!YF=O\ M=,5VUQ#>3?"2>*2
M>6]N6TIQYOE,CR_(<':WS D8Z\T =CN [CIF@%22 02.M>6:GK.GZK>VIT^\
MCN1%X7OO,:-LA25AP#_M<'CJ.]*FF_V.=!?0HVBU"]T*Y+,K$M<2K$C(6SU(
M8\$^M 'HMQJMK:ZG8Z?(S>?>F01;5R/D7<V3VXJ[N7)&1QU]J\BL'T5=8\+#
MP[*KZJ;*Z>9 Y+F7R.LH/1]WKSU[5G:,J&SL)DU'34U%K2<WL<$<S74Q\EO,
M6XR2%PW.6  (&WK0![;O3!.Y<#J<]*ADNA'>06_DS-YP8B1$RB8Y^8]LYX]:
M\ON-(TJS\'^%\7%A:&:)9I$U*-VM;N0P@'SG!&& Y4D]>QJ)+JZETG07TB"6
M&[CL]62T03&8,ZC"F-FP63/W<CI@4 >N;EY^8<>] 8$D @D=:\4U3_A&TAL3
MH$RM,VB:@UUY<A))\@<RY_Y:9SU^;KFMR?3CHEQ:?\(_&\5]=^';ISL8EIYE
M6,HS9ZL"QY//- 'IX8$D @XZ^U4KG5;6UU*QL)&;S[UG6':N1E%W')[<5Y5H
M"2++!)H.HZ:=1;3)RT%C',TLS>7\IG+$A7$FWE\'.1ZU<T)O#W_"1^#%TB96
MO6AG:\4.2Y?R1N,H/23=GKSU["@#T^6Z\J[@@\F9C-NPZ)E$P,_,>V>U3A@<
MX(./0UQOB_'_  D>@AIIH08;[,D()=?W!Y4#J1U'O6'X!>SMO$B6MHUA=^9I
MQ8WFF2.JL%9,&XB;.V4YX.<_>&* /3BP7&2!GIFAF4=2!]37E_C'][XUN(]6
MFTJ*Q73T:R_M3S!&3EO-,94@>8/D_P!K&,=Z=I>C6VLZYIUOK3G4U3P\C;ID
M>,2$RL [(W.['KR.M '?RZQ:1:C-IX+O=PVWVIHD0DE,D#'J20>*H3^)M'TV
M.\>19(I((8;NYC$.'42DJI8?WLJ0?3%>;:&MHZ)=W7EM?3>$CY4TI_>2,ID4
MX)Y)"!0>^*AOH+"&VU&1XX$O)O#^EO$Q #N/,(D*^O 3/X4 >V[@&"DC)[53
MU;5+;1=*N=1NRPM[:,RR;!N;:.N!WKR75EDEUO7FOM0TZSU1-0Q:23QS/>1Q
MY7R?(5#RI'90<Y;=WI_B]M)&F^,VUR8)K@D*V6]B)# 43RQ&/[I.[=CC.<T
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M849/]:Z&]N[/3K1[V\EBMX(5^:60@! 3CK]<5RGQ,TFTO?"=S>W,;22V:AH
M7.U6+K\VWH6'8GIDUA_$R]ENXM2L[K3M1.GV5L)(7CM7:*:<\AV<<!4'3/\
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MJ/B*+3+743=W"K?6$\DSW&IQ2"8^2SAX(QRI5@.%Z+G/K0!ZVB)$F$5409.
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MD4 ;H\*Z$-(&E?V7;FQ$GFB$C(#_ -X=P:;>>$O#]_9VEI=:3;26]GD6\>W
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MV\2[8XT& H]!7GOA/6/$=WHNBZ3;75F][)I_VZ:\NHW<",OM1-N[+,2#EL@
M#H:[+PUK$FMZ0+BX@6"ZBFEMKB-&W*LL;E&VGNN1D4 ;%%%% !1110 4444
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M1:6R-E^^=%V)O5PRE%&'!0'=ZTR\\:7MGJ"::VB*^H+;BYFMEO4#%2S +#N
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M ^1AD'N.#S6UHNHWESXKOK6:X=X$TZTE6,@8#MOW'IWP* (M/\"P6%WI<O\
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MG$C[W\S<I4DMSG QVXXJ&+QM->/%8V&C22ZR7E6>SDG5%M_*(#%I,'(.Y=N
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M%H8=VW]X&0+EN.N!VQ54>"H(4@>RU2^M+R"6=TNHMA8K,Y=T964JRYQC(R,
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M7.<XY^Y^M4K'QU/<_8+JXT22WTR\NFLTNC<*Q$@+#)3&=A*$9SGVQS0!H_\
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M3F16^T0^5(1O7&4SA6')Z<XZ4 7K7P)'86]HMCK6HVUQ:(\$-PHB+>0QSY3
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MB&*-8I Y&0=S%L'DG [#UFU_PA>:K?ZE>6U[!%).ED8!)&6"O;S&7YL$9#9
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MHV0D@N9)#G<%!RI7H.3QU]:UO^$KT^+3=2NYS(O]F.L=RFSYBQ5678,\AMX
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M3TWBZM(+PVKR,<;&\P<[1\V5!&<CKC%27GC32M+U^\TW5+B"R2"*&1)I9?\
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M>@7-G=W<.KVCV]GC[1()!B//3/U[>O:@#A=/^'UU):6VE7NDPP+;V[POJ/\
M:,TP<^68U>*$MA3SDAA@<@9J_P"&_"-Y::EITEWHEO;M81,K79U*:?S'*; 8
MD+84$$YW#@' '>MW5/'FAZ?H4>KQWD5S:O=1VVZ-_NLS '/&1M&6(ZX%7+GQ
M=X?L[E[>XU:VCF0;FC9N5& 02.W!% ')VGA?71I&B6DUG%')IUE>6CD3A@Y:
M,+&P]F/8]*/$GA>ZN?#&CP74D=K;V.CW%O>3EMP@8P(H.!RPRISCM7>OJ-G'
M>-:/<QK.L/VAD9L$1YQN/MFN=U/XA^';/1YK^"_M[U(YHX72*3IO;&3QTQDY
MZ'!Q0!D:=K&HZUX\TJ2>ULE-OIMRY6TNQ.&+&,!MP&%5L?+GDX/I7>6<D\UG
M#)<V_P!GG9 9(=X?8>XW#@X]:Q(=6\)Z+>QV-O/IEC<7FQQ%$JQF3=]TG ')
M[9ZUK:EJMAH]F;O4;J*V@#!=\C8R3T ]3["@#*T?2KRSU/Q+/-&HCOKM9;<A
M@=RB!$Y].5-9-CX:U*+2/!MK+$BOIN1=XD!V P.G'][EA6_/XKT&WTN#4I=6
MM19SG;%*) 0Y[@8Y)'<=J<FO6ES/IGV*XM+BVOQ(T<JS\D*N?D !W>_(Q0!Q
M/A_P/=Z?<Z5:7.C6[)ITH=M0?4IG60+G8R0[L*_(SGY1\V,\5TNLV6K0>*;#
M6M,LHKU4M9;2:%YQ$5W,C*X)!R!M((Z\C&:?'XSTN[U[3]+TV>"]^TM,DDD4
MP/DF-=W3'S ],YQQ5W4_%&AZ+/Y&I:I;6LNT-LE?!P<X./3@\^U '.>&?#6K
M:;<>'WO8H0;.WO$N&CDR \DH9<=R" :KZ1H&O^'KM-2M[""[ED^TP36YN0A5
M6N9)8W#8((P_(Z].M===^)-&L;NWM;G4K>.>Y56AC+9,@8X4C'4$]Z2#Q+HE
MSJ[Z3!JEK)?H2&@60%LCJ/<CN!R* ."B\#ZK#8Z'=76GQWMS:V\]O=6<-^]O
MC?+YBNDBD9QT(/8^HK<\,^&+S1]:M+E[*VM8!8S)(D$[RA97FWXRY+,<=3TS
MTKH#XCTE[6&>&_MW%P[Q0#?C?(@.Y?48VG/'&*K-XNT:TT_3[G4]2LK1[R(2
M1KY^Y2".H; RO/WB * .>TCPYK5IXFM[B&PBTJ)9Y'O9+6]9K>\0AL!;<\(Q
M)5B>,8/7-9VEQWW@Z\L0XL)+Y]*$-Q:SW@A\I4FD9958C#+^\8,!R..*[S4O
M$VB:0\":AJEK;-.-T8DD W+_ 'O8>_2I-6M]'GL_M.L064MK;@R^9=HK)&.[
M9;@?6@#BO &E7YL;34I(D$,^BK"K XS)YTK\#J!AU(/O55/!&I6L.C74VEC4
M)(=*BL9[:+47MFB="2&#J0&7YB"#Z CO7:0^+?#TFFM?QZO:?8XY!$\F_ 1C
MT4^F>U&K^*M/TOPE/XC1Q<6<<1DCV''F]@ >V3Q0!S]CX=U?PW/IU]INFV4[
MBQ-G<V<5RR+&QD,@9'DR6&68'//0CTJUI^@ZI%\+Y]%N(H1J<MK<(8T?Y-[E
MR &]/F%31?$#0_[2N;:[O;:UA00M;SR38\\2+G(! V@<#)]>U:^I^)-%T::&
M'4=3M;:289C620 D=,^P]SQ0!S7B#PK=7DFA7R60OFL;5K6>S6\>V8A@AW)(
MI'(*#@\$$]P*C?PMJ=IX21M+L;2UUNWO6OK>!;AY%W-E2KR.222A.3TSTKIK
MCQ!9V5]=1WES:06UO!'*TS3\C>Q4;EQ@#(&#GGVQ5F+6],FTAM62]A_L]5+F
MX+80 =3DT <Q#H&I^&;ZRN]'LXM1C334L)H7G$3[D=G$@8@@@EVR.O3K62WP
MYN[O^S8[R1%EM[6ZF%U!(0+>]EG65&5?XE4[L9XP.E=M;>*-#N]/>_M]3MY+
M9)5A>0-]UV("J1U!)(_.JVO^*;+0E^=XGD2:!)U:79Y*2L5$A.#Q\K?E0!S.
MI>'-8U'4;+7;[1DNKI[!;2[LX=2>W\N179@Z.I 9#N.0>1Q[U7N_!NIP65G#
M9Z':)<QVI2&[L-2EMY+64NS'<S$F2/+ \YYW<<UV\'B?0[G2I]4AU6U:R@.V
M6;S!A#Z'T/(X[Y%9E_X^T*TM]-N(;R*Z@OKP6@>-^(S@DEN,\<<=?F% $VNV
M6O3>%8+6PN]^HIY/VETD\EIU&/,"/@["W.#CC/:N37P?K+)KC)IZP+?BP:*.
M2_:X<&*4L^]WSS@YXX[5TMWXWLK#4+2SN?)#W6I/8H8IB^W:N=S?*,'.%V\X
MW#FMI=;TR2VM;A+V(PW4ODP.#Q(_/RCW^4_E0!S'BG1UFO-=OK^:&VT^;28H
M4N'D V31R2.#CV)4BM3P3:W,?AN&]OT"ZAJ3&^N@/X7DY"_\!7:OX56LO%GA
MWQ%H%Y?WIM18VETT4HNL,@*.0C?,,9. 0.O([UJ-XKT!-)75#JUK]A9_+67?
MP7_NXZ[O;K0!Q'ARSUG6] L=.-G;QZ9%JK737HGRS)'<,X0)C(8LH&<XQ^5:
MW_"+ZFWA%K15@34(-6?48$=\I)BX,JJQ'3<OY$^U=-;W^E0:$=1LI+;^S5C:
M<26^-A')8C;[Y_&L[3_'&B77ABRUVXO(;2WN@ %E?D/CE!Q\Q'L.U &'J&C>
M)-9NKZ^DL+>RDOK:/3!$9UE\F LS2RMQAC@X51]34=[I<V@_#[4-,O98((M)
M<3:1=-(H,@C(DB##KO##:>/FZ]37;C5M/.D'5EO(6T\1&8W"MN38!DMD=JAO
M[K1I#:IJ$EFX<-<P>>%(P@W&0$\#:"#GMF@"KX9L)=.\+P)<C%Y.KW-U_P!=
M9"7?\BV/H!7&>&['6]=\(^';5[*VAL+,"Y6Y6?)FVJPC0)CY3EAN)..#C.:Z
MRX\;Z$OA_4M7M+Z"]AL(B\J1/R3_  CVW'@'I3XO%/AO3="T^Z>]L[&SN8\V
MZ<*,=]J@#@=SC% '/WO@^_G\+>%HVMDGN]'C43V8NFA\T&/8P61",,.H['D=
MZDA\)7:>&-0-OIEM9:H]TE[:1?:Y)B)(MNSS)')R3M(.. #CGK7<?:K<6OVK
MSXOLVSS/.WC9LQG=NZ8QSFLJS\7>'K^"ZFM=8M)([5=\[>8!L7^\<]O?I0!R
M]QX'OKK2]-L)&16?3K^*_N-V=MQ<A26 _B&[=^ %6_[(U_7;O3_[5LK73X].
MMYDWQ3^;Y\LD1BRHP-J $GGGI74:5K6F:W;O/IE[#=1HVUS&V=I]".HJ*7Q)
MHL&L)I,NIVR7[D!8&<!B3T'U/8=30!QL&@^)[C^PH+G3-/CBTJSN+5C+<>:D
M[-#L4E0 =AQR.O/2J\?A/73I&MVEM8'3K2YTU[>/3GU$W"/.>CH6_P!6H&1C
M/.1P,5VT'BO0+G4DTZ'5K1[QV9%A$@W%E)!7Z\'CKQ3Y/$FBIK TA]3M1J!(
M MS(-V2,@?4^G6@#DM0TP77Q"TZS@FB:&6WBN-4@5LE6MCF(D>[.!SU""M7Q
MBS6>HZ!JD,EN;JUNI%CM[B7REN \3!E5R,!P.1GK@BM(ZOX<LO$#V/VJP@U:
MZ*AT&U9)#CY0Q[G'0'GTK O/&5AJ%YI&B36&G7LNI!WDCDN-\*(C[1@F,[V/
MI@=#SZ@&;H=MJ.NW$]^(;<>7XE%Q)Y4H9%C6 (<-CYR#P<=P?2KR^";V>^UR
MUN'CCTQ[:XATQE.60W/S2DCM@\#V)K:M_$^@Z9H.G7%W=:=IT-S'F"*&4&/
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M\DY0&2V;_5N%^8!A_$O2M?PIH$MAJEUJ,VC1Z:7A6",-?R74S#)9LLS%0O3
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MC]ZR$CG"@[O48./6NDMKF"\MHKFVF2:"50\<D;!E8'H01U% $M%%% !1110
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M,S#(5 50?,!S@+U':O35GADC\Q)HV0'!8,",_6CSX2K-YL>U6VL=PP#Z'WH
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M.TC!ZU@^,+RRFN?$#K:Z?;:E!=IM:X22:_;9LQ)&>/*CQT()& 2>M>V=Z,4
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MGPS<6\37,09I)U,>U 6S\X ? Z_>]Z]6CUK39FLEBO(G-Z7%MM.1*4!+8/L
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M"#3(FL)(T!2$"W9E:+'"G('(YX%>KU +NV^W?8A,GVD1^:8@?F"9QNQZ9R*
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MVK>3_:.E65WY'$7GP*^P>@R.![53\2>&;37]+N81!;1WS6LEM;W;PAFA#C!
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M [W+3:P9S>?NRVZ.$KA"K8X7  R#FJ5L=3&C^$H([J^NVUF%YKPS:I) 9G1
M4C63DIP2<+@MMY/6O4+3P_H]A>37EGI5E;W,^1++% JL^>3D@=Z6;0]*N=+3
M3)]-M9;", );/"IC7'3"]!B@#S^SNM2N3I&BZGJA2QGU&ZA:2UOR\A6--R6[
MS@*=V2P./F(0#/6JU[;KJ%Q:6,U[>75II_B:.TM9_M3A]C1;F0NI!8JWRACE
MATSUKTF30M)ETI=*DTRS;3U^[:F%?+'?A<8I\>CZ;#:VMM%I]LD%JXD@C6(!
M8F&<,H['D\^] %U2".#G''7-+5>ULK6R646MO% )9&ED$:A=SMU8^I/K5B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU>=UC& Y5<X'IDB@#5HKR_0_'OB'6KA+&.*Q:XO+)Y[>=;"XCBMYE 81R%R
MX(S\ZD<CITIOA_XF:GJVCZUKES96<6GZ-:8G@B;=+-= $MM.["Q\<9!)SUX-
M 'J5%>7Z)\2]0D>1]3M8KBW&FRWYDM+.>$0M&N\Q$R##Y'1EX)[=*VM!USQ7
M>V%GJM[;Z0=/O;-[E5@+K);G;N0')(D!'7&W% ';45YQ8^/-7NM$\#W;0V0F
MUZY,-T!&VU!AN4&[CH.N:YK2/&^NZ%HU[)=W5O>7-[X@FLHI9()7$)7[[;58
MLR8 VHHR/4T >V4T2*7*!U+#JN>17F8^(^K'0?DL8&U235HM,MII()8;>7S
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MP.*\0\1:)<0VOPXTJ^L8_$UPL=P&MUG"K<_NMPQ(Q PHP<GKM]ZLZW;S>'/
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M;BXDM]SRS.79CN/))Y->:W-[KNE:I+/XDUKQ-I%Z+TF/4$3[1I;1;_E4HI
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MNM5M]A7[-)9Q1C)Z-E1GBEUKP='K/B)-7:]>)DTZ>P\H1@@B7^+.>WI73T4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>%+"69H$G*M@R+G*],_PG\J .CHKEK/XC>$;^UO;FUUR"6&RC$MPZJW[M2<
MGCUI^D?$+PGKNH)8:;KEK<7<F=D0)!; R<9 S0!TU%4=5U?3M#L'OM4O(;2U
M0@-+*V!D]![GVK-M/&_AJ_T:[U>TUBWFL;,9N)4)/E#W&,C\J .@HKEM2^(O
MA'2+L6NH:W;V\YC20(ZM]UAE3T[@U:U'QKX<TK2[34[S5[>.QO#BWG!++)QG
M@@&@#?HK"T#QCX?\42SQZ+JD5X\ #2B,$;0<XZCV-;M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!'.)#!((C^\VG9GUQQ7D'@?5/!NG_#>6R\3RZ?'=)<2C4K:[ ,S
M3;SR4/S,>F, U['69/X=T6YU!=0GTFREO%Y$[P*7'XXS0!Y_<76DZ=\9;>[U
MEK>WL)-&1=(FN $A0ACN52>%;'TX^M<=XH>POKKQS=:/Y<FAROI\4DD/^JEN
M/-7>5(X/RYR1WKWG4-*T_5K?[/J-E;W<.<[)XPXS]#41T+23IHTTZ;:?85(8
M6WDKY8(.0=N,=>: /);'[7I/Q,\+>$[T.PTF>Z:RG;_EK:21?NQGU7:5/T%=
M2$3_ (7L4V)C^P <8'_/:NWFTVQN+ZWOIK2"2[MP1#.R O&#U"GJ,TO]GV?]
MH_VA]EA^V^7Y/VC8-^S.=N[KC/.* /"=>MX;R3Q5:7 +03^+K2*0 X)5EP?T
M-;&@S7UM\5-"\.ZEO>ZT:UO(([A_^7BW8*8G^NT8/N*]6?0-'D:5GTRT9I9U
MN9"85^>5?NN>.6'8U.^FV,FHQZB]I U[$ACCN"@,BJ>H#=0* /#8]:TRW^ 6
MKZ+-?6Z:JL\\!LFD F+M<$@!.IX(/3^57FN=2T[XCZDEEJVB:7+_ &58I(=7
M'RMA.B_,.1SG\*];D\.:)+J8U*32+%[X'/VAK=3)GUW8S4>H>%/#VJW;76HZ
M)I]W<, #+/;J[$#IR10!Y[XIU &3X>WE_J>F7&S5B9[NT<"WX4Y())  ]SUJ
M]I%Q8:A\;[J[T&6">S71@E]-;$-&TOF94%AP6V_H*[-_"?AZ73X;"31-/:SA
M8O' ;=2B,>I"XP":N:=I.G:1;F#3;&WLX2<E((@@)]<"@#Q_QW/-XJ\9:M80
M:)J&K6FFZ>]E&UD%(ANI<,7.XCD  <<]:36KZ+QWX.\#PZ@S"6XU1;&]"G#)
M*J,K?0YY_&O8[33K*P:=K2UA@:XD,TQC0*9'/5FQU/O5=/#^CQL&32[-66Y-
MV"(5&)CQYG3[WOUH \ET'4+^Y\=7UAK"D:II7AR>RN7/ FVR I(/]Y"I^N:S
M+J_T:Y_9\TK34N;2;6]L2VMM&ZM<+-YO&%'S XKW-M)TY[^2^:QMS=R1>0\Y
MC&]H_P"Z3U(]JIV/A/P[IETMS8Z'IUM<+]V6*V16'T(% %Z56.GL)@K2"([N
M.-V.:\AT^"ZN/V:+A=/C9KEH9_\ 5CYF07#%QQ_LAJ]G*A@01D'@@]ZKV5A:
M:;:):6-M%;6R9VQ1(%49.3@#W)- 'C_C+4_"NI?#'2K#P]+93:FS6XTRWM2I
MGCE!7^$?,I'.<UU'QB+CX9W6YE#B>WR3TSYB_I776OAW1;*^>^M=)L8+M\[I
MXX%5S^(&:M7^G66J6C6E_:PW5NQ!:*9 ZD@Y'!H \BL]0N7^*'AF;5M4T/6)
M66>"W&B, 8&*\O(,DE< @<C'6L_PCJ6KVMMJL=EXC\*Z?;_VM=$PZH/WV?,.
M3]X<>G%>PZ=X9T+1YS/INCV%G,1M,D%NJ-CTR!567P/X4GE>27PYI4DDC%G9
MK1"6).23Q0!B?%AHY?AK>MN5HWDM^5.0P,J=/:O']:BFETO4-!F5A!X26?:Q
MZ$S7*"+\D9J^D+G3+&\L?L-S:036@"CR'0%/EP5XZ<8'Y5!-H&CW!NS-IEI(
M;S9]I+0J?.VXV[N.<8&,^E 'FGCN_;5_&.F:(FC7NL66FVCW%[;V04L))4*1
MD[B!P-Q'UKG6U34=2\">%--?;!K>E>((=/9;M2=DBC]V74<D8*Y]<&O=(-.L
MK6[N+N"TABN+G;Y\J( TFT87<>^!TJN_A[1I+MKI]+LVN&F6=I3"NXR+]U\X
M^\.QH \R\/)?7'Q'UEO%%Q;Q:]8Z:\-M!:V_EPSV[8)E#$DMSQCM7(>$DO-$
MLO!WBO7_ "KOP]&[VL"]18;F^68]LELY/8 >U?0<^E:?<WT5]/9027<*LD<[
MQ@NBGJ >H!S47]AZ5_9']D_V=:_V=C;]E\I?*QG/W>G7F@#R:2_U&U^)WBTZ
M;KGA_3@YMBQU;GS!Y?&SYATYS]16E<:G:Q?$OPE>ZGJFENAT>X62[BD5;=WW
M ':2<8SGC-=W<>#/#%W+YMSX?TR:3:%W26J,< 8 Y'8 "G3>#_#5Q;P6\V@Z
M;)#;J4AC:V0K&"<D*,<#)S0!QG@>]TV+QEXYU.SN;:+0#-;A;@.%@,H4[RK?
M=ZD9(]16_P#$Y@WPO\0LI!!LF((Z'I6MJ/AO3KWPW<:#';P6UC.GEF.*%=JJ
M>N%Q@'T/8\U?FL+2ZL&L;BWCFM63RVAD7<K+Z$'K0!Y+XAOM*U+3O %KI%U9
M7.MQWUH0MM(KR1QK&?,W;>B],YKG_$.HZAKVJ>(?$6GZ'J%X;:ZA&F:C JF&
M%+5R7.2<X8[LX'3%>W:?X9T+296ET[1["TD==K/!;JA(],@5;L]-L=/LA96=
MI!;VH! AB0*@SUX''.: /.O%6IVNN-\/-5MMABO-5BE&,'JAR/PZ?A53QK<7
M=G\6M-?3]1TG3IAI$@\[4Q^YV^8,CJ/F/&.>QKTF/0-(AM[2WCTRT2&SD\RV
MC6%0L+\_,HQP>3T]:9J?AO1-9F2;5-)LKV1%VJ]Q KD#K@9% 'F7B749)++P
M=<ZGK&C7C0^(X3-<Z<P$"*.?F))P0.3DUJ6ES8:E\<(KK09K>X@CT=UU":U8
M,A8O\@9EX+?TKLQX/\-"P^PC0=-^R>9YOD?9DV;\8W8QC..,U=TW1]-T>%H=
M,L+:SB8Y9+>)4!/O@4 >:_$+4#JWC?3=#31[W6+/3H7N[VVLPI;?(I2/.X@<
M L?7FN>GU*34_@HFC:I&Z7NEZG;:?=0R<.%$B[<^GRD#\#7M\.G65O>7%Y#:
MPQW5SM\^94 >3:,#<>IQ5>70-'G>X>73+1VN722<M"I,K)]QFXY(['M0!Y#;
M-=Z9\1= \*WPD=](2^%K</\ \M[5X&,9^JX*G_=K/.HZ%+^SM#ITES9RZL59
M;:V5U:<2F=MN%'S X_2O=)M+L+F^AOI[."2[A5DBG>,%T5A@@'J 035&S\(^
M'-/NENK/0M.M[A/NRQ6R*P^A H S/&*6I^&M_%KWVHVYLU6[:U7?(G3+ =\'
MD^P-<)X?U$VOCCPS9R:EH7B:.6.1+2[M80EU9H(R<ML) 4C@@U[*R*Z,CJ&5
MA@@C((K/T_P_HVDSO-IVE65I+)]]X(%1F^I H \-MC!%8Z->:HH;0H/%=\;T
MNN8U8G]VSC^Z#GKZUU]OXECN_BI#916?ARZ2>WG$5_I\OFSQ0JI(#D<+D]J]
M(BT?38+.:TBL+9+:=V>6%8AL=F.6)'0DTS3M!TC2%==-TRSLQ)]\00JF[ZX%
M 'SJ4N/#_P *&ND#R:5XBMY(I@.1!=QS,$;V#(N#[J*[/5KN^M/BGOT_5='T
MZ4Z#"&EU;_5LN\?*O(^;.#] :]7;0=(?21I+:9:'3@<BU,*^6.=WW<8Z\_6H
M+_PKX?U699M0T6PNI50('FMU<A1T&2.E 'G6M:D#JO@"[U35]'N3'J-P)[NR
M<+;#]V<#)) (!&<GK6CX?GL;[XU:Q>:')#-8C28TO)K8AHFGWY7D<%MO]:[!
MO!_AIK*.R;0=--K&[2)";9-BL<9(&,9.!^5:&GZ7I^DVWV?3K*WM(<Y\N",(
MN?7 H \\U.YT_3?C:EWXADAAMI-*":;/=$")9 ^7 8\!L?YYKBO%+V%_=>-K
MG1C&^B2OI\4LD'^JDN/.7=M(X)VGDCU]Z]WU#2M/U:W^SZC96]W#G.R>,.,_
M0U&="TDZ:--_LVT^PA@PMQ"OEY!R#MQC.0#0!Y'9_:](^)7A;PG>>8ZZ7<7#
MV-R__+:U>(E!GU4@H?H*]%^(:K_PKSQ Q )%C+@D=/EK=FTRQN+ZWO9K."2Z
MMP1#,T8+Q@]=IZBI;FU@O;62VNH4F@E4K)'(NY6!Z@@]10!Y/XR5Q\'O#'V?
MRTF:XT_8S+\N[C!..HS4L<7B.'XQ>&QXBN]-N)39W7DFQA:,!=O.[<3FO2YM
M(TZXLH;.:QMY+6!E:*%HP50K]T@=L=JDDT^SFOX;Z2UA>[@5DBG9 70'J >H
M!H \1^'^J:K:^'X8X/$OA2RLUNYBUOJ'_'P!YIW9.X=>W'I7;?%]&D\%0NR-
M+I\=_;R7RH,YMPWS9QU&=IKH6\">$G8LWAK22Q.23:)R?RK=:*-HC&R*8R-I
M4C((],>E 'E7C#4= U?5O!L/ABXLKK5$U.*2+["RL8K8*=^[;]U<8X-:^II&
M/CAH2[%P=(N#C _OBNPT_P /Z/I,TDVG:79VDLGWW@@5"WU(%6'T^S?4([][
M6%KR-#&DY0;U4]5!Z@&@#RRWA\2R_%'QF/#EYIEMM%KY_P!NA>3(\OY=NTC'
M?K[5R44D\7PX\'O'<VD%POB64K/<C]RC9E^9N?NYKZ ATZRM[NXNX;6&.YN=
MOGRJ@#28&!N/? JE+X7T&>P2PET:P>SCD,J0-;J45SG+ 8QDY//O0!YKXDU&
M_N_AKXKCU+7?#NI,+1&C32.&0;QN+_,>.1BJL46KS>./"5CXONK*&TC"W6ES
M65L46>55XB=V.5/0X[\#O7I\'@_PU;17$4&@Z;%'<IY<RI;(!(N<[6XY&1FK
M]WI.G7T4$5W8V\\=NP>%9(PPC8="N>A% ''?%)-+ETG2DU*_GTUAJ"/:WZPB
M2*"8!MIE#'&TY(KS_4=2DFTGQU8W3Z-J5VNDK*^L:6FT2#=@1R8.W=WX]Z]W
MNK.VOK9[>[@BG@<8:.5 RM]0:I0^'-$M].FTZ#2;*.RG&);=(%"2?[P P: /
M-O#>HZ5I_P 1-8.K7EE;0OHNG@?:I40-\G(&X\UQZ/)#I.B7.G3VEI:/XKNY
M--FO!B!(2IVL>1\G6O<[OPCX<OYQ/>:%IUQ,%5 \MLC$*HP!DCH!4][X?T?4
MK2&UOM+L[FW@_P!5%+"K+'QCY01@<4 8O@W4+Z[:\34=<\/:E(-AC&D=4'.=
M_P QZ\8_&NLK,TSP[HNBR22:7I-E9/( KM;P*A8#H#@<UIT %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^='F)_?7\Z '44WS$_OK^
M='F)_?7\Z '44WS$_OK^='F)_?7\Z (OL=M_S[Q?]\"E^R6W_/"+_O@5-10!
M!]CMO^?>+_O@4OV.V_Y]XO\ O@5-10!!]CMO^?>+_O@4OV2V_P"?>+_O@5-1
M0!!]CMO^?>+_ +X%+]DMO^?>+_O@5-10!!]CMO\ GWB_[X%+]DMO^?>+_O@5
M-10!!]CMO^?>+_O@4OV.V_Y]XO\ O@5-10!#]CMO^?>+_O@4?9+;_GWB_P"^
M!4U% $'V.V_Y]XO^^!2_8[;_ )]XO^^!4U% $'V.V_Y]XO\ O@4OV.V_Y]XO
M^^!4U% $'V.V_P"?>+_O@4OV.V_Y]XO^^!4U% $/V.V_Y]XO^^!1]CMO^?>+
M_O@5-10!!]CMO^?>+_O@5#.VFVSA9S:1,WW1(54G\ZNUYOXP\,W/B3XA6L*1
M6BP?V1(K3WNG?:HU)D'"Y*A7[@YS[4 =\L-DTC(L<!=0"R@#(!Z9J%I=)6;R
M6DLA+G;Y99=V?3%<%HLEOX*\7ZE9WB:G- +"QMX+E;*6;S=B$$ED4C/(K(L;
M6"W\>:M-?6MNA;66EC,_AN6YD=?EPR7 X0<<<''6@#UH061E:(10&10"4P,@
M'OBF@:>3( +4F+_6 ;?D^OI7EVDGQ!%XLM_%EQHD\=KJEV]O,XD8S"W?"P!X
MMN4"% <YXWFL6STF6U^VV]CI%]+NTV^262?3WM[F E"0DLBDI<EFP >3WH ]
MI@;2[ERENUI*RC)6,JQ _"B(Z;-*T41M))%ZHA4D?A7"?#*"UMY0BP6D=S]B
M0/Y7AV2Q=<8R&E8XDY[<9(S7.Z)IT3-I4%CHES!X@AUYY[B\%@\6+;SG+[Y2
MH#*4.,9.<B@#UD7&C%BHFL=P!R-Z9&.M.CETJ;=Y4EE)M7<VUE.T>I]J\I^'
MVF6(N+2UU+3[,RR&X22"?PS()3EG^]<M\I!'MR#BE30WM-#U+3=+\.(M]JFO
M75KE;?R/]"64N5,@7Y8RJA1V^88H ]:,5BL/G%+<1;=V\@;<>N:%2P?R]JVQ
M\S/EXVG?ZX]:\HBMM0CT_3M+UO1;EM*T75'%U9Q(UPC6SH6@(PH\U$)VD ?P
MC(J]_9YGU;PR_A739]%A%Y?.K7EB[1IF,9;R]R[%;HH)7Z4 >E)!9R F.*!@
MI*DJ <$=130NGM$DH%L8W.%<;<$], ]Z\YLO[;TSX=ZU:06\SZS?:O=6T+I
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO]433;75X)+J1V2, ,%D9>H1R-K$>@)IGA3Q--XBEUM);5(/[-U*6R4JY;S
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MI:MI5IK>E7.F7\1EM+E-DJ!BNY?J.10!Y=XWL+>U^$.C265M;V\\TNGEI$B
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M,EP+[4'GAUMI;>1$S-)O0[B &P<=">E=5JTFOZEXB\?"V\2ZA86VCP1W%O#
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M=[G+-@=3[U)4<$*6\$<,8(CC4(H))P ,#D]:DH **** "BBB@ HHHH ****
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MEA#@%6WE?O!2&/3/';-=MX*\4:AKL^L:9K-E#;:KI$ZPS_9V+12!@2K+GD9
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M1J6H_P!HV/BS6]/NKBS6SOBFAW#I.HZLJF/Y&]Q0(](\%7UAJ7@S2;O3//\
ML;P#RQ<.7D7!((9CU(((S[5OU@^#(M)M_"6G6^A^?_9T*&.(SQ/&YP2"65@#
MDG)Z#K6]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_!D/[0_QVT[PCX@\)W_Q!ET>UUFU6UM[BWU2TA2QC4VQQ9F.9P4.7Z8<5E_
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MN/$7A>Z^'.G_ !)\0S-XACM;G1;*>_DLIH8XVB(N)5D0% "N\9SMQ5[XM_\
M!=:^^!'P?\577C+X8V/A?XB>'?',7@L:)?\ B8-IJ^=8)J,=S->Q0.546TB!
ME6)\2,%!(RP]$MO^"*?@6V^"=QX'7Q?XP:QNOAS:_#=KDFV\Y;.#4)+];@?N
MMOG&20J>-NT#Y<\UT7Q:_P""4/AGXI:[XRUVV\;>./"OBKQ1XNLO&MAK>CS6
M\=YX=OK;38]-Q;[XF5HY($.]95?)<GC   T/!=4_X+[:QK&D6OB'PE\%KKQ!
MX1T_PEHWB_Q)>S>($L[C1K>]U">PEB2)HCY\D<L)*X*ATRQV\ S?'3_@I?\
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MU_2O$"3V&SS6ET^]AO(T.]6&UGA56XSM)P0>:6H]#X0\*>./&'Q!L/@Y\(?
MOQ?_ &CM"M?C!X@UN[UGQ1\0].2Q\8Z?9Z99QR-:64<UM&(DE=U(D:-B KD$
M\BN'_::_:J^*WP=_9Z\=?#/6OBC\1KZ^^%_QH\->%V\9^&;=&\5:KH.HH)S
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MB8L1V\H\FZDE8L5=V3!\L$_H%\ OV0M%_9Q^,_Q.\5>'=5U:.P^*6HPZU?Z
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M&T_PCI.B:Q\3_&>H>*[>>ZT<:V5EM#;1"!/M*QPRQR21_*848+ND*Y-/X/\
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M,J%ZD&N=_P""87[ 'QH^'5OX\\2_%+Q3XJ\(^+/%FL^'KEI!K]IKVJ:C;:5
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M\4_BYX5\&^'KGPWX;T3Q!<6<-GH,$]J+-WA^S01/YBVXV*SLVWJ.12U#0V/
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M_@H7\2OVMOV_OA#-<>$]6^'_ ,+_ !AX7\2:IH</]LQWD?BBV@FMXH+FYA5
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M (*P^(M:^.^E:7JGPGGT_P"&E]XO3X;3^+TUR.1X/$IA#O +,H'-H)MT GW
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M'P\^.O@'[/??M >'_A+H/A[4=?\ &&M_#![:"33]D]NB27<ERC(T$<7GNT:
MR$<J, U]^>$=2M]8\*Z9=V=W)J%G=6L4T%TY^:YC9 5D/ Y8$'H.M>!_MJ?\
M$U_#/[;7BS2]5U3Q9XX\*M#IDWA_6K?0-06W@\3Z/-(DLNG7:LC Q,Z#YDVN
M 6 ;!(KU[X/?"N?X2Z;J]BWB+6->L[S4Y;S3X+Y8530[5E18["W\M%_<1!/E
MW[G^8Y8\4$G94444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 45^?GPZ_X*Z^-OB7^VGXK^'-MHGP
M)T?P]X/\=7OA2[.L_$P6/BBYM+0AI[VWTHVY:4"+<Z@/M)C<;@%)KU+X6?\
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MUFZT::WBL5,BJL4\;J'B &]7=\!9#''@E\@ ^GJ**X']IWX]Z7^R]^SYXO\
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M"??PY\2>)M6O]4M=6U*WUF^U/4)]-N+YFLEEU*V%M>;$ !42*-V-WRO\RX-
M'#^-OV]?&OPPU?\ X177/AMI*_$"XU/0+:ST^U\2&2PN+75IY[>.<W+6X96@
MEMIED3RSD*"C,&%=_P##O]KM=1_9[\=>-/%6B_V+=_#6[U2PUZQL;K[=&9;#
M+2&WD*QF177:5W(ARV"!BHO#7[!'@G0[B"\O+[Q9X@UF'5],U@ZMJ^KO=7TC
M:<7:S@9\ >1&99#L &XR,6+$DUW'AC]GWPQX7\,^,-%CLI+S2_'6HWNIZQ;7
MDAFCN9+Q0LZX/2-E&-HZ9- 'R[^T-^WI\5]#^$6M:;IGA/PYX-^(&H:+I?B'
M0KB?6#J%K%I]YJ$%E(9/]&P+N%[B+,>QXCOW!VVE3[9^TS\7/%?P4^$_@?3=
M-N;&;QEXVU[3/"2:K>1"6VLI[A6,MVT:B,2;5BD*H @9V08 R*IZ'_P3M\!:
M7X?U+3[NZ\5ZXVH6UCIZ7>J:Q)<W5A8V5TEU;64#D?)"LL:L1RS?Q,W&/3OC
M)\'=!^._@6X\.^)+62YT^:2.XC>&9H+BTGB<213PRJ0T<L;JK*RG((],@@'A
M?Q0\8_%7]G+4/#MGJ'C[2?%VG>(/&/AW3(;BYTJ"VU:."ZO##>0RQQ*L)B9=
MOERJJNI+@[L!JK?"3_@HY/\ $/XQZMX1D\-Z+J5Q#X<O_$5@OAC73K$DIM)$
MC>RD;R(X3<,9$V^3+*N<@D8!/;6G[ 7@F:=KS6K[Q9XJUJ34=/U"75]9U5KB
M]E%C(TMM;[@%58%=W)C15W%V+$GFH/A1_P $[O OP=\3Z?JFFZCXSNI-%T&Z
M\,:7#=ZY*T.EZ;<-&S6T"KMV!3$FQ\^8N/OGC !YCH__  5)U#4_@;>>+/\
MA$_#\DUKJ=C874=OK5U-'X=6XCD=GU6,6?VNS\DQB-C]G=6:1=K%0S#T+XW?
MM0ZW:_\ !/+7/BEX=DT6PUR/1?M]H]G>Q:Q8QR>8$RDJ@),A&2#@'G! ((&A
MI7[!7AW2/[2O(?%WQ*_X2;4OLJ-XC/B%_P"UHX+82"&W\S;M>%?.ERLJ/N+D
ML6(!'11_L?\ @F+]F6Z^$D=I?0^$;VWE@N ETPNIS+*9I96EZ^8\K,Y/JQX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/^&=0UG07UFSUTWM_JFJV\&GW4=QY:PWD5U)&MX\3,J3J2?G4&,[:^IO$_\
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M2>&_A+\;M(^/L#-_PDUG;6^GPI9M:6-P]H-,70TB^Q-,;U;6)A>@G:+5I_,
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MKB*.""Y: 3V B%KIZ>9 &@P?->/&6DRQK]!Z* "BBB@ HHHH **** "BBB@
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNZ5SG@7_ (*>V'B?XPR:/J7A^30?"-GHUKJ<OB*[\\0WC2Z3)JC?9U\K_5I
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "FNN]".1QC(ZBG44 >+^!OV3]1\(?$/5/%UU\0O$&N^)+BP71["^O+*T
M#6-@+E;AH66.-5G=MH3S9 6"],')/K'B73)M:\/:A9VUY-IES=V\D,5Y"%:2
MU=E*K(H8$%E)! ((R*T*S?%?]H'POJ7]D>3_ &M]EE^Q>;_J_/V'R]W^SNQG
MVH ^3_V@/^":'@7PM\"(X_ ]]H/PQU;2-$.C7FO&*WL%U>%WMR9+^<1YDD$L
M"3*[9/F$]G;.AXY_83U:X\9^&]6M?BM?:;?:M<ZN_B'7'CM5OM=FO[6TMHH(
M(3'Y"JMO:!5V@,OEJPW$M7CO_"F?&OQQ\-:7HNN:7\8M2\/Q:GX-O/$-OXCN
M;V*5M;CU93J4EN=P+6:6_P S^5_HHVHR#*DCZ1_X*"^#?$'B;P#X(_X173=4
MO]0T;Q3'?(=/A,DMD$T^^59N.5VR/& ?5E'>@">3]@S1M#\,M9^&/$6M>&;Z
MQUBSUK1+V!(9VT>6VTV'34C"2*5EC:WAPPDR27)R,"F:/_P3W\)Z/KOPYU$:
MOXBDO/A^FI9D:= VMSWSR3/<7)"CYX[B6::+9M"/(<#&!7AEEX&^*'@7PE8Z
M;J%[\:-2\(S6WA;4?$TD-[?7>N,\MK>+J*6TBDW*XGCM#-%;D,@8[0H9A6AI
MZ_$Y?C!HO]GQ_&S[9_:FE_V,VKM+_98\.BW'VW^T-I\C[83YF?-_TG?Y.W^*
M@#N/@]_P2Q\._"+Q&-3C\5:O>W"RZ0Y(T^SM?M']FWYO87F:*,--,[$K+-(2
M[CG(/->[?''X.V_QO\!_V/-J%]I%U:WEOJ6G:E:!3/I]W;RK+#*JN"K890"K
M AE+ ]:^*/'%KXM\!_#GX&^']6UKX[7'B/7O"&M:KJ-MI6IWT^K7&MB&Q\DW
M(5BZQ1RR, AQ"A;YP%+9J"S_ &A)_ NK0W!^+$?Q,D\-ZVGB^:%I_P"QO/,2
MC3CH^/W/FB3!7[,-P'F>;SB@#ZR^#/['VG_"#QMIOB5M?UC7/$$,6KG4;NY2
M)/[5N=2GM)IYV1%"Q[39QJB)A54D8)P:YS]KK]CCPO\ MQ7UC:WGBZ2T;3].
MO;":TMHK/4%\FX/E-.D<Z2"&X22)E6=5#KB1<]:\D_:OT[XE^!/C)X0T?P#I
M_P 4+C3?#?\ 8;0ZB-0U74X[^%M0VWP?8WD.RP,3*;UI&9"OE(-I-<7\/_A?
M\0/A9_PE&DZ?I/Q8L?"-KK<IUL6C7\E_/:R^*-5GF;3Y23,^^TEM'8VS;C&[
ME/G)H ^LO"O['.D^%]0TJZCUK5IY-)\4)XJ7>L8$LZZ2NF>6<+]PQKOXYW'K
MCBKW[6'[/NE_M'^"=)T75-<;15M=7@O8!)!!=6M_*H8"":VG5HKA&!)",#AE
M5ARHKY2U+P;\:M>\,WVJQ7GQ@MF\.^&;^^\)6S7ES%<W,@UMS8+?QJ?](NOL
M(C#13;F*,=XW9(^B/V[?AW/X\L?A7=0Z?XBU&'PW\0])U6[71WN?.@@7S4,K
MI 0S1JSH6R" NXD;0: ,SX??\$XO#WPX\ 6OAZV\1:_<6UI9:98I)(L"OLL=
M5N=2CX5 N6>Y:,X &U5P <FLOQQ_P2Q\%^-OB(GB:;4&;4+C4+R[OWN]&T_4
M&N(KC4)+[RHFN(7^SLDDKH)(\,4.#D@$9W['R_$8?'J'^WH_B,K_ -FZK_PF
MK>(#,=';4/MT7]G_ -F;_P!UL\CS_P#CV_=^7Y>_]Y61\8K'XRWG[?UJEK>:
M_:^"Y+W2%TUK.UU*:S;3SD:FDAA=;*-VRP\RY_>I^Z:')&" =AJ?[*?PS^*L
MG_".)X[&H7,-QXEN#9V.HVS743ZG<"2<A5RRFVE*[3CY2!OS6IX>_8'CBUZ\
MUGQ!X\\2>)M>U*]O;ZZO9[:UM][7.E+IA58XXPJ(D2AE _BSG(XKY'^#/['7
MCGX"_"'Q9K'@KPSXRT?Q=>>&?#UK//>W6I3W+PMK.I2:G' /,,HF^S^0S"'$
MH63*8=QGU#P79_$I-'\&_P#"=W7QFOO#NW4SI7_"*VNI6NH0W?VZ'[&EZ)G:
MY:);?S CWQ"$;_. .V@#USQ+_P $\/!OQ+^'VHZ7+K4VI17$6B0VT\UM:WT%
MK<:,CP1.T,B-%+N)=98Y 5/S#"]IK'_@G)X;L_ -]H*ZU?V\>I>%Y?#-P]E8
M6=C&%EO&O'FCAAB6*-O,<@*%VA<=3DG2_8%\!W7PH_9XUC1YM,\36>I6?BKQ
M%.UOJ\L[S3>;JEU/"\4DY(:.2&2)@R$QEF8]=U>7?\$\-7^*-]\??$LGBS2_
M'FE^&=1\.PW2P:^VI3I;:DMW*LD?FWF%,PB*;OLJ);L-I0'!- 'TC\&?@O'\
M&+CQ8+75+S4+/Q1K]UX@2">.-?L$ER0\L:,H!9#)N8;LD;L9P!7D_C/_ ()W
MV^O^*_&&IZ;X]\3Z#_PFT]\NIQ6MO:OOLKY(%N[16>,D;F@#I)]^,NX4X/'F
MO[3'@OXM)KGQ#UW0;SQXUK<>.-.LGMUN]4:WC\/+IT#RFSM[)A/@WA;S)+8>
M<0'4';N%2>$]"^/0_P"%9Z3/J'BJ^C\;:<CZYJ<L<]FOA]]-N)KB-959VDA-
M[;O;V[%CO<PLS@,S"@#ZVO\ X<Z;=?"^;PBBR0:/)I3:.J1M\T=N8O)P">X7
MN:\C\-_L&:7H_A'^R[OQ-K6I2/;^&K:6X>&"-I5T.<RP955"CS.%?'897!KY
MI^#'A'X^>,?"TVF^*-4^(EG_ &EJOAVWU]+1-6L[F&=M2']HRPW4\GRQ&VRK
MBR ME3#*P.172?'FR^-WA[X__$"V^'K>/]6:[T.[ATE[L7T-EHQ2RB$)C=V>
MQN]SJY0J4NQ,S&3<HH ]V_9>_8'\+_LI?$'5M<T&:!H[V&:VM+==&L;:6TAE
MG\]UDN8HEGN#N "F5SA0!@GFNB^,?[,]UX^^(,?BWPQXTUSP'XFDTS^Q;V\T
M^WM[I;^R$C2*C1SHRB2-W<I(N&7>PY!Q7(_\$]8/&T/P_P#$G_"77.M36;:L
M#HL.JV>I0W%M!Y$7FKOU)VNY%,WF$-*% R57*!2?F/QKXH^)'@/5?$5IKVH?
M&23P[JGC'2()M6MSJ6GW\D<VL.LEC! S,CN;<JHDTU_+:(*-@DH ^E-5_8K\
M*Z5XQTV%O'VOV>C2-HUQJ^@WM_#<2>(KBPF06,\T\H,^YIEB#[& F:-%]B[3
M/V!?"^I^ K73;/Q1JUU8IHEOH:7,1@??'!JG]H!\A=NXR QG'&W/&>:\6\&_
M#WXF7?CC0M6NM)\=20N-,LK2]U".4ZFFCCQ@)8XKN0_.)ETTAY=Y\Q5R7^8$
MU[3^PI\/M<^%7["T?ARPT_6M)\4Z4VL0P6^NM<,ZW9N[EHFW3DEH6+(RLI*%
M3D<4 <[>_L0I::EX\USX@_$B\TOPUJ&O:SJ^D6UM=165OH3ZC;FS^T_:657$
MPBEE4(6**TI(R2,5_AC_ ,$R?!WP,U?7-8E\97$;>*-$NM#F6.QL-+LU$UHL
M3RQ10QH@<10>8>N2'8YYQY)'\&/&7QPT+0=)UC2?C#J/ANUUSP9?:U!XFN+Z
M*X_MF._<ZI)%E@S6:Q>4S;/]&# -&."1[C_P4]^%%Y\2?A[X%FT_2?%&L2:'
MK]S*T&B&Y=XQ+HNIV\;210'YX_/E@1MX*A9&#?*S9 .@^"?[)K>#/VD[CQY)
M<6,VCV/A33O#.A)!<&=KT0IA]0F&Q4CF>/RX1Y98&-!ENBC8\"?L=V/@K]I_
M6/BA)KU[?:EJ-O-:QV_V&UM2L<K1L5GFAC62[">6!%YY8Q@L ><U\M^(OAI\
M9/A1\+[7P[X:E^(4OA>VC\+W&I_;+C5+NZCC:PNDOHK=K4_;%59X[0R16I!3
M/RJ%9A7T9H'@_P")'C;_ ()TWF@WVI7DGQ*U?PK>V<5W<PMI]P;B2.58-X9F
M>-]IC4N[;P?F;#9  -[XC> ]%_:*\5Z?KG@OXA0Z+XT\"FXL!J6BRVNHM;17
M&SS[6Y@?>A5C#&P#@,K1 @CG/!>/?^"7WA7XA:OX;U+4M=U+5-:TFU:RU'4M
M:T^QUFZU:)[DW3D-=0R"WD\UWVM"%"(VP  +CB-1@DNOA=>#X5?!OQIX'\3:
M/X3CTZ^U9-).CWMM$+BW\ZPM5< 7EP8UG=)DWHK*-LA:3%<WK7@?XI>.]*N[
M?1;[XW:3X-LX_$][X9,][?6NLN8].L38K=-(?M##[=]L,$=QEG4 ,&7 (!]%
M7?[$FEO?:/=6OB#6+6;2?$>LZ^"(H769=42=+BV(*\(!-\K#YAL')R<\W9_\
M$S_"*0V\%YK?B"\LX]-M]+DA)B3S8H=$?2 =RIE6,3^;D=) ,<<5XQ\1Y_&O
MPK\'VVD^(M8^,"Z#JGQ!\/(9+*]O)=8OH+C1O-OX()$/GM$;M7+10GY"'5 H
M  YKXM:K^T!8^$O!4=AI/Q4;7M+LK6ZM[M)=1GDN;=M7E CGBML6WVI-/,/G
M_;2[-GY$WJQ(![Q\7/\ @F@WQX\+6.F^,?B=XI\126=O=6(DO=+T^6&.WGB6
M(&*!H3'%<($!6Y"F0$MR V*G\<_\$ZO"?CS3[_P_?>)VNKR:[TSQ#86U_IUC
M?"QN;+3HM*:X-M-&RS130PQ!DD4JKC*E2:\CS\2/V:O@Q-XJU37OB))_8O@K
M1O&5^GB#69F74-:@O)#=Z8&F;$;7-O\ N?LZX7<\;;=PR>S^/?PK\96W[*GA
M'Q!'?>,9/B),R2ZI=Z?::A=W,T$[R73:?-]A<7D-NLC1J#;AMC1(&4Q[J /I
M[X*?"NQ^"'PMT7PGIK^99:);^1&XMH;;><EF/EPHD299B=J* *;\?_\ DA'C
M;_L 7W_I/)3?@+?:OJ7P2\)3>(-/U+2];DTBV-]:7]P+BZ@F\I=ZRR  .^<Y
M.!DYX'2NFU+3[?6=.N+6ZACN+2ZC:&:&10R2HPPRL#P002"#0!^97_!'/_@J
M]^S=\#/^"9/P=\)^+_C5\/\ P[XDT/0A;ZAIM[J:QW%G)YLC;'4]#@@_C3/V
MROV]O@S^U_\ MV_L8Z;\+_B7X2\<:AH_Q,FNKVWTB^6XDMHFTRY0.P'12V!G
MU-?8H_X)7?LTJ/E^ /P? '3'A*Q_^-UJ^ O^"=_P%^%OC+3?$7AOX,_#'0=>
MT>;[18ZC8>&K2WNK.3!&^.18PRM@D9!SR:6I5UN>T4444R0HHHH _*3_ ((G
M?\%//V>_V:OV#-+\)>/OC!X%\*>)K'7M9DN=-U'45AN( ]_,R;E/3*D$>QJ_
M_P %//\ @HO\"OVLY?V>?#?PV^*W@OQIX@@^-7AB]?3]*OQ/<+ D[AY-H_A4
MLH)_VA7VE<_\$N?V;;RZDFF^ WPCDFF<R2.WA2R+.Q.22?+Y)/-6O#'_  36
M_9[\&^)+'6-'^"/PJTS5=+N$N[.\M?"]G%/:S(P9)$=8P596 ((.014VZ%76
MY[A1115$A1110 5^:7CC]K7X9_LB?\%]OB5J_P 3O''AWP-INJ?"?1;2SN-7
MNA;QW,PO9V**3U8*,X]*_2VO*?B_^P]\&_V@/%__  D'CKX5_#_QAKGD);?V
MAK&@VU[<^4F2J>9(A;:-QP,X&30!X3\8_P#@M!^RCX@^$7BK3[/X_?#.XO+[
M1[NW@B35D+22/"ZJH'<DD"M;_@@\-O\ P1^_9_'_ %*L0_\ (DE=U_PZQ_9I
M_P"B!_!__P ).Q_^-U[!\/\ X=Z#\*?!FF^'/"^CZ;X?\/Z/$(+'3M.MDMK6
MSC!)"1QH JKR> ,<T ;E%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ=;?L4^!+'46N'M]4N(?M=EJ#6MSJ$DEJ9[733IB2&,G!+6FV-\\/L4GD9H
MK_!7]K)OBVVLVFH>%=7\(:Q8:+;>)+2TOIH;AKW3;D2^1.#$Q"L6@D5XF(9"
M!DD$&O/_  %_P4$M?B#KGA/3[_P-K-UI>H?\(^EUK[?9DM[/4-5M5N+0+;^8
M\G#%59E+",NO+#)K0^'MU\!OV7]#FN]/\<6NI0^+-2L? R7UUXC_ +6>V?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<U?5K>:2?4#:+:&\"W$J))Y2@"/**IVXX^M>QT %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#<R-#;.T<
M?FR*I*H"%WGL,G@9J:J>K;SIUQLN&M7\IMLRH',1Q]X Y!QUP1SB@#ROX%_'
MSQ1XW^+'B3P;XN\,Z1H>L:'IUGJV[2-6;4H(8[EI52VN',4?EW*^46*@,I1U
M96(-<KH7_!170'\%76J:QX5\::=>1^(M<T:'3+?2VO+R:VTJZ>">_P!B'B!0
MJEB>0Q* ,1DZ_P"RO\&6_9J^'VK:QJ7Q&O/%V@ZE =:GU#5-)M;&X9B&EEO+
MB:*-'E=D(R9!\JH  H  Q+K]B"Q\6:/_ &IX;^(?B32'U6_UC5+/4;&*UD(L
M-9E%S=6B[XR&C:5C)'(09(RPP2 !0!T'[5GQRT?P5\"-$^(%EX1D^(UK:W=G
MJ^D-;2)'!:^8 J7S2O\ <18IF((5F.[ '.1BZI^VM<1?MI2?"V&'PO8V-B]G
M!<7>IWMY#=7D]S;M.L5L%MFMV<(!A))T=CNPIQSVGQ8^$/@_2/V3[SP7J6K?
M\(MX)T/1X+)[^2X1/[/M+41[6:23*\+$ 6;W[U1\3_L]Q_&OX@>'_%-QXZU[
M4/!UO>6/B*R\/I';_89+JW >VG281^<(\[9/+W[68 ],@@"_M4?'#P'X(M=-
M\$^--.U;7H_'44\/]F:?9273S6T>P3.ZH0WEKYB;@F6(;A2,URWP?_;J\)ZC
M<:QX;F\-Z]X<;PO-K-E816VERS66I0:3<-!(EFR)^\D6,1L8E7C=M!;::U?V
MVOV>/#OQ^T#0+7Q1XJ?P[I?]HPV,<9LK2X%U<7$B)"(7FC9[>Y+X6.:%E=2Y
MP>>*GBK_ ()^^'_%/A)=(_X23Q-:1Q_\)"8YX)D6=3K#EY3OVY/EGA?[PSNW
M9- $VG_\%#O ^HR:=;_V=XOAUB^UV;P])I4FDD7EA<0VXNI6G 8K'$MNPE+[
MB-OOQ4$/_!2;X:W/A2^U17\08MWLOL=J^FF.YUJ&]E,5I<6JN0'AF=6"LQ7[
MISCC.=\&O^";GA?X0ZPMY_;%[J'F:E=:G/9QZ?9Z?8N]SIBZ=+&D%O$BQQF-
M=X5<'<3R1Q6;X'_X)>^'?AK\-O$'AO1==6TM]8AM;*)O^$8T<QBTMW+)!=1_
M9=M[NW$.\^YFPIX89(/0]JO/V@_#^F>!/#7B2Z75+/2_%5U;V=L;FQDADMI)
MPVP3HP#1#<NTEAPS*.XKSW1_^"C7PW\4>"=+US1I/$6M+KEK;76FV5EI<DE[
M?&XFN(HHDBX/F$VEPVUB $C+$@$9J_%3X$>!/A9^Q)I_PK\0>+]4T'09!:Z)
MIVL-*&U 7GG"6 PC8P\P2)E$"E55,8"KQAZI^P[X#^!NB7<FG>--6\%ZAJ_B
M^'6?#]^S02?V-="U,*6-O'(A1[<QB=O*<'F60Y'& 1WUA^W/\/M5\+W6L6]]
MJ4UG8Z?8ZE<8L) \*7=[+8I&RD9$J7$,B.AY0H<UY_X]_P""FFE> _A?<:I)
MX8U;4/$5M/>B73K!'N+:PAAU:;38IKJX"8A69XB5^4G.?X06J/2?^">?AGQE
MX+T&Y\-_$+Q1%X?UC3;*749K?[-,/%*IJ#ZM%<N[QDH9)[B5F\K:&27;@ "M
M'QK_ ,$V=+\2Z;=6>G>./%7A^WUH7$.NK:);/_;$$FI3:BD;;XSY?ERSR(&3
M!:,E6SUH'H=K^TE^UG:_LV>._!>F7GA[7-<M?%<>HR2/I-L]U=6BVD,<K-Y*
MCYDVLQ8Y&-HP&) INF?MU?#O7/B7I7ANQU.\O/[8-I#;ZK%:,=+-Q=0"YMK8
MSG@32PLKJN.C $AB!7'_ +34O@/XS_'7PKX=M_B_/X(\?>'_ +98P6^G&"1K
M@7L"I);2>=&\8E,:!D7(D!PP!XJ3PC_P3.\"?#_XX:-XPT/%C'HZV;+92:38
MW,SRVEJMK"RWDL+7,:^6B;D20!F7=QDY!'HGQ)_:E\.?#+XD6/A6ZM?$&H:E
M<0QW=V^F:9+>0:-;R2&*.>[=!^ZC9U8 \G"LQ 4$UQT/_!1KX>7&BWU[Y/BQ
M5@-F]A"VBS"?7H+N[6SM[BR3K-$]PZ(&&"-RD@ @GI?B5^S'_P )Q\5QXITW
MQ9KWAB34+*'3->M+!('BUNUAD>2.-FD1FB8&212\9#%'(]".-\(_\$\M)\/Z
MG87%]XO\3:U_PCK:9;Z MTMNO]CV%C?Q7T=H"D8\S=)#&K2OF0HB@$8R0>A7
MO_\ @I5X1U'X:>,-<T71O$TE[X7\.:AXACM-6TV73DOA8OY5W;I(RM^\AF*Q
MR  X+#&X<U#\0O\ @HW\/=+\#BYUZQUZSL)KJ72-9TC4-(N%U2'?9&XC46ZJ
MVX31E2N2 RMQ\PVUN:W^P/X?UOPIJ&DR:_XABCU'1O$&BM+&8A)''J]U'<S2
M*=G#QM& G;!Y!-<=X[_8#\*Z]J6BVOB[X@^(M1\7^(-=&HQZA+%;0W&KR6MB
M8HX!&D8C58K=&;Y0"Q#,22:!'6W'_!0/X<^#_!>GS-9^)[.2.>[L)=%72'6_
MTA+%8S<O/#G]W%"DD3%@3E9%V[LXJ;6_V\O#C_&'PIX1\.Z;JVOQ^(M:AT>3
M6XK9UTF!Y+"2^VI<8*R3"(1-LX&)?O;@5K!^,_\ P3)\(_&37;K5KK4I(]6N
MM9OM4\^\TBPU2.*.\BMHIX$BNH9(Q_QZQLDF-Z,6Y(.*VHOV%+70OB9I>MZ1
MXO\ $%CHNCZNOB*#PV(K;[#)J2V#67G,_E^8%:,AC&I"!P6 &2* /5OBW\5M
M'^"G@#4/$NO37$>GZ?L4K!"TT\\DCK''%'&OS/([LJJHZEA]:\QOO^"@O@C0
MSIZ:EI_C+2Y9D675([S0IHF\-1M.;=)+_/$*/*"%8%@0"V=H+5V'C/X)77QB
M^ =GX5\7:Q)_;OD6D]QJ^EHL+0ZA R2K<PJP*C$R!@I7!'!&#BO.?%/[ 3>.
MY7DUSXD>,M2DURVBL?%F8K2-/$MM%.T\4)58A]F52[IF':2C%2>] &DO_!1#
MX>P:AK\-S!XJLK?P^;\/>W&C2I:WHL+H6M\;>3I(MO(P+D8 7+#(!QEVW[7'
MP=_9J&H>&='L[^PM=+U*_EU7^S]-DDALO*E0WM_<29SY*33!7E)8[@PP0AQU
M%K^Q;X=B>P6XU#4KRUL?^$C1K>01^7<)K4_G7",-O1#\J8[=<FO.-2_X)-^"
M+_PAX'TO^UKZZO/!^F2://JFJZ7I^K7>KV\LPFE>0W,#K'<-("?/C56&]ASG
M@'H=3J7_  4&T*;XW:#X/T?PSXLU:WU#Q3=>%=0UP6/DZ;83V]C/=R,)68>8
MJB(!B!@*S-D[<&SH_P#P48^'/B#P_J%]:'Q%-);BUDT^R&EN+SQ!%=3&"VFL
MHNLT<L@*J3MQC+;1S6C)^Q9HR:AI]Q#K.J0MI_C"]\6[#'$T<_VRUFM+BS9=
MO^J:&=P",.IP0>*\Q^'O_!.3P#\+;V^\)Z#XJ.E^)X(;'5M#>RT?3+6_T:"T
MN6-O.YC@4WGSEHW:X+[U)! )+4!H>P?!']J*S^+WP&U3Q_<:/JVEZ?IM]JEN
MUG]FEFOC'9W,T', 7?YK>5GRP"03@$]3RMQ_P4>\#6^CQR?V/XZDUB35KG17
MT.'0WEU2"YM[3[9('B4D!1;XD#;B""!UXK?T3]D2UT_]F+Q!\,[KQ5XEOE\3
M-J,U[KADCAU!IKV>2>5P8U"##R$!=N"HVG(S7GW[,'[#/@GPY:V?BGPSXNN-
M<LKK5+S5HY+"QLK'3WFET\:7*L4-O$B1Q@1%@JCAP<DCB@1T'BS_ (*'^%;7
MQAX1T?PW8ZMXF_X2C4]'L6U&&UD33;!=2 DA$D^T@3&$^8(R!P0"5) /=_$_
M]IWP]\*_B)I?A>ZM/$6K:MJ4*W<T>DZ5+?#3+9I1$MS<F,'RXS(=H(!/#'&%
M)'DTW["GAGX0W_@VX_X6'X@T/P]I>I^'S)I<GV;[/KFJ60BM+-W<Q[U:7;&K
M1QE59PA !%>H?$K]G"7QK\6;+QAHOC#Q!X0U+[$FEZHNG)!(NJV:2^<D9\U&
M,3!BX$B8;:[#T( .%^!?_!1CP[\7/ %QJ=WX=\5:7JUKIS:G_9T6F37)U*$7
M9M"]FP4>>HFVJ6PH7>"?E^:IKW_@I7\.[#P[INH?8?&5Q]LCU*:[MK?1))KC
M1H].FBBOGNU4D1K"TT98@MD-D9JGXD_X)N>']>^'>G^'X_$WB"UCTS06T&"7
M9!()(SJ$5_F6-DV2J7A5&C8;'C9E8'.:/AW_ ,$V_#?P[\':QHUOX@UF2'6-
M+\0:7(8[6UMD@36'MI)S%%%$L:"-K<>6H7:H8@@X% '3:C^WS\/=*^)(\.W$
MVM1Q-//:#6_[-D_L<SP63WT\7VG[NZ.W0LW;)"@EL@>:_&?]NGX/_%WX67VF
MZMX?\6^(KE8?[53PTNFW,.H2VJP//'?LD;!EM&12?,)YY7:6&VLGQ/\ L5W4
M?[1>C:3KGB:PL?A/JE_?2V/AZ34?-N=:U&XT>>UGV(+9#'^Z,\Q'G2 ,K$*-
MQ D\!_\ !-+P;X7U/5=%\)_$*^T'QEH]DMA?7.BZ/I5C<0:5=0O$D$T45NJ.
MT@C9Q.X,F^/<".00#Z5_9\U6QU[X$>"]1TO2;70]/U+1+.\M].MO]38I+ D@
MB4X&0N[&<#.,XKLZP?AGX'M_AC\.?#_ANUFGN;7P_IUMID,TV/,E2&)8U9L
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MEF.CW5@]U/=MA/O021- 0."[Q<C=P >._#[]B+7-:\;^#]0N/ABGAGPOX?\
M&.BZM!H>HZC;7DFG36^FZA%?ZDFR1T'G32V8^5C)(8?,95)->Y?\% ?@1=_'
M+P)X+^P^%8/%UQX7\7V.LO9,T*R+$BRQM)&9F5-R&16QN!PIQDX!E_;E^/7B
MC]GFQ^'FK:#_ &7)I=YXG-MX@AN@[37%@FG7URZ0[5;$A^S@@G'*@$[2U7_V
M8OVDM>^+/BC5/#_BK0='T76+;1M-\2VO]E:BU];R6%_YXA1W9$*SHUO(& !5
M@59203@ ^7]5_8!^('@OX,6.@^$=';2=.D\.^$I?$FF1S07HUV^M&N!J49AF
MG2*:0H;?<))$CF$87>0,5];?L:?#W7OA9^S=X<T/Q%)J,FJ6?VAC'?&'SK6)
M[B1X8"(6>-5CC9$5%=PBJJ[VV[CB_$_]I'Q-X<^->I>'?#OAW1=2TCPCI=KK
M/B2ZU#4VM+@07$DRJMI&(V61T6!W.]D4Y"@[LUYE'_P4,\9?8]+MY/ _AW^V
MO&5KHNJ^&88]<=[?[%J=^EDGVQ_)S'+$9%=A&'5AD*V0: -KX?>!/'GPPNM6
M\#K\-;#Q%;ZEXZNO$L7BN^O+5M-2VN+TW?VB6,M]I-]"K>6BK$5+1QMYBKP/
M&E_8L^)&M^'=8TG_ (1/4M+NKNR6R\6:@VOQM_PGMTVN6=RMVA67>HCLX[K+
M2B-P)_)564 UW=M_P4=^($&@027WP^\+QZEK2"'1H8O$,AADN8];@TB?SW:
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M(GH?@WPS)XN\.RZDOB=+O7)(-/5+&ZAMW^Q3>26D:3S@X\Q4"!</@D4 =O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2-.\;:3;W_AR_EN6UN+3;BWU&VCDEMW86[Q7"@AA 5:*<2PMN4E,KST7B/\
MX)W:MXH\,SZ3=>+=/^SQGQ!%:/\ V8S.8=4UFVU0>;F3#/&T4D9*@!@RG"X(
M(5J=E\6?VDO@)\0/ACHNN>,/$&@WWAR'5WFL7NXYE:WO;-6,C-'M$D?E(S;R
MZA0C_-\K\WO U_\ !/\ 9,TC01H+:)X9M_BA<1/I0MTED?6CY0>,)PS>6D3
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M6<GP-\:*+RU).A7PQYJ_\^[^]> ?\$'O^4/W[/\ _P!BI#_Z,DH#H?6]%%%
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "H;O<UM(%D\EBI DP#L..O/''7FIJKWUE#J%G
M-;W$<<T%PACDC==RR*1@@CN".,4 ?$\GC/QG8B\AT7XD>,=2^'?BKQ%HGAJ+
MQ7J<EO\ :VNY;F5;^;3I%B54MG40P(Q4J)68QY !J2Y\?^-O'GPM\/PZ#\1O
M%5U\0[?6]6T/PS:60MOLVNPV.K2VRZMJ7[L[[86\2^8051BQV NZU](>%_V.
M_A3X(T'5])T?X;^"=+TK7H$MM1L[;1;>*WO8D)*)(@7:RJ22 1P3D4[Q-^Q_
M\*O&DVCR:M\.?!6H-X?M$L-,:?1H'.GVZ-N6&(E?DC#?,%7 SS0!XI\'_'OB
M[0OVU[FW\8ZEJU]I_C36=;LO#$5AXJAO=.MK>S5759[!(1Y#"-3\_G.PD.UU
M0LHKGOA1XD\=>+_VE_B/K5\OQBUCP_X1\<7MI;RZ;XATZ'08+:WMH7%NUDSB
MYD 9B" C%F;()'3ZL\/_  4\(>%/'NI>*-+\,>']/\2:PNV_U2VT^**\O!P<
M22JH9LD G)YP*Q)_V3?AA=?$IO&4GP_\'MXL>[6_;6#I,/VUKA0 LQEV[C(
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M_1/"6E^&)+AM.T^SL6O&1IS;PK'YI2-8DS@<[8T1!Z*H'04 :E%%% !1110
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M1K.BG]@3QA;?VQ8SV7F_\)M9MY7F1LF['E#.-V<9&<=:^H_^"/WPA\3? /\
MX)E_!KP;XPT>Z\/^)_#OAV.TU'3[C;YUI*'<E6VEES@CH3UH#H?2M%%%!(44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^]C>BTN9-/0@^8\-PZJ2H#?O%*Y!)K<_:(_X)[^'_P!HOXP6_B_4O$&L6-Q
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M&&W@N(I5CL+#R8VENOM6^SA: QV&)/EQ:K&"GRGB@#U#3/%D?Q@^!7BZ2S\
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MTN;BXOELXRETK>48R[JVX[2%SE0010![M17R[X>_X*0R7^DZA=:I\.]3\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ."??PWL-(UFSCL]=VZJEO#;S-K5RT^B0V]R+NWBL)"^ZUCBN%615C( 91U
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!YWJ'[*OPVU?XKMXZNO _ANX\7231SOJTEBC7+RQHJ1R%B.7144*QY 5<'
M@4Y_V5?AL?&>H>(CX%\+MKFJ>>;N^.GQF:X\^(PS;FQ_RTC9E?\ O \YKT*B
M@#SO0OV4OAMX6\0+JVF^!?#-CJ2:>-*6ZAL(UF2U\L1>4& R!Y8"<<[1C..*
MO^/OA-<>*O"^FZ3H?BSQ-X#M]+VI&^@+9;WC5=JQ,+JWG78!C&U0>.N.*[6B
M@#QW_AEKQ-_T7CXP_P#?&@__ "LH_P"&6O$W_1>/C#_WQH/_ ,K*]BHH \=_
MX9:\3?\ 1>/C#_WQH/\ \K*/^&6O$W_1>/C#_P!\:#_\K*]BHH \=_X9:\3?
M]%X^,/\ WQH/_P K*/\ AEKQ-_T7CXP_]\:#_P#*RO8J* /'?^&6O$W_ $7C
MXP_]\:#_ /*RC_AEKQ-_T7CXP_\ ?&@__*RO8J* /'?^&6O$W_1>/C#_ -\:
M#_\ *RC_ (9:\3?]%X^,/_?&@_\ RLKV*B@#QW_AEKQ-_P!%X^,/_?&@_P#R
MLH_X9:\3?]%X^,/_ 'QH/_RLKV*B@#QW_AEKQ-_T7CXP_P#?&@__ "LH_P"&
M6O$W_1>/C#_WQH/_ ,K*]BHH \=_X9:\3?\ 1>/C#_WQH/\ \K*/^&6O$W_1
M>/C#_P!\:#_\K*]BHH \=_X9:\3?]%X^,/\ WQH/_P K*/\ AEKQ-_T7CXP_
M]\:#_P#*RO8J* /'?^&6O$W_ $7CXP_]\:#_ /*RC_AEKQ-_T7CXP_\ ?&@_
M_*RO8J* /'?^&6O$W_1>/C#_ -\:#_\ *RC_ (9:\3?]%X^,/_?&@_\ RLKV
M*B@#QW_AEKQ-_P!%X^,/_?&@_P#RLH_X9:\3?]%X^,/_ 'QH/_RLKV*B@#QW
M_AEKQ-_T7CXP_P#?&@__ "LH_P"&6O$W_1>/C#_WQH/_ ,K*]BHH \=_X9:\
M3?\ 1>/C#_WQH/\ \K*/^&6O$W_1>/C#_P!\:#_\K*]BHH \=_X9:\3?]%X^
M,/\ WQH/_P K*/\ AEKQ-_T7CXP_]\:#_P#*RO8J* /'?^&6O$W_ $7CXP_]
M\:#_ /*RC_AEKQ-_T7CXP_\ ?&@__*RO8J* /'?^&6O$W_1>/C#_ -\:#_\
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MQ-_T7CXP_P#?&@__ "LH_P"&6O$W_1>/C#_WQH/_ ,K*]BHH \=_X9<\3?\
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M (;)^$__ $4;P9_X-H?_ (JC_ALGX3_]%&\&?^#:'_XJ@#TJBO-?^&R?A/\
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M10!B?\*U\._] '1?_ &+_P")H_X5KX=_Z .B_P#@#%_\36W10!B?\*U\._\
M0!T7_P  8O\ XFC_ (5KX=_Z .B_^ ,7_P 36W10!B?\*U\._P#0!T7_ , 8
MO_B:/^%:^'?^@#HO_@#%_P#$UMT4 8G_  K7P[_T =%_\ 8O_B:/^%:^'?\
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M)>3_ .*H ]@HKQ__ (;!A_Z)K\7_ /PEY/\ XJC_ (;!A_Z)K\7_ /PEY/\
MXJ@#V"BO'_\ AL&'_HFOQ?\ _"7D_P#BJ/\ AL&'_HFOQ?\ _"7D_P#BJ /8
M**\?_P"&P8?^B:_%_P#\)>3_ .*H_P"&P8?^B:_%_P#\)>3_ .*H ]@HKQ__
M (;!A_Z)K\7_ /PEY/\ XJC_ (;!A_Z)K\7_ /PEY/\ XJ@#V"BO'_\ AL&'
M_HFOQ?\ _"7D_P#BJ/\ AL&'_HFOQ?\ _"7D_P#BJ /8**\?_P"&P8?^B:_%
M_P#\)>3_ .*H_P"&P8?^B:_%_P#\)>3_ .*H ]@HKQ__ (;!A_Z)K\7_ /PE
MY/\ XJC_ (;!A_Z)K\7_ /PEY/\ XJ@#V"BO'_\ AL&'_HFOQ?\ _"7D_P#B
MJ/\ AL&'_HFOQ?\ _"7D_P#BJ /8**\?_P"&P8?^B:_%_P#\)>3_ .*H_P"&
MP8?^B:_%_P#\)>3_ .*H ]@HKQ__ (;!A_Z)K\7_ /PEY/\ XJC_ (;!A_Z)
MK\7_ /PEY/\ XJ@#V"BO'_\ AL&'_HFOQ?\ _"7D_P#BJ/\ AL&'_HFOQ?\
M_"7D_P#BJ /8**\?_P"&P8?^B:_%_P#\)>3_ .*H_P"&P8?^B:_%_P#\)>3_
M .*H ]@HKQ__ (;!A_Z)K\7_ /PEY/\ XJC_ (;!A_Z)K\7_ /PEY/\ XJ@#
MV"BO'_\ AL&'_HFOQ?\ _"7D_P#BJ/\ AL&'_HFOQ?\ _"7D_P#BJ /8**\?
M_P"&P8?^B:_%_P#\)>3_ .*H_P"&P8?^B:_%_P#\)>3_ .*H ]@HKQ__ (;!
MA_Z)K\7_ /PEY/\ XJC_ (;!A_Z)K\7_ /PEY/\ XJ@#V"BO'_\ AL&'_HFO
MQ?\ _"7D_P#BJ/\ AL&'_HFOQ?\ _"7D_P#BJ /8**\?_P"&P8?^B:_%_P#\
M)>3_ .*H_P"&P8?^B:_%_P#\)>3_ .*H ]@HKQ__ (;!A_Z)K\7_ /PEY/\
MXJC_ (;!A_Z)K\7_ /PEY/\ XJ@#V"BO'_\ AL&'_HFOQ?\ _"7D_P#BJ/\
MAL&'_HFOQ?\ _"7D_P#BJ /8**\?_P"&P8?^B:_%_P#\)>3_ .*H_P"&P8?^
MB:_%_P#\)>3_ .*H ]@HKQ__ (;!A_Z)K\7_ /PEY/\ XJC_ (;!A_Z)K\7_
M /PEY/\ XJ@#V"BO'_\ AL&'_HFOQ?\ _"7D_P#BJ](\%>*%\:>%[/55T_5-
M+6\0N+74;8V]U#R1AXSDJ>,X]"* -BBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKZAX5T-/+N(K>ZO+"4:A:W37D-M<+;3M)%%(TEJPD="J3*I=&W#H0-+X9_L
M> ?A;J5G>6<GB>^N[&[T^[MYM1UF:Z:+[!%<0VD8W'_5QQ7,B!>XVDY(S72?
M"']EGPS\#_%E]J>@W&OK'=+*EOIL^IRRZ=I:32^=*MO 3M0/)\W.2.BE5R*
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M^)8]!O-<D\-VOBN73BN@76IQLT;6J7&[.[S$>,.4$32*5#EN*UO@%^V/X?\
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MK(3^[=?E;!&0(_AG_P % /!7Q+\0:38QZ?XNT5/$VFW&L>&KO5]):UM_%%K
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M;&QU2TBCD"-,A5)(YE+N^ \;\!0V0#Y6?H%17PG^T)_P43^(GPVO]4DT.\\
MW$EUXJO/!UAHEQ:S/?:2UOC&IW)68;XGZ^6%0 3P8D8D@_;'AA;J'0[>WU#4
M+74M4M8DBO;BW@^SQRS!1N81;G,8.<A2S8!')ZT"-2BBB@ HHHH **** "BB
MB@#Y7MO^"8_A7XN^//BGXH^,6G:?XNUGX@:G);V_V2]NX8;/0XX5@M+)E5D#
M,%\V1\@KOG?&17!_#G]@;XW_  <^'/B#3]%\7> -8USQEX/B\':M>:LMWMME
MLA<V^GW\>U"TLGV2=%EA?8IDCW*^"0>T_:<_X*A6/[,?Q UO3]4\-69TGPW>
M65K=O=:_';:M?)<-&#<65@(W::&/S "\DD.XJX4-MR>3^$G[>?CCX=GXI:UX
MV\-W6L?#KPW\6=0\,/XE?4X8YM(LWO(K>W*6BQ9EM87E17<R"0;F(5PI- ]3
M-O?^";WQ8\!_L\>.OA[X'\2> OLOQ0\)Z?I.LW6KK=;M)U"#2XM.GEMU1#YT
M,T<*$*YC,9R1N^[7<ZI_P3@O?&WP#^/G@77->T^"'XO:Q'J=A<VD<DAL/+L[
M**,3*=N[]]:9(4C*-C(/2W;?\%)+V\\/:'XPB^'5U_PK7Q=KS^&=!UU]91;F
M[NVFDM[66:T\HF&UN+B/RUE$CN Z,T8!J]X=_P""F7A_7O#/@/5O[!OH;7Q%
MX4U?Q?XD5K@&3PA::8HCN5E7;F5_M>;=0-N61SVQ0&IPOA#_ ()P:[8S>)M7
MO_"OP2;4-2T*/0(=(N8]2UFQU")KA)KEI[FZ;SH5?RU\N*-66-@')E(%:'@O
M_@G_ .*O"_P5\9>&[K3_ (=:]H_B;6[2_LO NMWFH:KX?T*UBA"21VMW*OVB
M*620>:'$12,C"Q\YKH/V;?\ @IQH_P <OBAX-\,ZAI.BZ+-\2--N-5\.?8/%
M-KK%SMAC69H+Z&( VD_DL'"@R)\KKO#+@^[?'KXHK\#?@=XR\;26,FJ1^$=$
MO-::SCD$;W8MX'F,:L00I;9@$@X)H$<'^Q#^SCX@_9M^&FL:+X@UI;^/4M9G
MU#3M*AOKG4+/PW:.J*EA;SW/[Z6-2K/EPN#(0%"@"O/?!G[*OQD^!?P5O/A-
M\//%G@[3?!JO<V^@^([Q+AM<\,V4\COY26X0PW$L/F,L4K2QC"H61L'/G_[4
MO_!1;QQHW[,NK-<^$K[X5^*O%7@T^*_!]]%JL.INT<4]H+B"9?*58;E([F-M
MF)$*LV'W*177?%K_ (*U^&_A#XQ\:P2:;H]YX=^&-Y!IOB6_N/%%K9:D9FCB
MDG:RT]QONDA25"Q+QEB&6,.5(H O^,_V _$VN_#?]HW08?$FGW4WQALK&UTJ
M\U!I'FB:WTJ"R>2\94&7>2)G)C!&&Z#I7F?Q<_X)9?$+X@ZEXF_XF7P]UF^U
M7Q98>(K'Q/KCWMQJMC9VUS;3C2XH=AAMT40LB31-G:W,>26KTOQ__P %2M+^
M'OQBM= OO#^GPZ1<>*+/PNLLOB"-=:D:ZDCBBODTY8F/V,O(N'>9'9,L(R,9
M/A__ ,%2]+\7Q^+=:O= T[2_"?@N+5Y]8/\ PD<+^(M'CT\R!FN])9$DC$OE
MGR_+>7.Y"VT'(!ZD8_X)]>(KKX"Z?X/NM:T.22'XLR>/;ET\X1R6#ZK+>&W4
M[<B;RY-N<;=PZXYKQ#X)>'O'GB;XA_L]_#'2[=K[P?\ !OQ-<7=W<W7AW4=,
MU*"PM[*\M[<WGVB)((Y!YR1@02S><6W_ " &OHG]FK_@I'I?QR^+'AOPCJFE
M:#HNI>-M'GUO05TSQ7:ZX[1P"-I;>[2%5-M<+'*C[?WB$;P)"4(J']HW_@H3
MK7P/^)WQ'T'2?AK/XHL?A9X2M?&>MZ@VNQV6^TE-SNA@C,3F2X5;9V"L55L@
M%U.,@CR'P7_P2)\0?#6RTO1=&_X5U)9^$]4NM9T77K]M0NM2GDW32V<<EH[&
MUMWCEE7=<Q;F*Q_+&K,37M>N?L0:IX.T#X-:MX#U;2K/QM\&].ETN%M4CD;3
M]>M;F&..]AG*?/&TDD23+*H8JZ\JP8BJ%A_P4:OK)]>AU[X:ZII]Y:^#+?QW
MHUK::M!=2:GI\TX@"S,PC2UE1V1I 6=$0LV]MI%<;=?\%@[>UT[Q):VO@S2_
M$GB30=3\/:?#:^'O%*WVGWZZQ=M:0NMXUO& T4B-YB^61C!5FS0/4ZKXI_LA
M?%G]H>'4-<\5>-]"T?7M+U'2-6\'Z!IB2W6@:1=:?=?:1-<O(D<UQ).28W8*
M@C0+M4L,G'\3_L%?$'XN_'G3?BAXJUCPAI_B.W\1>';@Z9I;W$UG::5I4EU,
MR+-)&CRW,LMTQRT:(JJ!SR3S>I?\%$?$WPO_ &]/$/PSUC3UUCQMXHT;0#X4
M\!VFJ1_9H;A_MKW]P;YH4(@2*)'9V0D[ J1DFO6O^"B?QJ\9?!?P7\++SP7#
M=76L:U\1M%T>YTVUFBC_ +3MY_.$ELTLBD)&VT%G !"J2/0@M3G?%O[!7B;7
MO"OQ.L(M:T&.3QQ\5-+\>6C.)=L%I:RZ:[PR?+_K6%E)C&5^9<GKANB_L"^)
MM,\*^#-/;6M":3PS\8[[XC7#*)=LME/<WLRP+\O^N"W* Y^7*MSTJXW_  4;
MO8_B&WPS;P!)_P +F_ML:0OAQ-;5M/,!LOMHU WWE BU\C.3Y'F"0;/+[UD^
M+?\ @K'I?PH\/W&L>.O!>J^'='\,>(+GPGXSN8;P7W_"-:F(8YK)55(P;B"\
M$D:13#9B26-612W /4YGXB_\$LM:\5?$*[\8&Z\+ZUJD'CW6_$EGI-_>7UE9
MW>GZE:VD+0RW%O\ O8;B-K4.&170@E2#G(ZS]F#_ ()YZO\  7XW>#_&$EQX
M/M8]-T_Q NK6.CV\\2-=:E<VDL?EM(6>81QVVQYIF\R0X; S@>\^"-9\2?&?
M]GZSOM6TN^^&_B7Q'I9E:S2Z2\NM!DD4^7E]@1I4!4LNT@-E?F R<#]B#XZZ
MA^T3^S;H?B#6HXX?$%O-=Z/K*Q#;&;ZRN9;2X9!V5I(68#L& H$>)_ ;_@G_
M .//@1XB\-WUOJ?@?5OL_A/7_#&J17\-Q);@7NK2:C;RI&%'GJ-XCEC=H\C)
M5CTK4_9C_8R\<?LY?$?7/$VBVO@;PMI]YHT>G1>"]"UG4&\/WMYYZN^H,)HC
M]D=8]R)%!$P(;YF/!'D/_!97P/XF^._[8?[+?PNT7XG?$/X7Z;XZN?$*:E?^
M$M6DL;F7R+:VEC#!2%?#9 W X#-CK6>?^#?OQ$?^;T/VL/\ PJO_ *U!6I]?
M?M]?!K5?C]^R#XT\,Z$JR:]-;PW^F1,<+/=6EQ%=PQ$^CR0*F?\ :KQ?XG?L
M>^(_VL- ^-GBK2[ZQT.'XZ_#_1]$TRRU6">&ZT>X@%RT@NDV9&#.%PN3E&XZ
M5SO_  0;?Q%HWP@^,WA?Q%XV\7?$"3P+\5]9\.V6K^)-0DO;Z:VMTMU3<SL=
MO<[5PH+' YK[NH%L>+_MT>'=!US]C'QMH?B:/5)K'4-':RC&F6,U[>?:B +9
MH8XE9S()Q&5.  0"2 "1X;^S[^PY\3/ 'PU^#WQ 74=!N/C5HZ:IJ?C"WUOS
M(;+6[C6!%)=QM+"LC0R0M#;JC*CC$)4C!R/MJB@1\:^ OV _B-\'OBSI?Q.T
M77/!>L>/-0OO$%YXDL[\7-KI?_$UDM9!]E=$DD_T?[)"H#J/-&XDQD\>@? O
M]D3Q)\,O^"=E[\(=6UK1]0\47FBZSI\FIVT4D=E)/?273K)L.751YZY')&"!
MG@GZ*HH ^6O$O[ &I>.],^%NDZMK&GKI'A'X:ZKX"ULV_F>=</>V5G;>=;Y&
M-J_9W/SX/S+QUKE/$7_!/KXD_&[PCX2\-^/O$G@VWTWX;^&-3T/1;O18;AKC
M5[JZTY].CN[I)%58%CA=F,,;2;G;.\  5]H44 ?"VM_\$Q_%FIZ]X<\536OP
M]UOQ-'X)L?!^KV-]JVJV^GV\ECY@M[VWEMPDD@99#YD$B*#A=LB\DS2_\$UO
MB'\&OA)X_P#!?PKUOX>VVF_$[PC;Z%J;ZG8SV<>CWT5D]H]U:6\ =6AE1@?)
M9E\MAD,V2#]QT4#NSG?A9X3F\ _##PYH-Q)'--HNEVMA(\>=CM%$J$KGG!*\
M9YKXM^+G_!+[X@?$/Q?X@O/[1^'^L7FH>/+3Q;:>)M<>\N-8@L8+Z&Y32HXM
MABME1(S&LL3<KC,8+,U?>E% CY1\/?L&^)]&^"O@[PU)K6@M>>&_BT_Q GE4
M2^5+9G5+F\\A?ESYVR95Y&W<#SBN;_X)W_L^RV?[3_Q;^(D7]I_\(#_:5SIW
MP^M;_3Y+%K."\E6^U9XHY0KB*2^)"$J,K&<?+@G[2HH ^8%_X)N>&_B]\8OB
M=XS^+VGZ;XMOO&5XFGZ5#;7EW#%8Z## L<-I(%9-S,[7$L@^9=TW!-<U\'OV
M(OBM\ [?X=ZUH_B'P=X@\5_#_1-2\$>7JLMU'::GH$EVDU@S2K&TD=U D,*L
M C))\PW+PP^Q** /B/\ 9^_X)_\ Q<_9BTZQUKP_XD\ ZMXTU;0;W0?$AOH[
MJ'3V:34[R^MKVVVHS[H_MDBM X"OQ^\7&3O?LE_\$Y==^#GAW7-)\6:[I&I6
MOB#X8:/X"NY-+61)/.M4O4N)UWJ $870*#)(P<]L_7U% 'PO\"_^"6>O?"ZY
M\,)<Z?\ "6;_ (0'1+K3M,OKBWU'5GUV=[4VL4MQ;7$@CLXS&S>:ENSF3<5#
M(GRU:\(_\$WO%/AVT\61PZ'\)[/PSK^GV=BWP[DN]2U+PM=S1W#2RWP\U5:R
MN"I5(_(B94V[B'."/MZB@#PS]AO]FKQ!^S+X,\1:?K6K1S6FL:PU_I6AVNH7
M6HV/A>V,:)]DM[BZQ-(A96D.X*%,A"J *XKP=^RY\8OV??A=K7PU^&?B3P3:
M^#KN[O9- UG4X[DZOX4@NYI)GC6!%,5VT+RR&)GDBXV!@VWGZHHH ^4]7_8*
M\37'A#]H72_^$JM=4N/B[X6T[0=-U#4B[70FMM):Q>XO"J@%I)&WGRP>">!T
MKR/XU?\ !*#X@_$K0O&6G?VG\.]<O_$%]I]YIGB77WO9]0T.VMOLI_LVWMPI
MAAC#6[A)XR& E8F-FYK]"** /E;XJ?L*>)O'?@7]I;2[76-#M[CXV7=K<Z2\
MGF[-/$5A:VS"?"YY>!B-F?E8=\BOGCXK^"/&VFPZ]\"?!-N^H:1K'Q/L]>:*
M]\/:E!?P6S:K!?W@$[1?8VM599)$NO/WE<)Y1;!K],** /A/X=?\$E;KX?\
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MF4Y.T\9J:)^PUXTG_:BT'X@-#\/? 5U9ZX^KZ]J?@V[U"&X\5P-'(OV*[LG
MMVW,R%[AF=V,>Y50L0/KNB@ HHHH **** /%?'?[1?PW\-_$^Z\#^)-%NK5-
M>N&%SJ%_H971]1NH;47!C>=UVRRK;Q*V2" (@N[*X'FEK^W9\+?%/Q-O/$%]
M\/M6:^T>+1[?0]5N/#+/KFI2ZFUV+>.VC:/S1$Z6^Y7#@$2'<%P<[OCK_@FE
MX;^(O[0\_C[5O$&J77VC4FU%K&2SMGD(DL9+*2V^UE#<"U,<A985<*CY8=35
MSP!_P3^C\+>);'5=6\?^*/$UUI-UHTED;N"VC$$&EBZ6W@_=H-VY;IM[GYF*
M@\9- $.F_M[?#+QKX+\5:]H^GW09-+M+^Z?5M$FLUUBSEN#9@Y\MGE6.7S(6
M!4[6!&-IS7-^'OCO\ O!/C2;0_#7P\T/P_?7VNIX>2Z?P<-.LM7EMM4BM)T@
MFCA(F-O<%&Z!0P5L@ L.NE_X)WZ#+X/DT8^(M<\F3P^GA[S-D.X1+J1U#S/N
MXW[SL]-O;/-6O$_[ NA^)]3\'73^(-<A?P;XDU'Q+;B-8OW\MYJ<>HO&WR\*
MLD812,':3DD\T 8NH?\ !0CP;J][X9UKPWX2\3>(I-<\3VO@^+4TT@Q[8+IY
M@;B*9A\\ DM&W*"""@+*/ES'XZ_;*^$'C/X>:AXBU[P3K_B#PN;F>UO+Z[\'
MM=6DD%C,4EN7:12IMX9F<!CSG>54@$T:+_P3ATWPWXHU'Q$?&>I)JTVOZ?X@
M6ZBTRRLXPUE+-(#<1Q1K'<2ND\D;W#CS"H3D%<UB_$#_ ()H>#_V@/A7HF@V
MOCB^N-%TFSU;36DC@LM2C87\[7#2Q"1'C@N8V<!9D&\(2O\ $30!/<_MC_"V
M'XC>*KC7?AMJ$>M>"=8;1[*_A\,K?75U86EK:7K7\;HA>.U@^TQG.?ES&R@E
ML#O?AAJWP?\ C?XG\6>%] \"Z1J5CI=U;:AJEXWAF$:1?7DL$5S$ZRE-DT_D
MW$<FX D"0<YXKG?$W_!/%=1\5Z[K&D?$'Q-X>O/$ >"Y:VM+63_1I[*TM+J$
M;T/^L%E#(K_>B??MX;%=)\._A)IOP-\*_:/ ?BK2;7PW?^([2ZOI;V:.:WCL
MX+.#3VM(9!QO/V6(;F.X.7&>U &[^TU\3/!'@'PMI^C^,/#L_BV'Q!*T5IH%
MKHG]KRWHA0RR.+?:04B1=Q)'' &20#Y_J5U\)/VW+K4/A[I-OK4^FVNGZ;K=
MYJ.C69LM/FAE@5[*)KC: S&%E94 RBK_  X KO?V@?@Y;_%J'P[XFTSQK=>"
M=8\/F7^SM=LA;SQF&[0121E9@T;K("A4]0ZH1GH9OV=?V6-!_9E.IP^'[K4)
M++4+73K-(+IE?[.EE:K;(=P +,ZKN8GJQ.,#B@#F?^%N?"C]GWQGHOPWL=#D
ML_['EL8$FL]&::PT:YN$^SV23W &([B=0(D))8[E!(##/E>B?\%$_ _CS4/!
M'BKQ;\+=6L7FT74M:AU&YT@7U]X;BM=12REF8B,M#;D/YAE## !&T\FO4_B#
M^RYH7CKXDW?C+_A.+[3?#-]J&G:EXATF&2W-AJ=WI<RO;.\S O#LDBC$BHP#
M^2JG&#G*TG_@GAH^F^!]2T&3Q1KES:7WAK5_"L3&*!7MK/4+S[4<87YGC/R*
MQZ@_-D\T#T,KQ!^UK\ ;[P;KTFH>'K6\T'P_8,\ D\+">WUNSCO8X)/L";"+
MB-+R2)2%& [JP!!#5UW[0_C7PG\#?V6+KXG'X8IJS>!]/?7M)T4:-#'?V,[X
M<[%*G[/)O;,C+ROS'YB,'AO!?_!*#P7X$L->L=-U)K/3]4C6&T6WT73X+NSC
M^W17KK)=)")[C,D*J#*QVIQ@D CWWX[?"6U^/7P=\2>#;Z[NK"S\26,EC-<6
MX4RPJXP67<",CW% CYC^*7QG^&(^$^K:?XH\$W%KJEOJPN]4\,>%;*X$FHSV
MEG!J<WVT1PQF2VC:Y4R%@RDL,AF+)7J>G_M0_#GXU?#728_%6EVMQ%JUWI-C
M=Z;?V O;.WO;VPCU"%"778R+'(#YA  ([&JWQ-_8/M?&OB;7M>TCQGXB\*^(
M/$%_=W$]]90V\K);7=C;6<]J%D0KM*VL<BN?F1\D$CBLD?\ !/+1] UO2;Z;
MQSX@3PQHDFFZC>Z1-';+:WUQI^FC3UFEE*;U1K95+HK!=R[ACI0 >%_VC/A/
MXO\ $?@V\T_P1]C43W+Z'?:EX1EM93;FSN;XW6G-Y!W)*(9&^4JS$G@LRAJ%
MM^U7\*_BO^TGX1DGT?XA3?$#27GL=+T.ZTJXC.EB6%)'OY+?/EQ[H) !,_S!
M&9< DBMJP_8);4/#&BZ7JGQ-\::MIOAN":ST(1BVM7TVTDT^XL459(HPSRK'
M<$^<3N8HO;.<G]EO_@G+X7_9P^.$GBK3_%DVJ:W:626UUI\&GV5A;1[H1$LA
MAMT4HSK&&).2[!F).30!WGPQ\2?"/XZRWECHOAO0[Y?%VFQ>(]42;08UCO$^
MT201M=ADPTPEAF 63+ Q.>U'QB_:)^'O[).NZ;IU[H>H6]U?Z7<7W_$BT!KA
M;+3K21#//,8EQ'!$USO.>F]B 3FL/]FK]F;Q7\%_&.O:V]YHMC_PFGBN^UG6
M-/AD>[CM+ Q.MI9VTC(A&V9FG;Y5 :>4 $8)=^U7^S)J7QH^)>FZTWCA_!/A
M6W\+ZIX>UQX!$9KZ"]FM"T69D*1J8X9!YH(=69=N<G !EWG[;/P[T";7)-:\
M/9DLO$5_#:C2[#^TI;NW@L[9[C5G"H/+C$-TJNY).T@9;.!I:;\=O@U\+_'V
MD^';#PS;Z':Z@!<:;K%IX:%OH]S*EH]XJPW"H%:06\DK@J",.X#;BPKCOB!_
MP34^'/Q1URXT^U\06*ZYI%]<7C6USIVG:PVFVMY;VT)@-M<QR!,K9QM'*R[P
M=W+ XK9D_P"":.@I\?=-\=P^)]8MYM'OHK^QA2QL_M%L4T]K'R5NC$95MPC;
MUA4K&DF2!@D4 ._X:]^#?BOX4VE\W@_4M0TWQ(!I=EH[>$_.GU>T2(WFZ*':
M5EM5B8RY!*J200'.T^C76E?#'6OAUIOQ \G16\(6/AJ8P7,<0&GR:/-&DK(T
M(&QX=L:,$*G&. "2#XE/_P $AO"M[HK?:M=6[UQ=5;4X;J;PUICZ?$7MA;2#
M^SC#]E\QU =Y0@=I 'SQBOH+5O@9I,G[.DOPZ6W:ZT8:$=#2+<EJ9(Q#Y2\Q
MH$C/ .4CPIY"X&* /#O"W[5/PELO$6EZEHOA?6M!N/":C1HM+N=!N--;3;:[
MLKG40UK:K'L+2Q61;(V_* I(;Y38^._QJ^ 7CVUUBSUCP[_PE&I>)+""VGET
MC0#<:I=VTUC]J#1S(OF8BM)%D+!@8UE3'+ &']FW]B'QCIWBB3Q5\4/%']J>
M((=:L+^T@M98[F,6]GIUW81Q2R>1"K;UO)7;;&OS ')W$5'JO_!)CP3<_#31
M]"AU6ZFOM#UC4-4M-1U?2[+6,)>95K=H+B)HF2*$111';NC6"/DX.0#2_:K3
MX5_#;]D?3_B5IOP[TWQUX=\*0C7/#VB:39QK8ZC)?1B!)FA"^6R,MP&+LC$9
MW %@*V/$7[2'@"ST.'Q5J7AC3[CQQX;DO=$ME?3?WMEJ%MIC:A/:17+Q[XXO
M+4C>  3QMSQ79?%+X%^&_$?[-[?#.[U?^Q='ATF&W6X4P0RQ6UH86,@7:L:J
M-B;B%"+NZ+Q7$^+/V!-/\<_$C5->7QMXBAT/6+Z]UE=%ABMVM4O+W3&TZ:<2
M%#(RF)@ZH6VJX)Y#8H UOV,];\(?'/X3V?C[3_AWX:\*WUU?79V6=G \RR),
MR-()5C0EG*Y)QG)ZGK7A_@']L;P'K^A^'=4_X4SJEQ=:IXTM4@L+W3_M5UH5
MSJ.I7]HU_%YB%8HV?3VD_=,#N+Y"X!;ZD_9J^ %C^S+\)[/PCINH7VJ6MG//
M.MQ=A!*QED:0@[0!P6P..E>5^&O^"<NG>%K>06OC/7C-#K&G:KILKVMN?[/6
MRU*^OXX<;,2*S:A/&6;YMNT@@C- %3X ?MH?#G6/&5Y']@U#2_$GB_77LM7N
M=LEY8VUZ)Y;.SM9;H@*CS); QQ8POF8ZL-WIWQY?P-\./AVIUSP,OB;3;A4T
MN/2M.\.KJ3S1+F41>4%VB)=A?YL("!W(SY5X _X)5^"_AO\ &>Q\96.H--<Q
M:H=:NUN]%T^YN+FZ%Q+-&T=U)"TUNH,H4K$R[A&IR#DGU+]J?]F"S_:B\,:/
MIMYJT^EIHVI+J.PVD-]:7F$=#'/;3JT4JX<LNX'8ZJPY% '+>#OVL?A)\1O$
MFA>&=#TN75H_&FAV<Q:VT R6<5E,)EMH;O"_NT/ESJ%==BD,"5SSI_M >*_A
M7^SSX6\(Z9K_ (/T^\M6OV3P]HVF^'H[QK>:*-YGDMX%7"&-%9\H-W]T$G%<
M-X/_ .";WA[P7K_PLM5\::E<Q_"^UB.G6\UE9+J$ZP2.0RW*1K/'$QF598XR
M(Y,*"!DY],_:V_9A@_:M^'T/AVZUIM*M%E9Y5;2[348IU9&3_5W",$D7=NCE
M0JZ,,@GI0!E7_P"T!\)I;*2&^M;&.P35-0\/RM=Z/M@BE6S.I7BN&3Y8WA7>
MY(P[C!!:N9\>?MT>%;KP-X4UA? ?BS6+'5/%%II5O8WWA^6*^#26TUU;7EK
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M\#%;5]^P?I;W.CW5GXFUJSOM#_X1O[+-Y4,@']C"Y6/<K+@^<EU*K^G!7!%
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MW^R-IWQ3_:0\+_$R;Q%=8\.M%=6=K!96OF%ECD4*EZ$^T"W<2;G@WF.0@'%
M'D/P[_;0^"OQ*\!+<:U\,OL.N>(H9%AT)?"JWDOB57O9%E6T/E 72^?&7D)
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M.O%DWB#4M)\2>*K71?[(U*TMHOM7A6]TJ2>6VO+:0\EBTQ#HWRLN5/#&NO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAZ7>?"?P_J7C"^UFWCT+^WK:\M](19+.:\:5)KRR27SHHX"C>5$06="KE<D
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M'IOB/4/#\5W=>*=1U35TM)&@BU:[L5-JL5LD<DFVV>3#)$H 5<ECFN7\&_\
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MQ%X''Q#T34KCQ)?:;I?B:2/P]<:]=37D\MD]E:R_+/*2\L8N'G4$DXP5!PH
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MA?#6S\*6FAQ^#]+_ ++L;:YM(HFWN3'<S03S[G+%G:26V@=F<EB8ER:],HH
M\SUC]D3X:Z_J>CW5YX1TN:XT&YGN[-OG7:\URUU+O 8"5&N':79(&0.<@ TW
M0?V0?AGX:O-2EL?".FPR:K=07DX#2,HD@N!<Q>6I8B)%G42;(PJ;QD@FO3J*
M ,W0_#=IX=:\:TCDC;4+E[R??.\FZ5L D;B=HX'RKA1V%:5%>4?MN?M7Z'^P
M]^ROXT^*GB*&:[TWP?8&Z^RPL%DO)2P2*%2> 7D9%R>F<T >KT5^6OAC]KC_
M (*.3^$?#/Q>;X1_"OQ%X%\32VURO@/2KB9?$5K8W!79(978)N",&/)QU90
M<>D?MK?\%(?C7KG[7VC_ +.?[-?@WPW=?$O^P(O$?BC5?%4Q_L_PK;RA3'&Z
MQ'YG^9<D%@=ZA03D@'8_0*BOSK_9E_X*1_'CX5_M<2_L]_M->&/!MGXXU[P[
M=^(/!_B7PL\ATO6A;QN\D3QR'<I&QL?=.5P1\P-<5_P2=_X+<>,?VP/@-\6M
M-^(4.BZ;\5O!>BZCXE\/RV]BUM9ZYIL2RJDJ1,YWF&:/9)M;D,#QS0%F?J31
M7Y3W7[:'[:GQ<_X)J?#W]H3X=ZU\%;/2H? UYXC\90ZSIEP+F>XMWF<_9(T)
M4+Y,8 5G&6[@&K7[)G[9_P"V9XM_89\3_M#^/M9^#-QX"O/AW>^)/#-KI6F7
M$>IPWRKN@-S&Q\LQ@*^Y5D)Z<T#Y3]3J*_$-?^"K?[;7@7]C;3_V@]8\;?LK
MZQX/.GPZO+X;22:VUR>%W"^3Y6_Y9>>55B0/7&*^I_VIO^"LWQ0\1>(?@G\+
M_P!GWP)I.I?&+XS>%(/&4Z>(IF2P\*:=)&&\R8*06;<''/&%Z%F I70<I^BM
M%?G-\ /^"AW[1G[-O[:W@;X(_M6>&_ <W_"V$G3PEXN\&O*ME-=Q+N:UECDY
M!Q@9PI!9>H.1ZI_P1R_;8\=?MN?#'XGZMX\DT:2\\)_$#5/#=A_9UF;51:6[
M*(PX+MN?DY;C/H*8K'V+17#_ +2'CG4/AC^S[XY\2Z3Y/]J>'] OM1M#,GF1
MB6*!Y$W+D97<HR,C(K\X/V'/^"Y'C;]I/_@EQ\9/%FO0Z'I/QV^%7AJX\0I#
M_9[1V.IV<D32V=\D!?+1$@HP#8RH.1NP 1^J]%?G#X$_X*=_%3Q%^TA^Q;X7
MN)O#?]D_'3P9/KGBH#32LKW*0;P;=O,_=+N_A(;ZUZ1\5/VZ?'WA/_@L3H_P
M1LY-$'@6_P#AM?>*)4DL2UY]MB+A")=^/+^497;SZT#LS[6HK\E?^"2G_!<G
MXB_M Z/\<)OC=_PC,*^!?"EQXUT&?3=/-DMQI]M)<PSA@9'WD20KR,8_&O+_
M ("?\%U_VDO&/_!/3]ICXC>)E\$V?C3X6R^'6T*&/0V2""/4'E,@FC,Q,AV*
MF#E<=><TKH?*S]NJ*_'6[_X*A_MA_LNW7PO\6?$;7/V</B7X1\?:[INCMX?\
M&W$O_"0*+W&&6//WD!R<!@" #P<UZ'^V/^WE^U%>_P#!43QM\$_@WXN^!OA/
M1/"OAO3]=$_CN%X1)YZJ'1)E<[WW,"%VC !YHN@Y3]1Z*_,3XX_MJ?M5?L@_
M\$POBE\4/'?B[X%>*O&VBZM86_A^Z\(02WFF00R2(DR7"LRYD^<$8;@'->3>
M/_\ @JC^V%^QCHW@7QY\3/$G[,OQ$\%^)M7L-.N-!\)7<HUS9=8Y1"WWE![!
M@&P#P<T70<I^RE%0VMQ]JM8Y-K+YBAL,.1D9YJ:F2%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M $/.E_\ ?N;_ .(H_P"&]?A#_P!#SI?_ '[F_P#B* NSY/\ V5?@AXP\,_\
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M!_PK\0^/+[X+>%O['\4>$+>(PZS!'-;HORPL-^X?." I*L%R,$D=G^RKX?\
MC%^W3_P5)U[]HSQ3\%_%_P &_!?AGX=77A72M/\ $R>7JFJ74I)XBP#CYG.0
M,#"C))./O/\ X;U^$/\ T/.E_P#?N;_XBC_AO7X0_P#0\Z7_ -^YO_B*7*@N
MS\)_&/\ P3@^/ _8P^ [^%/AYX\TWQ-XNNO$?P[\:6?]B7"7-IH][JZW,<UR
MNW,4)56'F, NUCZU[C^T5^Q/\1M*^#/_  4/\.^'/AKXVNK7Q!K7A&W\(PVV
MBSR'7K:TC:-WM J_OE10-Q3(&>:_6?\ X;U^$/\ T/.E_P#?N;_XBC_AO7X0
M_P#0\Z7_ -^YO_B*.5!=GX2R_LCW^O:7X*M?V=_V'_C]\$_CIINHZ?+;^/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P $[OV%_P!L#Q'\1=-UCX%^&?B1X)DOFS_PD*M-H>F!<C)EE?:CKZKM=B.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP/PKO** ."C^&OBH1A?^%A:FS8P3_9MKUP.?N_C^-//PX\59_P"1_P!2[_\
M,-M>/_'?\YKNJ* .#_X5KXK^7_BX.I?+U_XEEKSQC^[Z\_A3C\./%.T_\7 U
M+V/]FVO''^[^-=U10!P9^&WBHR+_ ,5_J0 SQ_9MKSTQ_#VP?SI5^&WBH=?B
M!J3<D_\ (-M>.O'W?I^5=W10!PA^&_BH_P#-0-2_\%MKZ8_N^O-'_"MO%>/^
M2@:E][/_ "#+7IG./N^G%=W10!P@^&WBH8_XN!J7;_F&VO/_ ([_ )Q2'X:^
M*CM_XN!J7!&?^);:\\?[OXUWE% '"+\-O%0D+?\ "?ZEU&!_9MKQZ_P]Z5?A
MOXJ&/^*_U(],_P#$MM>?_'?\XKNJ* .!?X:^+"KK_P +"U)6;H?[,M?EX _N
M^O/XU)_PK?Q5_P!#_J77_H&VOKG^[^%=U10!P;_#7Q4R$#X@:FIQU_LVUX_\
M=_SB@_#;Q5O_ .2@:ETQC^S;7KQS]W_.:[RB@#A?^%<>*O\ H?\ 4O\ P6VO
MKG^[Z<4T?#?Q4'S_ ,+ U+&,8_LVU]3_ +/N!^%=Y10!PB_#?Q4(U7_A8.I$
M@8S_ &9:\]/]G_.:7_A7/BG/_(_ZE]/[-M?7_=_"NZHH X,?#7Q8 O\ Q<+4
MLJ.3_9EK\W!']WUY_"G'X;^*B#_Q7^I?^"VUXX_W:[JB@#A#\-O%1<'_ (6!
MJ8'/']FVO.>G\/:E7X;>*AG_ (N!J1Y)'_$MM>/_ !VNZHH X7_A7'BK'_)0
M-2[_ /,-M?3_ '?QIO\ PK7Q5_T4#4_O[O\ D&VO3.<?=].*^$_C+_P65^,7
M@KXA?M 2>'/AA\*]2\#_ +/VJ26>JW.K^.7TO5M1BCA$S-;V[6[(SE<@*9!E
ML 9)Q7N?[)'_  4PF_:P_:SE\"6?A5=)\/S?#31_B%9WT]RQO2;]E'V:2+;M
M78&^\&.<=,&@=CWO_A7'BK'_ "4#4NW_ ##;7T_W?QI#\-O%1Q_Q<#4NH/\
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MU @JOEGS(A\HW##CG@T!9GTJGPV\5*@!^(.I,?7^S;7GI_L_YS3O^%<^*O\
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MN1\./%0/_(_:EV_YAMK_ /$_YQ0/AMXJ#@_\+ U+&W&/[-M>3Z_=KP_]HO\
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ML\(WD+WGQ!7QVG]K!Q,6-ZL7V,YE1&X7S.=HY&>/J+_@H_\ L]?&;Q)^V-\
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M'P&_:7\$VVN6^AZE\.OA'X>\7>%/#6M-K*/?ZAI^H.\E@)H0@VNNXJW89XX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+P?_ .&^;_Y84 >T45XO_P *K^.7_18O!_\ X;YO_EA1_P *K^.7_18O!_\
MX;YO_EA0![117B__  JOXY?]%B\'_P#AOF_^6%'_  JOXY?]%B\'_P#AOF_^
M6% 'M%%>+_\ "J_CE_T6+P?_ .&^;_Y84?\ "J_CE_T6+P?_ .&^;_Y84 >T
M45XO_P *K^.7_18O!_\ X;YO_EA1_P *K^.7_18O!_\ X;YO_EA0![117B__
M  JOXY?]%B\'_P#AOF_^6%'_  JOXY?]%B\'_P#AOF_^6% 'M%%>+_\ "J_C
ME_T6+P?_ .&^;_Y84?\ "J_CE_T6+P?_ .&^;_Y84 >T45XO_P *K^.7_18O
M!_\ X;YO_EA1_P *K^.7_18O!_\ X;YO_EA0![117B__  JOXY?]%B\'_P#A
MOF_^6%'_  JOXY?]%B\'_P#AOF_^6% 'M%%>+_\ "J_CE_T6+P?_ .&^;_Y8
M4?\ "J_CE_T6+P?_ .&^;_Y84 >T45XO_P *K^.7_18O!_\ X;YO_EA1_P *
MK^.7_18O!_\ X;YO_EA0![117B__  JOXY?]%B\'_P#AOF_^6%'_  JOXY?]
M%B\'_P#AOF_^6% 'M%%>+_\ "J_CE_T6+P?_ .&^;_Y84?\ "J_CE_T6+P?_
M .&^;_Y84 >T45XO_P *K^.7_18O!_\ X;YO_EA1_P *K^.7_18O!_\ X;YO
M_EA0![117B__  JOXY?]%B\'_P#AOF_^6%'_  JOXY?]%B\'_P#AOF_^6% '
MM%%>+_\ "J_CE_T6+P?_ .&^;_Y84?\ "J_CE_T6+P?_ .&^;_Y84 >T45X#
MXX\$_'3PKX+UC5$^+W@V233;*:Z5#X ;#F.-F /_ !,.^*]-^ /CF\^)WP*\
M%>)-16%-0\1:#8ZG<K I6)99K>.1PH))"[F. 23CN: .QHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /$_V'QCPU\1O^RC^(_P#TODJ3_@H?
MXMU/P'^PI\7M8T>\GTW5--\):E/:W4#;9+>06[X=3U##J".AIG[$'_(M_$;_
M +*/XC_]+Y*J?\%/_P#E';\:O^Q.U+_TG>@#^1_3?$GCW6[*.ZCU3QQ>K<#?
MYZ7=Y*)3W.X,<G.<G/6O4/AI?>'SKFC?\)E>?M%+IO\ 9DG]KG12&G%_YA\O
M[/YKA3;^7C<7P^[.!BOZ&/\ @V]LH9O^"-WPA9XHV;RM0Y* G_D(7%?<W]FP
M?\\8O^^!0:<Q_(-\?+[PNNEZ;_PJR^_:.DOO-;[?_P )852$1X^7ROLSD[MW
M7=QBO,&U+X@1@EKKQT%49),UY@#\Z_M)_LZW_P"?>+_O@5S?QDT^W'PA\5?N
M8?\ D#W?\ _YX/03S'QQ_P &W'C+5O&W_!)7P'<:SJFH:M=6]]J5M'/>7#3R
MK&MW)M3>Q+$+G !/ P.@K[RK\_\ _@V2_P"42'@__L,ZO_Z6R5^@%!(4444
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MX<_'S_@G5XT^%'_!5#X)_ 6U_:J_:6N= ^*^BZOJ]]J<OBV7[;8/:1R21I"
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M8#^!G,DKA#T(0H2.XK]1O O@;1_A?X-TOP]X?TVSTC0]&MDL[&QM8Q'#:PH
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MQ5^PV%YJUXFEQO!96D9DGO'6YA*Q(H!)9B HP.IH#J=;^VG^V?X7_8D^$O\
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M\/4?VJO^BW?%C_P/D_\ B:_K@_X1K3/^@?8_]^%_PH_X1K3/^@?8_P#?A?\
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M_P#1+USG['?_ ":/\+?^Q0TG_P!(H: /1Z*** "BBB@ HHHH **** "BBB@
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M0!X[_P ,*^ _^>WCC_PLM6_^2*/^&%? ?_/;QQ_X66K?_)%>Q44 >._\,*^
M_P#GMXX_\++5O_DBC_AA7P'_ ,]O''_A9:M_\D5[%10!X[_PPKX#_P">WCC_
M ,++5O\ Y(H_X85\!_\ /;QQ_P"%EJW_ ,D5[%10!X[_ ,,*^ _^>WCC_P +
M+5O_ )(H_P"&%? ?_/;QQ_X66K?_ "17L5% 'CO_  PKX#_Y[>./_"RU;_Y(
MH_X85\!_\]O''_A9:M_\D5[%10!X[_PPKX#_ .>WCC_PLM6_^2*/^&%? ?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 <]\4_&K?#?X8^(O$0MOMG]@:7<ZD+??Y?G^3$TFS=@[<[
M<9P<9Z&OR"^'7_!U!\2_BOX9?6O#/['_ (O\1:/"QCGOM(U:[OK>%P 65I(]
M/*A@""02" 17ZQ?M2'_C&CXB?]BQJ7_I++7\_/\ P13_ &Y_VM/V;?V0K[PY
M\"?V=X_BIX4NM=N+J377BN'6WO'BB#P_)(J_(%0XZ_-R>E*6Q4=C]5/V(?\
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MF_L:?%;X9_#GX>^#5^,GQ&^)SPRV.CV.K"T2"VG(6WF:412Y\UCE1@?(K-G
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MQ#_P2<\7:CKUO8OJVBZEITN@33*/-CNGNHXW6,]?F@:;*CJ%R>E/4--CL?\
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M,/\ A;VL2:4UPVK_ &'^RML]I%OV^5)YF?M6<97[F,\\<#^W?_P7LT7]@?\
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M&O\ P29_X9O^*AFL?B]\!OB)8:6T-T3YU_ID8GC1@3RQA.$)[H8V]37Z??\
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M?"7P_KERML-7NY9F\@$@&3RI[6 NB9!;8Q('.#TKZ?\ ^"@?_!70?L2_M._
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M?\'A.HY_Z$EAU[?V4E2?\'87_(R_LE_]CO<_^AV%+4-+GV]_P4Y_X*W?#?\
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M-#XD?\$\_$'QRNO'\_AB:/XB>(8]4TK^R+Z2Y*PJ]R3YN^)-K?O5X&[OS7Z
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MO7TU\;/VA? O[-GA#^WOB!XO\.^#=%:00K>:Q?QVD3N>BJ7(W-[#)H [2BN
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M1?B-X-\/^,M+MI?/@@U2S6<6\G]]"1E&]U(S2U'S'Y"?\%'[;0=,\;_ML_\
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MX?B9'I<MK;_!S3G^'4>L*AMC.;F0:JUN)/E,X46P;'S!/;-?5]I^P=\&]/\
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M2\+Z+<W/P]N3=^&F-LJ_V)*8C#NMP,!/W9*<#&#BK1^#'A0_&)?B!_8.F_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@/\ [_2__$4?\/W/V0O^B^> _P#O]+_\10!];45\D_\ #]S]D+_HOG@/_O\
M2_\ Q%'_  _<_9"_Z+YX#_[_ $O_ ,10!];45\D_\/W/V0O^B^> _P#O]+_\
M11_P_<_9"_Z+YX#_ ._TO_Q% 'UM17R3_P /W/V0O^B^> _^_P!+_P#$4?\
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M/_INMZ /4/\ A$=)_P"@7I__ (#)_A1_PB.D_P#0+T__ ,!D_P *T** ,_\
MX1'2?^@7I_\ X#)_A1_PB.D_] O3_P#P&3_"M"B@#/\ ^$1TG_H%Z?\ ^ R?
MX4?\(CI/_0+T_P#\!D_PK0HH S_^$1TG_H%Z?_X#)_A1_P (CI/_ $"]/_\
M 9/\*T** ,__ (1'2?\ H%Z?_P" R?X4?\(CI/\ T"]/_P# 9/\ "M"B@#/_
M .$1TG_H%Z?_ . R?X4?\(CI/_0+T_\ \!D_PK0HH S_ /A$=)_Z!>G_ /@,
MG^%'_"(Z3_T"]/\ _ 9/\*T** ,__A$=)_Z!>G_^ R?X4?\ "(Z3_P! O3__
M  &3_"M"B@#/_P"$1TG_ *!>G_\ @,G^%'_"(Z3_ - O3_\ P&3_  K0HH S
M_P#A$=)_Z!>G_P#@,G^%'_"(Z3_T"]/_ / 9/\*T** ,_P#X1'2?^@7I_P#X
M#)_A1_PB.D_] O3_ /P&3_"M"B@#/_X1'2?^@7I__@,G^%'_  B.D_\ 0+T_
M_P !D_PK0HH S_\ A$=)_P"@7I__ (#)_A1_PB.D_P#0+T__ ,!D_P *T**
M,_\ X1'2?^@7I_\ X#)_A1_PB.D_] O3_P#P&3_"M"B@#/\ ^$1TG_H%Z?\
M^ R?X4?\(CI/_0+T_P#\!D_PK0HH S_^$1TG_H%Z?_X#)_A1_P (CI/_ $"]
M/_\  9/\*T** /CW_@D) EM'^TW'&JQQQ_'SQ2JJHVJHQ:< 5]A5\?\ _!(K
MK^T]_P!E^\4_^VE?8% V%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKX^^''PG_P"$=\6:/<6"6M]_PD^LW?E++=Q1./+GNWC.5<CYE.,U^W%?"?\
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M4 %%%% !1110 5\M_P#!9_\ :3'[*7_!,SXN>*HIEAU*31)-(T[YMK/<W?\
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MI842U01T9]F4445B;!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_!D"_P OQX7WTT_^C:_?Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?1A05T/T.\?_ !#T'X4^#]0\1>)=8T[0="TF(SWE_?W"V]O;(/XF=B /3W)
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MSD]4?I%1114%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]5DX%40PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /'_P#@H/\
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M(O[:'183XJM=%^V0/&[2MMF1C)M8*,CIFOEW]MKX=>!?A-^UCX^\,_#/6O\
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MQX3OX]4\.^*+&/4;"Y0_ZR-QD9]&!RI'8@CM5;DRNMC\(OV=_P#@T:^*VO\
MCC3V^*7CCP;H'AF&='OX="EFO[VZB!!:.-GCC2,L,C<<XSG!K]]_"'A/3_ G
MA32]$TNW6UTW1[2*RM(5Z111H$11]% %:E%42Y-A11102%%%% !1110 4444
M %%%% 'Q_P#\$BNO[3W_ &7[Q3_[:5]@5\?_ /!(KK^T]_V7[Q3_ .VE?8%
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M9]MN_+TW4?LT+_:%;S=[-N9CAV*\]*F[#E/T>U'_ (.#_P!C_3?^:S:'<?\
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ML;']@:;_ -#!9_\ @+<?_$4?V!IO_0P6?_@+<?\ Q%9-%!1K?V!IO_0P6?\
MX"W'_P 17[3?\&ZWP.C_ &?/V#?BM\9))HYM2^(U_'X9T2X6-XV^S09$A4.
M<&1Y#D<'RAZ5^)NB:%>>*=:L=+TZ"2ZU'5+B.SM(4&6FFD<(BCW+,!^-?TR>
M*/A99_LH?LX?"7X(Z65\GP#X?A_M H,":]D7=*__  *0R/[;ZTIJ[,ZLK1.)
M5=BX_N\5[M_P3]\,G5?C'>:D0?+TFP?![;I"%Q^6:\)K[$_X)[^$&TCX7ZEJ
M\B;6UB]Q&<<M'$-H_P#'B_Y5M+8Y8[GT!1116)L%%%% !1110 4444 %%%%
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M1RASH_GBKU#]A[_D]GX-?]CWH?\ Z<(*_<W_ (A"O@#_ -%"^,'_ (&Z?_\
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MS\P'T-</\>_V2_V4_P!NUII/B3\+8?!OB:Z'S>)/"I^QS[NFY_+&'_[:1O\
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M44 %%%% !1110 4444 %%%% !1110 4444 %>!_MB_\ !,[X(_MX:1)#\2O
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 "C;17CG_  4#\=ZS\,/V'/BUXB\/:A<Z3KFA^%-0O;"]
M@QYEK/' [)(NX$9! /((K\9?CA_P4V_:9\-_L _L0^+/!_Q \2:MX[\=3:Y<
M:U%Y<$C>*C:W$31P3KY?*^6'7";3@GOB@=KG[^T5^5?_  5%_P""I6O^-O\
M@FY\ /C%\%/&&I>$_P#A8'C?2;#4OL31F:%7+I=6,H=6P4D5E/ )V@]#4W_!
M:[X2?M)_LT?"WXK_ +07@W]JSQ9H/A;0TM[RQ\#6NA6PAME:2& QK=,S-]YR
M^2A]/>E=#Y3]3J*_++]E7X1_M)^"OV+=6_: \6?M6>+/'&GZI\+-2UJS\,W.
MA6]NNG7DNGM+!.+A6)9H' (R@#$<BOGG]@"Y^.W[9'[*_AOXA>(O^"D)^&^J
M:V)1-H&HVVE/<V?ER,@+%YHF^8+NY0<$=>M%T'*?NG17Y0_\%7_C!\8/V$?^
M"-O@'4/#?[0FJ>-O&MQXRM+.?XAV$%K#)K%I</=/M"KYL6Q5V+E2<^4#D<UX
M;^US\2/CM^PM^S7)\6M#_P""B&A_%#6=):UF3PA<6.FR-J)D9=T2K%+(S%<D
MD%5!"GD'%%T'*?NA17XW_P#!8#_@I'^T%X'^%W[''B[X9:AK'A7Q5\2K"76-
M8\-6D*-%K$J6]G<?9G216;RR&EP 0VU^N:[O_@J-_P %2O$'C?\ X)N? #XQ
M?!7QAJ?A/_A8'CC2;#4OL1C,T*N72ZL90ZM@I(K*> 3M!Z&F'*S]5:*_&']I
M7XU_&CXV_P#!:CXQ?"/2_P!K*^_9[\$^%=(L-3T][J.QDM#(]O;[H(Q.T?S,
MTC/]\GKQCI].?L9_LS_%>5OB);M^WB?C-<:QX8FTO319:9I\C^%+V61#%J0$
M$[[F4*RA&P#N//% <I^@5%?AO^T)X%_:\^ /_!1WX/\ [/+?MH^.M6?XK:9/
MJ']N_P#"/6D/]F>4TB[?(RWF9\O.=ZXSTK]9/V(?@3\0/V<_@G_PCOQ)^*VI
M_&3Q(-0GNO\ A(;_ $Z.PE\E]NR#RT9AA,'G.3NH)L>R4444 %%%% !1110
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M7/DZHD".RM=9DSN.T9\LJ.30%F?H]17Y4_L\?\%"O^"B_P"U1\%?#OQ"\%_
M7]GV_P#"WBJU^V:=<7'B.XMI)8]Q7+1M<;E.5/!K]&/V9M;^('B7X"^&;[XJ
M:)H?AOXA75IOUS3='N#<6-G/N;Y8I"S%EV[3G<>2>:!'?4444 %%%% !1110
M 4444 ?'_P#P2*Z_M/?]E^\4_P#MI7V!7Q__ ,$BNO[3W_9?O%/_ +:5]@4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445^-/_!0_P#X+7_&
M_P#9&_X+"S_#_3]2T-O@SX=N_#[ZY;2Z/$UQ!:7ODI,YN"=R_/+D'MC% TKG
M[+45^0/_  <$_P#!9[XQ?L/_ !^T7P;\$]6T.T73/"__  D/B66\TF/4#$)K
M@0VWWS\JGCIU+BON[]L#]ME?V1/^":^N_&35I+>35=+\*PWUJC( EWJ,\*+
M@3T::1<@=%SZ4!9GTA17YS_\$1/^"CWQ:_:-^('Q%^%'[0DFE+\4?"]IIWB3
M3OL5@EDMUI-Y CJ=B\$J7C;/4B;'\-4_@'_P4@^+'C_]L_\ ;?\ !FI:MI$G
MA_X'Z3/=^$8DTN-)+21(974RN.9AN4<-0/E/TDHKX[_X(6_MA>.OVZO^"=OA
MGXC?$:^L=2\5:I?7D%Q/9V26<3)'+M3$:\# []Z^Q*"0HHHH **** "BBB@
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MG\4_^"#GPUF^ LUM_P *ET[X@:;HVD1I!<6\<*1&Y62("X EP"6Y;KZUR_\
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MFUF((/N#7T!\:D_;1_:1\%_\(W\0/V5?V8_&6@^>EU_9^L>,)+RW\U.4DV/
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M?%RZU3P[)X=^+GAK3]&TJUADF-Y:S6\11VG!C"!23QL9CCJ!1J&ECY3^)_\
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M]L;QA\%_"WPE^)WB;7/ ?B&WT37-3L8K3^S=-@FX^W22-,I$2MP5"F3 )"D
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M<^ ?C%9KXEUJS^*-TNF>%O#MA8>9KFKWY=D:T2#. Z.I#,6V@8.>1FS\$O\
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MG(KZHIDA1110!\?_ /!(KK^T]_V7[Q3_ .VE?8%?'_\ P2*Z_M/?]E^\4_\
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M8?%CX?\ Q._X6CJ>F2W?V+3M1N)I-TUI!,X^4(!& S@ X8\< K4-#[:\4?\
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M$A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45\ ?MZ?MR_&[QM^W
M%H_[,/[-/_"+Z/XV70AXF\4^+/$%N;JU\/V;-MB5(<$.[94Y*MG>H ')&_\
ML(Z_^V-\//VD=3\(?'K5/AK\2?AZVG-=6GC;0V@TRXMKI>?L[6B[688#!B4&
MW@[B,@ [,^U-.T2ST42"SL[6T$S;Y/)B6/>WJ<#D^YJY7QRW_!=;]GI/'O\
M91USQ+_PCZZQ_P (^?&?_"/77_"*KJ&[;]F.H[?*W[N,_=[YQS7TM\;?B[:?
M!'X.>(/&ESINLZ[9>'M/DU%[31K0WEY=HHSMAC7EV(].W- CL**^%_V+/^"W
M'@WXY_L-Z]\;OB5I>I?"_0] OF@GDO+"?['=B25UMXK*8C-[*0JJ_E+Q(2N
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MW1_X1C58"-S[)97)5D7YB=Q  ;=M(P>W^"W_  51^ 7[3?C&?PQ\._B=X?\
M$GBC[+/=6UBB3PM?+$A9FA,B(LP &28RWR@GIS0!]%45^5OA_P#X+8_%K5?V
M /A;\4I-'\"CQ%XT^+__  @5_"ME<?9([#[6\.^-?/W";:H.XL5S_#VK]%/V
MD_VBO"_[)WP/\1?$+QI=W%GX;\,V_P!IO)+>W:XF(+!51(U!+.S,J@#N1TH
M[XC(H P*^)?^"/\ _P %,/&'_!1W7_C;<>)O"=OX+TWP+XE@TW0],EMY(=3@
MM98#(!>[W(\_H2%50-V,'&:]1_X*:?MGWG[$/[,DOB#0=/MM:\<>)-4L_#/A
M+3+D,T-[JEY((X?,"D,8T&YV ()"8R"P- 'T317YY_M>?\%'/C=X$_:EU;X1
M^ K7X3:1JGP_^':^.O$6N>,_M4-CKK*/WEMIZ1R*5&0?G=GV9Y'&3SOBO_@N
M'XE\=_"+]GFU\&Z+X'\#_$3XY:!=^)M0O/'5^\&@>#M.M"ZS7,S!HWE5WC;R
MQN3*X).2*!V9^EU%? _C7_@JE\1/V9/^":5Q\6_BAX3\!:EXUU#74\.^%8/"
MFOB\T/Q1+/+Y5K<B8%S#$VV1V7<Y"IU!.!5^&/[9O[47B7X4_&F]\O\ 9U\<
M7G@/P\=5T/6O!FL27UE+J40,D^D7-J)VE$@C21!+O0;RIVD9  LS] JXC1OV
M<?A_X;^+6I>/K#P/X3LO'&L*$OO$$&DP1ZG> *$ DN OF-\JJO+= !TK*_8_
M_:7T;]L3]F+P3\3=!5H]-\9:5#J"0L<M;2,,20D^J2!ESWVYKX _:;_X+-_&
MCX>^-/C]XD\*^'OA?:_#[]G3Q!:Z#J>@>(9[J/Q/XK,AC#3691A'&&\S]V"C
M[\<<YH$?J717PS^U!_P43^*&N?M3> ?@A\"]#\&V_CKQ/X*D\?ZM>^,DN)+3
M2+$8$=MY4#(YFDD)7);"XS@\UL_LZ?\ !8+PSX^_X)A7W[0_CG3H_"\GA=KS
M3==T>WF\XG5;:8P?9;8GES-)L$8(SB09Z$T#LSZ5\/?LX_#WPG\5M4\>:7X'
M\)Z?XVUL8U#7[?28(]2OOE"_O+@+YC_*JCECP *[BOD'_@B_^WIXS_X**?LF
MZEX^\=:+H_A_6K?Q1J&D)8:=%+&MM# R[$D$CLQE&XACP"1]T=*;^W+^V]\1
M_!?[6OPU_9_^#.E^#F^(7Q!TJ^\03:SXK$[Z3I-C:#G]U RR2R2,-H 8!1SS
MV!6/L"BOSB\-_P#!=^30?^"<_P 1_B=XR\'6-O\ $[X6^*'\":AX=L;QOL.H
M:P91% T4K LD$F2QSEE$;CG@UW?[(/[=?Q<O=:\?:E\8K[X#ZU\._!.@_P!L
M:AXC^'NNM=R:%=*&:;3KFU,DLC21JKYD&P$@84YX!V9]Q45\#_\ !,?_ (*Z
MZ]_P45_;2^+GA>'PFWA?X=^$]%T_5/#)U*REM=:OXKAV7[3.K/M6.50'C0("
M%(RQS7G>G?\ !83XR?M&?%W6KGX,V/P*D\(Z-XS?P?I7AOQ9XC.G^)_&OD2(
MEW>6A,BI%''O!"F.0D>I&* L?IY14-J[O;1M)'Y4C*"R;MVTXY&>^/6IJ!!1
M110 4444 ?'_ /P2*Z_M/?\ 9?O%/_MI7V!7Q_\ \$BNO[3W_9?O%/\ [:5]
M@4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5P_P *OV;OA]\"+W5KKP3X'\)^$;K7IVN=2FT?28+*2_E9BQ>5HU!=BQ)R
MV>237<44 %%%% '$>"?V<?A_\-?B%KGBSP[X'\)Z'XH\32M-J^KV&DP6]]J;
ML=S--,JAY"3R2Q.37;YQ110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY\7Z=I!_LJQB5B?LTERX5UR<8&W:68 <YPPZ'V!11102%%%% !1110 4444
M>/\ _!0?_DP;XX_]D_U[_P!-UQ1_P3X_Y,&^!W_9/]!_]-UO1_P4'_Y,&^./
M_9/]>_\ 3=<4?\$^/^3!O@=_V3_0?_3=;T ;?@S]I?PWXY_:)\:?#"Q74O\
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MD%GQ!^,_Q$^%W['%]\/?#_B#Q-J&DK^T;=?#07MWXB-GJ,&@?-+'8?VI(&:
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M_#6>:\TR\C$EKY2:@[XBGF"F3;A VPN3D,*\)^$7AC21\,OV7_#>FV_P@L_
MNJ2^+9=?L_%DTEKX=U'Q)!?F.TAU,V_6Y2U#F&.?"D*>"0M!7*?NQ8WT.I6D
M=Q;S17$$R[DDC<,CCU!'!I+?4;>YN9H(YXI)K? EC#AFBR,C<.HR.>:^)/\
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M[N:"3T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP+XN\+W/@O0[OP[XZU*?6-?T^Y@\Z#4[R8J9)W5B?G)13D8P5!&"*^1_CO\
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M/^R7\*%\2ZII^J:Y>:AJ-KH>BZ-ID:O>ZWJ5U(([>UBW$*&=NK,0%56)Z8H
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MG:9^QGXZ\8))K3Z3#X1O-7632+W[!J#0_9&E!MY\'R92OW7P=K8/:OF+P/\
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M>H^TJX3Q%^T'X9\+?'OPW\-;RXNE\5>+-,O-6TZ%;=VA>WM#&LQ:0#:I!E3
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M_@F!\6OAQ_P3RNO"6BMX'TWXQ^!/B+?>._ EU82-#HRR2W3R+%@IO@A:">>
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MW[0QM'%M4(L*#GEF). /M2B@+L****!!1110 4444 >/_P#!0?\ Y,&^./\
MV3_7O_3=<4?\$^/^3!O@=_V3_0?_ $W6]'_!0?\ Y,&^./\ V3_7O_3=<4?\
M$^/^3!O@=_V3_0?_ $W6] 'S5\>OV$_'7C#_ (*+6D6DZ9#-\"_B+JFE>./'
M$YFC"PZMHRLL%L8BVYTNR+-FPI ^R$DY(S/HOACXW?L=ZS\</!_AGX03?$[3
M_BAXJU/Q5X9UZUUBSM+.UDU&- ]OJ:S.LJ"&12=\:R;X\  $8K[NHH'<_-SX
M2?\ !.OQ]\!O$FE_#F32;_6O"_BCX!Q_#"[\76$\+6^AZDCW;R/-#(ZS-$?M
M V,BMG&"!7"_!/\ X)U>,;S1?A3\/=;^"/BO3[[P1J.EGQ#XEUSXF7U_X5>#
M3RA%SIUG'>AVFD:-&BB>%$BR0<A0#^KM% 79XW^W[\&-*_:"_8Z^('A+6-2M
M=&AU+299+;4;F01QZ?=P_O[>X+$C'ES11OUZ*:^/?@I^RKXZ_;O_ ."4WQ(\
M5:Q_9^D_%K]HP6OB5!=$M:PI9_9QIMJYQGR&2VW=./M3'!K[Q^.O[/O@G]IK
MP,?"_C_PSI?BSP^US%=MI^HQ>; TL9RC%>^#GKQ4_P 0_BCX2_9[\&6=]XBU
M+3O#.@BZM-'M7D'EPK-/(L%O H4<;G9$4 8Y'2@1\@_$3P+\8/\ @H1\3OA5
M:^)OA/??"'1/AKJ-SXAU?4M6U:TO6OKXZ?<V<-K9+;N[/ 6N6=Y)-GRHHVY.
M*\OT#X,?'[5OV;/V=O@W=?!C4-+_ .%+^-O#MQK_ (@DURQEL;^RT^X*^?9H
MLGFN&0K(P=4* $ ,2*_3RB@=V?./["_P7\3?"KXL?M#ZEX@T>32[7QE\19M9
MT>9Y4?[?9FRM8UE&UB5&^-QAL'@\8Q7F?_!2?QGXD^'O[<O[*NL>%?";>.-6
ML[OQ,3HT=U%:SW,!TU!*87E(C\Y5^959E#8(R,U]M5S?B?X2^&_&?COPWXGU
M31K*^U_P>UPVC7TJYFTXW$8CF,9[;T 4^U C\_\ QO\ LB?%KX]?' _&34_
M-QX;N_%'Q+\&3KX8DU&VN+O2M$T?[1YE]=LK^5YK/.Q\N-G(14')SCV7XN^"
M?B1^S9^WYX@^,7A/X?:A\5/"_P 0/"=AX>U#3]'O[6UU71;NQFGDBD"W+QI)
M;RI.0=KAD9<X(:O=?%?[7OPU\"Q>,I-7\8:7IZ?#VYLK/Q&92^-)FO-GV9)/
MEZR>8F,9^\.E>E4 ?G3/^R+\9=0_91\<>!;CPCIMGXB_:F^(&H:QXN<7$%]I
M_P .]'NUB27)<C[1="W@54\M67SY=V0$W%MQ^R?XF^&/_!-;XJ_ GQ9;VNAZ
M-\'T_M7X;^.Y9;>&WU.&U8ZA8S3*K!DN[>:+RYBRJ)/O@G<V/O&3XO>&8OBW
M'X#;6+5?%\VE-KB:62?/:R640F?IC:)"%ZYS7%?M;^$_A#\0/#7A70?C)I_A
MW5M)UGQ):6FAV6LPF6&ZU9@YMXU7&"Y ? ;@C.:"N8\/_P"">]WXV\$_LU>&
M_B9JW@'5/$'CK]HGQ7!XC\50V5S!"?#%G>(%@ED,S(7M[6UBMU*(#)ESA3S7
MK_\ P4;^&6O?&C]@_P"+7A/POILFK^(O$/AB]L=.LHY$C:ZG>,A$#.54$GNQ
M ]Z]IM[=+:!8XU6..-0JJHPJ@= !4E!)\H_M'?LER^+/^"7?B/P;HO@?1[CQ
MY>?#_P#LNWLX[2V2=K[[&J;!(<*&WY&[<!GG/>O#OBC^SO\ &!OBSX9A\0>!
M?B-XR^'D?@#0])TW2/!?BZW\.K::K#$RWB:M*LL4TT>3'Y;(\B(!)A26Y_1^
MN7U/XP>&='^*VE^![K6+6'Q9K5A/JECIC$^=<VT#(DLJ\8VJTB \_P 0H _.
M'X=?L/\ QN^"7_!.+P3?>&?!$-O\=_@KXZUC6M"T0ZG'-!J5G?75Q%/!'<L^
M&B>VN@X:0AB8 2 V*[;]HK_@EUKVF_L=_L\Z/X;TV]\8:Q\$]9&OZ]I%IKCZ
M+J'B:2ZMITU"2"]C9#'<F:YDE5BRA\,I8!J_1"B@=V?%?_!.O]EG4O!O[1WC
M#XCWGPSU[X=:;=:';^'M*3Q3XON_$'B*^43&>9I2UU/!!;A@@C127)WL2 =M
M<S_P64\$>(K#QQ\+?$WPWOK.T^(7C">[^%$L)G"7$^FZS$=TZCJ?LDD N <8
M #<@9K[ZKA;_ /9L\!:G\=K/XG7/A/1;CQ_IM@=+M==DMPUY;6Q))C1C]T'<
MPR.<,1G!Q0(^:_C-^S#XJ_9?^.GP5^(GPK\%/X[\-_#'P?=^ +_PS974%GJ*
M64OV9H;JU,S)$S(]L!(A=2ROD'*XKQ_Q[^R)\:/'_P 0M<_:&;X>K:^*)OB-
MX:\36?P_&L6YU";2-(M)[0[Y]WV=;R07,D@0.5 C52^:_2ZB@=V?G#\2/@9\
M:/VC_'G[4'BZ^^%FI>%+7XA_!V#PMX5TVZU2SFOKN[C:])BF\N4I%(S3+@;B
MH4C+Y) ^[/V?_#MYX/\ @/X)TG4;=K/4-*T&PL[F D'R98[>-'3*D@X8$<$C
MBNRHH$?F]\(OC)\3O /[2W[7FB^!?@_<?$:/7/&PAL[^WU:TM(;.]?2;5-E\
M)W5A; &-M\8<\R#;G&>[_P""</[!_B[]D?X[WVFZU:R7.@:?\)_#GA:/7(ID
M,=[?P37LEW'$,^8JHTZ[2R@%=O<$#[ \$_"+PS\./$/B35-#T6RTO4/&%^-3
MUFX@3:^HW(C6(2R'NVQ$7Z**F^)?Q(T/X/> =7\5>)M2M]'\/^'[22^U&^G)
M\JT@0;GD; )P ,\"@#\[XOV>?CQX?_X)^:Y^R%#\*%O_ .T(;[PW:_$(:Q:1
MZ#_95U=2R&^>(O\ :5N4AE8>2(SF50=^#FM[]LG]A7XJ?M9_%O0[K1=+L/#]
MC^S+IMK>_#NZU>*WG_X3K7D6-G$XRS1V CA6+:^UC+)YF,1J:^X?#7QZ\'^,
M/B$WA72]>L;WQ$NBV_B(V$9;S1I\[LD-STQL=E8#G/'2NQH _-7_ (*+^'_&
MGQ2\5_!/7O#^FR^!?B'\>-'G^$_B_P /W5W$^H:5IMXOVN:<&)G5_LGD7/S@
MD$7 Y&<5^BO@OPCI_@#PAI.@Z3;QV>E:+9PV%G;H,+!#$@1$ ] J@?A7,0_L
MV^ X/CS-\4%\):+_ ,+"FT\:6VOM;AKT6H_Y9!S]U>W&"1P>*[R@#X__ ."1
M77]I[_LOWBG_ -M*^P*^/_\ @D5U_:>_[+]XI_\ ;2OL"@ HHHH **** "O"
M?V^_V:_$'[2GPJ\.MX/U#3=/\9_#_P 5:;XST$:F&^P7EW92,PM[@IEECD1W
M0LH)4D''%>[5R_Q<^)MC\&?AWJGB?4K36]0L=)C626WTC39M1O9075,1P0JT
MDARP.%!( )Z T ?,/Q4^$_[5'[4/P9^*%CJ&O>%?@_>:YX;32/#&DZ'J#ZA)
M!?><))KV?4!#')&)(P8%2(?(K,Y^;%>(^"/^"7_Q"M/CQ\-_&6E_";X2_#'3
M_"=GK6FZK;:9XAN-5U;56OM*EM4N9;R6$&2-)"N(VRY\QF+< 5^@G@CXV^&_
MB)X\\5>&='U#[7K7@F2UBUJW\IU-C)<P^=$C$@ L8R&(&< C/-3:A\5;&P^+
M>G^#&L==;4M2TR;58[N/3)GTV..*1$9'N@OE)*2X*QLP9@"0" :!W9\IQ?L!
M>/K?_@GE\ O"NGW?AVQ^*_P)N-'UVQBNI7FTF_O+*-XY;2255#B*6.211(JY
M4[3CK6M\"?A9\=-2_;I\2?&?XEZ#X%\,Z.WPZ'AG2M(TK6Y+^2VN([[[2S3S
M-"@*OD_,JX4*!@G)K[ KD_C1\:/#?[/WP]N_%7BS4ETO1;.6&"2<HTG[R:5(
M8D"J"26D=%''5J!&'^R7\7->^/7[-_A#QAXH\/P^%==\06(NKO2X;A[B*U8L
MP&R1T1G1E 96**2&!P*^0_&O[ OQ>O?C]XFCL]-\*W7@W6/C5HOQ3MM7.L-'
M=);P1117-J]L8C\Z^665@^&SCBOLGX8_M!>&OB]X]\=>&=%N+N75/ASJ46E:
MRDMLT213RVZ7"!&/$@\N13E> >.HKNZ /DO]H_\ 8(UC]I']IOXF7VH75MI_
M@GX@?!Z7X?\ VR&7=>VMY)=RR&01$8*JCJP);DC&.]>)?L]?\$L_%NA^/?AK
M::]\'_V>O!]G\/;Z"]U;Q=I$!U+4?%!M4*P_9K>:$"R>239(\C.[)M(3KFOT
MAHH'=GPD_P#P3[^(TO\ P2*L/@N8]!_X3FWUN*_D7[>?L?EKKPOSB79G/D=M
MOWN/>OJ?]K3X VO[57[,WCKX<WE[+IL/C+1KC2OM<8W-:-(A"2@=]K;6QWQB
MO1J*!'P3K/[-G[2_QW^(/P'T_P >:#\,])\(_";6S<:Y>Z3KL\]SXC3^SKFS
M6XAB:!?('[T,8V9FRW#87GR;X<_\$7O%7@3P?HGPO/PK_9_O-+T748HV^)U_
M;F^U6]TN.?S</IDD)C-ZT8$1D:0Q@DN!G K](_C1\:?#?[/OP_NO%/BS4ETO
M1+.6&"2<QM)^\FE2&) J@DEI'11[M764 ?%?QI_8\^,FH?M!_M!7G@'4]'\-
MZ7\:/!-CIFD^*8=1>'4?"NIV5O-#'F )\\;^8")$<,GH:\7\ _\ !*OQ])\6
MO@WX@;X4_"GX?V7@75I/^$FGL/$EUK&N>(89]/GM);C[7-"&VJ9=_E,2S,>H
MQS^GE% 'Q/\ LS? 7]ISX ?#GX?_  8L;CX?Z7X'\ 7EM:-XZBNFNM2U?1+>
M3<MJ-.DAV17,L06)Y?,*K\SJ,X M6W[#WCR']AW]IOX?^7HJ^(/BMXC\4:GH
M"B])@,.H8^S^<^S]VW]X -CWK[.HH \3^+GP,U[QE_P3XU[X:V*V7_"3:AX"
ME\.PK).5M_M;6!@&9,<)O_BQTYQ7D5I^RY\3?A%\>O@+X[TG2_#&M6?@KX:O
MX%\46]QJ[6CZ>^VUD%U"WE,)D#P,I4[3@@CTK[)IDLGE1LQR0HSP,F@#SK]D
MKXN:_P#'K]G#PAXP\4>'XO"NN^(+$75WI<-P]Q%:L68#9(Z(SHRA65BBDA@<
M"O@']H/_ ()1?%SXRQ?&S1]4\*_#'QYKWC^\U2?0/B/XIUV[N;K1+&X5OLME
M%IQB9(7MU(B1XV"<!R#C!_1[X0_%"Q^,WP[T_P 2Z;9ZYI]GJ8<QV^L:;-IU
M['LD9#YD$RK(F2I(W 9!!'!%9_P5^/\ X;_: M_$TGAN:[N%\(>(;SPOJ7GV
MS0^7>VI43*NX?,H+###@]J /$_V=OV5_&G@+]K;P[XZUJWTNWTFQ^#FE^"[E
M(;WSIH]3@NC+*H&T!H@O1\C)_A%>,_#C_@GQ\8OV?/%NC_$WPM:^#]6\;>'?
M%GB^63P_?ZI)!::WHFLWJW$>VY6)O(N8C'&V"C*074GH:_0JB@#Y?_X)]? 7
MXJ_#/XH?'#QE\5K?PK9ZG\3_ !'9ZOI]IH5[)=0V-M%816X@9W1"74QD%L88
MDD # K2^%O[*&N:=^T=^TMK6O_8X_#/Q@32K;37MK@O<>5#IC6EP9%VC80S?
M+R<CGCI7T=10!^6_PA_X(V^*O!/ASP;\-[SX4_L^KIOA6_M4N_B5+;?;]4UC
M3;:57 _LZ6'8E[*BJC2-(R*Q9U&< >W?&']@_P"('Q-^+?[4&BK'H4/@7]H/
MPU:6]GKIOF^V:+?VUB;812VNS]Y$S$-O5\@9&,U]?_$+QS8?"_P%KGB;5GDC
MTKP]I\^IWKQQF1TAAC:20A1RQ"J< <FH/A=\1]+^,/PU\/\ BS0Y)IM'\3:=
M;ZK8O+$8I'@GC62,LC<J2K#(/(H ^+F_9H_:-^-WQ7^!NK>./#_PX\,Z/\);
M35K*\BTO79KZ?5IKG1Y;)+E-T""./>4_=G+ .Q).T Z:_L$?$%/^":7P#^%?
MEZ%_PEGP[UWPWJ&L+]N/V416-XLUQY4FS+G8#M&T9/I7W!10!X/J/[/GB2Z_
MX*4:;\4E73_^$3M/AU-X8D)G/VK[8^HI<#$>W&SRP?FW=>,=Z]XHHH ****
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MU6WNX9T1+ZUV2R7"P2!FCD#'R]ZJ1@YK[\KR;]G;]B7X8_LK:MJ>H>"/#/\
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M.* Y3ZFL_P!O'X;7?QZ^)?PW_MB:/Q-\)-$@\0^)%DMV6WM+.6,RAEDZ.50
ML!RNY<]:U7_:;T_7/V23\6M#TGQ%>Z7>>'?^$@L+$Z:_]HS1-%YD8-OD-N((
M)7(.*_-;Q;^Q7\>OB'\+/ ?CB/P3J6C_ !(_: U/6O#GQ4M&D3?X:T;5KBV_
M>2X/S+;V]D$ !.WSSCW_ %6UOP1%;_":\\-Z/#':PII+Z98P@[4B40F.-?8
M8'X4$GYV_LX_\%DO%'BSQG\#;SQ?8>+&T_Q[\/M1U*[T/3?"+2WVN:O%=0A)
M;*- TAMUA:7#;@A"DL<U]>:-_P %(OA/K'[--]\57UN^T_PWI>I/H=Y;7FG3
MPZK;:HD@B.G-9E?--V9&51$%))8=N:^4_P#@FI\#_B)X?^.'P$F\4?#?Q5X4
MA^&/PLU3P?JUUJL$2PI?B^MF3R71VWQR1JS*PZ@'.*ROC;^PE\2OB9\*/B=<
M6/AOQ"M[H/[13_$C3],L]272M0\1Z7'#'&SV-SG$<Q#.\3,1EHL<$@TM2M#[
M:_9W_;8\(?M(>+=6\-Z?9^*O#/BS1;6/4+K0/%&BSZ1J0M)"5CNDBE WPLP*
M[U) 88.#Q69^T5_P4#\"?LR_%O2/ >MV_BS5O&'B'2I-8TK2="T.?4[G4H8Y
M1'(L:Q@_.N=Q!P BDYKP/]@[]G35-1_;*N/B9<^!_C%X?T?0_"\FAV>J?$WQ
M7-?ZU>3SSI)+!#:"62-+9 BGS'.YG/R@ $F3]JOXM:M\%?\ @L#X$UK2_A_K
MWQ"C_P"%5:E#>6FAK#)J5C$=3@Q/#%(Z"3Y@J,JL&"N3SC%,D]@UK_@J5\(=
M!_9ZTGXG3:IK3>&]4\11^$FBCTB=M0T_569D-I<6NWS8I5==K*5R"5Z@@TWQ
M7_P4Y\">$;'PW#<>'?B9<>*O$]G-J5OX1M/"ES<>(;6SBE:)[FXM%!:"+>N%
M9R-^1MS7S+<?LD?$SQ-X>L_&NH>!]2TW4OB-^T3HOC^Z\,K)%<3>&](@B6W\
MZY*ML$A6%990A;:TF,D@U[!\6=*\<?LK?\%$O$?Q>T_X<^*/B=X-^(/@_3_#
MTR^&4@GU70KRQGN)%#0RR1[K>99\[E;Y74Y&&!H [+5_^"L/P;T[PQX#U6SU
M37M<C^)3W]MH5MI6BW%U>7%Y9!?M%B\"KYD=RK$KY;J""K9( S7/G_@M)\%4
M\*W6L,OCY;/0;IK3Q26\)WH/@B17V'^U?DQ:C^+DGY/F^[S7B?[,7['?Q*\,
M?MB_#'XC>)O!EQH\?BSQGXW\:ZMI\<T=S'X.CU"RMH;.WGD4[?.D$)9O+R [
MN,\9.MXX_9B\>WW[+/[?&DV_@_5I-6^)/B#5+GPU;+&GF:_%)I-I#&\/S?,&
M='0;B.5-+4K0^B/C5_P4E^'?P1^+Z^ ;FU\9>(O&%QHD/B*TTOP[H$^JSWME
M)(Z>;&(@00A3+9Q@,G4L!7E/Q+_X*P:=J7QO_9UL_AY9^(/%'@OXK7FI1ZG=
M6&@R7$R&WB=!:X8J89H;A29T9=T:(3TZ^?K\6?$7[.7_  4^AN+?X9>*O'TD
M?P/T2RU*VT!()=4TIUO9MN(I9$#HS@J^ULJ50G(Z9/@3]FCXH_!'Q]\&_BAK
M'P]UV\DU3XI^*O&'B'PYH,D-[<^$K?6K7R+9&&]5D$>Q&F,9.UI&QNQDL#Z>
ME_X*E_"Z+Q\VCK'XTN-'CU[_ (1=_%4'ANZE\.)J8E\@VIO54IN$W[HG[H?Y
M2V:T/^"GO[5&M?L9_L3>-/'WAW3[K4-=TJ!(['R[ WD5O*[A1+,@(Q$O.6)P
M"5SG.*^+]?\ V??C)\._C%KW_"J_ OQ9^&/Q*U#QH]^9=!UJ*[^%FNV<MYYD
ME]<V]U(Q@>6W+--'$BR&;=MR"#7VE_P4^^$WB7XY?\$^_BEX5\*Z<VL^)M6T
M1ELK&)U1KR5'23RT+$#<P0@9(&2*"2AXF_X*4^"?A]H?@ZWU#1_B%J?C#Q;H
MXUJ+PMIGAF>\UZVM!\KW-S:Q9\B/?P"Y&2<+FO5_V?/VAO"7[4?POLO&'@G5
M%U;0[YY(=YB>&:VFC8I+!-$X#Q2QN"K(P!!%?(FD:MX^^"'[6/\ PO:'X/?$
M3Q/X7^)W@#2_#]YI5E:V_P#PD?A:^L)KAA'/;23*#!*LQ.Y'.UER>&!'K_\
MP3/^"'BSX4?#_P"('B'QIHZ>%]:^*WCK4O&O_"/K<I<-H4-R(DBMY'3Y#+LA
M#N$R \C#)QF@#Z4HHHH **** "BBB@#Q_P#X*#_\F#?''_LG^O?^FZXH_P""
M?'_)@WP._P"R?Z#_ .FZWH_X*#_\F#?''_LG^O?^FZXH_P""?'_)@WP._P"R
M?Z#_ .FZWH A_P""@O[06M?LI?L4?$KXC>';73;S7/!^B3:C90:@CO:R2KC
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M1B%DR5V2 '!- [,_5*BOE3]H?XKZ]X?_ ."G7P;\*V/B'4;+1-8\$>*=0O\
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M% !1110 4444 %%%% 'C_P#P4'_Y,&^./_9/]>_]-UQ1_P $^/\ DP;X'?\
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M0!\?_P#!(KK^T]_V7[Q3_P"VE?8%?'__  2*Z_M/?]E^\4_^VE?8% !1110
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M/]HSXB-XLUJS\0:7XDN+%=*OM0\/Z_>:--JMFI)6WN3;2)YT:[FVA\E0S $
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M/VZ/^B8_L[_^%9J/_P CT?\ "R/VZ/\ HF/[._\ X5FH_P#R/0!]A45\>_\
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M_(] 'V%17Q[_ ,+(_;H_Z)C^SO\ ^%9J/_R/1_PLC]NC_HF/[.__ (5FH_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (W [$# 2(  A$! Q$!_\0
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M_(E'_"%>#?\ H4O#/_@ATK_Y$KIJ* .9_P"$*\&_]"EX9_\ !#I7_P B4?\
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M"O!O_0I>&?\ P0Z5_P#(E'_"%>#?^A2\,_\ @ATK_P"1*Z:B@#F?^$*\&_\
M0I>&?_!#I7_R)1_PA7@W_H4O#/\ X(=*_P#D2NFHH YG_A"O!O\ T*7AG_P0
MZ5_\B4?\(5X-_P"A2\,_^"'2O_D2NFHH YG_ (0KP;_T*7AG_P $.E?_ ")1
M_P (5X-_Z%+PS_X(=*_^1*Z:B@#F?^$*\&_]"EX9_P#!#I7_ ,B4?\(5X-_Z
M%+PS_P""'2O_ )$KIJ* .9_X0KP;_P!"EX9_\$.E?_(E'_"%>#?^A2\,_P#@
MATK_ .1*Z:B@#F?^$*\&_P#0I>&?_!#I7_R)1_PA7@W_ *%+PS_X(=*_^1*Z
M:B@#F?\ A"O!O_0I>&?_  0Z5_\ (E'_  A7@W_H4O#/_@ATK_Y$KIJ* .9_
MX0KP;_T*7AG_ ,$.E?\ R)1_PA7@W_H4O#/_ ((=*_\ D2NFHH YG_A"O!O_
M $*7AG_P0Z5_\B4?\(5X-_Z%+PS_ ."'2O\ Y$KIJ* .9_X0KP;_ -"EX9_\
M$.E?_(E'_"%>#?\ H4O#/_@ATK_Y$KIJ* .9_P"$*\&_]"EX9_\ !#I7_P B
M4?\ "%>#?^A2\,_^"'2O_D2NFHH YG_A"O!O_0I>&?\ P0Z5_P#(E'_"%>#?
M^A2\,_\ @ATK_P"1*Z:B@#F?^$*\&_\ 0I>&?_!#I7_R)1_PA7@W_H4O#/\
MX(=*_P#D2NFHH YG_A"O!O\ T*7AG_P0Z5_\B4?\(5X-_P"A2\,_^"'2O_D2
MNFHH YG_ (0KP;_T*7AG_P $.E?_ ")1_P (5X-_Z%+PS_X(=*_^1*Z:B@#F
M?^$*\&_]"EX9_P#!#I7_ ,B4?\(5X-_Z%+PS_P""'2O_ )$KIJ* .9_X0KP;
M_P!"EX9_\$.E?_(E'_"%>#?^A2\,_P#@ATK_ .1*Z:B@#F?^$*\&_P#0I>&?
M_!#I7_R)1_PA7@W_ *%+PS_X(=*_^1*Z:B@#F?\ A"O!O_0I>&?_  0Z5_\
M(E'_  A7@W_H4O#/_@ATK_Y$KIJ* .9_X0KP;_T*7AG_ ,$.E?\ R)1_PA7@
MW_H4O#/_ ((=*_\ D2NFHH YG_A"O!O_ $*7AG_P0Z5_\B4?\(5X-_Z%+PS_
M ."'2O\ Y$KIJ* .9_X0KP;_ -"EX9_\$.E?_(E'_"%>#?\ H4O#/_@ATK_Y
M$KIJ* .9_P"$*\&_]"EX9_\ !#I7_P B4?\ "%>#?^A2\,_^"'2O_D2NFHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** /S/HHHH _0KP5_R)OA+_L6=!_\
M35:5TU<SX*_Y$WPE_P!BSH/_ *:K2OE']JO]I7Q;\%_$_P (? 7@3PWX1U;Q
M7\3?$%G_ &?+\0/B OPVT+7;?3O%OA#2-1\">%=7E\$^-;?6O'NO6'B.XOK?
M1Y8M$.F^'-*UKQ,-2EBTF>W !]J45\O?%7XX_$[X9VMEXPG^"VEK\+M,\/\
MA/6/'^N>)?BKIVC>/=*U;Q1JQTE_!/@+P#X8\*>/=(^('B_0[F73K6[M;_Q_
MX'TC7-4UC3=*\$ZUXJN9)S;[W[1'QTC^!.B>!M3:/X=K)XW\>Q>!X=2^*OQ0
M'P@\#:*3X/\ &'C";4M8\9MX0\;BW=K;PA-IVGV T0G4-1U"UA^UVX!+ 'T'
M17P]XD_:Y\1:,M]JFB_#OP+XX\(?#SX:^!_BK\;_ !?X/^,TFJZ5X?\ "GQ
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M^D7D6L>*_!CPZ9X>U[5M-N=7M;[5+A=%43:5^H%% 'YX?L,?L4_"WX*_ /\
M9^G\=_LV_!CPK^T7X-\!>'H/&/BZ#X?_  RU'Q_8^,[:W U*[F^(GAZQU&ZU
M+5/. ,NL6/B&]^T, ZWDN-U>\_M<?"3Q#\9/@5XJ\/\ @1[:V^*GAJYT3XD_
M!O4KJ=+6'3/BU\.=5M?%O@2:6YE=((+2^UG3(M%U1KEOLDFD:KJ$%X&M99@?
MI:B@#\W_  %\$?C?;_LI?&K5?%OPR^%7B7]IC]HOQ5XH^*GQ'^$?Q9N;7Q?\
M.;H:SJUAI^D?!'6O$.AWLUCJEAX9^$NB:3X"\/>((Y[O0+#Q#!!KL]A=Z4MW
M:7'*_LS?!WXS_#CXQ76O^ OA-\7?@!^SWI/P>U_1[[X#?&+]H?2?B]I7BKXK
M/K.GZAX.O/A9I^F?$SXT:?\ "KP[I&FQ:YINN:C%K_AVWU%-1T:T@\ F#3&O
MK?\ 4JB@#S+X.>(OB7XL^&GA/Q#\8OAS9_"3XE:G8SR^*OAY8>+]-\>6GAJ]
MBOKNW@MXO%>CP6^F:H+NQAM=2)LUEBLVO#8&YNI+5[B3P;PC\*O'NE_MV?&G
MXRWV@^1\-O%O[.OP7\">'_$?]J:-+_:'BOPGXT^)NK>(-*_L>'49->M/[/T_
MQ#H]Q]NO=+MM-NOMGE65Y<SV]U'!]C44 ?FIXZ7]J)%^)/PL^,7[(/A?]N/X
M?:OXMU_6OAGXLA\4_ 7POH,/@_6+E)_#_@SXE^!/B=+X?FTK5_!B22:?)XN\
M)Z=XYFUVQ@AU3[);ZJ&M)O%]._84^(R_!'_@GE\%OB9X+\$_%S0?@O\ '7Q)
MXP^,OAO4KC1/%/@/PM\/-:\*_%X^'?"Z6/Q"D@N/'.B^!KCQ7X2\&Z?';Z/?
MWUPNEV^IQ:5!86S3V_[)T4 ?"'AG]G"X^ W[5O@GQ7^SO\-O#O@7]GSXA?#+
MQGX4^-_@KX>Q>%_ W@C0O'V@7NBZY\,/B6? %I<Z18WFN:E8GQ/X'U'5?"6A
M3:O+;7>ER>(VN-.L;2XL/N^BB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^&_C)^U#XW\&_M)?#G
MX%>!/ WA[Q+=ZC8VOB;Q!I&N_$;2_ WC+QQX=U'2/'+747PDT/7O#%WHGBZ?
MP=<>%[>]\176H^.?!-G9ZKJ?AKPY?7EM!XBCU2W]6M_VB=-U+]HN#X"Z+X:N
MM3L(? 7Q \3:W\11J20:1I_B[P!JOPOM=2^'NGZ6;"2;6]0M=)^*6BZMKVLP
M7]MINA7,EIX?C75=:.OVOAD ^CJ*^5/V8?VDG_:-T:3Q!!_PI&"S/A[PYX@;
M1OAI\>C\6O&?AS_A)XI[K3M,^(GAQ/AKX+B\$ZB;6WN(V@;5M89M2LM2L(PZ
MV$MTV+XD_:LOO#?C?Q/]H^'^F2? _P "_$_PY\%O&?Q5?QXT7B?3/B)XETKP
MYJ$$MC\-4\'7%C?^!-)O_&'ASPYKGB6\^(>D:_;:W<W_ /9_@K5-(T]=6NP#
M[%HKY5^!_P"T1XH^)^M^'M*\9_#&Q^'D'Q'^&"_&GX3W.F^/?^$WN->^'9O]
M LYHO&MJ?"'A6W\&>.[&'Q=X3O=0\-:%J/C_ $"*#6'2T\:WTUA<1GZJH _,
M^BBB@#]"O!7_ ")OA+_L6=!_]-5I7S?^U=\$/B-\;M"\-^'/"?B?P ?"<WB+
MPROCWX??%3X4Z=\4/!OB#1K/Q5HVJS:W%;#QCX!U2VU72;*SO8+C3[S6->T/
M7=+NI[!?#UKJK6VLP?2'@K_D3?"7_8LZ#_Z:K2NFH ^,]2_9L^*7]M_"3^R/
MC+X/U7P/\%_"/A+1_!WA#XH_"3Q+X[NI/&OAO3QI<_Q3U_6]!^-WP]LO$/C*
M6QC@3PZ^K>'+JQ\'7C7NLZ/;MKEVNIVWHVI^$OVAM=T/SK;XE_#7PGXTT7XH
M^+M9\-7=_P#":Z\>>$+SX:W-SK>F^%=!\4^'O^%@>$?$@\56?A^_M;F;Q+X0
M^('A4?VG L5[IVI:5/J>DWGT-10!^?%M^P[KFE:3K/AO0OC'8V/ASXK^&H?#
MO[1EK<_#&.ZU+QZ6\<>.O'6JW_PRU"T\<Z9:_"5M6G^)'BKPO)9:WI7Q6L;+
MP<N@6-C#!KVE7GB35_3M2_9DUNZ^(VKZM9?$;3;#X0>(_BWX1^//B'X9#P"9
MO%%U\4?!=AX8@TQM-^(Z^,;;3['P+?ZMX*\,>)M:\,7OP\U;7;G7+2_%AXVT
MO2-072K3ZYHH ^$]5_9A^+?CZSN[[QG\5O!GA_4OB_\ #?P9X _:?T;PW\,[
MV_M_&5IX/U#Q%<6L_P ,==NOB!92?#K5M2T3Q5JOA7Q'>Z_I/Q,TN^TU+*?1
M-&T"_M6OKKIO$?[*5[XB\;>)EF\?Z7%\#O''Q.\-_&CQE\*3X":3Q+J7Q#\,
MZ3X;T^WAT_XDQ^,+>QT_P'JM_P"#_#GB+6_#-Y\.]7UZXUNVOQI_C72](OUT
MFT^QJ* /E7X'_L[^*/AAK?A[5?&?Q.L?B'!\./A@OP6^$]MIO@+_ (0BXT'X
M=B_T"\FE\:W1\7^*K?QGX[OH?"/A.RU#Q+H6G> - E@T=WM/!5C-?W$@^JJ*
M* ,2]\/V&H7#W4]QK<<CA%*V7B;Q)IMN BA1LM-.U6UM(R0 79(5:1LNY9R6
M-3_A$M*_Y^_$W_A:^,O_ )?5TU% ',_\(EI7_/WXF_\ "U\9?_+ZC_A$M*_Y
M^_$W_A:^,O\ Y?5TU% ',_\ "):5_P _?B;_ ,+7QE_\OJ/^$2TK_G[\3?\
MA:^,O_E]7344 <S_ ,(EI7_/WXF_\+7QE_\ +ZC_ (1+2O\ G[\3?^%KXR_^
M7U=-10!S/_"):5_S]^)O_"U\9?\ R^H_X1+2O^?OQ-_X6OC+_P"7U=-10!S/
M_"):5_S]^)O_  M?&7_R^H_X1+2O^?OQ-_X6OC+_ .7U=-10!S/_  B6E?\
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M ,+7QE_\OJ/^$2TK_G[\3?\ A:^,O_E]7344 <S_ ,(EI7_/WXF_\+7QE_\
M+ZC_ (1+2O\ G[\3?^%KXR_^7U=-10!S/_"):5_S]^)O_"U\9?\ R^H_X1+2
MO^?OQ-_X6OC+_P"7U=-10!S/_"):5_S]^)O_  M?&7_R^H_X1+2O^?OQ-_X6
MOC+_ .7U=-10!S/_  B6E?\ /WXF_P#"U\9?_+ZC_A$M*_Y^_$W_ (6OC+_Y
M?5TU% ',_P#"):5_S]^)O_"U\9?_ "^H_P"$2TK_ )^_$W_A:^,O_E]7344
M<S_PB6E?\_?B;_PM?&7_ ,OJ/^$2TK_G[\3?^%KXR_\ E]7344 <S_PB6E?\
M_?B;_P +7QE_\OJ/^$2TK_G[\3?^%KXR_P#E]7344 <S_P (EI7_ #]^)O\
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M1WL[33;S1-1Z7P_^QQ\/_!OQ>\$?%3P9XF^)>C)X-\+_ !ET8>&=3^*_Q?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK2Q.$Q%-PKX3%496G1Q.&JTJU.234I1YH2_GN_99_P""JWQ2^ OQ,L_V-O\
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M?1110!^A7@K_ )$WPE_V+.@_^FJTKIJYGP5_R)OA+_L6=!_]-5I734 %%%%
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M%J2C)QG0KQ7M,/7K4Y)I]%%%>2>Z%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^3O[9&GWF
MD_M ^"M9\$^$/B%XA\:^+-.L](U#P#XC^">H_%W]GGX[6'ASP?\ $ZXT7P[J
M&M:)I]Y'\./%^F/K>M>'IM<\7>*?"'AS2;+Q-:^--:\)^.-%\,27FF=!IOPO
M_:;_ .&KM'\<>+O!'@2VU7QG\'OVHO#U_P#%+PM\3/'7BJQ\&Z+J7B'X-?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#\SZ*** /T*\%?\B;X2_[%G0?_35:5HZOK>E:##9W&KWB64-_JNE:
M):22)*XFU76[Z#3-*LQY,<A5[R^N8+:-W"Q*\BF61$RPSO!7_(F^$O\ L6=!
M_P#35:5^8W_!2O3/AK-JWP5UCQUXG^#,E]INL6]EI'PM_:-MKG1_AGX\MM4\
M=>!)=2N_"?Q*G@FL/A_\3-&&F6]M/J^D:7XT\3)X"U?Q(8?"2VA_MNP /U?H
MK\D?C-XH_9?\::C\%]$U ?#OX=_M%:_\,?A-K5CXY^.WCG2XOB-^R]\-?._M
MBUU'0=;^(VNR>([/XPZM+<:QH>D0^&GB\2>,?$$$6O\ Q-O[KPUX?B\[V[]J
M/QC\%/&K_!.\^)'B+X:>)/V9-#^.?C?PE\>9_&&H:/J'PMTOQ;X9^'_CW2_#
M.@_%AM3DD\*VNE:1\1X;&UDLO&^S0X/' \&^:@UA]!9@#] **_G^7_A$O^$<
M\:?\+&^P_P#"R_\ A5^D?\.Y?^$H^U?\+#^S?\+E^-O_  AG_"C/[8_XFW_"
M6?V3_P *F_X2G_A#/^*B_P"%:?\ "%_\)1_Q2/V&OI#Q"?!8_:.\6'6#X;'[
M8 _:W^$1^'90J/B@/V7QH7PP/B0^'#+_ ,5 /@6/"?\ PLX^,SHO_%"#QO\
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M%[?:_P#A:_\ PD'_  G/_%??8?-_M;_0_L%?JG0 45B7MQXDCN'73M*T2ZM
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M5NJ__,50!TU%<S]K\9?] 'PS_P"%;JO_ ,Q5'VOQE_T ?#/_ (5NJ_\ S%4
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M@#IJ*YG[7XR_Z /AG_PK=5_^8JC[7XR_Z /AG_PK=5_^8J@#IJ*YG[7XR_Z
M/AG_ ,*W5?\ YBJ/M?C+_H ^&?\ PK=5_P#F*H Z:BN9^U^,O^@#X9_\*W5?
M_F*H^U^,O^@#X9_\*W5?_F*H Z:BN9^U^,O^@#X9_P#"MU7_ .8JC[7XR_Z
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M*W5?_F*H Z:BN9^U^,O^@#X9_P#"MU7_ .8JC[7XR_Z /AG_ ,*W5?\ YBJ
M.FHKG[>Y\5-/$MWHWA^&V:11/+;^)M1NIXXB?G>*WD\)VD<TBC)6-[J!6/!E
M0<CH* "BBB@ HHHH **** /S/HHHH _0KP5_R)OA+_L6=!_]-5I6CJ^B:5KT
M-G;ZO9I>PV&JZ5K=I'(\J"'5=$OH-3TJ\'DR1EGL[ZV@N8T<M$SQJ)8W3*G.
M\%?\B;X2_P"Q9T'_ --5I734 %9FE:+I.APW5OH^G6>FPWVIZGK-Y'9P) +O
M5M9O9M1U74;DH 9[R_OKB:YNKB0M)+(Y+-@*!IT4 %!&01Z\<$@_F.1]1S11
M0!F:-HND^'=*T_0M!TZSTC1]*M8K+3=,T^".UL[*U@4+%!;P1*J1HH&>!EF+
M.Q9V9CIT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5@^*?"OAGQQX<UKPAXR\/Z-XK\*^(].N=)
MU_PYXATVTUC1-:TN\C,5U8:GIE_#/9WMI/&2LL%Q#)&PQE<@$;U%.,I0E&4)
M2C*,E*,HR<91E%J491E%QE&49).,HRC)-)III-3*,9QE"<8SA.,H3A.,9PG"
M47&4)PG&49QE&4HRC*,HRC*491E%M/\ FM^,_P#P3_\ VHO^":_Q"UW]J?\
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MM*Z:N9\%?\B;X2_[%G0?_35:5TU !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %?B]^WA_P25T+XU>+E_:?_9%\5-^S3^V3X;OG\1Z=XO\
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M/AC0_&?@OQ3ITVD^(O"_B33;75M$UG3I]I>UO["\CE@G0.D<T3,GF07$4-S
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MBB@ HHHH _L7_9B_Y-K_ &>O^R'?";_U M KW&O#OV8O^3:_V>O^R'?";_U
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M&;TJ>DL=P]F$E"GF&&E9SJ85N&8X*[IXG#24'5?W11117S)]F%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '\='[3O_)RG[0O_9<?BS_ZGNOUX=7N/[3O_)RG[0O_ &7'
MXL_^I[K]>'5_CSQ+_P E)Q'_ -E%Q!_ZO\\/]Z.$?^22X3_[)3A;_P!9GAL*
M***\4^@"BBB@ HHHH _L7_9B_P"3:_V>O^R'?";_ -0+0*]QKP[]F+_DVO\
M9Z_[(=\)O_4"T"O<:_V&X:_Y)OAS_LG>'_\ U09&?X,<7?\ )6\6?]E7Q3_Z
MTW$@4445[1\\%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP\$? 7X5^"_B7\6[J]^'?C_P[KGQ(E\3:CXT.N>&/ ^F:C\0UNO@MJO@S0_
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M)QE&4)PG*,HM.,FFF<S_ ,)KX-_Z&WPS_P"#[2O_ )+H_P"$U\&_]#;X9_\
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MX37P;_T-OAG_ ,'VE?\ R77344 <S_PFO@W_ *&WPS_X/M*_^2Z/^$U\&_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-LNPW_",Z1X[VI;PR6SE^29I_(D2%5CGF]./ _%DDI3R/%X>#VGC)X/!0_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M* /XZ/VG?^3E/VA?^RX_%G_U/=?KPZO<?VG?^3E/VA?^RX_%G_U/=?KPZO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ\-:GI6EZHGJLGB[XG>"OC=K>G6_Q8\2_&K3;+PU\0?'WQ-\!?\ "(?#S0O
MWP;\)I8W^J?"?0_#.K^&_"T'CD^/?$\T=AI<>E>.O'OC>7Q-H5CXK\;6NE>%
M;*/1;!P#[=HKX3_9N\??%J\\3_"JT^(7Q*OOB3:?'?\ 9O/Q\DLM0\,>"O#T
M'PU\1P:E\.UNO"W@[_A#_#^A7TO@*YL_B0EKI<7CN_\ &_B^*Y\-F:Y\8WPO
M+B*/B?'?QN^+GA[Q#\3_ (NV?C76/^$*^%O[2'@KX!P? B/PQX+;0?%?AS7-
M*^'5OK/BF;7I_#D_Q)D\>S:Y\0+C6/#TND^,]+\(0>'M'L-/OO!VJ7<U[K-P
M ?I%17PG^S=X^^+5YXG^%5I\0OB5??$FT^._[-Y^/DEEJ'ACP5X>@^&OB.#4
MOAVMUX6\'?\ "'^']"OI? 5S9_$A+72XO'=_XW\7Q7/ALS7/C&^%Y<11_=E
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M&^$+/6;'PUX<\3:/!K(T*W#6OQ3^+(NO#FC^&?$=OXLT/PEX OY/'$E]\,_
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MAS_LG>'_ /U09&?X,<7?\E;Q9_V5?%/_ *TW$AS/V3QE_P!![PS_ .$EJO\
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M_P"1-\)?]BSH/_IJM*Z:N9\%?\B;X2_[%G0?_35:5TU !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* /XZ/VG?^3E/VA?^RX_%G_U/=?KPZO<?VG?^3E/VA?^RX_%G_U/=?KPZO\
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MK_Q_XKL_$/A3PQ'X'U2]L?AYX;@A\#:7J7Q L]/N+K5YO^$WOD^RQ#[+HHH
M_,^BBB@#]"O!7_(F^$O^Q9T'_P!-5I735S/@K_D3?"7_ &+.@_\ IJM*Z:@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC/Q'\*AXF\:_L\? WX?^"-8\>Z?XD\,?%/3-'\9?#CXN_M1^*OAAXHO+"V^
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M1ME'"N"HJ?\ "6Z5_P ^GB;_ ,(KQE_\H: .FHKF?^$MTK_GT\3?^$5XR_\
ME#1_PENE?\^GB;_PBO&7_P H: .FHKF?^$MTK_GT\3?^$5XR_P#E#1_PENE?
M\^GB;_PBO&7_ ,H: .FHKF?^$MTK_GT\3?\ A%>,O_E#1_PENE?\^GB;_P (
MKQE_\H: .FKQS5/VB?V?M$U/4=%UKXZ?!S2-8TB^N]+U;2=4^)W@FPU/2]3L
M+B2TO].U&PN];BNK*^LKJ*6VN[2YBBN+:XBDAFC21&4=[_PENE?\^GB;_P (
MKQE_\H:_D)_:6F2X_:.^/\\8E5)_C9\59D6>":VF5)/'>O.HFMKF.*XMY0&
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M/_D]N8?]DIP?_P"J_-#IJ*YG_A+=*_Y]/$W_ (17C+_Y0T?\);I7_/IXF_\
M"*\9?_*&OZ"/Y<.FHKF?^$MTK_GT\3?^$5XR_P#E#1_PENE?\^GB;_PBO&7_
M ,H: .FHKF?^$MTK_GT\3?\ A%>,O_E#1_PENE?\^GB;_P (KQE_\H: .FHK
MF?\ A+=*_P"?3Q-_X17C+_Y0T?\ "6Z5_P ^GB;_ ,(KQE_\H: .FHKF?^$M
MTK_GT\3?^$5XR_\ E#1_PENE?\^GB;_PBO&7_P H: .FHKF?^$MTK_GT\3?^
M$5XR_P#E#1_PENE?\^GB;_PBO&7_ ,H: .FHKF?^$MTK_GT\3?\ A%>,O_E#
M1_PENE?\^GB;_P (KQE_\H: .FHKF?\ A+=*_P"?3Q-_X17C+_Y0T?\ "6Z5
M_P ^GB;_ ,(KQE_\H: .FHKF?^$MTK_GT\3?^$5XR_\ E#1_PENE?\^GB;_P
MBO&7_P H: .FHKF?^$MTK_GT\3?^$5XR_P#E#1_PENE?\^GB;_PBO&7_ ,H:
M .FHKF?^$MTK_GT\3?\ A%>,O_E#1_PENE?\^GB;_P (KQE_\H: .FHKF?\
MA+=*_P"?3Q-_X17C+_Y0T?\ "6Z5_P ^GB;_ ,(KQE_\H: /Y#OVG?\ DY3]
MH7_LN/Q9_P#4]U^O#J]L_:6F2X_:.^/\\8E5)_C9\59D6>":VF5)/'>O.HFM
MKF.*XMY0& D@GBCFB?,<L:.K*/$Z_P >>)?^2DXC_P"RBX@_]7^>'^]'"/\
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MR\_R:^F'_P GMS#_ +)3@_\ ]5^:!1117]!'\N!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?QT?M._\G*?M"_]EQ^+/_J>
MZ_7AU>X_M._\G*?M"_\ 9<?BS_ZGNOUX=7^//$O_ "4G$?\ V47$'_J_SP_W
MHX1_Y)+A/_LE.%O_ %F>&PHHHKQ3Z **** "BBB@#\(_B]_R5GXH?]E$\;?^
MI+J=>=UZ)\7O^2L_%#_LHGC;_P!274Z\[K^X<J_Y%65_]BO+/_5;EY_R(^(W
M_)Q?$3_LX/'W_K=\;A1117>?&A1110 4444 ?Z>?[ G_ "8E^Q5_V:5^SC_Z
MIWP;7UK7R5^P)_R8E^Q5_P!FE?LX_P#JG?!M?6M?U+E_^X8#_L!P/_J%@S_0
M;)O^1/D__8HRG_U598%%%%=9Z04444 %%%% !1110 4444 %%%% !1110!^9
M]%%% 'Z%>"O^1-\)?]BSH/\ Z:K2NFKF?!7_ ")OA+_L6=!_]-5I734 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5_'1^T[_R<I^T+_V7'XL_
M^I[K]?V+U_'1^T[_ ,G*?M"_]EQ^+/\ ZGNOU_)/TN/^2;X*_P"RBS;_ -4%
M$_N3Z#/_ "5OB%_V2F2?^M-7/#J***_A4_TD"BBB@ HHHH *_L7_ &8O^3:_
MV>O^R'?";_U M K^.BO[%_V8O^3:_P!GK_LAWPF_]0+0*_K;Z(__ "4G&O\
MV3N4_P#J_K'\.?3F_P"22\/?^RKSO_UF:![C1117]U'^;04444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y6?\%>_^3:_!'_9
M<?#7_J!?$NOYRJ_HU_X*]_\ )M?@C_LN/AK_ -0+XEU_.57^</TG/^3KXS_L
MG>&?_4+,#_6;Z'G_ "9++_\ LJ^,/_5AE84445_/I_404444 %%%% 'Z'_\
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M?^)'?!W_ .;*C_AOO]A+_H]7]DK_ ,2.^#O_ ,V5?YAE%'_$3L?_ -"G _\
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MT@HHHH **** "BBB@#\S?VL_&GQ@\#?M ?"37;SQQXS^&GP3LGAN=&\:^$_
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ML_\ J>Z_7AU>X_M._P#)RG[0O_9<?BS_ .I[K]>'5_CSQ+_R4G$?_91<0?\
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M/X8_YV?VEG_*4^<?]F^\-?\ U3Y^%%%%?I9_ H4444 %%%% ']#_ /P;0_\
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MO_R0?\0#SC_HI,H_\(,U_P#EA_F945_IF_\ #M?_ ()_?]&:_LX?^&E\'_\
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M;5M4T:._U/5-3O[B2[O]1U&_NWENKV^O;J66YN[NYEEN+FXEDFFD>1V8T?\
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MG_A-V?\ A1_PQM^RO_T07X:?^$W9_P"%'_$H_$G_ $6O#O\ X:<__P#EP?\
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M/,:E;#4<\XAS_.J6'K5*4U2J5</2SBE0JSI)4IU:%6=)*G.FE_F945_IF_\
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MA,%@\+*<4U&<L+@\)AI3BI>\HSEAI3BI>\HRBI>\F=-17,_\(EI7_/WXF_\
M"U\9?_+ZC_A$M*_Y^_$W_A:^,O\ Y?5L=1TU%<S_ ,(EI7_/WXF_\+7QE_\
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MBZ/H%M,)-.DBGFU:35OIB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "OBWXA_M5^+?@QJ6O7?Q?\
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M\\:^&_&MEIES?6D=_96^H77AO4]3@LY[RPEBO;6*YDCDN+22.YB5X75S5O\
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MO5-1L[Q_[-LM)_1FB@ HHHH _P PS_A@3]NW_HRK]K7_ ,1Q^,7_ ,QM'_#
MG[=O_1E7[6O_ (CC\8O_ )C:_P!/.BOS+_B&. _Z&V._\)L%_P#)'X)_Q /)
M_P#HI,W_ /"#*O\ Y8?YAG_# G[=O_1E7[6O_B./QB_^8VO[C_#WP U3XA?L
M=?\ !+3X2_$#P/XSL&\+>&/@G;_$2R_L76-'\5_"C6O#?[%/Q*T>S\0ZH9K%
M=0\ ^*O OQ(?P]'I.JZK!8W?AWQ[%H=N/*UC[+;O^LE%?1<.\)X;AVOBJ]#&
MXC%/%4:=&4:U*A34%3K.LI1=%MMMOE:EHEJM3[;@GPYP/!&+S#%X3-,;F$LP
MPM'"SABL/@Z$:4:&)EB5.#PTI2E*4I<C4[145=>\?D+9+\?'^*7C&3XN^$OC
M9HWA#2?B1\-?!GQC\8_!_2/'^GW?Q6\-^%O@Q\2QX7^(7@&Z^$9?XEW/@[7?
M&VJ?#Z[\8:7\-I#K7A+Q//?>%/$BMX1TCQ!=77I5EX/^,GCJ'X4:#XRO_C[I
M_A$?"K]L#4H9=$\:_%KX?>*9;2S^*?PXB_9B@^)7B;P?K?ASQ>GQ)/PGN[J6
M/3?$VL0^,;_4(?$S>(+>ZUVU\2*GZ845]6?HI\ ?$P?M">,_V*?&WA_5_ %E
MK>J>*_V+/$%OK-T^N^*#\8]3^*VM_!2\BO\ P[_PIVT^%Z6DFJ7OBFY>P>U@
M\<6^JB^F>VB\/)<HEDWDOQ_^ GQ4;X.ZW\2?%?BC4O&/Q$GMOV4/!NF:;\#?
M@IXCTS6/"7@3P)^T1\//'^OZQ_P@M_XA^.NN>-_&?AYGUS7&N_[.;1].T?2Y
M+4^")LZQ=:E^K-% 'YOC4;K1_BY\(/C7KUQ^T?\ &GX<>#_#OQ>\!W.L^,_V
M=O%UG\1/ 7Q"\<W?PJO/#GB*R^$W@SX$?#GQ3J7A>[\-Z%XL\,2?$'PY\.M<
MDT";7+_2]7UR#0M2UB32_7_V?(]4\/6?[2_Q9N?"'C'PYX"^(7Q5U7XH_#SP
M+>^$->TSQQ/X?L/ACX%T7Q%K@^&D^GP^+=!UWXC>-O#'BCQ1:>#=1T.P\7WM
MSJ\&HZSH=EXCUZ^L8_L&B@#\?? GPN_:M\/:@NI:EX/L_ OB;]HSX9>+-3\3
M^,/ OCSQWXPUKP_\>- \7>(?CU\+F^)-L?AWX'L? WA6WB\6>-?A)K%H_B3Q
M/I.I:/9>$?AY)JCZ?;Z7;ZHWQS??M.?$;_A'_B1J6I?&[X.> ?B/:_%O7K3P
MGIWPO_:*\:^+?A]X@T>?P!X1^#^AZSX ^!?Q1^%WQ"\.W.M>&-!\;^/YX/$Q
MU#X;3>(?$5[9>,[&VU-O"KC]A** /S)DL?C%8^&/COXP\<I^T?KGB >./@5X
M*TRW\/ZS\2?#,MIX"U?X8_LVWGQ1\4^%OAS\*KWQW93I9^-CX_E\6W'P<@\0
M^,K)X_''A7P!\1="N9M0\1V_GEWXM^+>A?#CP1H>L7/Q>UF"Z_:)^*%MI/A6
M_N_VIOA]X[\9?"6U^'6K:CH-VVL^%](^+G[6,'AO0/%.LZ=?)J%WH_B1/M0T
MW0_%VH^%K(:7I=I^O-<;XV^'7P^^)>FV^C?$;P)X-\?Z/9WBZC::5XV\,:)X
MJTVUU!(9K=+ZWL==L;^U@O$M[B>!;J*)9UAGFB#A)'5@#\E8].^,LD?PWB^'
M/Q*^(-KX(T;X3_"BR^&VL?#7X)?'3Q;9^,/C)I?C/QC9?'B3Q9I_ASXL?!OP
M7X;\3:CXDL]&B\4O^UYX;DT(W6H:MJMU<VNI6_Q @7[#\7:D/A)^T]XW^*GC
MWP3\1/%O@[QQ\$_ 7@KP'XA^'GPJ^('QEN_#.I>#_$/Q(UWX@>#]1T#X;>&/
M%_B3PM!XPM]>\(:O:ZI/I-MX>\57>B1Z1J&J+JVBZ%8W7V-HNB:-X;TG3M \
M.Z1IF@Z%H]G!IVD:+HMA:Z7I.E:?:QK%:V.G:;8Q06=C9VT2K%!:VT,4$,:J
MD:*H K3H _+[XH?##XA?&#PC\(?@GX,^ 5CX)^'UIX'^*GC?Q=X*\:_$#Q5X
M*\->%Y_%ECXB\ ?"[P];>,_#OPU^(^GWWB_2;3QEXE^(TO@*PLU@^'.NZ!X5
M>#58$TGPU/J/->$? _[2GQV\<^)KCQ3#8_""Y\??L8_"GX1_&G4/&GP7\8^*
M+#5O%ND_$C]H'PS\2M.^&VJW?C?X=:3I]X;:^N?$/AW4M7TSQM83Z!XJ\%^)
MYO#][HMW!;ZW^LU% &-X<T.T\,>'M"\-:?)=S6'A[1M+T.RFOY_M5]+::38P
M6%M)>7.U/M%W)#;HUQ/L3S9B\FU=V!LT44 ?B;^T'\$?^"YWB;XS?$+6_P!G
MS]L7]E_X?_!6_P#$-W+\-O".M^#]-;7M$\+?*-.L]?DUG]FKXF7EQK<<8*ZG
M=IXQU*SO;H27EE;Z3;3QZ39>-_\ #.?_  <9?]'[_LF_^$=X7_\ H+J_H6HK
MZFCQ9BZ-&E1CD_"DXTJ=.DIUN&,LJUIJG",%.K5G/GJU9*/-4J2]Z<Y2G+63
M2^)Q' F!Q->OB)<0\=4Y5ZU6M*GA^-,YH4*<JM2=1PH4*=/V=&C!S<:5*'N4
MJ<84XWC!-_ST_P##.?\ P<9?]'[_ +)O_A'>%_\ Z"ZOJ#]D#X0_\%C_  7\
M:]&UG]L3]JG]G/XM? I=*UZ'Q%X2\%>%;*T\7SZG-I-TGARYT.^T?X _"5+(
MVNN-8W.I3ZAKNI6TFE0WEE%HTEW=P7]A^NU%1B>*<5BL/6PT\HX6I1KTITI5
M<-PUEN&Q%-35G.AB*4_:4:L=X5(7E!ZI/8O!\$8+!8O#8RGG_&U>>&K4ZT:.
M,XQS?%X2JZ;YE3Q.%K4_98BA/:I1J6A4C[K:W7Y[ZQX%EG^#/QCM_%_A7XO6
MT<'[67B3XB:+J/PR\.Q:C\2/#<.D_%C2O$OAGXJ^#O"6N>'?$T'CNS\-W%E;
M>)4T&U\&>.3XITFSNK72O"GB>YE@TVX\@N]#^-_C?4?A/JOA;10E[IW[:]IX
MEL_C)XN_9E\<> =6\4^'K/\ 9C^)'A+4O'WQG^$DFL?#KQ)Y^D:E_9OPTLO'
MUW-\-]#\2BU\+SZ)H<6D#21K_P"L]%?,GV9\S?LM:'XJ\.>$OB%I?CO0Y-)\
M;CXU?$S4?%.IVFDWFA^$?&FHZWJT.MV_CCX?:/>M<R:5X.\1:1J.F3V^DG6/
M%%WH^M1:YI.M^+_%GB.QUGQ!J/TS110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 ?F?1110!]D>&/BKX"TWPUX>TZ]U[R;RPT/2;*[A_LO69/*N
M;6PMX)XO,BTZ2*3RY8W7?$[QMC<CLI!.Y_PN'X<_]#%_Y2-=_P#E9110 ?\
M"X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_
M^5E'_"X?AS_T,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_
MY2-=_P#E9110 ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_
M  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7
M?_E91_PN'X<_]#%_Y2-=_P#E9110 ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q
M?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_ .5E%% !
M_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E9110 ?\ "X?AS_T,7_E(
MUW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_^5E'_"X?AS_T
M,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E9110
M ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_  N'X<_]#%_Y
M2-=_^5E'_"X?AS_T,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7?_E91_PN'X<_
M]#%_Y2-=_P#E9110 ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y644
M4 '_  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_ .5E%% !_P +A^'/_0Q?
M^4C7?_E91_PN'X<_]#%_Y2-=_P#E9110 ?\ "X?AS_T,7_E(UW_Y64?\+A^'
M/_0Q?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_ .5E
M%% !_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E9110 ?\ "X?AS_T,
M7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_^5E'_"X?
MAS_T,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E
M9110 ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_  N'X<_]
M#%_Y2-=_^5E'_"X?AS_T,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7?_E91_PN
M'X<_]#%_Y2-=_P#E9110 ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\
MY6444 '_  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_ .5E%% !_P +A^'/
M_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E9110 ?\ "X?AS_T,7_E(UW_Y64?\
M+A^'/_0Q?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_
M .5E%% !_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E9110 ?\ "X?A
MS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_^5E'
M_"X?AS_T,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=
M_P#E9110 ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_  N'
MX<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7?_E9
M1_PN'X<_]#%_Y2-=_P#E9110 ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C
M7?\ Y6444 '_  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_ .5E%% !_P +
MA^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E9110 ?\ "X?AS_T,7_E(UW_Y
M64?\+A^'/_0Q?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E
M(UW_ .5E%% !_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E9110 ?\
M"X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_
M^5E'_"X?AS_T,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_
MY2-=_P#E9110 ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_
M  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7
M?_E91_PN'X<_]#%_Y2-=_P#E9110 ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q
M?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_^5E'_"X?AS_T,7_E(UW_ .5E%% !
M_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E9110 ?\ "X?AS_T,7_E(
MUW_Y64?\+A^'/_0Q?^4C7?\ Y6444 '_  N'X<_]#%_Y2-=_^5E'_"X?AS_T
M,7_E(UW_ .5E%% !_P +A^'/_0Q?^4C7?_E91_PN'X<_]#%_Y2-=_P#E9110
M ?\ "X?AS_T,7_E(UW_Y64?\+A^'/_0Q?^4C7?\ Y6444 ?#_E2?W?U7_&BB
$B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )( \X# 2(  A$! Q$!_\0
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M_(E'_"%>#?\ H4O#/_@ATK_Y$KIJ* .9_P"$*\&_]"EX9_\ !#I7_P B4?\
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M"O!O_0I>&?\ P0Z5_P#(E'_"%>#?^A2\,_\ @ATK_P"1*Z:B@#F?^$*\&_\
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M^A2\,_\ @ATK_P"1*Z:B@#F?^$*\&_\ 0I>&?_!#I7_R)1_PA7@W_H4O#/\
MX(=*_P#D2NFHH YG_A"O!O\ T*7AG_P0Z5_\B4?\(5X-_P"A2\,_^"'2O_D2
MNFHH YG_ (0KP;_T*7AG_P $.E?_ ")1_P (5X-_Z%+PS_X(=*_^1*Z:B@#F
M?^$*\&_]"EX9_P#!#I7_ ,B4?\(5X-_Z%+PS_P""'2O_ )$KIJ* .9_X0KP;
M_P!"EX9_\$.E?_(E'_"%>#?^A2\,_P#@ATK_ .1*Z:B@#F?^$*\&_P#0I>&?
M_!#I7_R)1_PA7@W_ *%+PS_X(=*_^1*Z:B@#F?\ A"O!O_0I>&?_  0Z5_\
M(E'_  A7@W_H4O#/_@ATK_Y$KIJ* .9_X0KP;_T*7AG_ ,$.E?\ R)1_PA7@
MW_H4O#/_ ((=*_\ D2NFHH YG_A"O!O_ $*7AG_P0Z5_\B4?\(5X-_Z%+PS_
M ."'2O\ Y$KIJ* .9_X0KP;_ -"EX9_\$.E?_(E'_"%>#?\ H4O#/_@ATK_Y
M$KIJ* .9_P"$*\&_]"EX9_\ !#I7_P B4?\ "%>#?^A2\,_^"'2O_D2NFHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#W4]QK<<CA%*V7B;Q)IMN BA1LM-.U6UM(R0 79(5:1LNY9R6-3_ (1+2O\
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M$W_A:^,O_E]7344 <S_PB6E?\_?B;_PM?&7_ ,OJ/^$2TK_G[\3?^%KXR_\
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MTU% ',_\(EI7_/WXF_\ "U\9?_+ZC_A$M*_Y^_$W_A:^,O\ Y?5TU% ',_\
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MK/\ ]-6LT >F>"O^1-\)?]BSH/\ Z:K2NFKF?!7_ ")OA+_L6=!_]-5I734
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5X;\?_P#D3=,_[&:S_P#35K->Y5X;\?\ _D3=,_[&:S_]
M-6LT >F>"O\ D3?"7_8LZ#_Z:K2NFKF?!7_(F^$O^Q9T'_TU6E=-0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7AOQ_\ ^1-TS_L9K/\ ]-6LU[E7AOQ__P"1-TS_ +&:S_\ 35K-
M 'IG@K_D3?"7_8LZ#_Z:K2NFKF?!7_(F^$O^Q9T'_P!-5I734 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !162^NZ3'KMMX9>]C
M77;S2+[7;;3BDOFS:3IMYI^GWUZL@C\CR[:\U73H'1I1*6NHV6-D#LNM24HR
MYN62ERR<96:?+)*+<96;M)*46T[-*4;K57TJ4:M)4W5I5*:K4H5Z+J0E!5:%
M252,*U-R2]I2G*C6C&I#FA*5*HE)NG-1****9F%%%% !1110 5X;\?\ _D3=
M,_[&:S_]-6LU[E7AOQ__ .1-TS_L9K/_ --6LT >F>"O^1-\)?\ 8LZ#_P"F
MJTKIJYGP5_R)OA+_ +%G0?\ TU6E=-0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ5_\B5TU% ',_P#"%>#?^A2\,_\ @ATK_P"1*/\ A"O!O_0I>&?_  0Z5_\
M(E=-10!S/_"%>#?^A2\,_P#@ATK_ .1*/^$*\&_]"EX9_P#!#I7_ ,B5TU%
M',_\(5X-_P"A2\,_^"'2O_D2C_A"O!O_ $*7AG_P0Z5_\B5TU% ',_\ "%>#
M?^A2\,_^"'2O_D2C_A"O!O\ T*7AG_P0Z5_\B5TU% ',_P#"%>#?^A2\,_\
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MTU% ',_\(5X-_P"A2\,_^"'2O_D2C_A"O!O_ $*7AG_P0Z5_\B5TU% ',_\
M"%>#?^A2\,_^"'2O_D2C_A"O!O\ T*7AG_P0Z5_\B5TU% ',_P#"%>#?^A2\
M,_\ @ATK_P"1*/\ A"O!O_0I>&?_  0Z5_\ (E=-10!S/_"%>#?^A2\,_P#@
MATK_ .1*/^$*\&_]"EX9_P#!#I7_ ,B5TU% ',_\(5X-_P"A2\,_^"'2O_D2
MC_A"O!O_ $*7AG_P0Z5_\B5TU% ',_\ "%>#?^A2\,_^"'2O_D2C_A"O!O\
MT*7AG_P0Z5_\B5TU% ',_P#"%>#?^A2\,_\ @ATK_P"1*/\ A"O!O_0I>&?_
M  0Z5_\ (E=-10!S/_"%>#?^A2\,_P#@ATK_ .1*/^$*\&_]"EX9_P#!#I7_
M ,B5TU% ',_\(5X-_P"A2\,_^"'2O_D2C_A"O!O_ $*7AG_P0Z5_\B5TU<KX
MO\=^"/A[ID&M>/O&7A7P/H]U?1:7;:MXO\0Z1X:TRXU.:WN;N'3H+_6KRRM9
M;Z6ULKRYBM(Y6N)+>TN9DC,<$K)E7KT,-1J8C$UZ.&P]&+G5KXFM1P]"E!.*
M<ZM?$5:%&E!.44YU:U."<HIR3E%2VP^&Q.,KTL+A,/B,7BJ\U3H8;"8>OBL3
M7J-2:IT<-A:&)Q%:HU";4*.'JS:A-J#49.,G_"%>#?\ H4O#/_@ATK_Y$H_X
M0KP;_P!"EX9_\$.E?_(E>:?\-._LU_\ 1POP._\ #L^ O_E_1_PT[^S7_P!'
M"_ [_P .SX"_^7]>5_K+PW_T4?#O_B09!_\ /P]O_5'BW_HD^*__ !%N)O\
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MC-9_^FK6: /3/!7_ ")OA+_L6=!_]-5I735S/@K_ )$WPE_V+.@_^FJTKIJ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_*S_ (*]_P#)M?@C_LN/
MAK_U OB77ZIU^5G_  5[_P"3:_!'_9<?#7_J!?$NOS'QH_Y-1Q]_V3N(_P#4
MW)S]B^C[_P GM\,?^RKPO_JOSX_G*HHHK_*T_P!I@HHHH **** "OU3_ ."0
MG_)RGC?_ +(=XE_]3WX:5^5E?JG_ ,$A/^3E/&__ &0[Q+_ZGOPTK].\%_\
MDZ_ /_918?\ ]0LX/Q[Z07_)DO$[_LE,5_ZL,A/Z-:***_U2/\6 HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPWX
M_P#_ ")NF?\ 8S6?_IJUFO<J\-^/_P#R)NF?]C-9_P#IJUF@#TSP5_R)OA+_
M +%G0?\ TU6E=-7,^"O^1-\)?]BSH/\ Z:K2NFH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXC'4_$:Z1XPNM&\-WNM>%(M U3V#X5?M(:;\6_C+\6_AGX?\,747ACX:^%_
M7B'1/B/-J:/8?$.3Q5XI^*O@S7AH&A_8([BVT'POXD^%>K:/:^([C498O%=V
M+^\T>P3P[;:-K_B3Q+XM?LD>/?C)^T1X2\9^,_B!X<U'X2^%[:\UOP\B_#F'
M1_C7X"U8^(? VI7'@[P1\9?#/CS0[G0M!\2VN@ZSINHZW:> I?%T/A'7?%OA
M2X\7WKZ_IFJ:%K:)^Q[<?!3Q=XF^(?[./B_6]-US5/AK\"_@]X:\*?%CQ[\;
M/BMX/\,>$/AU\2/$&M>*KB6+QG\7-6EU/[?X$\4W.A^$-.CMK-_ VH:7=W^A
MWDB>,O$ME<?)X>IQ52Q=:52C7KY?2SW%5*CJ2P4<76RQX:LJ5#!8-0DGAJ55
MX:49PQL*V)JI<BPU-X^FOZ SC!^ F/X=RRA@LRRO*>,,=X4Y%@L%3PM#B:OP
M]EG'-/.\MGF.:\3\13Q%"4,YQ^!AG=*OA\3PQBLLR3+ZE15Y9WBH\)8N6SXG
M_:XO_#/COQ5]H^'>ER? ?P#\5/#/P.\;_%M_B"T/BG2OB5XHTCPQJ-O+8?#"
M/P7<V&H?#_2-0\:>&?#.O>*+WXDZ-XBM=>N=1_L[P+JNC:<NL7G+:)^V[J-C
MX,UGQ[\5OA%'X%T'4/@%JO[2WPIM_#GQ#MO'&L^-OAQITN@P1Z%XHM[[PGX(
MTGP+\4+B;QCX(B?PSINM^._"4$GB5 OQ"N!IUX5ZGQ/^R/?^)O'?BK[1\1-+
MC^ _C[XJ>&?CCXW^$C_#YIO%.J_$KPOI'AC3K>*P^)\?C2VL-/\ A_J^H>"_
M#/B;7O"][\-M9\176O6VH_V=XZTK1M171[/EM$_8BU&^\&:SX"^*WQ=C\=:#
MI_P"U7]FGX4W'ASX>6W@?6?!/PXU&709X]=\47%]XL\;Z3XZ^*%O-X.\$2OX
MFTW1/ GA*>3PTA7X>VXU&\#34_UQ^L5_8\_)?%_5O:_V9]5]OS9CR^UM_M']
MF_5?[*_L_P#YBO[1^O?7?]F-L)_Q+?\ V1E/]H_4_K/)P_\ VU]0_P!>?[<_
MLGV/!_M_J//_ ,)/^NO]N?Z__P"N-O\ A!_U-_U7_P!6?^%NY[=\+_C;XHUN
M\^)?ACXS^!/#_P *_'7PKT/PSXR\1V'A;Q_>?$WP?/X(\867B*[T37-,\6ZA
MX%^&VJSW=K/X0\4:9XATRX\&VL.FZAI).FZGKEA=VU^_B.B?MNZC8^#-9\>_
M%;X11^!=!U#X!:K^TM\*;?PY\0[;QQK/C;X<:=+H,$>A>*+>^\)^"-)\"_%"
MXF\8^"(G\,Z;K?COPE!)XE0+\0K@:=>%>TT/X&?&W2M;O?%'BGXE?#GXC>*_
MB=KG@[PI\:KZ'X7:QX#\)S_ ;P9X3^(=G:>%/!'A5_B;XXU?1_&&H>)_&,FK
M:EXDU'QAK6F7<^HWZ6WAS2M-AMK&'B]$_8BU&^\&:SX"^*WQ=C\=:#I_P"U7
M]FGX4W'ASX>6W@?6?!/PXU&709X]=\47%]XL\;Z3XZ^*%O-X.\$2OXFTW1/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7Y6?\%>_P#DVOP1_P!EQ\-?^H%\2Z_5.ORL_P""O?\ R;7X(_[+CX:_
M]0+XEU^8^-'_ ":CC[_LG<1_ZFY.?L7T??\ D]OAC_V5>%_]5^?'\Y5%%%?Y
M6G^TP4444 %%%% !7ZI_\$A/^3E/&_\ V0[Q+_ZGOPTK\K*_5/\ X)"?\G*>
M-_\ LAWB7_U/?AI7Z=X+_P#)U^ ?^RBP_P#ZA9P?CWT@O^3)>)W_ &2F*_\
M5AD)_1K1117^J1_BP%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %>&_'__ )$W3/\ L9K/_P!-6LU[E7AOQ_\ ^1-T
MS_L9K/\ ]-6LT >F>"O^1-\)?]BSH/\ Z:K2NFKF?!7_ ")OA+_L6=!_]-5I
M734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^5G_  5[_P"3:_!'
M_9<?#7_J!?$NOU3K\K/^"O?_ ";7X(_[+CX:_P#4"^)=?F/C1_R:CC[_ +)W
M$?\ J;DY^Q?1]_Y/;X8_]E7A?_5?GQ_.51117^5I_M,%%%% !1110 5^J?\
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M>,O_ )0T =-17,_\);I7_/IXF_\ "*\9?_*&C_A+=*_Y]/$W_A%>,O\ Y0T
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MU%<S_P );I7_ #Z>)O\ PBO&7_RAH_X2W2O^?3Q-_P"$5XR_^4- '345S/\
MPENE?\^GB;_PBO&7_P H:/\ A+=*_P"?3Q-_X17C+_Y0T =-17,_\);I7_/I
MXF_\(KQE_P#*&C_A+=*_Y]/$W_A%>,O_ )0T =-17,_\);I7_/IXF_\ "*\9
M?_*&C_A+=*_Y]/$W_A%>,O\ Y0T =-17,_\ "6Z5_P ^GB;_ ,(KQE_\H:/^
M$MTK_GT\3?\ A%>,O_E#0!TU%<S_ ,);I7_/IXF_\(KQE_\ *&C_ (2W2O\
MGT\3?^$5XR_^4- '345S/_"6Z5_SZ>)O_"*\9?\ RAH_X2W2O^?3Q-_X17C+
M_P"4- '345S/_"6Z5_SZ>)O_  BO&7_RAH_X2W2O^?3Q-_X17C+_ .4- '34
M5S/_  ENE?\ /IXF_P#"*\9?_*&C_A+=*_Y]/$W_ (17C+_Y0T =-17,_P#"
M6Z5_SZ>)O_"*\9?_ "AH_P"$MTK_ )]/$W_A%>,O_E#0!TU%<S_PENE?\^GB
M;_PBO&7_ ,H:/^$MTK_GT\3?^$5XR_\ E#0!TU%<S_PENE?\^GB;_P (KQE_
M\H:/^$MTK_GT\3?^$5XR_P#E#0!TU%<S_P );I7_ #Z>)O\ PBO&7_RAH_X2
MW2O^?3Q-_P"$5XR_^4- '345S/\ PENE?\^GB;_PBO&7_P H:/\ A+=*_P"?
M3Q-_X17C+_Y0T =-17,_\);I7_/IXF_\(KQE_P#*&C_A+=*_Y]/$W_A%>,O_
M )0T =-17,_\);I7_/IXF_\ "*\9?_*&C_A+=*_Y]/$W_A%>,O\ Y0T =-17
M,_\ "6Z5_P ^GB;_ ,(KQE_\H:/^$MTK_GT\3?\ A%>,O_E#0!TU%<S_ ,);
MI7_/IXF_\(KQE_\ *&C_ (2W2O\ GT\3?^$5XR_^4- '345S/_"6Z5_SZ>)O
M_"*\9?\ RAH_X2W2O^?3Q-_X17C+_P"4- '345S/_"6Z5_SZ>)O_  BO&7_R
MAH_X2W2O^?3Q-_X17C+_ .4- '345S/_  ENE?\ /IXF_P#"*\9?_*&C_A+=
M*_Y]/$W_ (17C+_Y0T =-17,_P#"6Z5_SZ>)O_"*\9?_ "AH_P"$MTK_ )]/
M$W_A%>,O_E#0!TU%<S_PENE?\^GB;_PBO&7_ ,H:/^$MTK_GT\3?^$5XR_\
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M]/$W_A%>,O\ Y0T =-17,_\ "6Z5_P ^GB;_ ,(KQE_\H:/^$MTK_GT\3?\
MA%>,O_E#0!TU%<S_ ,);I7_/IXF_\(KQE_\ *&C_ (2W2O\ GT\3?^$5XR_^
M4- '345S/_"6Z5_SZ>)O_"*\9?\ RAH_X2W2O^?3Q-_X17C+_P"4- '345S/
M_"6Z5_SZ>)O_  BO&7_RAH_X2W2O^?3Q-_X17C+_ .4- '345S/_  ENE?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF2\3O^R4Q7_JPR$_HUHHHK_5(_Q8"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ JCJ>IZ;HNG7^L:SJ%CI.D:59W.HZIJFIW=O8:=INGV4+W%Y?7]]=21
M6UG9VEO')/<W5Q+'!!#&\LKHBLPO5\Y_M2>9_P *QTGS/M']C?\ "XOV?_\
MA+/(^S>7_P (A_PO#X?_ /"1_P!I?:OW7]A_V;YW]O[OD_L3[?YW^C>=7-C<
M0\+A,3B8Q4Y4*,ZD8-M1<DX17,TFU!.HI5&E=4X5&M4FO;X:RF&?<09+DM6O
M/#4LTS'#X.K7IPA4JTZ=18FK4="G4E&G4Q,Z>#G0PM.I)4YXO$X.$[PE.%3J
M[GX_?!RT^,>F? "X^(_@N/XO:OX;OO%5CX#;Q7X;7Q3+I=C]AD8#PXVK#Q ;
MFZL+XZO8Q)I3)=Z/8ZGJ4<IMK&9QT_A7XH?#/QWJ_B?P_P""/B)X%\9:_P""
M;Q-/\9Z)X5\6Z!XAU?PC?RW%]:1V/B?3=(U"\O= O)+K2]3MDMM5AM)GN-.O
MH50R6EPL?Y/_ !9T'Q%9_MH:EHGPI\,_$:[UWQY-=:_XB\%?%'X&ZIXK^%5K
MK-Q?_!OPVW[07P;^.&E:8WACX?:UX4TG2-%\83Q^*?&FOWMKK?PZ/A?1_A_X
M,\5>.=-U35.J_9O\1^*O@;#\.[WXCZ9\5I?!GPW_ &?O"GPS^)3^/?V>[;0]
M6^$OQ7U[QY\*_!'AWX<?!#Q/X*^%6@ZQ\4_AOXAUB3Q+J?C/5]*\6?&;1[>V
M\(^"/%FI>-EFU%;S7/D,/Q3C'F-?"XO"4:>%H9GB\+4QM.&,=&EAJ4H1I7JR
MA&G.M3@_K>-GR0CA:,^6K1<8TL37_HO./ ?AN/!N4Y]P_P 0YEC,_P TX%X>
MSW!<-8O$\.0S''YUF%+%5L<XX"AB*^+P^6XS%4_[ X9PRQ6)KYYF>'=;!9G3
MJU,=DF5_IC<?%CX66GQ"LOA'=_$KP!:_%?4M(?Q!IWPQN/&7AV'XA:AH$?G^
M9KEEX+DU%?$EUI"?9;G?J4&FR62_9I]TX\F3;%X1^+_PF\?S>+[;P'\4/AWX
MVN/A]J5QHWCV#PCXV\->))O!&L6GVC[5I7B^+1M3O7\-:E;?9+K[18ZRME=0
M_9KCS(E\F3;^;?Q%\%>/=2\:?&'X1Z3X+\?K\4_B%^V!\,/COX"^+5O\.?$T
MGP]T?X:^'/"7PJLY_$E[\7K;29/ VF:OX1TCP;XL^'2>!]:\2Z?X\U#[1!_8
MWAF_\.:U!J4_FEM\-?B#\2O@E)X(\ _"3XB>"O$7PQ_X)Y^(OV<_'FE>+OAQ
MK'P[A\6?$UKGX=RQ_#3PA=^+;#0O#OQ&TV:V\'?$.UM_''@S4_$'PUG_ .$Z
MMVM_%T@UB],94XGS.&(KTHY5&LJ+Q;A3IT\R5>O.C+,8+ PD\.Z'UW#T\%A\
M=C)WEAJF#S+"PP;GB%:K.$\"^",3E&4X^MQYB,OGF$.'XXK&8K%\%2RO*\/F
M='@_$3XIQ5&&<T\T?#.<XOB7..%>',*Z=+.\+Q'P5GF)XC6'R:HI8']>?A[\
M4/AG\7- /BOX4?$3P+\3O"ZWUUI;>)/A[XNT#QIH"ZG8E!>Z<=8\-ZAJ6G"^
MLS)&+JT-S]HMS(GFQIO7-7PC\7_A-X_F\7VW@/XH?#OQM<?#[4KC1O'L'A'Q
MMX:\23>"-8M/M'VK2O%\6C:G>OX:U*V^R77VBQUE;*ZA^S7'F1+Y,FWXK\)>
M/M/O?B'\6_'>B>&/B?\ "_PY^T#IOP>^ WPHN?%_P;^)'P_UN\^+OASP7\9-
M5O\ Q#JG@GQ)X5T;Q;X5\.Z'HTWASPW'XS\0:#IGAB_G\,PP:7J]YI=OI]Y)
M\R6WPU^(/Q*^"4G@CP#\)/B)X*\1?#'_ ()Y^(OV<_'FE>+OAQK'P[A\6?$U
MKGX=RQ_#3PA=^+;#0O#OQ&TV:V\'?$.UM_''@S4_$'PUG_X3JW:W\72#6+TQ
MZU.)L9"G1]C@Z&-K>SQTJM/#0S%/%2H3Q*POU&,\.YT8XC#489C;'I2G@IM8
M?VE5TO:<&#\$.'J^*S-9GQ#FO#&7_7.%Z.!QF=8C@V<<AI9K0R66>+BFKALW
MIX;,JV3YUF=?@SGX4D\/A^)</"IG'U/ 1QJPGZDP?M*?LZ7/PZO_ (OVWQ]^
M"MQ\)=+U+^QM3^*,'Q4\"R_#K3M8^TP6?]E7_C:/76\-6>I?:[JVM?L-QJ<=
MU]IN8(/*\V:-6]+TWQ7X6UI]*CT?Q+H&K2:[H2>*=$CTW6=.OWUCPS(]I&GB
M/2DM;F5M0T)WU"P1-7M!-I[/?6BBX)N80_Y/ZM<W^K?M'^&OVL-*^$OQJLOV
M?O"_BKX=:;KOAZ?]GKXJ6OQ%F\3Z+\%OV@/!(^)%A\"KCP9%\8;_ $WP?=_$
M3P1\/_[8\/\ @'4IYK9Y]7T9;[PAX?O-;M/8_@SX:U_PI/\ L>Z;<:!JWA/Q
M!>^,/VJ_$]QX3NK:RLM5\+_ OQI?^.?&&D>'O$&GRL;O2[72-9USX$V5[H]N
M([K1M>ATC2;V&!;*>%*P7$>-KXB5*KA,.Z4:M*E&M1AF--8BG/&83"T\?A_K
M5&$/JF-^MU%@J4Y/$JIEV.=:])T91QXF\&N&,JR>CC\!Q!G$,=7P&/S"KEV9
MXG@W%RR?&87AWB'/,5PEFRR',L1B/]8.&5P_A*G$V88>C3R2>#XSX6AECIYA
M3S&A5_1RO#?C_P#\B;IG_8S6?_IJUFO<J\-^/_\ R)NF?]C-9_\ IJUFOL3^
M<#TSP5_R)OA+_L6=!_\ 35:5TU<SX*_Y$WPE_P!BSH/_ *:K2NFH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW_[(=XE_]3WX:5^5E?JG_P $A/\ DY3QO_V0[Q+_ .I[\-*_3O!?_DZ_ /\
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MI'X1B^(?_""N?$D?A*/P]%XO"^&([55D^(W]B_\ "Z_B7]C_ .$8_P"&XO\
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M7_H2O$W_ (%^#?\ YK: .FHKF?[>U7_H2O$W_@7X-_\ FMH_M[5?^A*\3?\
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M?@W_ .:V@#IJ*YG^WM5_Z$KQ-_X%^#?_ )K:/[>U7_H2O$W_ (%^#?\ YK:
M.FHKF?[>U7_H2O$W_@7X-_\ FMH_M[5?^A*\3?\ @7X-_P#FMH Z:BN9_M[5
M?^A*\3?^!?@W_P":VC^WM5_Z$KQ-_P"!?@W_ .:V@#IJ*YG^WM5_Z$KQ-_X%
M^#?_ )K:/[>U7_H2O$W_ (%^#?\ YK: .FHKF?[>U7_H2O$W_@7X-_\ FMH_
MM[5?^A*\3?\ @7X-_P#FMH Z:BN9_M[5?^A*\3?^!?@W_P":VC^WM5_Z$KQ-
M_P"!?@W_ .:V@#IJ*YG^WM5_Z$KQ-_X%^#?_ )K:/[>U7_H2O$W_ (%^#?\
MYK: .FHKF?[>U7_H2O$W_@7X-_\ FMH_M[5?^A*\3?\ @7X-_P#FMH Z:BN9
M_M[5?^A*\3?^!?@W_P":VC^WM5_Z$KQ-_P"!?@W_ .:V@#IJ*YG^WM5_Z$KQ
M-_X%^#?_ )K:/[>U7_H2O$W_ (%^#?\ YK: .FHKF?[>U7_H2O$W_@7X-_\
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ML)E.&I9'2HRR13RFI\;?\,::-) =;N_CE\=K_P",D/B;0?$NE_M"W5Y\(_\
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M=?E9_P %>_\ DVOP1_V7'PU_Z@7Q+K\Q\:/^34<??]D[B/\ U-R<_8OH^_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *_*S_@KW_P FU^"/^RX^&O\ U OB77ZIU^5G_!7O_DVOP1_V7'PU
M_P"H%\2Z_,?&C_DU''W_ &3N(_\ 4W)S]B^C[_R>WPQ_[*O"_P#JOSX_G*HH
MHK_*T_VF"BBB@ HHHH *_5/_ ()"?\G*>-_^R'>)?_4]^&E?E97ZI_\ !(3_
M ).4\;_]D.\2_P#J>_#2OT[P7_Y.OP#_ -E%A_\ U"S@_'OI!?\ )DO$[_LE
M,5_ZL,A/Z-:***_U2/\ %@**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *\-^/_ /R)NF?]C-9_^FK6:]RKPWX__P#(
MFZ9_V,UG_P"FK6: /3/!7_(F^$O^Q9T'_P!-5I735S/@K_D3?"7_ &+.@_\
MIJM*Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_DZ_ /_ &46'_\ 4+.#\>^D%_R9+Q._[)3%?^K#(3^C6BBBO]4C_%@****
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MK!^TI^SI<_#J_P#B_;?'WX*W'PETO4O[&U/XHP?%3P++\.M.UC[3!9_V5?\
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M^1-\)?\ 8LZ#_P"FJTKIJ9 4444 %%%% !1110 4444 %%%% !1110 4444
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M_#WK]I3_ *$CX'?^$UX]_P#GET?\/>OVE/\ H2/@=_X37CW_ .>77Y644?\
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MFE@:E7)\HQ=3*L;G.2T*\<1_;N<XC*\HG'X&^&GB@:!X;^+.L3:5X[^'=O\
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MV-#$8?%4HU\+B*&*H35X5L-7HXBC-?W:M"K7I2WUY:C:ZI/0****S-@HHHH
M**** "BBB@#^<K_@KW_R<IX(_P"R'>&O_4]^)=?E97ZI_P#!7O\ Y.4\$?\
M9#O#7_J>_$NORLK_ "M\:/\ DZ_'W_918C_U"R<_VG^C[_R9+PQ_[)3"_P#J
MPSX****_,3]A"BBB@ HHHH _JF_X)N_\F7?!G_NHG_JU_'5?<5?#O_!-W_DR
M[X,_]U$_]6OXZK[BK_6SPW_Y-YP)_P!D?PW_ .JC"'^''BU_R=/Q)_[+SBW_
M -7N."BBBOM#\^"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K\K/^"O?_)M?@C_LN/AK_P!0+XEU^J=?E9_P5[_Y-K\$?]EQ\-?^
MH%\2Z_,?&C_DU''W_9.XC_U-R<_8OH^_\GM\,?\ LJ\+_P"J_/C^<JBBBO\
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MX:M_X:8^*7_"RO\ A6O_  HO_A"O^*)^'7@[^Q?^$Q_X7%_PDG_(@>$?"O\
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M 7Q-^)7PB\>_LV_&'X=^'=-\/?!WQWXLU_3?%_CCQ!X U&TTWQ%X1TWPY?\
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M\<?_  FO 7_SRZ_G*HH_XF<\5_\ H,X=_P#$9P7_ ,\ _P")//!+_H7\5_\
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MAG_PK=5_^8J@#IJ*YG[7XR_Z /AG_P *W5?_ )BJ/M?C+_H ^&?_  K=5_\
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M\*6IFF>4/I\CR70_H ^U^,O^@#X9_P#"MU7_ .8JC[7XR_Z /AG_ ,*W5?\
MYBJ^EI<:<10IQHXK&T\VP\=%A\[P>#SBE;JE+'8>>(A?JZ>*A+^]HCXZOX<\
M(SJRQ&"RZMD.+F[O%\-9CF.05^;HY1RW%T\+4L]HU<#4@M;05VS^?T_ML_\
M!;/]FX^5^T-_P3^\-_M"^&M//S^*O@)>74NNZK:1;!/?SQ> M2^)WV)0!(^V
M\^&OAUHU5II+5;8+*?0/AY_P<(_LAW^JCPM\>OA[\=?V:_%EL\::Q;>,O!,O
MB;1-+:08(>7PQ)/XW=HF5_-6?X>VC&/RVA$SM)%#^X7VOQE_T ?#/_A6ZK_\
MQ5<!\0/AEX?^+.EG0_BG\&/@W\2M%*NG]D>/H[/QCI@23&]18^(?AUJ-L Y
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MJ*YG[7XR_P"@#X9_\*W5?_F*H^U^,O\ H ^&?_"MU7_YBJ .FHKF?M?C+_H
M^&?_  K=5_\ F*H^U^,O^@#X9_\ "MU7_P"8J@#IJ*YG[7XR_P"@#X9_\*W5
M?_F*H^U^,O\ H ^&?_"MU7_YBJ .FHKF?M?C+_H ^&?_  K=5_\ F*H^U^,O
M^@#X9_\ "MU7_P"8J@#IJ*YG[7XR_P"@#X9_\*W5?_F*H^U^,O\ H ^&?_"M
MU7_YBJ .FHKF?M?C+_H ^&?_  K=5_\ F*H^U^,O^@#X9_\ "MU7_P"8J@#I
MJ*YG[7XR_P"@#X9_\*W5?_F*H^U^,O\ H ^&?_"MU7_YBJ .FHKF?M?C+_H
M^&?_  K=5_\ F*H^U^,O^@#X9_\ "MU7_P"8J@#IJ_*S_@KW_P FU^"/^RX^
M&O\ U OB77Z6_:_&7_0!\,_^%;JO_P Q5?EU_P %:Y]?D_9Q\%+JNF:/96X^
M-GAPI+I^N7NIS--_P@GQ("QM!<^'M)1(BAD9IA<NZNB((&$C21_F/C1_R:CC
M[_LG<1_ZFY.?L7T??^3V^&/_ &5>%_\ 5?GQ_/%1117^5I_M,%%%% !1110
M5\9_MR?\DF\/?]E$TG_U&O%M?9E?&?[<G_))O#W_ &432?\ U&O%M?6\!_\
M)9<-_P#8TI_^F,<?S3],C_E%CQX_[-]C_P#U<<(GY5T445_89_RZA1110 44
M44 %?UJ?\&M__-\W_=LO_OP=?R5U_6#_ ,&P$NLQ?\-P?V18:9?;O^&:?M']
MHZM=:7Y6/^%_^5Y/V;1=8\_?F7S-_P!G\K8FWSO,;ROK.!_^2HRS_N<_]0<2
M?HWA-_R7^0_]U/\ ]5../ZYZ*YG[7XR_Z /AG_PK=5_^8JC[7XR_Z /AG_PK
M=5_^8JOZ$/[2.FHKF?M?C+_H ^&?_"MU7_YBJ/M?C+_H ^&?_"MU7_YBJ .F
MHKF?M?C+_H ^&?\ PK=5_P#F*H^U^,O^@#X9_P#"MU7_ .8J@#IJ*YG[7XR_
MZ /AG_PK=5_^8JC[7XR_Z /AG_PK=5_^8J@#IJ*KVC7;V\37T%O;W9!\Z&TN
MI;VWC;<P4174UG823 IM8L]I"0Q90K!0[6* "BBB@ HHHH **** "BBB@ KP
MWX__ /(FZ9_V,UG_ .FK6:]RKPWX_P#_ ")NF?\ 8S6?_IJUF@#TSP5_R)OA
M+_L6=!_]-5I735S/@K_D3?"7_8LZ#_Z:K2NFH :Z)*CQR(LD<BLDD;J'1T<%
M71U8%65E)5E8$,"000:BMK:VLK:WL[.W@M+2T@BMK6UMHHX+:VMH(UB@M[>"
M)4BA@AB18XHHU6..-51%50 )Z* "@@$$$9!X(/0CT-%% #(HHH(HX88XX888
MTBBBB18XHHHU"1QQQH B1H@"HB@*J@*H  %/HHH **** "BBB@ HHHH ****
M "BBB@ K^'>O[B*_AWK^+_I>?\T!_P!W/_[PC_03Z"G_ #<__NSO_?D"BBBO
MXO/]! HHHH **** "O[B*_AWK^XBO[0^B'_S7_\ W;'_ +W3_/OZ=?\ S;#_
M +O'_P!]L****_M _P ^PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K'U[P[X?\5:7<Z'XHT+1_$FBWJA+S1]>TRRUC2[M!T6YT_4(+BT
MG4=EEA<>U;%%-2<6I1;C*+3C*+<91:U34HN,DT]4TTT]4TQ2C&<91G&,XR3C
M*,XQE&46K.,HRC*,HM:-2C)-:--:'YL?&#_@D+_P3L^-(NY_$'[,W@GPGJUR
M':/6_A2^J?"FZM;B3 >[73? E]HGAN^N&^8N-8T+4X'D=YY(&N")1\%W_P#P
M08O_ (47MSK?[%'[=_[2'[.NH&9[V+2+_5)M:TFZG8[C8W-YX$U7X8SC3I2$
MA<ZIIOB1VMD\J]AU$LS'^ANBOHL)Q=Q)@J?L:6<8NMA]$\+CI4\SPDDOLRP^
M94L=3<?*ZMNFG9KY''\ \'9C5^L5N'\!A\6FW''99&KDV.A)[RAB\FKY95C+
MSM*]K--73_A^_;G\"_\ !3KX(?%GPYH'QY^*'PX_:;UNS^'.D2^&M?L8;*RO
MO^$%;Q-XNCL+#5I)M ^'.I7.M0ZS%XANII;R\\27ABNK6,:Q>PI!9VOQ>O[4
MWB/PNRQ?%+X->+O#2HVV34].CEFLY>2"]O%JMMIUJZ C ,6LW*MSAP1@_P!#
MG_!7O_DY3P1_V0[PU_ZGOQ+K\JV575D=0RL"K*P#*RL,%6!R"""00000<&O\
M^O%3Q4X(Q'B-QEE7'/@?P+Q%'"YW6P[S_AG,.(_#OBRM!87+)>WQ..R/&YGD
M6/Q:]K)*MC.&XJ2A3]I&HX1:_P!1?!;P3\1L+X3\ 9UX;?20\3.$YXWAW#XI
M<,<999PGXL<#T)O&YQ!8?"9=Q+EV3<2Y;@6Z$9.AE_%TW%SJJE*E&I)2\%\.
M?M,_!?Q)L2/QA;Z-<OC-KXCMKK1O+STWWUS%_9/7(.S47VXRV%*EO;-.U72]
M8MUO-(U*PU2T?&RZTZ\M[ZW;/(VSVTDL39'(PQS7 >(_@O\ "KQ9YC:YX$\/
M3S2Y\R[L[,:1?N22<OJ&D-87K'))!:X.,UXEJ/['_A""Y;4/ WC#QEX'U+_E
ME+:7POK:'&2OEA3IVJ<$Y._6&!  4*<L?@/[*^C7Q+KE_%GBAX78RIMAN*N'
MLG\1^'J<W]G^V>$<5P_Q%3H)MKVE?(<55C32<HUJLG%?I[SKZ7W"&F:<#^#'
MC1E]+XL7P3Q7G_A+Q56IQ^W_ *O\=8+BGA.KB912?LL-Q-@J,ZLFH3H4(J3^
MNZ*^-?\ A!OVL/!//AOXCZ)X_P!/B'RV'B1%&HW!7[N^;5;:69-PX.WQ-&"S
M?/G:KJI_:"^,?@_Y/B7\#-4$$>1<ZQX6>ZET^';G)#*NNZ<^X E5;780P#,K
M,H.#_B7S-\X][P\\0O"CQ*C/6C@LDXVP/#O$=2_PP_U6X^I\(YI*N]%[#"XK
M'3YVJ4'6J/E#_B:C(L@7)XK>%?C?X02IZ8C,>(_#K,N+.$J36DJG^NGA?5X[
MR6.&CJ_K.,P66T_9QE6J+#T8N3^R:*^9_#O[6GP;UPI%>ZKJGA>Y<A?(\0:3
M<(@DZ,IN]*.J642J0?WES/;KC&=KG97NVA>+O"OBB(3>&_$FAZ['MW$Z3JME
M?L@P"1*EM/))$RY =)51T/RNJL"*_.N*O"_Q'X'<UQAP)Q;PY3INTL3FF09E
M1P&]KQS2EAL9E,XMV491S7EDVE%R;L?K'!/C-X2>),:;X"\3.!N+*M5<T<'D
MO$^48C-%IS-3R:OB\OSRG)*[E">2<T$FYJ"5S^LC_@F[_P F7?!G_NHG_JU_
M'5?<5?#O_!-W_DR[X,_]U$_]6OXZK[BK_3+PW_Y-YP)_V1_#?_JHPA_D'XM?
M\G3\2?\ LO.+?_5[C@HHHK[0_/@HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *_*S_@KW_P FU^"/^RX^&O\ U OB77ZIU^5G_!7O
M_DVOP1_V7'PU_P"H%\2Z_,?&C_DU''W_ &3N(_\ 4W)S]B^C[_R>WPQ_[*O"
M_P#JOSX_G*HHHK_*T_VF"BBB@ HHHH *^,_VY/\ DDWA[_LHFD_^HUXMK[,K
MXS_;D_Y)-X>_[*)I/_J->+:^MX#_ .2RX;_[&E/_ -,8X_FGZ9'_ "BQX\?]
MF^Q__JXX1/RKHHHK^PS_ )=0HHHH **** "OZU/^#6__ )OF_P"[9?\ WX.O
MY*Z_K4_X-;_^;YO^[9?_ 'X.OK.!_P#DJ,L_[G/_ %!Q)^C>$W_)?Y#_ -U/
M_P!5../ZU****_H0_M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KPWX__ /(FZ9_V,UG_ .FK6:]RKPWX_P#_ ")NF?\ 8S6?_IJUF@#TSP5_
MR)OA+_L6=!_]-5I735S/@K_D3?"7_8LZ#_Z:K2NFH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K^'>O[B*_AWK^+_ *7G_- ?]W/_ .\(_P!!
M/H*?\W/_ .[._P#?D"BBBOXO/]! HHHH **** "O[B*_AWK^XBO[0^B'_P U
M_P#]VQ_[W3_/OZ=?_-L/^[Q_]]L****_M _S["BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH _G*_X*]_\G*>"/\ LAWAK_U/
M?B77Y65^J?\ P5[_ .3E/!'_ &0[PU_ZGOQ+K\K*_P K?&C_ ).OQ]_V46(_
M]0LG/]I_H^_\F2\,?^R4PO\ ZL,^"BBBOS$_80HHHH XWQ%\._ GBT.?$GA#
MP]K,K@@W5[I5I)?+G.3'?B);V)CGEHIT;WKPG7?V0?A5J$INM!?Q'X.O48R6
M\NC:O)<P12G/S&+5TU"X"C)(2VO;4J<!75 4/U117Z+PKXN^*/!$84^%/$'B
M[),-!<JP&&SS'5\J=.UG2ED^95,VRB5&4;PE2_LRG3<)2CR)2E?\GXV\"/!?
MQ'E4J\;^%G G$6,JRYY9IB^&\MPV=JI?F5:&?931R//85XS2G&O_ &Q5K1J1
MA/VC<(I<O\-OB%-\"?"6E>"D_P""W/Q&^ GB#PW'JTA^"6I?!;]I/QGH?@^X
MU:]U#4+&T&K^%;;Q=X)O+37].O[+Q3)+I%K<+IU[KMP)M/36K2Z+=U'^WK\=
M?#C6J^%O^"[/@#5X[=S=!O%W[,'[0MU)]J63>D,JZK^RCXQ^W6;;5WQ7<C0!
M2\7V)XR0_P"*O[5W_)?O'O\ W*W_ *A?AROG>O[]X9^D#QSB.&\@JXW \&8^
MO5R7+)UZ^)X/R2$J]6>"I.I5G2P.&R[#4Y5)RE.4,/A\/1C*<E3HTX-07_-?
MXS9C#A'Q?\4^%\@H9A@,IX<\1>,\CRNG'C#CRO7I9?E7$6/P6#A5Q.-XIS"O
M7J0P^'I0G6K5:M2HX*4YSE[S_HO'_!6O]M_P_#&I_P""JW[(WCEYYV=G/[-_
MQLM)K.-%C AD"_L%^#X&@F.XJ8ENKD-YF^6)/)%.?_@O5^V]X>6Y=?CI^R)X
M[+W"011)\&_C?9M#''Y^Z\MC)X*\&H;>?$8=+R66Z&8/+M8?])(_G.HKW/\
MB.V?R_C<)>'E;O\ \8S4H7UO_P PN<4+;):6V\W?\U_UYXIA_N^?9]A]-/\
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M=N]_N/[C-/\ ^#D/]DK^SAK/B#X!?M6:5HUS*EOIFK:?X3^&FJ:=?W :Z6>
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M?PYMP+BDO^?N2<1X2;U7VL/FV(IQT3O:#UEII%7P=(_X*>_\$]M;3?9_M@_
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M:\6U]<6VN:+>A39ZQI=V&<1*;;4+2<-(2 (U,4SY<EE 09;+#CD5\C_MR?\
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MK6:]RKPWX_\ _(FZ9_V,UG_Z:M9H ],\%?\ (F^$O^Q9T'_TU6E=-7,^"O\
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MG^C[_P F2\,?^R4PO_JPSX****_,3]A"BBB@ HHHH _&?]J[_DOWCW_N5O\
MU"_#E?.]?1'[5W_)?O'O_<K?^H7X<KYWK^TN%O\ DF.'?^Q'E7_J#1/^4/Z1
M7_*0'CC_ -G<\1?_ %K<U"BBBO>/QL**** "BBB@#_0^_P""%_\ RBP_9<_[
MK;_ZT7\7*_6JOR5_X(7_ /*+#]ES_NMO_K1?Q<K]:J_IK(?^1'DW_8KP'_J+
M2/[UX/\ ^22X8_[)_)__ %7X<****]8^C"BBB@ HHHH **** "BBB@ HHHH
M**** "ORL_X*]_\ )M?@C_LN/AK_ -0+XEU^J=?E9_P5[_Y-K\$?]EQ\-?\
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MXA_]#C@__P +\W_^<A_47_$[/A9_T(>//_#9D7_T1'\O]%?U ?\ #K_]D/\
MZ$[Q-_X77B7_ .3:/^'7_P"R'_T)WB;_ ,+KQ+_\FT?\2I>(?_0XX/\ _"_-
M_P#YR!_Q.SX6?]"'CS_PV9%_]$1_+_17]0'_  Z__9#_ .A.\3?^%UXE_P#D
MVC_AU_\ LA_]"=XF_P#"Z\2__)M'_$J7B'_T..#_ /POS?\ ^<@?\3L^%G_0
MAX\_\-F1?_1$?R_U_._7^E!_PZ__ &0_^A.\3?\ A=>)?_DVOG?_ (<(_P#!
M,7_HB/B;_P /%\6?_FPK]+\._ 3B_A+^U_[1S'AVM]?^H^Q^I8O,:G+]6^M^
MT]I[;+*%K^WAR<O->TK\ME?^!?IQ<999]);_ (AG_J+0QV5?ZF?ZW_VI_K53
MH8+V_P#;_P#JY]3^H_V7B,W]I[/^R,3]9]O]7Y.>A[/VO-/V?^?/17^@Q_PX
M1_X)B_\ 1$?$W_AXOBS_ /-A1_PX1_X)B_\ 1$?$W_AXOBS_ /-A7Z7_ ,0V
MSS_H*RO_ ,'8K_YD/X%_X@5Q;_T,.'__  JS#_YVG^?/17^@Q_PX1_X)B_\
M1$?$W_AXOBS_ /-A1_PX1_X)B_\ 1$?$W_AXOBS_ /-A1_Q#;//^@K*__!V*
M_P#F0/\ B!7%O_0PX?\ _"K,/_G:?Y\]%?Z#'_#A'_@F+_T1'Q-_X>+XL_\
MS84?\.$?^"8O_1$?$W_AXOBS_P#-A1_Q#;//^@K*_P#P=BO_ )D#_B!7%O\
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M=5_Z'7Q-_P" G@W_ .9*C^P=5_Z'7Q-_X">#?_F2H Z:BN9_L'5?^AU\3?\
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M9D7_ -$1_+_17]0'_#K_ /9#_P"A.\3?^%UXE_\ DVC_ (=?_LA_]"=XF_\
M"Z\2_P#R;1_Q*EXA_P#0XX/_ /"_-_\ YR!_Q.SX6?\ 0AX\_P##9D7_ -$1
M_+_17]0'_#K_ /9#_P"A.\3?^%UXE_\ DVC_ (=?_LA_]"=XF_\ "Z\2_P#R
M;1_Q*EXA_P#0XX/_ /"_-_\ YR!_Q.SX6?\ 0AX\_P##9D7_ -$1_GS_ +5W
M_)?O'O\ W*W_ *A?AROG>O\ 0Z\6?\$/?^"<GCCQ!?\ BCQ1\(/$VJ:[JGV7
M[=??\+8^)EEY_P!BLK;3K7_1=.\3VEG%Y5G:6\/[FWCW^7YDF^5W=N=_X<(_
M\$Q?^B(^)O\ P\7Q9_\ FPK^@\E\*>(<NR?*LOKXS)Y5L#EV"P=65*OC)4I5
M<-AZ=&<J;E@H2<'*#<7*$9.-FXIZ'^)/BMX:9[QUXH>(W&N4XO*L/E7%_'7%
M?$^6X?,*^*I8^A@,]SS&YGA*6-I8?!XFA3Q=.AB80Q$*.(KTH55.-.M5@E-_
MY\]%?Z#'_#A'_@F+_P!$1\3?^'B^+/\ \V%'_#A'_@F+_P!$1\3?^'B^+/\
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MJ*YG^P=5_P"AU\3?^ G@W_YDJ/[!U7_H=?$W_@)X-_\ F2H Z:BN9_L'5?\
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M ,+KQ+_\FT?\.O\ ]D/_ *$[Q-_X77B7_P"3:/\ B5+Q#_Z''!__ (7YO_\
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M)_@Q/J-GXD^+FF+H.EZQ\6=%O;SP7HFN7UV^EZY+IGA>]FT/X1_'GX0GX?\
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M;)-/N;K5(-6^$_PNM/".B:!IUCI6A^#/"VAPZKI>DZ#;1VF]+V*\U'6?H^@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5X;\?_\ D3=,_P"QFL__
M $U:S7N5>&_'_P#Y$W3/^QFL_P#TU:S0!Z9X*_Y$WPE_V+.@_P#IJM*Z:N9\
M%?\ (F^$O^Q9T'_TU6E=-0 4444 %%%% !1110 4444 %%%% !1110 4444
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M7[P44 ?EEX"7]F%?B[^S4O[$O_"M#XD7Q!X@7X^'X2MICZP?@Z/ASX^&H?\
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M:;^T]KLOPOB36/C[<Z7=S?'=OAV?C#%K7[.>I>"'2+X0)X^.A:9\?5\':?\
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M2![BVF$:@;] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5X;\?_ /D3=,_[&:S_ /35
MK->Y5X;\?_\ D3=,_P"QFL__ $U:S0!U?A'Q=X4M?"GABVN?$_AZWN;?P]HL
M%Q;SZUIL,\$\6FVT<L,T4ERLD4L4BLDD;JKHZE6 8$5T/_":^#?^AM\,_P#@
M^TK_ .2Z** #_A-?!O\ T-OAG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNBB@
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M@ _X37P;_P!#;X9_\'VE?_)='_":^#?^AM\,_P#@^TK_ .2Z** #_A-?!O\
MT-OAG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNBB@ _P"$U\&_]#;X9_\ !]I7
M_P ET?\ ":^#?^AM\,_^#[2O_DNBB@ _X37P;_T-OAG_ ,'VE?\ R71_PFO@
MW_H;?#/_ (/M*_\ DNBB@ _X37P;_P!#;X9_\'VE?_)='_":^#?^AM\,_P#@
M^TK_ .2Z** #_A-?!O\ T-OAG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNBB@
M_P"$U\&_]#;X9_\ !]I7_P ET?\ ":^#?^AM\,_^#[2O_DNBB@ _X37P;_T-
MOAG_ ,'VE?\ R71_PFO@W_H;?#/_ (/M*_\ DNBB@ _X37P;_P!#;X9_\'VE
M?_)='_":^#?^AM\,_P#@^TK_ .2Z** #_A-?!O\ T-OAG_P?:5_\ET?\)KX-
M_P"AM\,_^#[2O_DNBB@ _P"$U\&_]#;X9_\ !]I7_P ET?\ ":^#?^AM\,_^
M#[2O_DNBB@ _X37P;_T-OAG_ ,'VE?\ R71_PFO@W_H;?#/_ (/M*_\ DNBB
M@ _X37P;_P!#;X9_\'VE?_)='_":^#?^AM\,_P#@^TK_ .2Z** #_A-?!O\
MT-OAG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNBB@ _P"$U\&_]#;X9_\ !]I7
M_P ET?\ ":^#?^AM\,_^#[2O_DNBB@ _X37P;_T-OAG_ ,'VE?\ R71_PFO@
MW_H;?#/_ (/M*_\ DNBB@ _X37P;_P!#;X9_\'VE?_)='_":^#?^AM\,_P#@
M^TK_ .2Z** #_A-?!O\ T-OAG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNBB@
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M@ _X37P;_P!#;X9_\'VE?_)='_":^#?^AM\,_P#@^TK_ .2Z** #_A-?!O\
MT-OAG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNBB@ _P"$U\&_]#;X9_\ !]I7
M_P ET?\ ":^#?^AM\,_^#[2O_DNBB@ _X37P;_T-OAG_ ,'VE?\ R71_PFO@
MW_H;?#/_ (/M*_\ DNBB@ _X37P;_P!#;X9_\'VE?_)='_":^#?^AM\,_P#@
M^TK_ .2Z** #_A-?!O\ T-OAG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNBB@
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M@ _X37P;_P!#;X9_\'VE?_)='_":^#?^AM\,_P#@^TK_ .2Z** #_A-?!O\
MT-OAG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNBB@ _P"$U\&_]#;X9_\ !]I7
M_P ET?\ ":^#?^AM\,_^#[2O_DNBB@ _X37P;_T-OAG_ ,'VE?\ R71_PFO@
MW_H;?#/_ (/M*_\ DNBB@ _X37P;_P!#;X9_\'VE?_)='_":^#?^AM\,_P#@
M^TK_ .2Z** #_A-?!O\ T-OAG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNBB@
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M@ _X37P;_P!#;X9_\'VE?_)='_":^#?^AM\,_P#@^TK_ .2Z** #_A-?!O\
MT-OAG_P?:5_\ET?\)KX-_P"AM\,_^#[2O_DNBB@ _P"$U\&_]#;X9_\ !]I7
M_P ET?\ ":^#?^AM\,_^#[2O_DNBB@ _X37P;_T-OAG_ ,'VE?\ R71_PFO@
MW_H;?#/_ (/M*_\ DNBB@ _X37P;_P!#;X9_\'VE?_)=>.?&_P 0:#J_A33[
M;2=;TC5+E/$-I.]OIVI65[.D"Z;JT;3/%;32R+$LDL:-(5"!Y$4D,Z@E% '_
!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
